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The endometrium is the inner lining of the uterine cavity, composed of distinct 
epithelial and stromal cell compartments with the latter containing fibroblasts, a 
vascular compartment and fluctuating populations of immune cells. The endometrium 
is a highly dynamic tissue that undergoes cycles of proliferation and stromal cell 
differentiation (decidualisation) followed by tissue shedding (menstruation) and rapid 
repair/remodelling, all under control of fluctuating concentrations of steroid hormones 
secreted from the ovaries. This is known as the menstrual cycle.  
In response to the ‘injury’ inflicted as a consequence of decidual breakdown and 
shedding, the endometrium exhibits a unique capacity to restore tissue architecture by 
rapid tissue repair. This repair process is tightly regulated to ensure that the 
endometrium heals consistently every month throughout a woman’s reproductive 
lifespan, without the accumulation of fibrotic scar tissue which could have a negative 
impact on fertility. 
The initiation of menstruation is triggered by the withdrawal of progesterone as a 
consequence of the demise of the corpus luteum within the ovaries which precipitates 
an increase in production of inflammatory mediators, focal hypoxia and activation of 
matrix metalloproteinase enzymes culminating in endometrial shedding. In contrast 
the cellular and molecular mechanisms responsible for the rapid and scar-free tissue 
repair of endometrium remain poorly understood. Parallels can be drawn between the 
repair process of the endometrium and that of the foetal skin and oral mucosa which 
also exhibit ‘scarless’ healing, including rapid reepithelialisation, widespread cellular 
proliferation and migration and a short time to wound closure. However endometrial 
repair also shares key features of the wound healing experienced by adult tissues that 
exhibit scarring including extensive angiogenesis and a substantial inflammatory 
response. The endometrium appears to be unique, fitting in a gap between tissues that 
typically undergo ‘scarless’ or ‘scarring’ tissue repair. 
In women, endometrial shedding is considered an inflammatory event and the 
culmination of a cascade of inflammatory signals result in the accumulation of a 
diverse population of immune cells within the tissue. Whilst we believe immune cells 
play a key role in regulating spatial and temporal tissue breakdown and shedding their 
 
 
role in repair and restoration of tissue homeostasis remains poorly understood. One 
process essential for endometrial repair is restoration of the luminal epithelial cell layer 
(re-epithelialisation) and imaging studies have demonstrated that this appears not only 
to be rapid but also to occur synchronously with tissue degeneration and shedding. 
Re-epithelialisation was previously thought to be governed by proliferation and 
migration of glandular epithelial cells in the basal (unshed) tissue compartment, 
however new data suggest a role for trans-differentiation of stromal cells into epithelial 
cells which merits further investigation. In addition to role(s) for immune and stromal 
cells in regulation of endometrial tissue function, a role for somatic stem/progenitor 
cells capable of differentiating into mature endometrial cells to regenerate the tissue 
has also been claimed.  
In summary, whilst progress has been made in understanding the processes governing 
endometrial decidualisation, breakdown and shedding the regulation and roles of the 
different cell types that participate in scar-free repair of the tissue remain poorly 
defined. The studies in this thesis set out to address this gap by addressing three key 
aims:  
Aim 1. To investigate the phenotype and location of immune cell populations during 
scarless tissue repair. 
Aim 2. To identify and characterise a putative population of mesenchymal 
stem/progenitor cells in endometrium. 
Aim 3. To investigate the contribution of putative mesenchymal stem/progenitor cells 
to endometrial tissue repair. 
The aims were addressed using a recently refined and extensively characterised mouse 
model in which endometrial shedding (‘menstruation’) and repair occurs over a 48 
hour period following removal of a progesterone stimulus.  Importantly the Saunders’ 
group have already demonstrated that this model recapitulates the key features of 
human menses including overt vaginal bleeding, immune cell influx, tissue necrosis, 
transient hypoxia, re-epithelialisation and most importantly simultaneous breakdown 
and repair. Uterine tissues recovered 12, 24, and 48hrs after removal of progesterone 
and were investigated using immunohistochemistry (spatial organisation), flow 
cytometry (quantitation of cell subpopulations), FACS sorting (isolation of 
 
 
subpopulations) and molecular profiling (qPCR, RNAseq and single cell sequencing) 
with additional insights from bioinformatic analysis. 
To address Aim 1 endometrial shedding and repair was studied in Macgreen® mice: 
in this transgenic line all the cells of the mononuclear phagocyte lineage (monocytes, 
monocyte-derived macrophages) express green fluorescent protein. 
Immunohistochemistry revealed striking spatio-temporal changes in both numbers and 
location of GFP+ cells during endometrial breakdown and repair, the most prominent 
changes occurring 24hrs after removal of progesterone. Flow Cytometry quantified 
several immune cell populations with a significant increase in GFP+ cells during 
repair, the majority of which were GR1+F4/80- (inflammatory monocytes). These 
novel data provided compelling evidence to support a role for inflammatory 
monocytes in endometrial repair and provide the platform for future studies on the role 
of these cells in scarless healing. 
To address Aims 2 and 3 Pdgfrβ-BAC-eGFP® transgenic mice in which GFP was 
expressed under control of promoter elements of the Pdgfrβ gene was used to identify 
putative mesenchymal progenitor cells and investigate their role in endometrial repair. 
GFP+ cells were located exclusively within the endometrial stromal compartment and 
examination of tissue sections revealed that two subpopulations could be distinguished 
based on the both the intensity of GFP and expression of CD146 (Mcam). 
Characterisation by immunohistochemistry, flow cytometry and qPCR identified a 
GFPbright subpopulation located adjacent to CD31+ endothelial cells that were 
classified as pericytes based on location and phenotype (NG2+, CD146+, CD31-). 
When menstruation was stimulated in Pdgfrβ-BAC-eGFP® mice detailed analysis 
using flow cytometry revealed an increase in the perivascular pericyte subpopulation 
during active healing (24hrs) and also identified a new previously unidentified sub-
population of GFP+ cells which had a unique phenotype during repair. Evidence that 
GFP+ cells contribute to restoration of epithelial repair was obtained with an increase 
in expression of the epithelial cell marker EpCAM and GFP+ cells in the renewed 
epithelial cell layer. RNAseq and single cell sequencing combined with bioinformatics 
complemented these findings by identifying novel changes in gene expression in both 
endometrial fibroblasts and pericyte populations consistent with induction of novel 
 
 
pathways and trans-differentiation of stromal cells by a mesenchymal-to-epithelial 
transition (MET).  
In conclusion, using a mouse model of endometrial breakdown and repair a 
heterogeneous population of myeloid cells and a putative population of endometrial 
progenitors (pericytes) have been characterised, quantified and novel changes in gene 
expression identified. Adaptation of these cell types to the insult of endometrial 
shedding appears to play a key role in temporal and spatial regulation of rapid, scar-
free endometrial tissue repair. These novel findings may inform the development of 
new approaches to treating gynaecological disorders associated with aberrant 
endometrial repair such as heavy menstrual bleeding, Asherman’s syndrome and 





















The endometrium is a complex multicellular tissue that forms the inner lining of the 
womb (uterus).  During each menstrual cycle the endometrium changes in preparation 
for a the arrival of a new embryo however if a woman does not get pregnant this tissue 
is no longer required so it breaks down and is shed from the uterus at menstruation an 
event experienced by the woman as her ‘period’. Thus ‘periods’ are the result of 
endometrial tissue loss resulting in a bloody ‘wound’ inflicted on the luminal layer of 
endometrium not dissimilar to wounds found elsewhere in the body following serious 
injury. However unlike other tissues such as the skin, that respond to a wound by 
developing a scar, the endometrium has an amazing ability to completely and rapidly 
repair over just a few without the accumulation of any scar tissue. This is incredible 
and unparalleled scarless healing process may happen ~400 times during a woman’s 
reproductive life and is of course absolutely essential to the continued reproductive 
success of the uterus… and our species! 
Although the hormonal regulation of the menstrual cycle has been the focus of many 
scientific studies, the precise factors that ensure scarless healing of the endometrium 
are not well understood. In the current study, the contribution that two types of cells 
play in endometrial tissue repair were investigated – these were immune cells and a 
putative population of endometrial progenitor (stem) cells called pericytes. We 
selected these two cell types because immune cells are claimed to be instrumental in 
clearing up debris in other injured tissues and their numbers have been reported to 
increase during menstruation. Stem cells are specialised cells that can transform into 
any other cell types; tissue resident stem/progenitors may provide a tissue with a 
reservoir from which it can replenish lost cells. Stem cells have been identified in the 
endometrium although their identity has also been questioned and their contribution to 
scarless repair remains the subject of debate.  
In the lab we artificially induced menstruation (periods) in mice that were genetically 
modified so that immune cells and stem cells were labelled for ease of identification. 
In the mice we documented dynamic, time dependent changes in the populations of 
immune cells during scarless healing with a striking influx in one particular population 
known as monocytes during active healing. A population of putative endometrial stem 
 
 
cells was identified close to the blood vessels and not only did we unexpectedly find 
an increase in their numbers during repair but also evidence to show that these cells 
have the ability to transform into difference types of cells to help replenish the lost 
tissue and return the endometrium to its normal state.  
In summary novel findings obtained during these studies revealed that both immune 
cells and stem cells have fundamental roles to play in scarless endometrial healing. We 
are excited by these results because we believe this new knowledge can open the door 
to developing new treatments for gynaecological conditions where repair does not 
work properly and fertility is compromised, but also for other tissues of the body where 
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Chapter 1 Introduction 
The human endometrium, located in the central portion of the uterus, is a complex 
multicellular tissue that undergoes repeated cycles of proliferation, degeneration and 
shedding during each menstrual cycle. The endometrium is unusual amongst adult 
tissue in that it exhibits an unparalleled capacity for rapid scar-free repair. The studies 
in this thesis have used the Edinburgh mouse model of simulated ‘menses’ as a 
physiological tissue system in which to study the mechanisms contributing to scarless 
tissue repair. In the following literature review the wound healing response and its 
possible progression to fibrosis as exhibited by most adult tissues will be discussed to 
place the studies on endometrium in the context of wound healing. A more detailed 
assessment of the structure and function of the endometrium, the physiological 
changes that take place during menstruation and the animal models used to study 
menstrual physiology will be used to highlight what is known in the field and reveal 
gaps in the current knowledge.  
1.1 Wound healing  
1.1.1 Wound healing and tissue repair 
Wound healing is an essential physiological process that maintains tissue homeostasis 
in response to injury, and when impaired, predisposes to various pathologies (Shaw 
and Martin 2009). Wound healing is a tightly regulated process involving a range of 
cell types that work together to coordinate the overlapping phases of wound healing: 
coagulation, inflammation, tissue replacement and resolution (Bodnar et al. 2016, Sorg 
et al. 2017). Cellular and molecular mechanisms associated with wound healing in the 
skin are outlined in Figure 1-1. Briefly, following an injury, inflammatory cells are 
recruited to phagocytose cellular debris and stimulate the proliferation and migration 
of fibroblasts into the wound bed to synthesis extracellular matrix (ECM) components 
(Gurevich et al. 2018, Cash and Martin 2016). Rapid cellular proliferation and 
migration occurs resulting in reformation of the epithelium and new blood vessels 
(Shaw and Martin 2016). Fibroblasts differentiate into contractile myofibroblasts to 
contract the edges of the wound and lay down collagens which then form scar tissue. 
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Resolution involves apoptosis of myofibroblasts and cessation of the inflammatory 
response (Tomasek et al. 2002, Hinz 2007). Despite relatively rapid wound closure, 
remodelling of the scar tissue occurs over the following months to years however in 
severe wounding, correct architecture of the tissue may never be regained. What is 
more, the tensile strength is only 70% that of normal skin and therefore full function 
cannot be regained (Larson, Longaker and Lorenz 2010). Cutaneous wound healing 
therefore is described as a fibroproliferative response resulting in the incomplete 
regeneration of the original tissue (Shaw and Martin 2016, Shinzawa et al. 2007). 
 
 
Figure 1-1. Cellular and molecular mechanisms of the wound healing response in the 
skin, composed of four overlapping phases: coagulation, inflammation, proliferation and 
remodeling. Wound healing in the skin involves a host of effector cells and signalling 
pathways leading to the deposition of granulation tissue which matures into scar tissue and 
takes weeks-months to resolve (based on Shaw and Martin 2009, Diegelmann and Evans 
2004). 
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1.1.2 Mechanisms of normal wound healing with self-limiting fibrosis  
1.1.2.1 Coagulation phase 
The wound healing response has been most well characterised in the skin with a ‘full 
thickness’ wound shown to damage several structures including the epidermal 
keratinocyte layer, the dermal layer including fibroblasts, blood vessels, hair follicles, 
sweat glands and the basement membrane (McNeil and Kirchhausen 2005). Trauma 
to the skin results in ruptured cells and damaged blood vessels which emit both 
chemical and mechanical ‘damage’ signals initiating the wound healing response 
(Shaw and Martin 2009). To stop local haemorrhage, the coagulation cascade is 
triggered whereby blood components enter the site of injury and platelets interact with 
exposed collagen and other elements of the extracellular matrix which causes their 
activation and aggregation (Diegelmann and Evans 2004). Fibrin is formed from 
fibrinogen by the action of the protease thrombin and together with aggregated 
platelets, forms a clot made up of a network of insoluble fibrin fibres (Shaw and Martin 
2009). This clot plugs damaged blood vessels and serves as a provisional matrix upon 
which healing events can take place and endothelial cells, smooth muscle cells, 
fibroblasts, leukocytes, epithelial cells and stem cells can bind and migrate 
(Diegelmann and Evans 2004). The fibrin network of the clot also binds growth factors 
to establish chemotactic gradients which facilitate cell recruitment and constitutes a 
storage pool that can be secondarily released by matrix metalloproteinases (MMPs). 
Often the outcome of wound healing is influenced by the thickness of fibrin fibres, the 
number of branch points and the permeability of the clot at the wound site (Nurden et 
al. 2008).  
Platelet degranulation further affects blood vessels by stimulating vasodilation, 
increasing blood vessel permeability and MMP production influencing the recruitment 
of inflammatory cells to the site of injury (Duffield et al. 2013). Activated platelets 
also secrete a number of cytokines and growth factors including PDGF, CXCL4, 
bFGF, VEGF, RANTES and TGFβ which can influence multiple processes including 
inflammation, angiogenesis and fibroblast migration (Bahou and Gnatenko 2004). In 
particular, PDGF is involved in the chemotaxis of macrophages, neutrophils, 
fibroblasts and smooth muscle cells and stimulates proliferation of fibroblasts and 
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smooth muscle cells while TGFβ stimulates macrophages to release cytokines such as 
FGF, PDGF, TNFα and IL1, enhances fibroblast and smooth muscle cell chemotaxis 
and modulates collagen and collagenase expression (Diegelmann and Evans 2004). 
1.1.2.2 Inflammatory phase 
The inflammatory response begins when immune cells escape the vasculature through 
damaged blood vessels and potentiates in response to increasing levels of cytokines 
and chemokines secreted by damaged tissue. The first cells to be recruited are mostly 
neutrophils and this is followed by influx of monocytes (Eming, Krieg and Davidson 
2007) both of which have important roles in removing dead, damaged or infected tissue 
from the wound (Duffield et al. 2013). Neutrophils become activated and have primary 
roles in killing invading microorganisms and influencing aspects of repair including 
angiogenesis, resolution of the fibrin clot and re-epithelialisation (Theilgaard-Mönch 
et al. 2004). Monocytes can differentiate into macrophages upon extravasation from 
the circulation, initiating distinct gene expression signatures in response to signals 
coming from the tissue microenvironment (Martinez et al. 2006). Macrophages play a 
critical role in restoration of tissue integrity by phagocytosing cellular debris, damaged 
matrix and spent neutrophils. It has been reported that classically activated or ‘M1’ 
pro-inflammatory macrophages are present in early phases of wound healing while 
alternatively activated or ‘M2’ anti-inflammatory macrophages are seen to persist later 
in repair (Deonarine et al. 2007). Increased expression of MMPs by inflammatory cells 
helps to clear tissue debris during early stages of repair (Davis and Saunders 2006). 
Whether inflammatory cells are an essential requirement for effective wound healing 
remains an area of intense research interest although it is clear that immune cells play 
a major role in orchestrating processes such as angiogenesis and fibrogenesis (Martin 
and Leibovich 2005). 
1.1.2.3 Tissue replacement phase 
During the tissue replacement phase of skin wound healing closure of the wound gap 
and reconstitution of lost tissue is achieved. Although this phase begins within hours 
of wounding the time to wound closure depends upon the size and location of wound 
and additional factors including age and the health of the tissue (Shaw and Martin 
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2009). Angiogenesis is essential to a robust wound healing response and involves the 
sprouting of damaged blood vessels into the wound site to deliver nutrients, oxygen 
and growth factors to the site of injury (Shaw and Martin 2009). Re-epithelialisation 
is achieved by the proliferation and migration of keratinocytes in the vicinity of the 
wound. Injured epithelial cells undergo phenotypic changes to acquire a migratory 
phenotype known as an epithelial-to-mesenchymal transition (EMT), governed by 
activation of a gene expression programme including the transcription factor SNAIL 
(Duffield 2014) and driven by TNFα and IL1β in a TGFβ-dependent mechanism (Fan 
et al. 2001). During this transition, keratinocytes decrease cell-cell and cell-matrix 
adhesions to allow ‘crawling’ over the provisional collagen and fibronectin rich clot 
and increase expression of MMPs in order to create a pathway at the interface between 
the scab and viable tissue (Ilina and Friedl 2009). Injured or activated epithelial cells 
are a potent source of TGFβ and PDGFs which both believed to be important in 
activating fibroblasts and pericytes during tissue repair (Chen et al. 2011, Liu et al. 
2011). Stem cells that reside in the epidermis and region of hair follicles also respond 
to injury by committing to an epidermal phenotype and migrating to participate in 
repair (Ito et al. 2005). Epithelial stem cells in the hair follicle bulge region respond to 
wounding by generating transient amplifying cells that also partake in re-
epithelialisation (Ito et al. 2005).  
Alongside healing of the epidermis, the damaged dermis must be reconstituted. The 
fibrin clot formed during the immediate response is replaced by granulation tissue 
which is a temporary structure laid down by stromal fibroblasts originating from 
various sources: healthy dermal fibroblasts at the wound edge, circulating fibrocytes, 
bone marrow derived progenitor cells, multipotent dermal progenitor cells and 
perivascular pericytes (Hinz 2007, Fernandes et al. 2004, Rajkumar et al. 2006). In 
addition the mechanical stress in the wound and immune cell secretion of PDGF, 
TGFβ1 and IL13 stimulates mesenchymal cells such as fibroblasts and pericytes to 
differentiate into myofibroblasts (Wynn and Barron 2010). Myofibroblasts express 
alpha smooth muscle actin (αSMA)  and form stress bundles which have contractility 
properties promoting connective tissue contraction and closure of the wound edge 
(Hinz et al. 2012). αSMA is also expressed by vascular smooth muscle cells although 
their contractions are reversible and short-lived whereas myofibroblasts generate 
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irreversible and long-lived contractions (Castella et al. 2010). Myofibroblasts also 
secrete factors that are both mitogenic and chemotactic for epithelial and endothelial 
cells to stimulate the formation of new ECM, epithelium and blood vessels (Duffield 
et al. 2013). Fibroblasts and myofibroblasts instigate wound closure and contribute to 
the synthesis, bundling and alignment of collagen fibres which when not aligned 
correctly is the main constituent of scar tissue (Bodnar et al. 2016). 
Pericytes residing in close proximity to blood vessels are reported to have various roles 
in wound healing (Crocker, Murad and Geer 1970, Mills, Cowin and Kaur 2013, 
Murray et al. 2014). For example, during wound healing, pericytes interact with 
platelets, endothelial cells and inflammatory cells to instigate new vessel growth 
(Thomas 1999). Pericytes also secrete various cytokines to influence immune cell 
infiltration and may act as precursors for myofibroblast transition through 
PDGF-dependent mechanism (Bodnar et al. 2016). In vitro pericytes have been shown 
to migrate towards proteolytic digests of ECM, consistent with the important property 
of progenitors to migrate to the site of injured tissue for reconstruction (Crisan et al. 
2009). 
1.1.2.4 Resolution phase 
The resolution of wound healing returns cutaneous tissue to pre-injured appearance 
and full functionality through various changes including refinement and maturation of 
blood vessel network within the scar (Adams and Alitalo 2007), remodelling of the 
deposited ECM to correctly align collagen bundles and myofibroblast apoptosis (Hinz 
2007, Ulrich et al. 2007). Myofibroblast activation is a normal response to injury and 
normal wound healing (Hinz et al. 2012) however during the resolution phase 
myofibroblasts undergo apoptosis and are cleared by immune cells to avoid excessive 
ECM deposition. The mechanisms responsible for apoptosis in these cells remain 
unknown but a greater understanding of their regulation may help our understanding 
of fibrosis (Desmoulière et al. 1995). The inflammatory response resolves upon 
completion of wound healing through neutrophil apoptosis and clearance by 
macrophages, or emigration through lymphatics (Eming et al. 2007). 
Anti-inflammatory cytokines such as resolvin E and annexin I further de-activate 
immune cells (Shaw and Martin 2009). Wound healing is imperfect with many tissues 
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not regaining full function or architecture that recapitulates the pre-injured state 
(Larson et al. 2010). 
1.1.2.5 Hormonal regulation of wound healing 
Observational studies in elderly men and women have identified endogenous 
oestrogens and androgens (testosterone; T, dihydrotestosterone; DHT) as being 
respectively enhancers and inhibitors of repair (Gilliver et al. 2009).  
Age exacerbates androgen effects in male keratinocytes which may explain why older 
males experience wound healing difficulties (Fimmel et al. 2007). These studies have 
been complemented by studies in rodents in which hormone levels have been 
manipulated. Acute reductions in androgens (T or DHT) has been linked to reduction 
in leucocytosis and pro-inflammatory signalling molecules including IL-6, TNFα and 
MMPs. (Gilliver et al. 2009, Gilliver et al. 2006, Ashcroft and Mills 2002). In the 
absence of androgens (castration of male mice), inflammatory function of 
macrophages and fibroblasts are dysregulated with concomitant decreases in IL-1 and 
IL-6 associated with accelerated wound healing (Nitsch et al. 2004). The use of 
transgenic mice with targeted deletion of Ar in myeloid cells induced by cross-
breeding Arflx mice with those carrying a LysMCre (Clausen et al. 1999) has revealed 
evidence for a role for androgen-dependent signalling in modulating macrophage 
function (Lai et al. 2009). In the MARKO mice healing was accelerated, a result not 
recapitulated by Ar ablation in other cell types (keratinocyte, fibroblast).  In contrast 
stimulation of macrophage AR increased the inflammatory response and TNFα 
expression and topical application of a compound that degrades AR resulted in 
accelerated healing highlighting a potential novel treatment strategy (Lai et al. 2009). 
Androgen effects are most pronounced during the early stages of wound healing. 
Androgens can affect the rate of re-epithelialisation by increasing β-catenin 
expression, but do not affect proliferation of dermal fibroblasts (Ashcroft and Mills 
2002). Androgens also inhibit the expression of MMP1, 3 and 7 (Schneikert et al. 
1996).  
Topical administration of oestrogen to cutaneous wounds in elderly patients can 
accelerate wound healing and increase wound strength (Ashcroft et al. 1999). 
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Oestrogens can alter the inflammatory response, inhibiting chemotaxis of 
polymorphonuclear leucocytes to reduce the number present in the wound (Ito et al. 
1995). In particular the neutrophil population is affected with an associated decreased 
in elastase resulting in reduced degradation of fibronectin and increased collagen 
deposition. Oestrogens also decrease expression of macrophage migration inhibitory 
factor (MIF) (Ashcroft et al. 2003): MIF represses the actions of anti-inflammatory 
cytokines such as IL-6, IL-1β and Il-8 thereby affecting signalling cascades associated 
with wound repair (Calandra and Bucala 1995, Hardman et al. 2005). Oestrogens have 
been found to increase the expression of ECM components including procollagen 1, 
fibrillin 1 and tropoelastin while decreasing MMP1 expression and thereby affecting 
ECM remodelling (Son et al. 2005). Oestrogens also increase GM-CSF secretion by 
keratinocytes which in turn increases keratinocyte proliferation and migration whilst 
also stimulating endothelial and inflammatory cells, accelerating the repair response 
(Mann et al. 2001). Oestrogen classically binds to one of two receptors: ERα and ERβ, 
both of which have been found to have differing roles in wound healing. ERα 
expressed by endothelial cells has been shown to have a role in enhancing angiogenesis 
(Arnal et al. 2010) and mediating the activity of VEGF (Ashcroft et al. 1999). 
Oestrogen action via ERβ promotes cutaneous wound healing in mice irrespective of 
effects on inflammation, while the anti-inflammatory effects of oestrogens are 
believed to involve both receptor subtypes (Campbell et al. 2010). Finally activation 
of ERα or ERβ in human keratinocytes enhanced migration and proliferative capacity 
in vitro; ERβ signalling did not increase the expression of TGFβ1 making it a potential 
target to enhance wound healing without side effects of stimulating a fibrotic response 
(Merlo et al. 2009).  
1.1.3 Mechanisms of chronic wound healing and the progression of 
fibrosis 
When an injury is repeated, the wound healing response may be dysregulated resulting 
in hyperproliferation, persistence of myofibroblasts and prolonged inflammation with 
fibrosis and excessive scar formation (Wynn 2008, Fan et al. 2008, Duffield et al. 
2013). Fibrosis encompasses various morphological changes in the affected tissue 
including loss of cellular homeostasis and tissue architecture, ECM deposition and 
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dysregulated cellular phenotypes. Scar tissue can distort normal tissue architecture and 
inhibits efficient tissue function. Despite differences in the presentation of fibrosis in 
different tissues, common mechanisms include sustained secretion of proteolytic 
enzymes, growth factors, fibrogenic cytokines and angiogeneic factors all of which 
stimulate excess ECM deposition (Duffield et al. 2013).  
Myofibroblasts have been identified as key players in pathogenic fibrosis due to their 
production of ECM proteins and proteoglycans, making them the focus of various 
studies investigating their origins, activation, deactivation and apoptosis (Duffield et 
al. 2013). During fibrosis, myofibroblasts accumulate and produce collagen, 
EDA-containing fibronectin, various soluble mediators and reactive oxygen species 
(ROS). They also secrete a variety of lipid mediators, cytokines and chemokines 
thereby potentiating the inflammatory response (Phan et al. 1999). In normal wound 
healing myofibroblasts arise from fibroblasts through fibroblast-to-myofibroblast 
transition (FMT) and are essential for wound closure (Leavitt et al. 2016) however 
persistence of myofibroblasts at a site of injury associated with resistance to apoptosis 
results in the continued formation of scar tissue and progression of fibrosis (Hantash 
et al. 2008, Haldar et al. 2016, Greenhalgh, Iredale and Henderson 2013). The 
mechanisms underlying development of an apoptosis-resistant phenotype remain 
unknown (Thannickal and Horowitz 2006). As pericytes have been identified as 
precursors for fibrotic myofibroblasts, with the first conclusive evidence being 
generated in the kidney using lineage tracing methods (Humphreys et al. 2010), 
pericytes have also been implicated in pathological fibrosis. Pericyte-derived 
myofibroblasts have been identified in kidney fibrosis as collagen-producing cells 
(Ballhause, Soldati and Mertens 2014, Duffield 2014, LeBleu et al. 2013) and in 
dermal fibrosis where the majority of collagen producing cells were generated from a 
pericyte subpopulation (Dulauroy et al. 2012). Notably, treatment of cutaneous 
wounds with a PDGFRβ inhibitor (imatinib mesylate) delays wound healing causing 
a reduction in proliferation and differentiation of fibroblasts and pericytes thereby 
reducing numbers of myofibroblasts (Rajkumar et al. 2006). 
Macrophages have also been identified as key players in the progression and 
persistence of fibrosis through both direct effects on ECM remodelling and indirect 
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effects by regulating myofibroblast activity and endothelial cells (Lupher and Gallatin 
2006, Anders and Ryu). Fibrocytes are a distinct subset of collagen-producing cells 
derived from peripheral blood monocytes that enter tissues following injury and 
promote angiogenesis and tissue repair but are also key players in scar formation and 
chronic inflammation observed during fibrosis (Herzog and Bucala 2010). In the 
setting of fibrosis, macrophages and fibrocytes are often located in close proximity to 
collagen-secreting myofibroblasts and produce growth factors and cytokines that can 
suppress or stimulate myofibroblasts activity (Herzog and Bucala 2010, Koh and 
DiPietro 2011). Monocytes can promote fibrosis by differentiating into M2a-like 
macrophages and fibrocytes which in turn secrete fibroblast stimulating factors such 
as TGFβ1, PDGF, FGF2, IGFBP5, CCL18 and Galectin-3 (Wynn and Vannella 2016). 
M1 macrophages are also implicated in progression of fibrosis by causing 
hyperinflammation in neighbouring tissues (Duffield et al. 2005). Notably it is now 
appreciated that functional heterogeneity within macrophage populations may impact 
on the progression of fibrosis or its resolution with different subclasses having the 
potential to impact on tissue repair responses to injury (Hesketh et al. 2017). Recent 
studies report that many factors can induce a pro-fibrotic phenotype in macrophages 
e.g. IL-1, Il-13, CSF1, CCL17 and CCL2 and once activated these cells can amplify 
levels of pro-fibrotic cytokines and growth factors thereby driving and accelerating 
myofibroblast activation and fibrosis progression (Shapouri-Moghaddam et al. 2018).  
1.1.4 Mechanisms of scarless healing 
1.1.4.1 Foetal skin 
It has been reported that wounds on human foetal skin during the early, but not late, 
gestational period exhibit scarless wound repair (Gurtner et al. 2008). Although this 
process is not fully understood some differences between wound healing in the foetal 
and adult skin have been recorded (Figure 1-2). Foetal skin has much decreased tensile 
strength which consequently decreases the amount of mechanical signalling from the 
wound region. This is relevant because the focal adhesion kinase (FAK) pathway has 
been implicated in linking mechanotransduction with fibrosis (Wong et al. 2011). 
Furthermore, clinical trials using a device designed to reduce mechanical forces on 
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healing wounds resulted in reduced scar formation (Longaker et al. 2014). Foetal skin 
wound healing also has a reduced inflammatory component whereby platelets do not 
form aggregates, there is less infiltration by neutrophils and decreased secretion of pro-
inflammatory cytokines such as TGFβ and interleukins (Leavitt et al. 2016). Foetal 
wounds express more TGFβ3 than TGFβ1 while adult wounds show greater TGFβ1 
expression, a known driver of fibrosis (Leavitt et al. 2016). 
Alterations in the phenotype and function of cells in foetal and adult skin have been 
noted with proteomic analysis of foetal and adult skin fibroblasts revealing differences 
expression relevant to the wound healing response (Ho, Marçal and Foster 2014). 
Notably, mid-gestational keratinocytes can modulate the gene expression profile of 
adult dermal fibroblasts causing increased proliferation and migration and 
downregulation of precollagen1, collagen 1, TGFβ1, TGFβ2, TIMP2 and TIMP3 and 
upregulation of precollagen 3, collagen 3, TGFβ3, MMP1, MMP2, MMP3 MMP9 and 
MMP14, while fibroblasts co-cultured with late-gestational keratinocytes showed a 
more pro-fibrotic phenotype (Wang et al. 2015). In foetal wounds collagen III and IV 
are rapidly deposited by fibroblasts in a network that reflects the architecture of 
uninjured skin while in adult wounds collagen I predominates giving greater strength 
and rigidity but inhibiting cellular migration. Foetal fibroblasts have greater capacity 
for migration and there is no evidence for myofibroblast differentiation (Larson et al. 
2010). Human foetal skin has been shown to heal without a scar even when 
transplanted into the subcutaneous tissue of an immunodeficient adult mouse (Larson 
et al. 2010) suggesting wound healing responses are intrinsic to the tissue.  
1.1.4.2 Oral mucosa 
An example of an adult tissue that exhibits minimal scarring is the oral mucosa (Figure 
1-2). As with foetal skin, the inflammatory component of wound healing in the oral 
mucosa is diminished (Glim et al. 2015): there are significantly lower numbers of 
macrophages, neutrophils and T cells observed in oral mucosal wounds when 
compared to wounds of equivalent size in the adult skin. This is accompanied by 
decreased expression of the pro-inflammatory cytokines IL-6 and TGFβ1 (Szpaderska, 
Zuckerman and DiPietro 2003). When compared to the skin, the oral mucosa also 
displays decreased expression of fibronectin, ED-A fibronectin and chondroitin 
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sulfate. Myofibroblastic expression of αSMA is dependent on ED-A fibronectin in 
addition to TGFβ signalling suggesting that the ECM of the oral mucosa is less likely 
to support myofibroblast differentiation (Leavitt et al. 2016, Tomasek et al. 2002).   
 
Figure 1-2. Overview of cellular and molecular characteristics of scarless regeneration 
and scar formation during wound healing. Key processes are displayed as they increase or 
decrease across the wound healing spectrum: scarless, scarring and non-healing wound repair. 
Features highlighted include angiogenesis, inflammation, epithelialisation, ECM remodelling, 




Wound healing is a complex interplay of various cell types and signalling pathways 
that orchestrate a highly regulated process to return a tissue to its pre-injured state. 
Dysregulated tissue repair results in the accumulation of ECM products and the 
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development of fibrosis which occurs in most adult tissues upon repeated injury and 
has severely negative impacts on tissue function. Physiological examples of scarless 
healing exist in the foetal skin and oral mucosa where a diminished inflammatory 
response and altered myofibroblast phenotype have been highlighted as key 
differences. The endometrium is also an example of an adult tissue that can undergo 
scarless repair and current understanding of this process is discussed below. 
1.2 The endometrium 
1.2.1 Development of the endometrium 
Development of the female reproductive tract occurs prenatally arising from the 
intermediate mesoderm and differentiating from the embryonic structures known as 
the Müllerian ducts (Kobayashi and Behringer 2003). Humans and other higher 
primates have a simplex uterus with a single uterine cavity formed through the fusion 
of the two Müllerian ducts at approximately 8 weeks of gestation during Carnegie 
stages 22-23 (Hashimoto 2003, Kobayashi and Behringer 2003). During gestational 
weeks 16-24 the uterus undergoes extensive growth (Pietryga and Woźniak 1992) and 
the mesenchyme differentiates into both the stroma and myometrium by gestational 
week 22: endometrial glands differentiate from columnar luminal epithelium, 
extending from the lumen to the myometrium (Beckman and Feuston 2003). 
Primordial germ cells migrate into the genital ridge and populate the developing 
gonads from around 5-6 weeks of gestation (Makabe and Motta 1989). Subsequent 
development of the ovary is characterised by proliferation of somatic components, 
differentiation of the gonadal cortex and differentiation of primordial germ cells into 
clusters of oocytes (Motta, Makabe and Nottola 1997). This process continues until 
oocytes reach meiotic arrest in the 22nd gestational week (Makabe and Motta 1989). 
The female reproductive tract is controlled by the hypothalamic pituitary ovarian 
(HPO) axis. Briefly neurons in the hypothalamus produce pulsatile secretions of 
gonadotrophin-releasing hormone (GnRH) from the onset of puberty binding to GnRH 
receptors in the pituitary and stimulating production and secretion of luteinising 
hormone (LH) and follicle stimulating hormone (FSH) (Marshall et al. 1991) (Figure 
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1-3). These pituitary hormones stimulate the production of steroid hormones oestrogen 
and progesterone by ovarian tissue. Oestrogens are produced in a two-step process: 
LH binds to LH receptors on thecal cells on the outer layer of follicles stimulating the 
conversion of cholesterol to androgens which are transported inwards to granulosa 
cells; granulosa cells have FSH receptors and upon binding, FSH stimulates the 
conversion of androgens to oestrogen (Yen 1977) (Figure 1-3). Oestrogen is required 
to support the development of the oocyte within the follicle and creates a positive 
feedback loop to the hypothalamus and pituitary gland. After ovulation the follicle 
undergoes leutinization and becomes the corpus luteum (CL) which synthesizes and 
secretes progesterone (Bates and Bowling 2013, Timonen et al. 2002). Steroid 
hormones are essential for the growth and function of the human endometrium and 
govern cyclical changes that take place during the menstrual cycle (Section 1.2.3). 
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Figure 1-3. Overview of the hypothalamic pituitary ovarian (HPO) axis that governs 
function of the femal reproductive tract. Gonadotrophin releasing hormone (GnRH) is 
released from the hypothalamus in the brain which stimulates release of leutinising hormone 
(LH) and follicle stimulating hormone (FSH) from the pituitary gland. These hormones act on 
the ovary to regulate follicular development and synthesis of the steroid hormone oestrogen. 
Rising oestrogen levels activate positive feedback on the pituitary gland resulting in a 
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1.2.2 Tissue architecture of the adult endometrium in women and 
mouse 
The human uterus comprises two principle components: a thick muscular outer layer 
known as the myometrium and a multicellular internal layer known as the 
endometrium which lines the internal uterine cavity. The myometrium consists 
predominantly of muscle fibres interspersed with blood vessels, lymphatics and 
nerves, and is responsible for uterine contractions during menstruation and parturition 
(Naftalin and Jurkovic 2009). The endometrium is a dynamic tissue that undergoes 
monthly cycles of tissue remodelling in response to fluctuating levels of 
ovarian-derived steroid hormones during the menstrual cycle (Critchley and Saunders 
2009). The purpose of the menstrual cycle is to ready the endometrium for 
implantation of a blastocyst and then further support the development of a foetus 
throughout pregnancy. 
 
Figure 1-4. Histological appearance of the human uterus. The human uterus is comprised 
of two principle components: the outer muscular myometrium and the inner multicellular 
endometrium. The endometrium is composed of two distinct layers: the outer basalis and inner 
functionalis. Modified image (Original image available at: 
http://medcell.med.yale.edu/histology/female_reproductive_system_lab/uterus.php). 
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The human endometrium is composed of two morphologically distinct layers: the basal 
layer and the functional layer. The outer basal layer is directly adjacent to the 
surrounding myometrium creating the endometrial-myometrial junction which is 
highly vascularised (Tetlow et al. 1999) and remains intact throughout the menstrual 
cycle (Padykula et al. 1989, Naftalin and Jurkovic 2009) (Figure 1-5). The functional 
layer is luminal to the basal layer and represents a transient tissue which proliferates, 
degenerates and is shed during menstruation (Figure 1-5). Both layers of the 
endometrium have a well-defined stromal compartment containing fibroblasts, 
vasculature (vascular smooth muscle cells, pericytes and perivascular fibroblasts) and 
immune cells and a distinct epithelial compartment (Garry et al. 2009, Ludwig and 
Spornitz 1991, Thiruchelvam et al. 2013, Berbic, Ng and Fraser 2014). The luminal 
surface of the endometrium and the glands are lined with a single layer of columnar 
epithelial cells. The luminal epithelium represents the interface between the 
endometrial mucosa and the uterine cavity (Niklaus, Murphy and Lopata 2001) (Figure 
1-5).  
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Figure 1-5. Histological assessment of human endometrial structure. The endometrium is 
composed of two distinct layers (Figure 1-4) comprising both stromal and epithelial 
compartments. The stroma is composed of fibroblasts, endothelial cells that make up blood 
vessels and immune cells. The epithelium is composed of epithelial cells that line both the 
inner lumen and glands (image adapted from the Human Protein Atlas: 
https://www.proteinatlas.org/; original image available at: 
https://www.proteinatlas.org/learn/dictionary/normal/endometrium)  
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1.2.3 The human menstrual cycle 
The menstrual cycle is split into three phases governed by changes in circulating 
hormone concentrations and consequently tissue morphology (Figure 1-6): the 
menstrual phase involves the degeneration of the functional layer; the proliferative 
phase involves regeneration of the functional layer; and the secretory phase involves 
the differentiation of the new functional layer in preparation for the implantation of a 
blastocyst (Bartelmez 1957, Ferenczy, Bertrand and Gelfand 1979, Garry et al. 2009). 
Noyes et al examined the histology of 8000 human endometrial biopsies to describe 
the stages of the menstrual cycle which was determined on average to be ~28 days in 
length. The onset of menstruation is considered to be day 1 and the proliferative phase 
follows on from days 4-14. Ovulation occurs between days 14-16 and the secretory 
phase begins on day 16 and is often designated as: the early-secretory phase (days 16-
19), the mid-secretory phase (days 20-24) and the late-secretory phase (days 25-28). 
The cycle ends on day 28 and starts again with the onset of the subsequent menstrual 
phase (Noyes, Hertig and Rock 1975). The morphological and cellular changes that 
take place during each phase of the cycle are outlined below. 
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Figure 1-6. Overview of the cyclical changes in circulating hormone levels and 
morphology of the endometrial functionalis during the human menstrual cycle. LH and 
FSH secreted from the pituitary stimulate synthesis of steroid hormones. Menstruation occurs 
on day 0 (hormone depleted environment) and involves sloughing of the functional layer after 
which the endometrium goes through rapid tissue repair. The oestrogen dominant proliferative 
phase occurs from days 4-16 of the cycle involving cellular proliferation and angiogenesis. 
This phase culminates in ovulation in response to the ‘LH surge’ after which the corpus luteum 
(derived from the ovulated follicle) secretes progesterone. During the secretory phase at days 
20-28, progesterone induces decidualisation of stromal fibroblasts in preparation for the 
implantation of a blastocyst. In the absence of a blastocyst, progesterone concentrations fall 
stimulating a cascade of cellular and molecular events that culminate in sloughing of the 
functional layer during menstruation (based on Bates and Bowling 2013). 
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1.2.3.1 The proliferative phase 
The proliferative phase (follicular phase) is under the control of increasing levels of 
oestrogens (predominantly E2) secreted by ovarian follicles as they grow and increase 
the expression of aromatase (Bates and Bowling 2013, Turner et al. 2002).  Oestrogens 
stimulate extensive cellular proliferation in the functional layer and increased mitotic 
events in epithelial, stromal and vascular cells (Ferenczy et al. 1979), coupled with the 
development of a voluminous glandular network and extensive blood vessel system 
(Hess, Nayak and Giudice 2006). Proliferative changes increase the overall thickness 
of the endometrium from 2mm up to 14mm in just 10 days (Johannisson et al. 1987, 
McLennan and Rydell 1965, P. Hess et al. 2006). Oestrogen receptor isoform α (ERα) 
is expressed by stromal cells  and epithelial cells of both the lumen and glands 
(Critchley and Saunders 2009). Human endothelial cells are ERα-/ERβ+ but 
perivascular cells express both ERα and ERβ: the impact of E2 on the endothelium 
may be mediated directly through ERβ or indirectly via ERα in perivascular cells 
(Critchley et al. 2001b). Over the course of the proliferative phase epithelial cells 
become more ciliated which is important for distributing secretions in the subsequent 
phase (Campbell et al. 1988). Studies using human explant cultures have identified 3 
phases of response to E2 with respect to proliferation and known E2 regulated genes 
including PR (Platz and Giovannucci 2004). 
Studies in transgenic mice have shown E2 dependent signalling via ERα is critically 
important for stromal-epithelial interactions in the endometrium (Winuthayanon et al. 
2010). E2 upregulates the secretion of insulin growth factor 1 by stromal fibroblasts 
(Igf1) (Zhu and Pollard 2007) that  stimulates the proliferation of both stromal 
fibroblasts and epithelial cells (Walker et al. 2010, Irwin et al. 1993), and expression 
of epidermal growth factor receptor by epithelial cells which increases binding of EGF 
a potent mitogenic factor (Watson, Franks and Bonney 1996, Taketani and Mizuno 
1988). ERα signalling upregulates progesterone receptor (PR) expression which is 
essential for priming the endometrium for morphological changes that will occur 
during the secretory phase (Couse and Korach 1999, de Ziegler et al. 1998).  
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1.2.3.2 The secretory phase 
The secretory phase is also known as the luteal phase (Bates and Bowling 2013): the 
corpus luteum (CL) formed after ovulation, synthesises high levels of progesterone 
reducing epithelial and stromal cell proliferation by downregulation of ERα (Felix and 
Farahmand 1997). Progesterone also further upregulates the expression of PR by 
stromal and glandular epithelial cells (Wang et al. 1998). From days 17-20 during the 
early secretory phase glandular epithelial cells accumulate glycogen granules in their 
cytoplasm and then secrete glycoprotein-rich products into the glandular lumen to fill 
the uterine cavity. Glands become more tortuous and epithelial cells become highly 
secretory with a ciliated phenotype (Campbell et al. 1988). From days 20-22 increased 
vascular permeability results in stromal oedema accompanied by coiling of spiral 
arterioles in the functional endometrium (Bates and Bowling 2013). On day 22 
maximum oedema is reached and this, alongside increasing levels of P4, stimulates 
stromal fibroblasts to go through a non-reversible differentiation event known as 
decidualisation. Decidualisation occurs during the mid-secretory phase and is the 
conversion of spindle-shaped stromal fibroblasts into epithelial-like cells known as 
decidual cells (Gellersen and Brosens 2014, Dunn, Kelly and Critchley 2003). 
Decidual cells accumulate collagen and laminin (Church et al. 1996) and secrete 
insulin-like growth factor binding protein 1 (IGFBP1) which further stimulates 
progesterone regulated decidualisation (Matsumoto, Sakai and Iwashita 2008). 
Stromal decidualisation initiates in regions directly under the luminal epithelium and 
in the perivascular niche around spiral arterioles and then radiates throughout the 
endometrium (Dunn et al. 2003). This spread is believed to occur through paracrine 
signalling with cytokines such as IL-11 and activin released from decidualised cells 
stimulating surrounding fibroblasts (Evans and Salamonsen 2012).  
Decidualisation is an essential process to prepare the endometrium for the implantation 
of a blastocyst (Salker et al. 2010). The endometrium is only receptive to a blastocyst 
during the mid-secretory phase in the ‘window of receptivity’ which lasts for ~3 days 
and is determined by transient expression of adhesion molecules by the epithelium 
(Acosta et al. 2000). During the late-secretory phase, decidual cells secrete chemokines 
including CCL7, CCL13, CCL21, CCL22,  CXCL8 and CX3CL1 which stimulate 
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recruitment of leucocytes to the endometrium (Evans and Salamonsen 2012): the 
numbers of leucocytes in the tissue reach a maximum at days 27-28 and persist into 
pregnancy if implantation occurs  (Salamonsen, Zhang and Brasted 2002). Gene 
expression studies comparing the transcriptome of human endometrial biopsies from 
the proliferative and secretory phases have identified genes that may be responsible 
for the preparation for pregnancy such as apolopoprotein (Apo) E, PGE2 receptor, 
glucarunytransferase, Dkk-1, IGFBO1, osteopontin (SPP1) and laminin, among others 
(Kao et al. 2002, Riesewijk et al. 2003). If a pregnancy ensues, decidual cells go on to 
form the maternal component of the placenta (Moffett and Loke 2006) however if a 
pregnancy is not established, the CL regresses and menstruation occurs (Jabbour et al. 
2006, Critchley and Saunders 2009). 
1.2.3.3 The menstrual phase 
Regression of the CL (luteolysis) in the late-secretory phase results in a rapid fall in 
circulating ovarian-derived steroid hormones, notably progesterone, which triggers a 
series of cellular, molecular and vascular changes that culminate in breakdown and 
shedding of the functional layer of the endometrium (Salamonsen 2003b, Niswender 
et al. 2000, Salamonsen 1998). Menstruation is characterised by decidual 
degeneration, epithelial cell death and blood vessel necrosis resulting in sloughing of 
endometrial tissue into the uterine lumen which together with tissue exudate and blood 
are lost via the vagina (Jabbour et al. 2006). Menstruation only occurs in mammals 
following spontaneous or induced decidualisation (Evans, Kaitu'u-Lino and 
Salamonsen 2011). 
Menstruation has been classified as an inflammatory event because the mechanisms 
and cellular changes involved are similar to those observed during a physiological 
inflammatory response; an immediate increase in the expression of prostaglandins, 
cytokines and chemokines secreted by stromal decidual cells in response to 
progesterone withdrawal (Maybin et al. 2011b, Jabbour et al. 2006, Evans and 
Salamonsen 2012, Jones et al. 2004). The production of these factors further stimulates 
an influx of immune cells into the tissue which release MMPs and proteolytic enzymes 
to degrade ECM components and facilitate tissue breakdown (Critchley et al. 2001a, 
Kelly, King and Critchley 2002). Progesterone withdrawal has been shown to induce 
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the secretion of MMP precursors, urokinase-type plasminogen activator (uPA), tissue-
type plasminogen activator (tPA) among other regulatory molecules which may all 
contribute to a rapid breakdown in tissue architecture (Evans and Salamonsen 2012). 
At the onset of bleeding the decidualised stroma and associated blood vessels 
disintegrate without an accompanying haemostatic reaction however within 20hrs 
blood vessels become partly or totally sealed by intravascular thrombi containing 
aggregated platelets and fibrin, mirroring the response observed during wound healing 
in other tissues (Christiaens et al. 1980, Christiaens et al. 1983). Furthermore, 
vasoconstriction of the spiral arteries prevents local haemorrhage and causes ischemia 
and focal hypoxia (Garry et al. 2010, Henriet, Gaide Chevronnay and Marbaix 2012, 
Maybin and Critchley 2015, Cousins et al. 2016d).  
Elegant scanning electron microscopy (SEM) studies have revealed that decidual 
shedding is a piecemeal process with areas of shed endometrium existing beside areas 
of unshed endometrium, so that tissue repair occurs simultaneously with breakdown. 
Following the sloughing of the functionalis, the exposed basalis is rapidly covered 
with a fibrinous mesh within which blood components and other cell types become 
trapped. This mesh provides a provisional matrix upon which new epithelial cells 
develop and migrate (Garry et al. 2009). Similarly the expression of fibronectin and 
various integrins increases in the endometrium during menstruation and subsequent 
repair most prominently in the uppermost zone of the denuded stroma. Fibronectin 
interacts with specific integrins and is known to enhance cell adhesion and migration 
during wound healing (Slayden and Brenner 2006).   
In women endometrial breakdown and repair is tightly regulated to prevent excessive 
blood loss and regain structural integrity of the organ. Individual factors implicated in 
regulation of endometrial tissue shedding and repair are further detailed in section 
1.3.2.  
1.2.4 The mouse oestrous cycle 
Spontaneous decidualisation and menstruation are limited to the higher-order primates 
including humans, 4 species of bat, the elephant shrew and a recently described 
member of the Spiny mouse species (Acomys cahirinus) (Bellofiore et al. 2018). The 
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majority of rodents including rats and mice have a relatively short reproductive cycle 
known as the oestrus cycle (Caligioni 2009). The first detailed analysis of the mouse 
oestrus cycle was by Allen in 1922 who observed both external and internal signs of 
oestrus in 90 animals. The presence of specific cell types in vaginal lavage was used 
to define 4 distinct phases: proestrus (P) by nucleated epithelial cells; oestrus (O) by 
cornified epithelial cells; metoestrus (M) by cornified epithelial cells and leucocytes; 
and dioestrus (D) by leucocytes (Allen 1922, Caligioni 2009, Byers et al. 2012).  
As in women regulation of endometrial function in the mouse is governed by 
fluctuating levels of ovarian-derived steroid hormones (Figure 1-7 (A)). During the P 
and O phases the endometrial stroma undergoes extensive proliferation in response to 
increasing circulating levels of oestrogen. Unlike in the human endometrium however, 
the stroma does not undergo spontaneous decidualisation in response to increased 
levels of progesterone during M, rather the presence of a blastocyst is required. In 
addition, the stroma does not breakdown when progesterone levels drops (D), instead 
the tissue is reabsorbed before the cycle begins again (Caligioni 2009, Fata, Chaudhary 
and Khokha 2001, Strassmann 1996). The mouse uterus is composed of two uterine 
horns (Figure 1-7 (B)) which is morphologically different to the human simplex uterus 
(Figure 1-7 (C)). Despite additional differences in the cycle, the cellular composition 
of endometrial tissue is remarkably similar between humans and mice: the outer 
muscular myometrium encloses the multicellular endometrial stroma containing 
stromal fibroblasts and blood vessels, and the lumen and glands are lined with 
epithelial cells (Figure 1-7 (D)) (Fata et al. 2001). Such similarities in structure and 
the availability of countless transgenic mouse strains, make the mouse an attractive 
model in which to interrogate mechanisms associated with endometrial function.  
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Figure 1-7. Comparison of the mouse oestrus cycle with the human menstrual cycle. (A) 
Schematic representation of cyclical changes in steroid hormone levels across a 4 day oestrous 
cycle (mouse) and a 28 day menstrual cycle (human). Both species experience increasing 
concentrations of oestrogen during the follicular phase with a peak just prior to ovulation. 
Progesterone concentrations increase during the luteal phase. Anatomical structure of the (B) 
mouse and (C) human uterus (Adapted from Gargett, Chan and Schwab 2008, Fata et al. 2001). 
(D) Cross section through a mouse uterine horn displaying the outer muscular myometrium 
(M), endometrial stroma (S) embedded with glands (G), and the lumen (L) lined with epithelial 
cells (E) (Author’s own H&E images). 
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1.3 Endometrial repair 
1.3.1 Post menstrual repair 
It has been postulated that as well as initiating tissue breakdown the withdrawal of 
progesterone initiates endometrial repair processes. This is supported by microarray 
analysis of human endometrial explants cultured in the presence or absence of 
hormonal support in vitro, where hormone deprived explants had a gene signature in 
line with ‘wound healing and inflammation’ (Gaide Chevronnay et al. 2012). 
Menstruation is the culmination of vascular, cellular and inflammatory changes which 
leaves the luminal surface in a ‘wounded’ state (Maybin and Critchley 2015). In order 
to limit blood loss and regain tissue function for the subsequent cycle, rapid 
re-epithelialisation and structural reorganisation is required without the accumulation 
of any functional damage or fibrotic scar tissue (Salamonsen 2003a, Cousins et al. 
2014, Maybin and Critchley 2015). Although the human endometrium is the only adult 
tissue that undergoes regular and repeated cycles of degeneration and regeneration 
under normal physiological conditions (Gargett and Masuda 2010) parallels can be 
drawn between mechanisms of post menstrual endometrial repair and the wound 
healing response of the skin and oral mucosa (Figure 1.1) (Shaw and Martin 2009, 
Leavitt et al. 2016, Critchley et al. 2006a). In foetal skin and oral mucosa it is believed 
scar-free healing is facilitated by a diminished inflammatory response and altered 
fibroblast phenotype (Szpaderska et al. 2003, Martin and Leibovich 2005, Leavitt et 
al. 2016). This appears to be in contrast to endometrium which experiences both a 
significant influx of immune cells and cascade of inflammatory signals during 
menstruation (Evans and Salamonsen 2012). Hence it appears the endometrium may 
represent a tissue that sits between scarless and scarring tissue repair and studies on 
this tissue may therefore shed new light on the mechanisms of each process. 
Whilst morphological and cellular changes that occur during the various phases of the 
menstrual cycle have been well documented less is known about the mechanisms that 
govern post-menstrual endometrial tissue repair. Decidual shedding and repair was 
documented as a ‘piecemeal process’ which occurred simultaneously in regions 
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throughout the uterine cavity (Figure 1-8), with an important role for the stromal 
compartment being highlighted (Garry et al. 2009).  
 
 
Figure 1-8. Visualisation of the human endometrium during menstruation using 
hysteroscopy (A, C, E) and scanning electron microscopy (SEM) (B, D, F). Decidual 
shedding is a progressive piecemeal process with areas of denuded stroma and exposed glands 
found alongside regions of unshed tissue at 24hrs (A-D, black versus red versus white arrows). 
At 48hrs new epithelial cells are present (D, yellow arrows) and by 72hrs the luminal surface 
is almost completely re-epithelialised (F, yellow arrows) (Adapted from Garry et al. 2009). 
 
Endometrial repair occurs in a steroid hormone depleted environment as regression of 
the CL results in low levels of circulating steroids. Using a mouse model of 
endometrial breakdown and repair in which mice were ovariectomised (described fully 
1.7.5), Kaitu’u-Lino et al reported complete healing occurred even if mice were fed a 
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soya-free diet and treated with an aromatase inhibitor consistent with E2-independence 
(Kaitu'u-Lino, Morison Nb Fau - Salamonsen and Salamonsen). Similarly, a xenograft 
technique has been used whereby human endometrial explants are transplanted 
subcutaneously into mice and menstrual changes induced by administering E2 and P4 
to mimic the 28-day human cycle. Upon steroid hormone withdrawal explants are seen 
to undergo tissue degeneration but return to a proliferative phenotype within 4 days in 
the absence of hormonal support (Matsuura-Sawada et al. 2005).  
1.3.2 Factors reported to regulate menstrual shedding and repair 
1.3.2.1 Hypoxia 
Progesterone withdrawal is associated with an increase in the synthesis of 
prostaglandins inducing arteriole vasoconstriction which results in an increase in focal 
hypoxia and expression of VEGF (Figure 1-9, orange pathway) (Maybin et al. 2011a, 
Maybin et al. 2011b, Cousins et al. 2016d).  Hypoxia is considered an important 
regulator of endometrial breakdown and repair (Semenza 1998). Hypoxia stabilises 
hypoxia-inducible factor 1α (HIF1α), a transcription factor that mediates a cell’s 
homeostatic response to reduced oxygen availability (Semenza 1998). In the 
Edinburgh mouse model of endometrial breakdown (Section1.7.5) striking spatial and 
temporal fluctuations in hypoxia have been visualised with changes being correlated 
with changes in gene expression of VEGF and CXCL12 suggesting hypoxia has a role 
in driving both the angiogenic response and inflammation (Cousins et al. 2016d). In 
the same model stabilisation of HIF1α has been shown to enhance re-epithelialisation 
of the denuded stromal surface (Figure 1-9, yellow pathway) with pharmacological 
reduction in HIF1α delaying complete repair (Maybin et al. 2018).  Evidence for 
stabilisation of HIF1α in human endometrial tissue has been detected during the 
secretory and menstrual phase and is believed to regulate the expression of genes 
involved in angiogenesis including IL8 (Maybin et al. 2011b, Maybin et al. 2011a). 
Using endometrial biopsy specimens it has been shown that in vitro P4 withdrawal 
increased IL8 secretion but only in the presence of hypoxia (Maybin et al. 2011b). 
Contrasting data were published by Coudyzer et al who used a xenograft model of 
menstruation where fragments of human endometrium were engrafted to 
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ovariectomised immunodeficient mice: in this model they could not detect evidence 
for increased HIF1α and concluded that hypoxia is not required to trigger menstrual-
like tissue breakdown or repair in human endometrium (Coudyzer et al. 2013). 
 
 
Figure 1-9. Schematic representation of mechanisms that trigger the initation of tissue 
breakdown and shedding during menstruation. Progesterone withdrawal stimulates an 
increase of COX1 and a decrease in PGDH which results in an increase in prostaglandin 
synthesis. This induces hypoxia through PGF2α-stimulated vasoconstriction, and immune cell 
infiltration through PGE2-stumlated vasodilation (orange pathway). Hypoxia increases 
expression of HIF1α which stimulates cytokine release (orange pathway) and epithelial cell 
proliferation and migration (gold pathway). Hypoxia also stimulates release of CXCL12 which 
enhances macrophage function (green pathway) and the activation of stem/progenitor cells 
(yellow pathway). Decreased expression of TIMPS and increased expression of MMPs by 
immune cells and fibroblasts results in breakdown of decidualised tissue (blue pathway). ↑: 
increase, ↓: decrease, COX2: cyclooxygenase, PGDH: prostaglandin dehydrogenase, PGF2α: 
prostaglandin F2 alpha, PGE2: prostaglandin E2, MMPs: matrix metalloproteinases, TIMPS: 
tissue inhibitors of MMPs, HIF1α: hypoxia-inducible factor 1α, VEGFA: vascular endothelial 
growth factor A, MET: mesenchymal to epithelial transition (Figure compiled by author based 
on research by Critchley et al. 2006b, Maybin et al. 2011a, Gaide Chevronnay et al. 2012, 
Salamonsen and Woolley 1999, Punyadeera et al. 2006). 
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1.3.2.2 Matrix metalloproteinases (MMPs) 
MMPs are zinc-dependent endopeptidases that when activated cleave almost all 
components of ECM (Nagase, Visse and Murphy 2006): TIMPs are endogenous tissue 
inhibitors of MMPs. The cyclical remodelling and breakdown of ECM observed 
during the menstrual cycle depends on MMPs the activity of which is tightly controlled 
to allow for efficient tissue breakdown, concurrent repair and accurate remodelling in 
preparation for the next cycle (Gaide Chevronnay et al. 2012). The role of MMPs in 
endometrial breakdown was first described in vitro using human endometrial explant 
cultures to demonstrate oestrogen and progesterone supress the expression of MMP1, 
3 and 7 suggesting that hormones regulate MMP expression in endometrial tissue 
(Marbaix et al. 1996b). This hypothesis was supported by an elegant study in 
ovariectomized macaques, where progesterone implants were removed at the end of 
the simulated cycle but replaced at staggered time-points from 12 to 72hrs after initial 
withdrawal (Slayden and Brenner, 2006). Replacement up to 24hrs after withdrawal 
prevented menstruation and prevented increases in endometrial MMP1, 2 and 3. 
Replacement after 36hrs had no effect on menstruation and partially blocked MMP 
production, with significantly less endometrial MMP2 expression. Other studies have 
confirmed an immediate increase in MMP1, 3, 7, 9, 11 and 12 in response to 
progesterone withdrawal (Figure 1-9, blue pathway) (Goffin et al. 2003, Vassilev et 
al. 2005, Salamonsen and Woolley 1999).  
Using an in vivo human explant technique Vassilev et al demonstrated that high levels 
of TIMP mRNAs are maintained throughout the menstrual cycle supposedly to 
regulate the extent of tissue degradation, while various MMPs (MMP-1, MMP-3, 
MMP-7, MMP-10) were upregulated during menstruation and endometrial repair 
which apparently overwhelms the actions of TIMPs. Of particular note in this study 
was that MMP10 was expressed at very high levels during menstruation and located 
throughout the endometrial stroma, being identified as a menstruation-associated 
MMP (Vassilev et al. 2005). In a mouse model of endometrial breakdown and repair 
MMP3, MMP7, MMP9 and MMP13 were significantly upregulated during 
menstruation and postmenstrual repair but administration of two MMP inhibitors, 
doxycycline and batimistat, had little effect on endometrial repair suggesting they are 
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not key mediators (Kaitu'u et al. 2005). The mouse model has been further used to 
demonstrate integrin-fibronectin interaction and MMP-facilitated cell movement 
during re-epithelilisation (Evans et al. 2011). In a recent study using the Edinburgh 
mouse model administration of DHT resulted in delayed restoration of the luminal 
epithelium associated with changes in expression of MMP3, MMP9, Snai3 and 
osteopontin, important regulators of MET (Cousins et al. 2016b). 
It is believed that leucocytes play an important role in menstruation in part by releasing 
MMPs (Figure 1-9, green pathway). In a mouse model, MMP7 and 9 colocalised with 
leucocyte subsets particularly neutrophils (Kaitu'u et al. 2005). In a xenograft model, 
MMP1, 2 and 9 were increased following progesterone withdrawal concurrent with an 
infiltrating leucocyte population (Guo et al. 2011); co-culture studies have revealed 
that BM-derived mast cells and neutrophils release MMPs when cultured with human 
endometrial stromal cells (Salamonsen et al. 2000). Neutrophils contain high levels of 
MMPs and have the ability to activate resident MMPs to initiate endometrial 
breakdown (Gaide Chevronnay et al., 2011) and depletion of granulocytes using an 
anti-mouse GR-1 antibody (expressed on BM-derived monocytes and neutrophils) 
decreased the expression of matrix modifying enzymes such as MMP3, 9 and 10 and 
impaired tissue repair (Menning et al. 2012).  
An in vitro study of human endometrial stromal fibroblasts demonstrated that activated 
platelet-rich plasma enhanced cell migration and proliferation and significantly 
increased  the expression of MMP1, MMP3, MMP7, MMP26 and various cytokines 
specifically in endometrial fibroblasts and MSCs (Aghajanova et al. 2018). The 
withdrawal of progesterone triggers focal expression of MMPs specifically in regions 
undergoing lysis, mediated by cytokines such as IL-1α, LEFTY-2 and TNFα (Gaide 
Chevronnay et al. 2012). It has been reported that MMPs undergo receptor mediated 
endocytosis through the low density lipoprotein receptor-related protein 1 (LRP-1) 
which clears active MMPs during the proliferative and secretory phases. Loss of 
LRP-1 during tissue shedding also enhances MMP activity during endometrial tissue 
breakdown (Gaide Chevronnay et al. 2012). Active forms of MMP2 and MMP9 are 
significantly reduced in menstrual endometrium of women with HMB (Malik et al. 
2006) further supporting a role of MMPs in efficient endometrial tissue repair. 
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1.3.2.3 Angiogenesis  
Endometrial repair and regeneration requires a substantial angiogenic response. 
Biosynthesis of VEGF, a signalling molecule that plays a key role in stimulating 
growth of new blood vessels, is triggered by hypoxia in the menstrual phase and then 
by oestrogen in the subsequent proliferation phase (Figure 1-9, pale blue pathway) 
(Punyadeera et al. 2006). In a rhesus macaque model VEGF mRNA is upregulated in 
the glands and stroma 1-2 days after progesterone withdrawal and VEGFR1 and 2 is 
increased in endothelial cells immediately below the luminal surface, implicating 
epithelial-derived VEGF in neoangiongenesis during endometrial regeneration (Nayak 
and Brenner 2002). Fan et al showed that blocking VEGF action (VEGF Trap) during 
menstruation in both primate and mouse models, completely inhibited 
neoangiogenesis while not affecting existing vessels. What is more the process of 
re-epithelialisation was also inhibited and additional in vitro studies confirmed that 
migration of luminal epithelial cells involved signalling through the VEGFR-NP2 on 
stromal cells. (Fan et al. 2008). In human endometrium changes in VEGF ligands and 
receptors were associated with increased expression of HIF1α in menstrual and early 
proliferative phase (Punyadeera et al. 2006) with results obtained that mirrored those 
in primates extending the understanding of VEGF and the hormonal regulation of 
VEGFR-NP1 during menstruation (Germeyer et al. 2005).  
1.3.2.4 Re-epithelialisation: epithelial proliferation and migration  
One of the most fundamental processes of endometrial repair is complete restoration 
of the luminal epithelial cell layer. In women re-epithelialisation begins on day 2 of 
menses and full epithelial coverage of the denuded stromal surface is achieved by day 
5 (Garry et al. 2009). In depth morphological analysis of the human endometrium 
during menstruation showed that a fibrinous mesh is rapidly produced that covers the 
denuded surface of the basalis endometrium. It is upon and within this fibrinous mesh 
that new epithelial cells develop and migrate to re-epithelialise the surface (Garry et 
al. 2009). Originally it was believed that new epithelial cells arose from epithelial cells 
residing in basal glands that were preserved during decidual shedding (Novak 1946). 
Ferenczy updated the hypothesis in the 1970s by suggesting that new epithelial cells 
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also arose from proliferation of intact surface epithelium bordering regions of denuded 
stroma that was not lost during shedding (Ferenczy 1976). When Garry et al analysed 
tissue morphology during active bleeding they discovered that immediately before and 
during menstruation, epithelial cells of the glands undergo apoptosis and are shed with 
the decidua to be replaced by small rounded epithelial cells. As these cells did not 
appear to be  proliferating it was hypothesised that some of the new epithelial cells 
were arising through differentiation of the stromal compartment (Garry et al. 2009). 
A study by Kaitu’u et al exploring cell proliferation in a mouse model of menstruation 
showed that  during early stages of breakdown and repair extensive luminal epithelial 
cell proliferation occurred with a population of glandular epithelial cells proliferating 
during the later repair stage (Kaitu'u-Lino, Ye and Gargett 2010). More recently, using 
the Edinburgh menses mouse model Cousins et al showed epithelial cells of the lumen 
and glands undergo extensive proliferation during repair while a small amount of 
proliferation was also detected in the stroma. Detailed immunohistochemistry revealed 
that epithelial cells in regions of the denuded surface were smaller and more rounded 
and appearing to ‘roll’ across the surface of the stroma, in line with a migratory 
phenotype. To support this data significant increases in stromal mRNAs (Cdh2, 
Vimentin, Wnt4) were detected in the early repair phase which decreased in later 
phases while epithelial genes (Cdh1, Wnt7a, Krt18) were decreased in early phases 
and increased in later phases (Cousins et al. 2014). This suggests that residual 
epithelial cells undergo a morphological change to exhibit a migratory phenotype, 
indicative of an epithelial-to-mesenchymal transition (EMT) (Figure 1-10). 
Interestingly, in vitro, human endometrial epithelial cells respond to hypoxia by 
decreasing expression of E-cadherin and increasing expression of N-cadherin, 
Vimentin and Snail, changes known to be indicative of EMT. Overexpression of 
HIF1α induced changes characteristic of EMT under normoxic conditions and it was 
concluded that hypoxia can stimulate EMT of endometrial epithelial cells, essential to 
migration (Xiong et al. 2016). As transient focal hypoxia is present in endometrial 
tissue in the initial phases of tissue breakdown and repair (Maybin et al. 2018) it may 
be that hypoxia may drive EMT and the acquired migratory phenotype of epithelial 
cells during initial phases of endometrial repair. 
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Figure 1-10. Overview of the epithelial to mesenchymal transition (EMT). During EMT, 
polarised epithelial cells (blue) undergo a functional and morphological transisition into 
migratory mesenchymal cells (orange). Epithelial cells express markers such as E-Cadherin, 
Occludins and Cytokeratins while mesenchymal cells express N-cadherin, Vimentint and 
Fibronectin. Cells of an intermediate phenotype (green) express markers of both epithelial and 
mesenchymal cells however upon complete transition epithelial markers are lost. The reverse 
process of mesenchymal to epithelial transition (MET) can also take place whereby 
mesenchymal cells undergo a transition into an epithelial phenotype (based on Kalluri and 
Weinberg 2009). 
 
1.3.2.5 Mesenchymal to epithelial transition (MET) 
There is a range of evidence suggesting stromal cells have a role to play in 
re-epithelialisation (Baggish, Pauerstein and Woodruff 1967). Studies using SEM 
identified groups of newly formed epithelial cells that were not associated with gland 
structures or residual luminal epithelium (Garry et al. 2009), suggesting stromal cells 
may be transdifferentiating into epithelial cells a process called 
mesenchymal-to-epithelial transition (MET) (Kalluri and Weinberg 2009, Maybin and 
Critchley 2015). Fate mapping studies carried out using Amhr2-Cre;Rosa26-EYFP 
double transgenic mice in which EYFP is expressed exclusively by the mesenchymal 
cell compartment detected EYFP in endometrial epithelial cells lining the lumen 
following parturition or in a pseudopregnancy model of menstruation. These MET 
cells could also be detected by co-expression of mesenchymal and epithelial cell 
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markers (vimentin and cytokeratin respectively) (Patterson et al. 2013). Cousins et al 
provided evidence that re-epithelialisation involved luminal and glandular epithelial 
cell proliferation and migration and a MET by cells of the stromal compartment in 
proximity to the denuded surface (Figure 1-11). Using detailed 
immunohistochemistry, they located cells in the stromal compartment adjacent to areas 
of denuded stroma that expressed both vimentin (stromal marker) and pan cytokeratin 
(epithelial marker) indicative of a MET. This study also highlighted dynamic changes 
in expression of genes implicated in regulation of EMT and MET including WT1, 
Snai1, Snai2, Snai3, Cdh1, cytokeratin, Wnt1, osteopontin and Vim (Cousins et al. 
2014).  
 
Figure 1-11. Immunohistochemistry demonstrating the three synchronous mechanisms 
by which re-epithelialisation occurs during endometrial repair in the Edinburgh menses 
mouse model (24hrs following P4 withdrawal). (A-A’) BrdU expression identifies epithelial 
cell proliferation in luminal epithelial cells (black arrows). (B-B’) Pancytokeratin expression 
identified epithelial cells that have a rounded morphology and appear to be migrating over the 
denuded stromal surface. (C-C’) Evidence for pancytokeratin expression by mesenchymal 
cells of the stromal compartment indicative of an MET (Adapted from Cousins et al. 2014). 
 
In summary the current consensus is that three synchronous mechanisms contribute to 
re-epithelialisation during endometrial repair: glandular epithelial cell proliferation 
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and migration, luminal epithelial cell proliferation and migration and MET by cells of 
the endometrial stroma (Garry et al. 2009, Patterson et al. 2013, Cousins et al. 2014) 
(Figure 1-11). These studies do not discriminate between different stromal cell 
populations and it has been proposed that stromal LRCs may also have the ability to 
proliferate and differentiate into epithelial cells during endometrial repair although to 
date there is no definitive evidence for this. 
1.4 Endometrium and inflammation 
Inflammation is a key regulator of the wound healing response (Cash and Martin 2016, 
Gurevich et al. 2018, Vannella and Wynn 2017). However excessive and persistent 
inflammation is associated with chronic non-healing wounds, fibrosis and abnormal 
tissue repair (Zhao et al. 2016, Qian et al. 2016) while scar-free tissue repair of foetal 
skin and oral mucosa is associated with a reduced inflammatory response and cell 
influx (Martin and Leibovich 2005, Morris et al. 2014, Szpaderska et al. 2003).  
Menstruation is now considered to be an ‘inflammatory’ event as progesterone 
withdrawal stimulates a cascade of inflammatory signals including increased release 
of cytokines, chemokines and prostaglandins (Maybin et al. 2011b, Evans and 
Salamonsen 2012, Critchley et al. 2001a). Similarities between the processes occurring 
during menstruation and the inflammatory response of normal wound healing was first 
observed by Finn et al using a mouse model of menstruation who noted that the first 
morphological change in the uterus following P4 withdrawal was an infiltration of 
leucocytes into the stroma (Finn and Pope 1986). Interactions between these 
leucocytes and the decidualised stromal cells result in the release of pro-inflammatory 
mediators which in turn stimulate the production and activation of various degradative 
enzymes culminating in the rapid breakdown and shedding of the decidua (Evans and 
Salamonsen 2012). Menstruation has been proposed as a ‘model of self-limiting 
inflammation’ (Maybin and Critchley 2015). 
A number of inflammatory mechanisms have been highlighted to playing a role in the 
co-ordination of the menstrual inflammatory response. The activity of reactive oxygen 
species (ROS) scavenging enzymes (superoxide dismutases) changes in response to 
fluctuating hormone levels throughout the menstrual cycle and importantly decreases 
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upon withdrawal of progesterone (Sugino et al. 2002). This results in an increase in 
ROS which stimulate various downstream signalling pathways including the NFκB 
pathways culminating in the production of inflammatory cytokines, chemokines and 
prostaglandins (Sugino et al. 2004). NFκB target genes include MMP9, COX-2, 
CCL1, CCL3, CCL5, CXCL1, CXCL8, IL-6, IL1β, GM-CSF and TNFα (Evans and 
Salamonsen 2012). 
It is believed that progesterone acts as an anti-inflammatory mediator during the 
proliferative and secretory phases in part by suppression of the COX-2 enzyme which 
synthesises prostaglandins from arachidonic acid, and stimulation of prostaglandin 15 
dehydrogenase enzyme (PGDH), the enzyme responsible for conversion of 
prostaglandins to inactive metabolites (Figure 1-9, orange pathway) (Evans and 
Salamonsen 2012, Catalano et al. 2007). In women taking Mifepristone, a potent 
antiprogestagen, serum progesterone levels are significantly reduced which results in 
a decrease in the expression of PGDH and an increase in cyclooxygenase-2 (COX2), 
consistent with progesterone withdrawal during menstruation stimulating an 
upregulation in the synthesis of prostaglandins which are key mediators of the 
inflammatory response (Hapangama et al. 2002, Jensen Dv Fau - Andersen, Andersen 
Kb Fau - Wagner and Wagner). Different prostaglandins have different roles in the 
inflammatory response. Specifically, PGF2α promotes vasoconstriction of the spiral 
arteries and smooth muscle contraction contributing to the hypoxic environment and 
menstrual shedding respectively (Fan et al. 2008). On the other hand, PGE2 stimulates 
vasodilation and therefore may enhance oedema and leucocyte infiltration (Figure 1-
9, orange pathway) (Jensen Dv Fau - Andersen et al. , Evans and Salamonsen 2012). 
Prostaglandins also have roles in mediating the production of cytokines such as 
CXCL1 and CXCL8 involved in leucocyte recruitment and growth factors such as 
adrenomedullin and VEGF important to endometrial repair (Evans and Salamonsen 
2012). Notably, the ratio of PGF2α:PGE2 has been found to be significantly lower in 
the endometrium of women suffering from heavy menstrual bleeding (HMB) 
suggesting a link between the regulation of prostaglandin synthesis and the extent of 
bleeding during menstruation (Smith et al. 1981). 
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1.4.1 Immune cell populations in the endometrium 
The immune system has two components: the innate immune system which is 
non-specific and is stimulated immediately to recruit immune cells including 
neutrophils, macrophages and natural killer cells to the site of infection/injury; and the 
adaptive immune system which is more specialised and activated when specific 
antigens are presented to T cells and an antigen-specific response is generated (Berbic 
et al. 2014). Cytokines, chemokines and growth factors stimulate leucocyte 
recruitment to endometrial tissue during the menstrual cycle.  For example, 
progesterone withdrawal upregulates the expression of cytokines and chemokines 
including CXCL8 which is a neutrophil chemotactic factor (Maybin et al. 2011b) and 
CCL-2 which is a monocyte chemotactic factor (Jabbour et al. 2006b, Critchley et al. 
1999). Several cytokines including CCL2, CXCL1, CXCL8 and CX3CL1 have been 
found to be expressed perivascularly (Slayden and Brenner 2006, Catalano et al. 2007, 
Wallace et al. 2009, Jolicoeur et al. 1998) whilst others including TNFα, CXCL12, 
CXCL8, CCL2, IL-1β, CXCL1 and endothelin are expressed in the epithelium and 
stroma (Berbic et al. 2014). Leucocytes may also secrete cytokines which can 
exacerbate the inflammatory response.  
Immune cells account for ~10% of cells in endometrial stromal during the proliferative 
phase, ~25% of cells in the secretory phase and up to 40% of cells in the menstrual 
phase (Starkey, Clover and Rees 1991, Kamat and Isaacson 1987, Salamonsen and 
Lathbury 2000, Maybin and Critchley 2015), summarised in Figure 1-12. The major 
leucocyte populations present in the endometrium during menstruation in women are 
uterine (u) NK cells and mast cells which proliferate within the tissue, and neutrophils, 
macrophages, and eosinophils which are recruited from the circulation (Salamonsen 
and Woolley 1999). Using a xenograft model of menstruation where human 
endometrial tissue is transplanted subcutaneously to immunocompromised mice, it 
was shown that human CD45+ cells increased and peaked during the secretory phase 
while mouse CD45+ cells increased during the menstrual phase and peaked 3 days 
following progesterone withdrawal, suggesting that tissue resident immune cells are 
important during endometrial tissue breakdown while immune cells recruited from the 
circulation have a more prominent role in endometrial repair (Guo et al. 2011). 
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Figure 1-12. Schematic representation of cyclical changes in the immune cell population 
of the endometrium during the menstrual cycle. Top panel represents fluctuations in steroid 
hormone levels that govern the menstrual cycle. Bottom panel displays the increase in 
abundance of immune cells during the secretory phase which peaks during menstruation. The 
contributing immune cells are symbolized with the increasing size relating to relative 
abundance. The table outlines immune cell populations and present in the endometrium and 
their relative abundance during different phases of the menstrual cycle as a proportion of total 
cells present in the endometrium (based on Starkey et al. 1991, Kamat and Isaacson 1987, 
Salamonsen and Lathbury 2000, Maybin and Critchley 2015). 
 
Chapter 1: Introduction  41 
 
1.4.2 Role of uNK cells  
Natural killer (NK) cells are large, granular lymphocytes which target infected cells 
by secretion of granular protein such as perforin and granzymes which induce an 
apoptotic response (Berbic et al. 2014). A specialised subset of uterine NK cells exists 
in the endometrium, identified as CD56bright which have lower cytotoxic ability but 
more potent cytokine secretion than their peripheral counterparts. uNK cells increase 
in  number during the secretory phase (Bulmer and Lash 2005) as a result of in situ 
proliferation as demonstrated by expression of Ki67 (Kämmerer et al. 1999). uNK 
cells (CD56brightCD16-) can be distinguished from peripheral blood NK cells  
(CD56dimCD16bright) and account for the majority of leucocytes present in the 
endometrium during the late secretory phase and through to early pregnancy (Jabbour 
et al. 2006b). uNK cells have been implicated in vascular remodelling during the 
menstrual cycle and placentation (Manaster et al. 2008) as they are located in close 
proximity to spiral blood vessels and have been shown to secrete IFNγ which dilates 
and thins the walls of spiral arteries to enhance blood flow to the implantation site 
(Jabbour et al. 2006b). uNK cells accumulate in perivascular regions and express 
angiogenic factors including placental growth factor, angiopoietin 2 and VEGF-C 
which stimulates endothelial cell proliferation and migration and are therefore 
implicated in angiogenesis (Li et al. 2001, Hanna et al. 2006). HMB is associated with 
altered endometrial vasculature and it has been found that in women with HMB there 
are reduced numbers of uNK cells during the secretory phase which may impact on 
vessel development (Biswas Shivhare et al. 2015).  
Cyclical changes in uNK cell number are considered consistent with hormonal 
regulation (Henderson et al. 2003): uNK migration has been shown to be enhanced by 
administration of E2 in vitro and conditioned media from uNK cells treated with E2 
can increase angiogenesis by human endometrial endothelial cells, in a CCL2-
dependent manner (Gibson et al. 2015). The mRNA for ERβ and GR but not ERα or 
PR, has been detected in purified human uNK cells and it is believed that oestrogens 
and glucocorticoids can act directly on uNK cells while progesterone acts indirectly 
(Henderson et al. 2003) potentially via stromal cell secretion of IL-15 and prolactin. A 
role for uNK cells in endometrial repair has not been proposed. 
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1.4.3 Role of neutrophils 
Neutrophils are polymorphonuclear cells, representing the most abundant leucocyte in 
the circulation of human blood with a short life span of only a few hours. In many 
inflammatory responses, neutrophils are the dominant cell population in the initial 
leucocyte influx and primary mediators of the inflammatory response, recruited 
quickly to sites of infection/injury where they persist for days, release pro-
inflammatory mediators and phagocytose pathogens and cellular debris (Berbic et al. 
2014, Martin and Leibovich 2005). The endometrial neutrophil population shows a 
dramatic change in numbers during the human menstrual cycle and they are the most 
prominent leucocyte present during decidual tissue breakdown (Kamat and Isaacson 
1987) being reported as 6-15% of total cell number peri-menstrually (Lathbury and 
Salamonsen 2000). In a recent study immunostaining of human endometrial tissue 
sections using an antibody directed against neutrophil elastase reported 
immunopositive staining restricted to samples recovered during active menses 
(Armstrong et al. 2017). In the endometrium neutrophils influx through spiral arteries 
in response to chemokines secreted by decidual tissue and the vessels themselves 
(Jones et al. 2004). 
In a mouse model of simulated ‘menstruation’ Kaitu’u-Lino et al used anti Ly6B2 
antibodies to identify putative neutrophils and reported they were low in number 
during the proliferative and secretory phase and most abundant 24hrs after 
progesterone withdrawal. Using the RB6-8C5 antibody to specifically deplete 
neutrophils from both the circulation and in peripheral tissues, it was shown that there 
was aberrant tissue breakdown and marked delay in repair, suggesting that the 
neutrophils are essential for endometrial repair. Authors also reported that F4/80 
expressing macrophages were in low abundance and therefore unlikely to contribute 
to endometrial tissue repair (Kaitu'u-Lino, Morison and Salamonsen 2007). Another 
study used an anti-mouse GR-1 antibody to target and deplete neutrophils resulting in 
decreased expression of MMPs and dysregulated endometrial repair (Menning et al. 
2012). When human endometrial stromal fibroblasts are cultured with human blood 
neutrophils there is an increase in the secretion of MMPs identified above as critical 
mediators of endometrial tissue breakdown (Lathbury and Salamonsen 2000). 
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Characterisation of the inflammatory response during menstruation in the Edinburgh 
mouse model demonstrated that Ly6G+ putative neutrophils peaked at 24hrs during 
active repair (Armstrong et al. 2017).  
Neutrophils synthesize and release a wide range of immunoregulatory cytokines and 
can initiate and orchestrate immune responses (Martin and Leibovich 2005). 
Neutrophils in the endometrium during menstruation express VEGF-A, an 
angiogenic factor which plays an important role in the regulation of vascular 
permeability and new blood vessel formation (Mueller et al. 2000). Neutrophils 
contain granules which hold a variety of degradative enzymes including neutrophil 
elastase, cathepsin C, MMP9 and proteinase 3 which can activate latent forms of 
pro-inflammatory mediators including TNFα and IL-1β (Evans and Salamonsen 
2012). Furthermore neutrophils have been shown to express the antiproteinase and 
antimicrobial molecule elafin during menstruation, a molecule involved in the 
regulation of proteolytic enzymes (King et al. 2003). Neutrophil granule subsets 
have specialised functions and their specific release depends on signals from the 
immediate environment. Some granules contain proMMP8 and proMMP9 released 
when neutrophils are stimulated, which are then activated by proteolytic cleavage 
by mast cell tryptase, MMP9 and MMP3. In this way an MMP cascade is initiated 
which is central to endometrial tissue breakdown and repair highlighting an 
important role for neutrophils in endometrial repair (Evans and Salamonsen 2012).   
1.4.4 Role of macrophages 
The mononuclear phagocyte population belongs to the innate immune system and 
includes monocytes and macrophages which have a longer life span than neutrophils. 
Upon extravasation from the circulation and migration to the tissue, circulating 
peripheral blood monocytes differentiate into mature macrophage phenotypes (Martin 
and Leibovich 2005). In recent years however, the simple view that all macrophages 
arise through differentiation of circulating monocytes after they extravasate from the 
blood stream and enter peripheral tissues (Van Furth and Thompson 1971, Martin and 
Leibovich 2005) has been challenged. New data from lineage tracing experiments in 
mice suggest there are at least three origins of tissue-resident macrophages: those 
Chapter 1: Introduction  44 
 
arising from haematopoietic stem cells or yolk sac progenitor cells established during 
development or those being continuously replaced by BM-derived progenitors in 
response to changes in tissue microenvironment (Ginhoux et al. 2010, Schulz et al. 
2012, Wynn, Chawla and Pollard 2013). Furthermore, the circulating monocyte 
population is heterogeneous and therefore distinct recruitment mechanisms may exist 
that may vary between tissues (Evans and Salamonsen 2012). The primary role of 
macrophages in inflammatory responses is to phagocytose and destroy pathogens and 
cellular debris and secrete inflammatory mediators including cytokines, chemokines 
and growth factors (Berbic et al. 2014). Macrophages also have roles in maintaining 
tissue homeostasis and regulating other immune cell populations and are believed to 
have important roles in wound healing (Wynn and Barron 2010, Wynn and Vannella 
2016, Mosser and Edwards 2008). For example macrophage depletion in transgenic 
mouse model has been shown to delay closure of skin wounds and to impair 
neoangiognesis (Goren et al. 2009). Tissue-resident macrophages represent highly 
plastic cell populations that responds to signals in each specific microenvironment and 
therefore a complex spectrum of activation states and phenotypes exist, reflected by 
surface receptor expression and secretion of molecules (Mosser and Edwards 2008, 
Radzun 2015) (Figure 1-13). Despite such variation, all macrophages exert precise 
roles in the immune response through phagocytosis of apoptotic bodies and 
modulation of other immune cells through the secretion of inflammatory factors (Stout 
and Suttles 2004). 
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Figure 1-13. The heterogeneous phenotypes of monocytes and macrophages. Monocytes 
derive form precursor cells found in the bone marrow and can have one of three phenotypes: 
classical monocytes, resident monocytes or patrolling monocytes each of which display 
different surface markers. Monocytes differentiate into macrophages upon extravasation of the 
circulation into peripheral tissues. Macrophages have been described to have either a 
classically activated M1 phenotype or an alternatively activated M2 phenotype with distinct 
functional attributes, although it is now believed a phenotypic spectrum exists for this cell type 
(based on Biswas et al. 2012, Das et al. 2015, Ferrante and Leibovich 2012, Dunster 2016, 
Dalmas, Clément and Guerre-Millo 2011). 
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To identify macrophages in human tissues antibodies directed against CD68 are used: 
using antibodies against CD163 can further differentiate between CD163high tissue-
resident macrophages and CD163low vascular-associated macrophages (Tremellen and 
Russell 2012). Macrophages have been detected in the endometrium throughout the 
menstrual cycle (Bonatz et al. 1992). Immunostaining for CD68 identifies cells that 
are most abundant during the late secretory and menstrual phases of the cycle, located 
predominantly in the decidualised stoma (Garry et al. 2010). Macrophages account for 
1-2% of the stromal cells during the proliferative phase which increases to 3-5% during 
the secretory phase, and reach a peak during the menstrual phase where they account 
for approximately 6-15% of cells in the tissue (Figure 1-12) (Kamat and Isaacson 1987, 
Salamonsen, Marsh and Findlay 1999, Salamonsen et al. 2002). Specifically, in the 
decidua macrophages represent ~20% of the immune cells and two distinct subtypes 
have been identified: CD11chigh and CD11clow which have 379 differentially expressed 
genes between them as determined by gene expression analysis by RNA microarray. 
Further analysis showed that genes enriched in CD11chigh macrophages were 
associated with lipid metabolism and inflammation while genes enriched in CD11clow 
macrophages were associated with ECM formation, muscle regulation and tissue 
growth. Notably both decidual subsets secrete both pro- and anti-inflammatory 
cytokines which may represent a phenotype unique to the endometrium which is 
important in maintaining a balance for foetal-maternal tolerance during pregnancy 
(Houser et al. 2011). Although macrophage numbers change throughout the menstrual 
cycle they express ERβ and GR but do not express ERα or PR (Hunt, Miller and Platt 
1998). The administration of exogenous oestrogen to women undergoing IVF has been 
associated with increased macrophage numbers in the endometrium (DeLoia et al. 
2002). Treatment of peripheral blood monocyte-derived macrophages with cortisol 
resulted in secretion of factors that altered endometrial endothelial cell expression of 
angiogenic genes (Thiruchelvam et al. 2016). 
The increase in macrophage numbers over the menstrual cycle is accompanied by a 
marked increase in immunoexpression of CXCL2 and CXCL8 in human tissues, 
complemented by in vitro cytokine secretion analysis of macrophages differentiated 
from peripheral blood monocytes (Evans and Salamonsen 2012, Maybin et al. 2018). 
These chemokines have roles in neutrophil chemotaxis and stimulating phagocytosis 
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and therefore macrophages are key mediators of the inflammatory response (Biswas 
et al. 2012). The huge increase in expression of macrophage-derived cytokines and 
proteases which stimulate the breakdown of collagens and ECM proteins have 
implicated macrophages in the initiation of decidual breakdown during menstruation 
(Salamonsen and Woolley 1999, Critchley et al. 2001a, Jeziorska et al. 1996). 
Furthermore it has been suggested that macrophages, as active phagocytes, have a 
primary role in apoptotic cell clearance and glandular remodelling (Garry et al. 2010). 
Production of VEGF by macrophages has implicated them in stimulating 
neoangiogenesis and revascularisation following tissue breakdown (Jabbour et al. 
2006b).  
In the endometrium of normal cycling mice, F4/80 immunopositive macrophages are 
abundant and located throughout the endometrial stroma (Mackler et al. 2000) and 
have been shown to change in number during the oestrous cycle, accumulating 
predominantly beneath epithelial cells expressing CSF-1. In op/op mice (recessive 
mutation in CSF1 gene) uterine macrophages are immature and reduced in number and 
apoptotic epithelial cells accumulate in the uterine lumen, highlighting a role for 
macrophages in epithelial cell clearance during oestrous (Shimada-Hiratsuka et al. 
2000). In contrast, using a mouse model of simulated ‘menstruation’ it was reported 
that F4/80 expressing macrophages do not associate with areas undergoing tissue 
remodelling were located distal to the lumen (Kaitu'u-Lino et al. 2007). The evidence 
presented above highlights is consistent with macrophages having the potential to play 
multiple roles in endometrial tissue function including regulation of breakdown and 
subsequent repair. 
1.4.5 Other immune cell types 
1.4.5.1 Mast cells 
Mast cells (MC) are granulocytes with roles in inflammatory processes. Human mast 
cells can classically differentiate into MCt or MCtc sub-types which express tryptase 
(t) only or tryptase and chymase (tc) respectively (Jabbour et al. 2006b). Both subtypes 
of MC have been identified in the human endometrium although in small numbers, 
with MCt preferentially located to the functionalis and MCtc preferentially located in 
Chapter 1: Introduction  48 
 
the basalis (Jeziorska et al. 1996, Sivridis et al. 2002). Recently our understanding of 
the MC phenotypes present in the endometrium was expanded to include three 
protease-specific phenotypes: MCt, MCtc and MCc, however the functional 
significance of distinct phenotype remains to be determined (De Leo et al. 2017). 
Endometrial MCs express ERβ and GR but not PR (Jabbour et al. 2006b). Notably the 
numbers of MCs do not changed dramatically according to cycle state although MCs 
do become activated prior to and during menstruation (Jeziorska et al. 1996, Drudy, 
Sheppard and Bonnar 1991). When MCs are activated they degranulate and release 
pre-formed mediators such as histamine, tryptase, bradykinin, heparin and 
proteoglycans. They can also release newly-synthesised mediators including 
platelet-activating factor, prostaglandins and leukotrienes (Berbic et al. 2014). Such 
mediators control cytokine action and activate MMP cascades and activation of other 
proteolytic enzymes resulting in the degradation of ECM essential to endometrial 
tissue breakdowns (Salamonsen et al. 2000, Berbic et al. 2014, Zhang et al. 1998). 
MCs can secrete precursors of MMP2 and MMP9 (Evans and Salamonsen 2012) and 
alter vascular permeability through release of histamine (Berbic et al. 2014, Menzies 
et al. 2011). These results suggest MCs might play a role in menstrual tissue 
breakdown but this requires confirmation. 
1.4.5.2 Eosinophils 
Eosinophils are cells of the innate immune system that are resident in mucosal tissue 
and arise from a common progenitor shared with basophils (Hogan et al. 2008). 
Eosinophils contribute to various physiological and pathological processes and can be 
a source of both regulatory and pro-inflammatory cytokines depending on their 
activation state (Kita 2011, Hogan et al. 2008). Eosinophils have only been identified 
in the human endometrium just prior to the onset of menstruation (Jeziorska et al. 
1996). Eosinophils are immunopositive for ER and GR (Peterson et al. 1981) but 
negative for PR (Aerts, Christiaens and Vandekerckhove 2002) mirroring other 
endometrial immune cell populations. Eosinophils can be detected by expression of 
eosinophil cationic proteins (ECP1 and ECP2) and when these proteins are 
extracellular the eosinophils are deemed to be activated (Acharya and Ackerman 
2014). Eosinophils express VEGF and MMPs when activated (Okada et al. 1997) 
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and endometrial eosinophils have been shown to express MMP9 (Jeziorska et al. 
1996).  A full characterisation of these cells and functions during the menstrual cycle 
remain to be determined.  
1.4.5.3 Dendritic cells 
Dendritic cells (DCs) are a heterogeneous population of leucocytes that play an 
essential role in modulation of the immune response, functioning primarily as antigen-
presenting cells (Inaba and Inaba 2005). DCs patrol through peripheral tissues and 
upon capture of foreign antigens, undergo maturation which alters their phenotype and 
function. Activated DCs migrate to lymph nodes and present processed antigens to T 
cells via MHC proteins. This activates T cells and launches the adaptive immune 
response (Bonasio and von Andrian 2006).  Although DCs have been identified in the 
endometrium, phenotype and functions are poorly characterised. One study reported 
there are significantly more immature DCs in the endometrium when compared to 
mature DCs with mature DCs mostly located in the basal stroma in both the 
proliferative and secretory phases. The functional significance of these findings remain 
unknown although it is suggested DCs may enhance localised regulatory mechanisms 
related to the immune response (Schulke et al. 2008) during pregnancy DC behaviour 
is altered to maintain tolerance (Tagliani and Erlebacher 2011). DCs express PR and 
progesterone appears to regulate DC function in the endometrium by limiting secretion 
of pro-inflammatory cytokines (Butts et al. 2008). A role in menstruation has not been 
described. 
1.4.5.4 T and B lymphocytes 
Lymphocytes such as B cells and T cells have crucial roles in the adaptive immune 
response. B cells are involved in the humoral immune response whereby they secrete 
antibodies against specific antigens, and then internalise and destroy the antigens. T 
cells (CD8+ cytotoxic T cells, CD4+ helper T cells, FOXP3+ regulatory T cells) are 
involved in the cellular immune response launched upon presentation of specific 
antigens through release of cytotoxins (Berbic et al. 2014). Following antigen-specific 
responses, specialised B and T cells retain a memory against that specific antigen and 
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therefore upon subsequent invasion, are rapidly activated to clear the antigen (Berbic 
et al. 2014).   
During the menstrual cycle the endometrium contains very few B cells (Thiruchelvam 
et al. 2013), which are thought to have a more prominent role in the maintenance of 
foetal tolerance during pregnancy by secreting immunomodulatory molecules such as 
IL-10, and fighting against infection (Fettke et al. 2014). While increases in differential 
lymphocyte count in the blood during the secretory phase can be attributed to increases 
in cytotoxic T cells, helper T cells and uNK cells (Tikare, Das and Dhundasi 2008) 
such changes are not reflected within the endometrial tissue itself. Both cytotoxic T 
cells and regulatory T cells (Tregs) are seen to decrease between the proliferative and 
secretory phase while γδ T cells remain unchanged, which is thought to promote a 
permissive environment at the time of implantation (Flynn et al. 2000). Tregs are a 
distinct subtype of T cells that play crucial roles in immunological regulation and 
suppression. Tregs have been shown to influence the proliferation and activation of a 
wide range of immune cells to alter cytokine release. Tregs ensure that immunological 
responses are tightly regulated (Berbic et al. 2014). To date no roles in endometrial 
repair have been asigned to either T or B cells. 
1.5 Endometrial progenitor cells 
1.5.1 Identification of stem/progenitor cells in human endometrium 
The endometrium exhibits an extensive regenerative capacity and it has been proposed 
that this is faciliated by tissue resident stem/progenitor cells (Dimitrov et al. 2008, 
Gargett, Schwab and Deane 2016). The concept of endometrial stem/progenitor cells 
was first introduced in 1978 by Prainishnikov (Prianishnikov 1978) however the first 
real evidence for the existence of stem/progenitor cells came from Chan et al who 
identified rare clonogenic cells (CFUs) in purified human endometrial cells (Chan, 
Schwab and Gargett 2004). Since then, a growing body of work has developed for the 
identification and functional classification of stem/progenitor cells some of which is 
detailed in the following sections. 
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A number of terms have been used to describe functions of adult stem/ progenitor cells: 
proliferation potential is the number of times a cell population doubles from a single 
cell (Gargett, Chan and Schwab 2007); self-renewal is a cell’s ability to divide and 
produce identical progeny (Bach, Renehan and Potten 2000). In contrast 
differentiation is defined as the ability of a cell to completely change phenotype and 
gene expression profile to take on the appearance and function of a different type(s) of 
cell (Figueira et al. 2011). Tissue reconstitution is the ability of a pure population of 
cells to give rise to multiple cell types of a tissue become organised to recapulate the 
architecture of the tissue in vivo (Gargett and Masuda 2010). A recent review by 
Gargett and colleagues has highlighted the importance of using functional assays and 
informative identification markers to identify endometrial stem progenitors (Gargett 
et al. 2016).  
1.5.1.1 Epithelial stem/progenitor cells 
During menstruation the glands in the basal compartment remain intact while both 
glands and surface epithelium in the functional layer are shed leaving a denuded 
stromal surface (Clancy 2009, Maybin and Critchley 2015). It has been reported that 
the basal glands contain a population of epithelial progenitor cells that can generate 
new epithelial cells to re-epithelialise the exposed surface (Gargett et al. 2007, Cousins 
et al. 2014). Epithelial progenitor cells have been also been identified by in cell 
suspensions derived from hysterectomy specimens (Chan et al. 2004, Schwab, Chan 
and Gargett 2005, Gargett et al. 2009). In these studies epithelial CFU showed stem 
cell properties such as self-renewal, proliferation, and differentiation into gland like 
structures composed of cells expressing cytokeratin in 3D culture with a stromal feeder 
layer (Gargett et al. 2009). Furthermore the Hoechst exclusion assay identified side 
population cells in the epithelial fraction of endometrium with stem cell properties 
(Cervelló et al. 2011, Kato et al. 2007, Kato 2012). Kato et al showed that epithelial 
SP cells aggregated into glad-like structures when cultured in Matrigel which had 
positive expression of epithelial cell markers e-cadherin and CD9 (Kato et al. 2007) 
which supported evidence generated for clonogenic epithelial cells (Gargett et al. 
2009). 
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A study investigating specific cell markers for identifying endometrial epithelial 
progenitor cells compared the gene profile of magnetic bead selected 
EpCAM+N-cadherin+ with EpCAM+N-cadherin- epithelial cells. N-cadherin+ cell 
were found to be more clonogenic, underwent more population doublings than 
N-cadherin- cells,  differentiated into cytokeratin+ gland-like structures in vitro, and 
were localised to epithelial cells in the base of glands in the basalis. Authors concluded 
that N-cadherin can be used to isolate human endometrial epithelial progenitor cells 
and may recognise a more primitive cell population (SSEA-1 positive) suggestive of 
an epithelial hierarchy in the basalis (Nguyen et al. 2017). Similarly, using single cell 
sequencing technologies Wu et al reported transcriptomic profiles of uterine epithelial 
from neonatal to sexually mature mice in vivo. This study identified and characterised 
ALDH1A1 as a marker that enriched for a population with stem/progenitor properties 
during early development with high proliferative and self-renewal capacity with the 
ability to undergo EMT and located mainly in newly formed basal glands (Wu et al. 
2017). Despite clear progress being made in identifying markers expressed by 
epithelial stem/progenitor cells, none have been shown to be exclusive to this 
population alone. The discovery of distinct epithelial stem/progenitor cell markers is a 
necessary prerequisite for prospective isolation and further characterisation. 
1.5.1.2 Stromal (mesenchymal) stem/progenitor cells 
Mesenchymal stem cells (MSCs) are multipotent cells that have been found to reside 
in many adult tissues and can produce more than one type of differentiated cell. MSCs 
have been identified in many adult tissues including the bone marrow, adipose tissue, 
dental pulp, pancreas, placenta, dermis and skeletal muscle, most predominantly 
located in the perivascular niche (Crisan et al. 2008, Feng et al. 2011, Hwang et al. 
2009, Marquez-Curtis et al. 2015, Murray et al. 2014, Phinney and Prockop 2007, Hass 
et al. 2011, Kalinina et al. 2011). MSCs represent a rare population of undifferentiated 
cells that have several properties that make them ideal candidates for regulating tissue 
homeostasis, including self-renewal, proliferative potential, multilineage 
differentiation and immunomodulatory activity (Crisan et al. 2008, Feng et al. 2011). 
During cell division MSCs undergo asymmetric cell division and thereby maintain the 
stem cell populations whilst also giving rise to differentiated progenitor cells which 
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are responsible for producing differentiated progeny called transit-amplifying cells 
(Kalinina et al. 2011) (Figure 1-14). 
 
 
Figure 1.14. Schematic representation of the hierarchy of stem-cell differentiation. Stem 
cells can undergo self-renewal or differentiate into progenitor cells. Progenitor cells can 
proliferate extensively and give rise to more differentiated transit amplifying cells which 
finally differentiate into terminally differentiated functional cells with low proliferative 
capacity. CFU assays with human endometrial cells produce both large and small colonies. It 
is believed that the large colonies arise from stem/progenitor cells while the small colonies 
arise from transit amplifying cells (based on Chan et al. 2004).  
 
In general MSCs are reported as plastic adherent cells that can differentiate in vitro 
into adipocytes, osteoblasts and chondrocytes (Crisan et al. 2008, Crisan et al. 2009), 
and express the following cell surface markers: CD29, CD44, CD73, CD90 and 
CD105 (Dimitrov et al. 2008) whilst being completely distinguishable from cells 
expressing CD31, CD34 or CD45.  
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1.5.2 Identification of putative MSCs in the endometrium 
1.5.2.1 Human endometrium 
Chan et al discovered a small population of colony forming cells in single cell 
suspensions of both epithelial and stromal cells isolated from human hysterectomy 
samples. They showed in vitro that 0.22±0.07% and 1.25±0.18% of epithelial and 
stromal cells respectively formed individual colonies following a 15 day culture 
period, identifying both large and small resulting colonies. It was hypothesised that 
large colonies had arisen from true stem/progenitor subpopulations which have a 
greater self-renewal capacity whilst the smaller colonies had arisen from transit-
amplifying cells (Figure 1-14) (Chan et al. 2004). A further study reported that 
proportions of clonogenic cells did not change across the menstrual cycle (Schwab et 
al. 2005). Further investigation has shown that clonogenic endometrial stromal cells 
exhibit properties of MSCs including self-renewal, a high proliferative potential and 
capacity multilineage differentiation in vitro into four mesodermal lineages at the 
single cell level: adipocytes, chondrocytes, osteoblasts and smooth muscle cells 
(Dimitrov et al. 2008, Gargett et al. 2009) however the proportions and preference for 
lineage differentiation is unknown at present.  
Other studies have used the Hoechst exclusion assay to detect side population (SP) 
cells which relies on the fact that stem cells have the ability to extrude the DNA 
binding dye Hoechst 33342 due to their increased expression of the ATP-binding 
cassette transporter protein ABCG2/Bcrp. Using this method the human endometrium 
has been shown to contain up to 5% SP cells in freshly isolated and short-term cultures 
of endometrial cells thought to represent a mixture of epithelial and stromal 
stem/progenitor cells (Cervelló et al. 2011, Hu et al. 2010, Kato et al. 2007, Kyo, 
Maida and Inoue 2011). It has been shown that the percentage of SP cells varies 
between subjects (0-5.11%) and higher percentages of SP cells were detected in both 
the proliferative and menstrual phases of the cycle (Masuda et al. 2015, Kato et al. 
2007, Tsuji et al. 2008, Masuda et al. 2010). SP cells in the endometrial stroma were 
located in both the basalis and functionalis and predominantly found in proximity to 
blood vessels (Kato et al. 2007). Characterisation of stromal SPs confirmed they 
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expressed markers of undifferentiated cells including c-kit/CD117 and Oct4 (Cervelló 
et al. 2011) and were negative for the stromal cell differentiation CD13, however when 
cultured in Matrigel aggregates of stromal-like cells formed which expressed CD13 
consistent with differentiation (Kato et al. 2007). In long-term cultures of SP cells they 
proliferated slowly and were able to form CFU which was in contrast to non-SP cells 
that became senescent after 3 months (Masuda et al. 2010).  
SP cells have also been shown to differentiate into multiple mesodermal lineages in 
vitro and upon engraftment under the kidney capsule of immuno-comproimised mice, 
reconstitute endometrial-like tissue in vivo (Cervelló et al. 2011) (Miyazaki et al. 
2012). In another study, flow cytometry analysis indicated that endometrial SP cells 
were a mixed population as 51% expressed CD31 (endothelial), 27% expressed 
EpCAM (epithelial) and 10-14% expressed CD10 or Pdgfrβ (stromal) (Miyazaki et al. 
2012). Although isolation of SP cells is believed to enrich for endometrial 
stem/progenitor populations it is unclear whether these populations are heterogeneous 
with only a subset of cells possessing stem cell-like properties. 
1.5.2.2 Mouse endometrium 
The Hoechst exclusion assay has only been used to identify SP cells in postpartum 
mouse endometrium but not in tissue from mice experiencing oetrous cycles. In these 
assays SP cells were enriched in clonogenic cells and differentiated in culture although 
their exact identity was not determined (Hu et al. 2010). The label retaining cell (LRC) 
method is more commonly used to identify stem/progenitor cells and their in vivo 
location in rodents. This method is based on the finding that stem/progenitor cells 
undergo less cell divisions than ‘fast cycling’ differentiated cell populations and 
therefore retain DNA integrated labels (eg. BrdU) for longer (Gargett et al. 2007). 
Using this technique, LRC cells have been identified as 3% of epithelial cells and 6-9% 
of stromal cells in the mouse endometrium (Chan and Gargett 2006b, Kaitu'u-Lino et 
al. 2012, Cao, Chan and Yeung , Patterson and Pru 2013). The LRC method has 
identified a putative endometrial stem/progenitor cell population cells in both the 
epithelium and in the stroma adjacent to blood vessels (Figure 1-15 (B)) (Gargett et al. 
2016). Further methods of identification were therefore required to compliment current 
knowledge and fully characterise mouse endometrial stem/progenitor cells. 
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In summary, labelling and clonogenic assays have been used to identify putative 
endometrial epithelial and mesenchymal stem/progenitor cells in human and mouse 
endometrium (Figure 1-15 (A-B)) with the latter located predominantly in a 
perivascular region (Schwab and Gargett 2007).  
 
 
Figure 1-15. Hypothesised location of stem/progenitor cells in human and mouse 
endometrium. (A) In human endometrium epithelial progenitor cells are located in the base 
of glands in the basalis while MSCs are located near blood vessels. Human endometrial MSCs 
have been identified as clonogenic or SP cells. (B) In mouse endometrium, LRC hypothesised 
to be stem/progenitor cells are located in the luminal epithelium and near blood vessels in the 
stroma (based on Gargett and Masuda 2010). 
 
1.5.3 Identification of cell surface markers on putative endometrial 
mesenchymal stem cells 
1.5.3.1 Human endometrium 
The expression of typical stem cell markers such as Oct4, c-kit, CD90, CD44, CD73, 
CD166 (Cho et al. 2004, Cervelló et al. 2007, Indumathi et al. 2013) and MSC markers 
such as CD29, SUSD2 and CD105 (Schwab and Gargett 2007, Dimitrov et al. 2008, 
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Phinney and Prockop 2007, Hwang et al. 2009, Marquez-Curtis et al. 2015) have been 
confirmed in human endometrial MSCs (studies using immunohistochemistry and 
flow cytometry on cells identified by the clonogenic and SP techniques). When 
analysing clonogenic stromal cells by flow cytometry Gargett et al reported they 
expressed MSC markers CD29, CD44, CD73, CD90, CD105, CD140b and CD146 but 
did not express endothelial or immune cell markers such as CD31, CD34 and CD45, 
although these were also present in other cell types and hence not MSC specific 
(Gargett et al. 2009).  
In another study, the RNA binding protein Musashi-1 which is known to be involved 
in the control of asymmetric cell division of neural and epithelial progenitor cells, was 
found to be more highly expressed in the human endometrium than the myometrium, 
and more abundant in the basalis when compared to the functionalis. Cells expressing 
Musashi-1 also expressed Notch1 and telomerase and were concluded to be 
endometrial MSCs (Götte et al. 2008). The same group reported that there was an 
upregulation of Musashi-1 expressing cells during the proliferative and menstrual 
phases of the cycle and increased numbers detected in lesions of endometriosis and 
endometrial carcinoma (Götte et al. 2008).  
When culturing human endometrial stromal cells, it was also noted that they only 
formed colonies when PDGF-BB was present in the culture medium which lead to the 
hypothesis that endometrial MSCs expressed Pdgfrβ (Chan et al. 2004, Schwab et al. 
2005). Notably Pdgfrβ and the adhesion molecule CD146 are expressed by MSCs in 
bone marrow, dental pulp and other tissues (Shi and Gronthos 2003, Bühring et al. 
2007, Armulik, Genové and Betsholtz 2011). In a study by Schwab and Gargett, cells 
co-expressing Pdgfrβ and CD146 were isolated from human endometrial biopsies and 
compared to Pdgfrβ-CD146- cells. The Pdgfrβ+CD146+ cells represented 1.5% of the 
sorted population and were enriched 8-fold for CFU when compared to Pdgfrβ-
CD146- counterparts (7.7±1.7% versus 0.7±0.2%, p<0.0001). They also had the ability 
to differentiate into various mesodermal lineages including adipogenic, chondrogenic, 
osteogenic and myogenic. Immunohistochemistry located cells co-expressing Pdgfrβ 
and CD146 to the perivascular niche and showed that Pdgfrβ was also expressed by 
stromal fibroblasts while CD146 could also be detected in myometrial tissues. The 
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authors hypothesised that co-expression of these markers identified perivascular 
pericytes which were responsible for mesenchymal differentiation (Schwab and 
Gargett 2007).  
Further to this, a study was undertaken to identify a single marker for purifying MSCs 
from the human endometrium using an antibody panel with novel specificities. The 
protein SUSD2 (sushi domain containing-2) which is identified by the W5C5 antibody 
was found on the previously identified endometrial MSC population. SUSD2+ cells 
represented 4.2±0.6% of the total endometrial stromal cells, were located in the 
perivascular niche and when xenografted under the kidney capsule of 
immunocompromised mice, gave rise to endometrial stromal tissue (Masuda et al. 
2012). Immunohistochemistry and flow cytometry revealed they all expressed CD146 
and the majority also expressed Pdgfrβ. Once isolated SUSD2+ cells exhibited 
significant potential for clonogenicity (3.8%, 14.7 fold increase over W5C5- cells), 
self-renewal and multilineage differentiation in vitro when compared to their SUSD2- 
counterpart (Masuda et al. 2012). Notably, SUSD2+CD146+ cells generated more 
CFUs than Pdgfrβ+CD146+ cells and were more highly increased during the 
proliferative phase of the cycle (Masuda et al. 2012). This study was the first to report 
a single marker which could be used to identify MSCs in the human endometrium: 
RNA sequence analysis of cultured endometrial SUSD2+ and SUSD2- confirmed that 
SUSD2+ cells had a gene signature consistent with a pericyte phenotype (Murakami 
et al. 2014). 
1.5.3.2 Mouse endometrium 
Putative MSCs in the mouse endometrium using the LRC method have been located 
near to CD31+ endothelial cells of blood vessels and have been shown to express c-
kit/CD117 and Oct4 (Cervelló et al. 2007) and other typical MSC markers including 
Pdgfrβ, CD146, CD44, CD90 and Sall4 (Chan and Gargett 2006b). They were 
negative for CD45 (leucocyte marker), and positive for αSMA (myofibroblast marker) 
leading to the hypothesis that they are perivascular cells or pericytes (Chan and Gargett 
2006b).  
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A study by Deane et al, (Deane et al. 2016) investigated the expression of mouse 
telomerase reverse transcriptase (mTert) as a putative stem cell marker. Rare mTert 
expressing cells were located in the endometrial stromal and epithelial compartments 
and showed morphological heterogeneity. The subpopulations of mTert+ cells also 
expressed epithelial (EpCAM+), endothelial (CD31+) and haematological (CD45+) 
markers hence as with traditional LRC techniques mTert identified a heterogeneous 
population of cells in the endometrium and was not specific to  MSCs. In a more recent 
study a cell population co-expressing Pdgfrβ and CD146 was identified in mouse 
endometrium in a perivascular location, as these two markers were also expressed by 
mouse embryonic stem cells the authors concluded these cells might play an important 
role in human endometrial development (Parasar et al. 2017).  
In summary evidence for a cell-specific marker for stromal MSC/stem/progenitor cells 
in the mouse endometrium remains limited although comparing results from mouse 
and human suggest the stromal MSC may have a perivascular location and exhibit 
expression of Pdgfrβ and CD146 suggestive of a pericyte phenotype (Gargett et al. 
2016).  
1.5.4 Perivascular pericytes in the endometrium  
Pericytes are mural cells that sit on the outer surface of blood cells in close contact 
with underlying endothelial cells, often encapsulated in the same basement membrane 
(Mills et al. 2013, Ansell and Izeta 2015, Bodnar et al. 2016, Spitzer et al. 2012). They 
have a fibroblast-like morphology with a prominent cell body and large nucleus and 
several long cytoplasmic processes which allow them to be in contact with more than 
one endothelial cell through adhesion molecules such as fibronectin, N-cadherin and 
β-catenin (Mills et al. 2013, Armulik et al. 2011), outlined in Figure 1-16. 
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Figure 1-16. Schematic representation of the structure and function of pericytes. (A) 
Pericytes are cells that have membranous processes that wrap around endothelial cells of blood 
vessels. (B) Pericytes are embedded in the basement membrane of blood vessels and kept in 
close contact with endothelial cells through adhesion molecules such as N-cadherin (N), 
fibronectin (FN) and β-catenin (C) Pericytes and endothelial cells are in close proximity and 
release factors to regulate each others function (proliferation, migration, maturation) including 
PDGF and Angpt1. Other factors that regulate pericyte and endothelial cell function include 
TGFβ, EGF and Cxcl12 (based on Armulik et al. 2011, Ribatti, Nico and Vacca 2015). 
 
Pericyte-endothelial cell communication is fundamental to the survival and function 
of each cell type. When PDGF is knocked out in mice it is embryonically lethal and 
the embryos exhibited vessels that were completely denuded of pericytes resulting in 
severe haemorrhage (Holmgren et al. 1991). This study suggests pericyte proliferation 
and migration is regulated by endothelial cells and vice versa (Armulik et al. 2011). 
Pericytes are present to varying degrees, in every human tissue with primary roles in 
regulating blood flow, perfusion of fluids, cells and proteins between capillaries and 
tissues, and supporting vascular development (Mills et al. 2013, Ansell and Izeta 2015, 
Bodnar et al. 2016, Spitzer et al. 2012). The most well described function of pericytes 
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is to regulate vessel tone and permeability of mature vessels as well as modulating 
angiogenesis (Ahmed and El-Badri 2017). Pericyte coverage is variable between 
tissues with the relative density proposed to be related to specific functions in each 
tissue. In the retina and central nervous system (CNS) the pericyte to endothelial ratio 
is 1:1 offering tight support to these regions of high blood pressure whereas in the 
skeletal muscle this is as low as 1:100 in vasculature that experiences much lower 
blood pressure (Bodnar et al. 2016).  
Pericytes have previously identified as having putative stem-cell functions as they are 
clonogenic and capable of giving rise to cells of the mesodermal lineages including 
chondrocytes, adipocytes and osteoblasts (Mills et al. 2013, Murray et al. 2014, Feng 
et al. 2011). Moreover it has been suggested by several groups that pericytes are MSCs 
as they express the MSC markers CD105, CD73 and CD90 (Bodnar et al. 2016), or 
that all MSCs are pericytes (Caplan 2008, Cano, Gebala and Gerhardt 2017, de Souza 
et al. 2016). Pericytes express Pdgfrβ and CD146 which supports the hypothesis that 
they represent MSC like cells. Other receptors expressed by pericytes include Egfr, 
αSMA, Desmin, NG2, Rgs5 (Mills et al. 2013), Angpt2, Igf, Ngf and Pdgf (Ansell and 
Izeta 2015, Crisan et al. 2008) some of which have been found to be expressed by 
stem/progenitor cells in the human endometrium (Spitzer et al. 2012, Ansell and Izeta 
2015, Crisan et al. 2008, Crisan et al. 2009). Murine pericyte markers include Pdgfrβ, 
NG2, CD13, αSMA and Desmin (Armulik et al. 2011). 
Although the markers detailed above can be used to identify pericytes in human and 
mouse tissues, none of them are exclusive for pericytes (Bodnar et al. 2016)  nor are 
they expressed uniformly by pericytes in all tissues consistent with adaptation of cells 
to local tissue environments (Mills et al. 2013). Expression of these markers can also 
vary depending on the type of vessel they are surrounding for example NG2+/αSMA+ 
pericytes surround arterioles while NG2-/αSMA+ pericytes surround venules and 
NG2+/αSMA- pericytes surround capillaries, and αSMA expression has been found to 
correlate with the extent of vasoconstriction in a vessel (Crisan et al. 2012). Although, 
Pdgfrβ and CD146 are considered to be ubiquitously expressed by pericytes in all 
tissues (Bodnar et al. 2016) these markers are also expressed by a number of other cell 
types.  
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In summary, there is some limited evidence related to the characterisation of pericytes 
as MSCs in uterine tissues although it has been suggested that endometrial MSCs may 
be similar to vSMC, pericytes or even  endothelial cells since MSC progeny appear to 
share common markers with these cell types (Gargett et al. 2007). 
1.5.5 Role of endometrial stem/progenitor cells in endometrial repair 
Although stem-like cells have been identified in the human endometrium the precise 
contribution of these cells to endometrial repair and remodelling remains unclear 
(Schwab et al. 2005, Schwab and Gargett 2007, Cervelló et al. 2007) although some 
evidence has come from use of xenograft and LRC experiments. Using unfractionated 
single-cell suspensions of endometrium from hysterectomy tissue that were grafted 
under the kidney capsule of immunocompromised mice, Masuda and colleagues were 
able to generate endometrial like tissue which expressed markers of stromal cells 
(vimentin, CD10, CD13), glandular epithelial cells (CD9) and endothelial cells 
(CD31), some of which had associated αSMA+ vascular smooth muscle cells with a 
functional response to oestrogen and progesterone inducing a menstrual-like cycle 
(Masuda et al. 2007). Engraftment of purified SP cells also resulted in formation of 
endometrial tissue comprising both stromal and epithelial compartments with an 
associated establishment of vasculature (Cervelló et al. 2011, Masuda et al. 2015). 
These results indicate that a population of putative stem/progenitor cells exist in 
endometrial tissues that have the ability to regenerate endometrial tissue in vivo, 
however their phenotype was not further defined.  
A study by Kaitu’u et al used the LRC technique in mice to identify putative 
stem/progenitor cells during endometrial repair with results suggesting that a 
population of epithelial progenitor cells might reside in the basal glands and that 
stromal LRC could have an active role to play in endometrial repair (Kaitu'u-Lino et 
al. 2012). Similarly, a LRC study looking at postpartum endometrial repair showed 
that stromal LRC numbers were maintained throughout pregnancy, located at the 
inter-implantation/placental loci, and upon parturition were shown to proliferate 
(BrdU+Ki67+) with stromal LRC returned to a prepartum pattern of distribution by 
postpartum day 7 (Cao, Chan and Yeung 2015). Using more sophisticated genetic fate 
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mapping, Patterson et al have shown that during postmenstrual and postpartum 
endometrial repair in mice, stromal cells have the ability to undergo a mesenchymal-
to-epithelial transition, demonstrated by EYFP expression in the endometrial 
epithelium of Amhr2-Cre;Rosa-Stopfl/fl-eYFP mice (mesenchymal specific) (Patterson et 
al. 2013). This result has been recapitulated by others (Cousins et al. 2014) confirming 
a role for mesenchymal cells in both post menstrual and postpartum repair. Despite 
current knowledge, the precise phenotypes of the cells described in each of these 
different studies remain unknown. 
As almost every study based on identifying and characterising stem/progenitor cells in 
the endometrium have localised them to the perivascular niche, it has been postulated 
that the endometrial stem/progenitor cells in the stroma may be the same as the 
perivascular pericytes described above (Tintut et al. 2003, Gargett et al. 2016). Notably 
cells isolated from endometrial tissue by co-expression of Pdgfrβ and CD146 had 
colony forming ability and multilineage differentiation potential when cultured in 
adipogenic, osteogenic, myogenic and chondrogenic induction medium. Putative 
MSCs/pericytes expressed gene signatures associated with self- renewal, 
multipotency, differentiation and immunomodulation (Spitzer et al. 2012) and 
expressed high levels of CXCR4 which when bound by CXCL12 is known to stimulate 
the migration of MSCs suggesting they are poised to respond to chemotactic signals 
released during endometrial injury and repair (Spitzer et al. 2012). Although it is 
speculated that endometrial pericytes may contribute to the regeneration of 
endometrial tissue following menstruation, their precise contribution is unknown.  
A few studies have suggested bone marrow progenitor cells could contribute to 
endometrial repair. Using a mouse model where HLA-mismatched bone marrow 
transplants were undertaken, donor-derived cells were detected in the endometrial 
tissue accounting for 0.2-48% of epithelial cells and 0.3-51% of stromal cells 
suggesting that BM cells might make a small contribution to endometrial tissues 
(Taylor 2004). In a further BM transplant study, BM cells were harvested from a 
transgenic donor (ubiquitous GFP expression) and injected into irradiated mice. GFP+ 
cells were found in the endometrial stroma as soon as 3 months post-transplant 
comprising 47.3-72.2% of the total BMDCs in the stroma by 12 months. BMDCs were 
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not detected in the epithelial compartment until 12 months (Morelli, Rameshwar and 
Goldsmith 2013). Gene expression profiling and in vitro assays have been performed 
to compare human endometrial MSCs with BM-MSCs which found a large degree of 
similarity between the two cell types although endometrial MSCs were found to have 
greater population doubling. 52 core genes were shared including those associated with 
stemness, self-renewal and members of the Notch, TGFβ, FGF and Wnt signalling 
pathways. 16 genes were significantly downregulated in eMSCs including VCAM1 
and IGF and 16 genes were significantly upregulated including the following cytokines 
and growth factors: G-CSF, GM-CSF, VWF, IL1β, GDF15 and KDR. Differences 
suggest endometrial MSCs are better suited to have roles in angiogenesis, cell 
adhesion, proliferation, migration and differentiation (Gaafar et al. 2014). Definitive 
roles remain to be determined. 
1.6 Disorders of the endometrium that might be associated 
with aberrant endometrial repair or regeneration 
It is believed that abnormalities in the regulation of physiological endometrial repair 
during the menstrual cycle may contribute to disorders of the endometrium including 
endometriosis, endometrial cancer, heavy menstrual bleeding (HMB) and Asherman’s 
syndrome (Dimitrov et al. 2008). Although these conditions are prevalent and pose a 
substantial health burden, little is known about their pathogenesis (Gargett and Chan 
2006) and it is possible that alterations in the number, function, regulation and location 
of endometrial stem/progenitor cells and/or immune cell populations may be involved 
in the aetiology of these conditions (Chan and Gargett 2006b, Gargett and Chan 2006, 
Du and Taylor 2007). In addition, in all these conditions a putative link to the 
malfunction in macrophage behaviour has been suggested and therefore careful 
characterisation of macrophage phenotype and function in physiological endometrial 
repair and proliferative disorders is required. Thus if the contribution(s) of 
stem/progenitor cells and/or macrophages to the scar-free repair process exhibited by 
endometrial tissue can be determined such knowledge could inform the development 
of cell-based therapies or treatments that would manipulate an abnormal cell response 
to treat endometrial disorder such as those outlined below.  
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1.6.1 Heavy menstrual bleeding 
Heavy menstrual bleeding (HMB) is defined as abnormal menstrual bleeding in excess 
of 80ml per cycle affecting in 1 in 3 women in the perimenopausal period (Hapangama 
and Bulmer 2016). An excessive or unresolved inflammatory response is often 
associated with delayed healing and is thought to underpin the pathophysiology of 
HMB. It has been shown that the endometrium of women suffering from HMB 
displays an increased inflammatory response with increased levels of pro-
inflammatory TNFα expression (Malik et al. 2006) and increased expression of COX 
1 and COX-2 which promote excess synthesis of prostaglandins (Smith, Jabbour and 
Critchley 2007). HMB was also found to be associated with a shift in the PGF2α/PGE2 
ratio with increased concentrations of PGE2 measured in menstrual blood which may 
impact on vessel stabilisation during endometrial repair (Smith et al. 2007). In a study 
by Biswas et al, endometrial leucocyte populations were compared in the endometrium 
of women with and without HMB suggesting dysregulated NK number and function 
may contribute to the disorder possibly by adverse impacts on vascular maturation 
(Biswas Shivhare et al. 2015). 
It is well known that endometrial macrophages are key players in regulating the 
initiation of menstruation and have been localised to regions of endometrial repair and 
remodelling (Thiruchelvam et al. 2013, Salamonsen et al. 2002). In women 
complaining of unscheduled bleeding, Clarke et al found that there was an increase in 
the number of macrophages and associated cytokines in the endometrium (Clark et al. 
1996) and therefore dysregulation of macrophages may have roles in abnormal 
endometrial bleeding although mechanisms are poorly understood.   
Pericytes are known to have roles in regulating endothelial and blood vessel function 
including angiogenesis, vasoconstriction and regulation of blood flow (Armulik et al. 
2011). It has been shown that women with HMB have increased blood flow during 
menstruation when compared to healthy controls which is suggestive of a decreased 
hypoxic response and lack of vascular smooth muscle function (Hurskainen et al. 
1999). In one study the association of pericytes and blood vessels in endometrial 
tissues was compared in healthy controls and women suffering from HMB and it was 
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concluded that low pericyte coverage of endometrial vessels found in the endometrium 
from women suffering from HMB may contribute to vessel fragility and excessive 
blood loss during menstruation (Andersson et al. 2015). Irregular bleeding is also 
observed in up to 60% of women using HRT with significant differences in 
endometrial blood vessels including a decreased density of endothelial cells, decreased 
organisation of endothelial cells and significantly reduced number of pericytes 
supporting vessel structure in women taking HRT. This study suggests that irregular 
bleeding can be attributed to dysfunctional blood vessels which may in part be due to 
loss of pericyte support (Hickey et al. 2003, Hickey et al. 2008). 
Although the precise mechanisms responsible for the origin of HMB are unknown, 
links to defective blood vessel and pericyte function and an aberrant inflammatory 
response have been drawn. Understanding mechanisms that drive endometrial repair 
may highlight important roles for immune cells and putative stem/progenitor cells and 
manipulation of these cell populations may provide novel strategies in the management 
and/or treatment of this common disorder. 
1.6.2 Asherman’s syndrome 
Asherman’s syndrome (AS) is characterised by a thin atrophic endometrium and 
intrauterine adhesions and scars composed of fibrous tissue; it presents with symptoms 
including amenorrhea, pregnancy complications and infertility, occurring in 13% of 
women undergoing routine infertility evaluation (Gargett and Healy 2011). AS most 
frequently arises following damage to the basal layer of the endometrium as a result 
of infection or trauma especially in the postpartum period which is thought to deplete 
the endogenous stem/progenitor cell population (Kodaman and Arici 2007, Sahin 
Ersoy et al. 2017). The application of stem/progenitor cells as a therapeutic option to 
treat AS is under consideration. Notably it has been shown that post-injury delivery of 
BM-MSCs in a mouse model of AS improved reproductive outcome (Alawadhi et al. 
2014). Ersoy et al showed that intrauterine administration of CXCL12 resulted in 
increased engraftment of endogenous BM-MSCs into the uterus in a mouse model of 
AS which resulted in a shorter time to conceive and larger litter sizes, restoring 
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reproductive outcome to be comparable to controls. Notably a decrease in fibrosis and 
return to normal uterine structure was also observed (Sahin Ersoy et al. 2017) 
In a human trial with a patient suffering from severe AS, adult autologous stem cells 
were isolated from the patient’s own bone marrow and endometrial angiogenic stem 
cells separated using immunomagnetic isolation and antibodies against CD9, CD44 
and CD90. A total of 39 million marker-positive cells were administered to the 
patient’s uterine cavity under ultrasound guidance after curettage, and subsequently 
the patient was given cyclical hormonal therapy; 14-19 days later there was an increase 
in endometrial thickness detected and good vascularity with the presence of mature 
spiral vessels. IVF was later performed and a pregnancy was established (Nagori, 
Panchal and Patel 2011). A similar trial was carried out by Gargett and Healy during 
which the thin endometrium of an AS patient was successfully treated by 
transplantation of BM fibroblasts and MSCs to the uterine cavity with concurrent 
curettage. The authors argue that both methods may have independently or 
synergistically promoted endometrial growth: BM cells by promoting angiogenesis 
and tissue growth through the secretion of trophic factors; and the curettage by 
stimulating endogenous stem/progenitor cell populations to regenerate endometrial 
tissue (Gargett and Healy 2011). 
Improved understanding of the mechanisms of physiological endometrial repair might 
improve treatment of AS without the requirement of stem-cell transplantation but more 
investigations are required. 
1.6.3 Endometriosis 
Endometriosis is a condition where endometrial-like tissue grows outside the uterus 
primarily on the peritoneum, ovaries and rectovaginal septum (Giudice and Kao 2004, 
Giudice 2010). It affects 6-10% of women of reproductive age and is associated with 
severe pelvic pain and irregularities in menstruation and is present in up to 50% of 
women presenting with infertility (Giudice 2010, Sensky and Liu 1980). The most 
widely accepted theory for why some women develop endometriosis is based on transit 
of endometrial cells and tissue fragments into the peritoneal cavity during 
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menstruation which attach to the peritoneum, invade into the tissue and establish a 
nerve and blood supply (Sampson 1927, Corwin 1997, Giudice 2010). A role for both 
inflammation and endometrial progenitor/stem cells in the aetiology of the disorder 
has been proposed by multiple authors (reviewed by Vercellini et al. 2014). 
The activation of macrophages has been reported in both peritoneal fluid and ectopic 
endometriotic lesions and a significant increase in macrophage cell numbers has also 
been detected in the intra-uterine endometrium of women with endometrosis (Berbic 
et al. 2009). Expression of fractaline/CX3CR1 was also increased. This factor 
important for lymphocyte and monocyte chemotaxis that has been shown to enhance 
stromal cell proliferation and invasion (Hou et al. 2016). These studies suggests a link 
between immune changes in the eutopic endometrium and the pathophysiology of 
endometriosis and associated pain and infertility, however it is still unclear whether 
these changes are primary or secondary to the establishment of disease (Jolicoeur et 
al. 1998, Berbic et al. 2009, Akoum et al. 2006, Hou et al. 2016)  
In a study using a mouse model of endometriosis in combination with MacGreen 
reporter mice as donors and recipients (reciprocal transfers) Greaves et al reported that 
macrophages from both the recipient peritoneum and donor menstrual endometrial 
tissue contribute to the inflammatory microenvironment of the endometriotic lesion 
(Greaves et al. 2014). Bacci et al reported that macrophage in patients with 
endometriosis were alternatively activated (expressed high levels of CCL63/CD206) 
and that adoptive transfer of alternatively activated macrophages enhanced lesion 
formation in mice (Bacci et al. 2009). Mei et al found that peripheral blood-derived 
monocyte (PBMC)-driven macrophages co-cultured in vitro with endometrial stromal 
cells from women with endometriosis displayed lower phagocytic activity and an 
immunosuppressive phenotype when compared to healthy controls.  
It has also been proposed that stem/progenitor cells in menstrual tissue contribute to 
formation of endometriosis lesions: there is evidence to show that women with 
endometriosis have a more extensive basal compartment in their endometrium to start 
with (Leyendecker et al. 2002, Leyendecker, Wildt and Mall 2009, Hufnagel et al. 
2015). Some endometriotic lesions are monoclonal suggesting a single cell origin 
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whilst others are polyclonal and believed to originate from stromal cells, BM-MSCs 
and stem/progenitor cells from retrograde menstrual tissue (Kao et al. 2003). Human 
endometrial MSCs isolated from women undergoing laparoscopy were shown to 
express MSC markers including CD73, CD90, CD105 and CD166 and differentiate 
into osteoblasts, adipocytes and chondrocytes in vitro and have high tropism to 
endometriotic tissues in vivo (Cheng et al. 2017). When endometrial MSCs isolated 
from eutopic and ectopic endometrial tissue from women with endometriosis were 
cultured with HUVECs a subpopulation of MSCs was found to express CD31 and 
form tube like structures. These cells had increased expression of VEGFR2, TEK 
receptor tyrosine kinase and vascular endothelial-cadherin mRNAs and unchanged 
expression of c-myc, Vimentin, N-cadherin and SUSD2. This suggests that MSCs 
have the ability to undergo endothelial differentiation and may be involved in the 
development of vascular support for endometriotic lesions (Canosa et al. 2017). 
Whilst the proportion of different stromal cell types in the endometrium in women 
with or without endometriosis appear to be similar (CD90+ fibroblasts, αSMA+ 
myofibroblasts) (Konrad et al. 2017), changes in the epithelial cell phenotype has been 
noted with both K19 and MUC1 being significantly decreased and vimentin increased 
in endometriotic lesions suggestive of an EMT transition (Konrad et al. 2018). In 
ovarian endometriosis increased expression of genes associated with EMT including 
vimentin, slug and N-cadherin was noted in association with an increase in Mmp7.  
Matsuzaki et al also hypothesised that EMT-like and MET-like processed are involved 
in the pathogenesis of endometriosis. By analysing molecular markers of EMT such 
as cytokerain, E-cadherin, N-cadherin, Vimentin and β-catenin in various forms of 
endometriosis they showed that epithelial cells of ‘red’ lesions showed decreased 
expression of epithelial markers and increased expression of mesenchymal markers  
while epithelial cells of ‘black’ lesions had increased expression of epithelial cell 
markers and some expression of mesenchymal cell markers. This suggested that the 
regulation of EMT and MET may be important in the pathophysiology and progression 
of endometriosis (Matsuzaki and Darcha 2012). The activity of endometrial 
stem/progenitor cells may be important in establishing lesions so understanding how 
stem/progenitor cells give rise to endometrial tissue during repair may highlight ways 
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to hinder lesion development. Further to this as it has been shown that endometrial 
MSCs show significant tropism for endometriotic lesion tissue when applied both in 
vitro and in vivo (Cheng et al. 2017) and therefore may have potential in serving as 
vectors for targeted delivery of therapeutics. By increasing our understanding of how 
specific immune cell and stem/progenitor cell populations respond in normal 
endometrial repair novel targets may be identified and therapeutic strategies 
developed. 
1.7 Model systems for studying endometrial repair 
Studies seeking a greater understanding of the mechanisms responsible for 
endometrial breakdown and repair carried out by examining tissue samples recovered 
from endometrium across the menstrual cycle have been complemented and enhanced 
using ex vivo human tissue explants/xenografts and animal models. Developing 
informative animal models recapitulating the mechanisms of endometrial 
shedding/repair has not been easy as menstruation is only a natural process in a few 
Old World Primates (Finn 1987, Emera et al. 2012a), bat species (Rasweiler 1991, 
Rasweiler and de Bonilla 1992, Rasweiler, Badwaik and Mechineni 2011) and the 
recently discovered Spiny mouse (Bellofiore et al. 2017, Bellofiore et al. 2018). 
Although menstruation does not occur naturally in laboratory mice ‘menstrual’ models 
based on induction of artificial decidualisation and hormonal manipulation are 
attractive as they can benefit from availability of a large number of transgenic lines. 
These different models are discussed below. 
1.7.1  Xenograft models 
One of the most striking examples of the use of endometrial explants were the studies 
by Markee (1940) who transplanted endometrium from rhesus macaques into the 
anterior chamber of the eye and was then able to directly observe changes in tissue 
architecture and vascular constriction (Markee 1978).  
By manipulating the steroid microenvironment, the human menstrual cycle can be 
mimicked in tissue xenografts that can be maintained long-term in immune 
compromised mice as recipients. For example changes consistent with menstruation 
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can be induced by treatment with oestradiol-17β for 14 days followed by treatment 
with oestradiol-17β plus progesterone for 14 days followed by cessation of hormonal 
support (Matsuura-Sawada et al. 2005). Interestingly when samples from the 
functional layer of human endometrium were transplanted and stimulated to undergo 
a simulated menstrual event, hormonal withdrawal induced a rapid decrease in graft 
volume which was stopped when oestrogen was applied again however the grafts did 
not increase in size thereafter (Coudyzer et al. 2015). These data would be consistent 
with a role for basal endometrium in endometrial regeneration. 
In other studies mouse CD31+ cells were detected in both transplanted and host tissues 
consistent with the establishment of a blood supply. An increase in the number of 
human CD45+ immune cells has also been noted, showing a peak during the simulated 
secretory phase. In contrast, a peak in mouse CD45+ cells was seen 3 days following 
P4 withdrawal and surpassed the number of human CD45+ cells indicating that 
recruitment of immune cells from the circulation is an important response to 
endometrial tissue breakdown: the expression of MMP1, 2 and 9 were also 
significantly increased after P4 withdrawal consistent with endometrial tissue 
breakdown (Guo et al. 2011). A role for hypoxia has also been investigated using this 
method with authors reporting they did not find significant HIF1-α immunostaining 
after hormone withdrawal concluding that hypoxia was not essential to trigger 
menstrual-like tissue breakdown in human endometrial xenografts (Coudyzer et al. 
2013). Human endometrial tissue has also been regenerated from endometrial 
clonogenic (Chan et al. 2004), SP cells (Cervelló et al. 2011) and perivascular SUSD2+ 
cells (endometrial MSCs) when transplanted beneath the kidney capsule in 
immunocompromised mice (Gurung et al. 2018) extending studies on endometrial 
tissue fragments and supporting a role for stem/progenitor cells in tissue regeneration. 
1.7.2  Non-human primate models 
The rhesus macaque is an example of a non-human primate that undergoes 
spontaneous decidualisation and menstruation during a 28 day cycle and this species 
has been widely used for studying the process of menstruation (Demers et al. 1972). 
Rhesus macaques have the advantage of being trained to allow for vaginal swabs to 
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detect bleeding and the insertion of tampons to quantitate blood loss. In addition, 
naturally cycling macaques often display spontaneous menstrual disorders making 
them ideal for clinically relevant studies of conditions like heavy menstrual bleeding 
(Brenner and Slayden 2012). The structure of the macaque uterus is morphologically 
similar to the human uterus and contains the same cellular compartments: luminal 
epithelium, functionalis, basalis and myometrium which undergoes similar processes 
of decidualisation and spiral artery formation in preparation for pregnancy (Brenner et 
al. 1996). To reduce variability in bleeding patterns, macaques can be ovariectomised 
and treated with a hormone regime that recapitulates the cycle allowing for consistent 
collection of tissues from the premenstrual, menstrual and postmenstrual phases 
(Brenner and Slayden 2012, Brenner et al. 1996). 
In this species dynamic roles for MMPs and TIMPS in endometrial breakdown and 
repair have been demonstrated (Brenner et al. 1996). Significant increases in the 
expression of fibronectin, Itga5 and Itgb1 were also noted during menstruation, 
concentrated in the glandular epithelium and stroma of the functionalis (Cao et al. 
2007). Notably VEGF mRNA was upregulated 1-2 days after progesterone withdrawal 
and in the healing epithelium during repair which was accompanied an increase in 
VEGFR1 and 2 in endothelial cells immediately below the luminal surface, implicating 
epithelial-derived VEGF in neoangiongenesis during endometrial regeneration (Nayak 
and Brenner 2002). Further to this, Fan et al demonstrated that blocking VEGF action 
during menstruation completely inhibited neoangiogenesis and disrupted the process 
of re-epithelialisation. These studies provided key insights into the importance of 
VEGF in postmenstrual endometrial repair (Fan et al. 2008, Germeyer et al. 2005).  
A critical window for the duration of progesterone withdrawal has been identified by 
adding the progesterone secreting pellet back at multiple time points between 12 and 
72hrs following withdrawal. Notably menses could be blocked if progesterone was 
added back 12 and 24hrs after removal, but rescue was reduced at 30hrs and 
menstruation proceeded if add back of progresterone was 36hrs or later indicating that 
a critical period of progesterone withdrawl exists and lasts approximately 36hrs in the 
macaque. Notably progesterone replacement significantly inhibited the expression of 
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MMP1, 2 and 3 further implicating upregulation of MMPs as critical to the induction 
of menses (Slayden and Brenner 2006). 
1.7.3 Spiny mouse 
Recently, natural menstruation has been reported in the spiny mouse (Acomys 
Cahirinus) a species of rodent originating in desert areas in Northern Africa  
(Bellofiore et al. 2018). To investigate the menstrual cycle in these mice, vaginal 
sampling was performed for two complete cycles revealing that mean menstrual cycle 
length was 8.7±0.4 days with red blood cells observed over 3.0±0.2 of the days, and 
the endometrium was thickest when plasma progesterone concentrations peaked 
(Bellofiore et al. 2017). The spiny mouse menstrual cycle displayed both ovarian and 
uterine phases as in other menstruating species: during the follicular phase the 
endometrium was thin; during the luteal phase angiogenesis and decidualisation were 
observed; and the onset of cytological and haemorrhagic changes coincided with 
regression of the CL and a drop in plasma progesterone concentration (Bellofiore et 
al. 2017). The spiny mouse also displays unique physiological traits such as scar-free 
wound healing in the skin (Mamrot et al. 2017). Although not yet fully investigated 
this rodent offers  potential as non-primate model in which to study physiological 
mechanisms of endometrial breakdown, shedding and repair (Bellofiore et al. 2017). 
1.7.4 Mouse pseudopregnancy model 
 Pseudopregnancy can be achieved by mating female mice to vasectomised males and 
four days later administering an intrauterine injection of oil to artificially induce a 
decidualisation response. Progesterone withdrawal is achieved by ovariectomy two 
days following decidualisation: decidual tissue breakdown and shedding was reported 
to be complete by 24 hours following P4 withdrawal and complete re-epithelialisation 
was observed by 48 hours (Fan et al. 2008). Using this model, Fan et al demonstrated 
that VEGF is essential for neoangiogenesis, regulating vessel stability and 
re-epithelialisation during endometrial repair by administering a pharmacological 
VEGF inhibitor at the time of steroid withdrawal. Mice treated with the inhibitor failed 
to fully repair and dysfunction in the vasculature was observed (Fan et al. 2008). This 
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pseudopregnancy model has been used in combination with inhibition of Wnt7a where 
there is a failure of re-epithelialisation and degradation of the basal gland 
complementing studies in primates that localized WNT7a to newly formed luminal 
epithelium and upper glands during endometrial repair (Fan et al. 2012). 
In a modified version of the pseudopregnancy mouse model Rudolph et al 
administered the potent progesterone receptor antagonist mifepristone two days after 
induced decidualisation instead of performing ovariectomy. This blockade mimicked 
progesterone withdrawal and stimulated decidual tissue breakdown. Bleeding was 
evaluated by vaginal lavage however blood was also visible at the opening of the 
vagina (Rudolph et al. 2012). 
1.7.5 Mouse model of simulated ‘menses’ 
A mouse model of ‘menstruation’ based on hormone manipulation and artificial 
decidualisation was first described in 1984 by Finn and Pope. Mice were 
ovariectomised to deplete endogenous steroid hormone production and then primed 
with a hormone schedule to mimic the fluctuating hormones experienced by women 
during the menstrual cycle: ovariectomy and seven days rest; two days of oestradiol 
(100ng/100μl); three days of rest, three days of oestradiol (20ng/100μl) and 
progesterone (1mg/100μl) followed by an intraluminal injection of oil 4-6h later. In 
rodents, unlike humans, decidualisation only occurs naturally in response to blastocyst 
implantation. The decidualisation reaction has been likened to the formation of 
granulation tissue in response to the presence of a foreign body (the implanting 
blastocyst) and so it is believed that the insertion of oil into the uterine lumen mimics 
this physiological event. The exact mechanism by which this occurs however is largely 
unknown (Finn and Keen 1963, Finn and Pope 1984). One problem with this model 
was variation in the extent of decidualisation however if decidualisation had occurred, 
removal of progesterone resulted in tissue breakdown and a ‘menses like’ which shared 
key features of human menstruation incluiding tissue necrosis, inflammation and 
luminal shedding (Finn and Pope 1984).  
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The model was updated by the Salamonsen Group who modified the protocol to use 
inbred mice and to include a silastic progesterone-secreting pellet to replace injections 
which ensured a steadily increasing concentration of circulating progesterone, 
considered to be more comparable to what happens in women (Brasted et al. 2003). 
Using this model decidualisation was successfully induced in the uterine horns and 
endometrial breakdown was initiated 12-16hrs following progesterone withdrawal. 
The entire decidua was detached and shed at 24hrs and re-epithelialisation of the 
luminal surface was almost complete by 36hrs, while restoration of endometrial tissue 
architecture was achieved by 48hrs. The authors also demonstrated changes in CD45+ 
leucocyte numbers cellular apoptosis as determined by TUNEL staining in the 
endometrium during tissue shedding (Brasted et al. 2003). Notably this study was the 
first to define the endometrial breakdown and repair phase as being complete 48hrs 
following withdrawal of progesterone. A further refinement to this model led to the 
establishment of the Edinburgh model (Cousins et al 2014; 2016): specific differences 
were use of a transvaginal route to induce decidualisation (reduction in number of 
surgeries) and an increase in exposure to the progesterone secreting pellet from 2 to 4 
days ensuring a more robust and reproducible decidualisation response. In common 
with other reports shedding was maximal at 24hrs after progesterone withdrawal and 
tissue restored at 48hrs. (Figure 1-17). 
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Figure 1-17. Schematic of the Edinburgh menses mouse model. (A) The pink box 
represents the oestrogen dominant proliferative phase, the blue box represents the progesterone 
dominant secretory phase and the red box represents the menstrual phase of the model. Tissue 
breakdown and shedding is stimulated by removal of progesterone and complete endometrial 
repair is observed within 48hrs of this. (B) Respresentative image of the phases of the human 
menstrual cycle recapitulated by the Edinburgh menses mouse model. Ovex: ovariectomy, E: 
β-oestradiol at 100ng/100µl then 5ng/µl, P: progesterone (adapted from Cousins et al. 2014). 
These mouse models have been widely used to study mechanisms associated with 
endometrial tissue breakdown and repair: Wang et al showed that replacement of 
progesterone at 8 and 12hrs blocked menstrual-like bleeding while replacement at 16-
24 hrs had no effect on bleeding (Wang et al. 2013). This study identified the critical 
window to be within the first 12hrs following P4 withdrawal, a lot shorter than that of 
the macaque model. Kaitu’u et al maintained females on a soy-free diet with additional 
administration of the aromatase inhibitor letrozole demonstrating repair in the absence 
of measurable oestrogens (Kaitu'u-Lino et al.). Hypoxia has been found to be an 
important regulator of endometrial breakdown and repair (Semenza 1998). Striking 
spatial and temporal fluctuations in hypoxia were displayed using HypoxyprobeTM 
detection system with the epithelium exposed to hypoxic conditions during 
endometrial repair. The changes in hypoxia were correlated with changes in gene 
expression of VEGF and CXCL12 suggesting hypoxia has a role in driving both the 
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angiogenic response and inflammation (Cousins et al. 2016d). Furthermore, hypoxia 
has been shown to stabilise HIF1α and drive endometrial repair where 
pharmacological reduction of HIF1α delays complete repair and pharmacological 
stabilisation rescues the delay. This study identifies HIF1α as a potential therapeutic 
target for HMB (Maybin et al. 2018). 
A study by Kaitu’u et al used the LRC technique and a mouse model to show that 
BrdU signal in the luminal epithelium rapidly decreased during post menstrual repair 
indicative of extensive proliferation while glandular epithelium remained constant. In 
contrast during the later repair phase glandular epithelial cells decreased BrdU 
expression suggesting that a population of epithelial progenitor cells reside in the basal 
glands that are important during postmenstrual repair (Kaitu'u-Lino et al. 2010). 
Cousins et al later demonstrated that re-epithelialisation occurred through three 
synchronous mechanisms: luminal and glandular epithelial cell proliferation and 
migration and a mesenchymal to epithelial transition (MET) by cells of the stromal 
compartment in proximity to the denuded surface (Cousins et al. 2014). Stromal LRC 
were also identified throughout endometrial breakdown and repair although this was 
significantly decreased during endometrial repair indicative of proliferation in 
response to wounding (Kaitu'u-Lino et al. 2012). 
The inflammatory response has also been the subject of many studies. Depletion of 
granulocytes using an anti-mouse GR-1 antibody (expressed on BM-derived 
monocytes) decreased the expression of matrix modifying enzymes such as MMP3, 9 
and 10 and impaired tissue repair (Menning et al. 2012). Another study where 
neutrophils were specifically depleted by application of the RB6-8C5 antibody, 
confirmed a delay in endometrial repair in the absence of neutrophils. The authors 
reported that F4/80 expressing macrophages were in low abundance and therefore 
unlikely to contribute to endometrial tissue repair (Kaitu'u-Lino et al. 2007). Further 
characterisation of the inflammatory response during menstruation revealed that 
Ly6G+ neutrophils peaked in number at 24hours associated with significant increase 
in the expression of cytokines and chemokines including CXCL1, TNF, CCL2 and 
IL-6. These dynamic changes were recapitulated in human tissue samples at 
corresponding phases of the cycle thereby validating the use of this mouse model to 
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recapitulate inflammatory processes during human menstruation (Armstrong et al. 
2017). 
The distribution of MMPs has been examined by Kaitu’u et al revealing important 
roles for MMP7 and MMP9 during endometrial tissue breakdown and MMP3 and 
MMP7 during re-epithelialisation. The application of two MMP inhibitors did not 
affect endometrial breakdown or repair processes suggesting that while MMPs are 
important, they are not the key mediators during post-menstrual repair (Kaitu'u et al. 
2005). The mouse model has been further used to demonstrate dynamic expression 
and functional importance of ECM interactions (Evans et al. 2011) and the expression 
of activin A in specific epithelial and stromal cell populations which may have a role 
in regulating re-epithelialisation (Kaitu'u-Lino et al. 2009).  Furthermore an important 
role for androgens has been recognized in regulating repair processes whereby 
administration of DHT resulted in delayed restoration of the luminal epithelium 
associated with changes in expression of MMP3, MMP9, Snai3 and osteopontin, 
important regulators of MET (Cousins et al. 2016b). 
1.8 General conclusions and aims of the study 
The endometrium is a complex multicellular tissue that experiences cyclical episodes 
of ECM remodelling, inflammation, hypoxia, vascular changes and tissue repair in 
response to menstruation, all of which may have important roles to play in scar-free 
regeneration (Spitzer et al. 2012, Salamonsen 2003b). Strict regulation of cyclical 
‘injury’ and ‘repair’ episodes is an unparalleled physiological response that is essential 
to successful reproductive function (Maybin and Critchley 2015). Despite knowledge 
on cellular and molecular changes that govern endometrial tissue breakdown during 
menstruation, the precise mechanisms that underpin rapid scar-free healing are yet to 
be fully elucidated.  Progress is hindered by the fact that it is very difficult to obtain 
tissue samples of defined stages of the menstrual cycle and the onset of vaginal 
bleeding, which is considered to be the start of menstruation, actually only occurs 
when the endometrial surface and blood vessels are breached while initiation of 
molecular and cellular events happen well before that (Evans et al. 2011). Tissue 
breakdown and repair also occur simultaneously and therefore human endometrial 
Chapter 1: Introduction  79 
 
samples are likely to contain a mix of pre-menstrual tissue, tissue that is degrading and 
tissue that has repaired (Garry et al. 2009), making it difficult to tease apart 
mechanisms associated with each. The development of robust mouse models of 
endometrial breakdown and repair that mimic the events of the human menstrual cycle 
provide a platform for initial investigations which can later be translated to human 
tissues. 
Endometrial macrophage numbers increase in the endometrial tissue during the 
secretory and menstrual phase with prominent roles in regulating tissue breakdown 
(Thiruchelvam et al. 2013) however their presence and function during subsequent 
tissue repair is at present unknown. Tissue resident macrophages are highly plastic 
cells that exhibit diverse phenotypes in response to signals in their local 
microenvironment (Das et al. 2015). The current study aimed to phenotype and 
characterise macrophage populations specific to the endometrium during homeostasis 
and in response to the ‘wound’ inflicted during menstruation. In-depth characterisation 
of endometrial macrophages could lead to new insights into the role of macrophage 
heterogeneity in the regulation of scar-free endometrial tissue repair. 
The striking regenerative capacity of the endometrium has led to the hypothesis that a 
population of stem/progenitor cells exist in the basal endometrium that are not lost 
during menstruation but instead are are mobilised to differentiate and reconstitute lost 
tissues (Gargett et al. 2016). A population of stem/progenitor cells has been identified 
as clonogenic or SP cells in the human endometrium and as LRC in the mouse 
endometrium. These cells share properties and characteristics of MSCs and can be 
further identified through co-expression of Pdgfrβ and CD146 (Schwab and Gargett 
2007). Recently it has been proposed that endometrial stem/progenitor cells may be 
perivascular pericytes which have stem-cell properties, however the physiological role 
for these cells remains undetermined. This study aims to further characterise 
endometrial stem/progenitor cells and investigate how this population responds during 
endometrial breakdown and repair with the aim of highlighting a role in scar-free tissue 
repair exhibited by the endometrium.   
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It is clear that a balance in tissue degradative and tissue repair mechanisms is key to 
regulating endometrial regeneration during the menstrual cycle. Further understanding 
of this balance and how it may be tipped to one or the other side may provide important 
insight into regulatory mechanisms of scar-free tissue repair with potential to identify 
new therapeutic targets for both gynaecological conditions and conditions associated 
with scar formation elsewhere in the body. 
1.9  Hypothesis 
The endometrium can provide a model system in which to investigate the mechanisms 
of physiological scarless wound healing. 
1.10 Aims 
1. To investigate the relationship between tissue resident and transient immune 
cell populations in endometrial repair. 
2. To identify and characterise a putative population of mesenchymal progenitor 
cells in endometrium. 
3. To investigate the role of mesenchymal progenitor cells in endometrial repair 
and regeneration.  
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Chapter 2 Materials and Methods 
2.1 Animal Work 
All animal procedures were carried out according to best practise and in line with the 
Home Office Animals (Scientific Procedures) Act 1986 under the project licence 
numbers PPL60/4208 and PPL70/8945 held by Professor Philippa TK Saunders, and 
personal licence number PIL IE9547CC3.  
Animals were housed in standard conditions with a constant light cycle of 12hours and 
food and water provided ad libitum. 
Wildtype C57BL/6 mice were bred in house from available breeding stocks. 
2.1.1 Transgenic mice 
2.1.1.1 The Pdgfrβ-BAC-eGFP knock-in reporter mouse line 
Platelet derived growth factor receptor beta (Pdgfrβ), also known as CD140b is a cell 
surface receptor belonging to the family of receptor tyrosine kinases which transmit 
signals from the cell surface to the cell interior once stimulated by PDGF (Hewitt et 
al. 2012). This ligand-receptor interaction is important for a variety of essential 
mesenchymal cellular processes including proliferation, growth, de-differentiation, 
movement and development, whilst also having roles in many diseases such as cancer 
(reviewed by(Raica and Cimpean 2010). In general, Pdgfrβ has been found on cells of 
mesenchymal origin including stromal cells such as fibroblasts and pericytes which 
support the function of parenchymal cells and secrete ECM to maintain tissue 
architecture (Hewitt et al. 2012). 
Pdgfrβ-BAC-eGFP reporter mice (C57BL/6 background) carry one copy of a bacterial 
artificial chromosome (BAC) construct in which an enhanced green fluorescent 
protein (eGFP) reporter gene, followed by a polyadenylation sequence, is inserted into 
a BAC clone (RP23-10L16) at the initiating ATG codon of the first coding exon of the 
Pdgfrβ gene. Therefore eGFP expression is driven by the regulatory sequences of the 
Pdgfrβ gene resulting in mesenchymal cell specific expression of eGFP. Founder 
stocks were obtained from Professor Neil Henderson (Centre for Inflammation 
Research, University of Edinburgh) [Originally obtained from GENSAT (Gene 
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Expression Nervous System Atlas) and deposited in MMRRC (Mutant Mouse 
Regional Resource Centre- STOCK Tg(Pdgfrβ-EGFP)JN169Gsat/Mmucd, 
031796-UCD) (Henderson et al. 2013)]. 
2.1.1.2 The Csf1r-eGFP ‘MacGreen’ reporter mouse line 
Macrophage colony stimulating factor receptor 1 (CSF1r, CD115) is expressed by cells 
of the mononuclear phagocyte system and regulates differentiation, proliferation and 
cell survival. The gene is expressed selectively in monocyte and trophoblast cell 
lineages but has also been found to be expressed by some granulocytes. CSF1r is 
encoded by the c-fms (Csf1r) proto-oncogene (Sasmono and Williams 2012). The 
fms-eGFP ‘MacGreen’ reporter mice (C57BL/6 background) have a reporter gene 
construct containing 3.5-kb of 5’ flanking sequence of exon 2 and the entire intron 2 
sequence of the Csf1r gene driving expression of eGFP to cells expressing CSF1R, 
namely cells of the mononuclear phagocyte system. The generation of these mice has 
been previously described (Sasmono et al. 2003) and founder stocks were obtained 
from Dr. Bernadette Dutia and Professor David Hume (Roslin Institute, University of 
Edinburgh- STOCK Tg(Csf1r-EGFP)1Hume)(Cousins et al. 2016c). 
2.1.1.3 The Csf1r-mApple ‘MacApple’ reporter mouse line 
Macrophage colony stimulating factor receptor 1 (CSF1r, CD115) is expressed by cells 
of the mononuclear phagocyte system and is encoded by the c-fms (Csf1r) 
proto-oncogene (Sasmono and Williams 2012). The Csf1r reporter construct used to 
generate the Csf1r-eGFP ‘MacGreen’ transgenic mouse line, described above 
(Sasmono et al. 2003), and a construct encoding the fluorescent protein Csf1r-mApple 
(Balic et al. 2014) were ligated with T4 ligase to create a Csf1r-mApple/Csf1r-
rtTA construct. This construct was used to generate the Csf1r-mApple reporter mouse 
line at the University of Edinburgh’s Central Biological Services Transgenic Core 
facility by microinjection of the transgene into the pronuclei of fertilised oocytes from 
C57BL/JOlaHsd mice. The resulting mApple expression is in cells of the mononuclear 
phagocyte system (Hawley et al. 2018). Stock mice (female) were obtained from Dr 
Steve Jenkins (MRC Centre for Inflammation Research, University of Edinburgh, 
STOCK- Csf1r-mApple/Csf1r-rtTA). 
Chapter 2: Materials and Methods  83 
 
2.1.1.4 The hCD68-GFP reporter mouse line 
CD68 is a transmembrane protein with roles in antigen processing and as a scavenger 
protein however, the exact function is yet to be confirmed. CD68 is expressed by 
myeloid cells, specifically monocytes and macrophages (Iqbal et al. 2014). To generate 
the hCD68-GFP reporter mouse line, a complementary DNA fragment encoding eGFP 
(pEGFP-N1 vector, Invitrogen) was cloned into the 1265 vector containing the 
promoter and intron one of human CD68 (2.9kb). DNA was excised from the cloning 
vector and injected into C57Bl/6J mouse oocyte. This generated mice in which GFP is 
expressed under control of CD68, expressed therefore by myeloid lineage cells (Iqbal 
et al. 2014). Stock mice (female) were obtained from Dr Jenna Cash (MRC Centre for 
Inflammation Research, University of Edinburgh), originally obtained from The 
Jackson laboratory- STOCK- Tg(Cd68-EGFP)1Drg). 
2.1.1.5 The NG2-CreERTM BAC tamoxifen-inducible mouse line 
Neural/glial antigen 2 (NG2) also known as chondroitin sulfate proteoglycan 4 
(Cspg4), is an integral membrane proteoglycan found on many cell types including 
oligodendrocyte progenitor cells (OPCs), chondroblasts, myoblasts and pericytes 
(Ozerdem, Monosov and Stallcup 2002). NG2 may be either membrane bound or 
secreted and associated with the extracellular matrix and is believed to have functions 
in cell adhesion, cell-ECM communication, proliferation, migration, axonal growth 
and regeneration. NG2 expressing cells are most prominently described as 
oligodendrocyte progenitor cells in the central nervous system (Zhu et al. 2011). 
NG2-CreERTM BAC mice carry once copy of a 208kb BAC construct containing the 
entire NG2 (Cspg4) gene with 60kbp of 5’ and 114kbp of 3’ flanking sequences, and 
a CreERTM fusion gene, where cre recombinase is fused to a G525R mutant form of 
the mouse oestrogen receptor ligand binding domain followed by a rabbit beta-globin 
polyA signal, inserted into the first exon of the NG2 gene. The mutant oestrogen 
receptor does not bind its natural ligand (17β-oestradiol) but binds with the synthetic 
oestrogen receptor ligand 4-hydroxytamoxifen (OHT or tamoxifen). When 
NG2Cre-ERTM BAC transgenic mice are bred with mice containing loxP-flanked 
sequences (Ai14 reporter mouse outlined below), tamoxifen-inducible cre-mediated 
recombination is expected to result in deletion of the floxed sequences in the NG2 
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expressing cells specifically. Founder stocks were obtained from The Jackson 
laboratory- STOCK B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J).  
2.1.1.6 The Ai14 reporter mouse line 
Ai14 reporter mice are a Cre reporter strain. They contain a 
Rosa-CAG-LSL-tdTomato-WRPE targeting vector designed with a CMV-IE 
enhancer/chicken beta-actin/rabbit beta-globin hybrid promoter (CAG), an FRT site, 
a loxP-flanked STOP cassette, tdTomato sequence (DsRed fluorescent protein), a 
woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), a polyA 
signal and an attB/attP-flanked PGK-FRT-Neo-PolyA cassette. This entire construct 
was inserted between exons 1 and 2 of the ubiquitously expressed Gt(ROSA)26Sor 
locus. The loxP-flanked STOP cassette is designed to prevent transcription of the 
tdTomato. When bred to mice that express Cre recombinase, the resulting offspring 
will have the STOP cassette deleted specifically in the cre-expressing tissues or cells, 
resulting in robust tdTomato fluorescence. Stock mice (female) were obtained from 
Professor Neil Henderson (MRC Centre for Inflammation Research, University of 
Edinburgh) [Originally obtained from The Jackson Laboratory- STOCK 
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze] (Henderson et al. 2013). 
2.1.1.7 Tamoxifen induction of NG2-CreERTM BAC transgenic mice 
Tamoxifen (Sigma, Cat. #T5648-1G) (TMX) was dissolved in sesame seed oil to a 
concentration of 20mg/ml and left overnight on a roller at 37°C (light protected). For 
TMX administration, an intraperitoneal (IP) injection of 125µl was given to each 
mouse (standard 25g weight) for 5 consecutive days (TMX dose 100mg/kg). 
 
 
2.1.2 Genotyping transgenic reporter mice 
2.1.2.1 Preparation of Stock buffers 
Stock buffers of 0.5M Ethylenediaminetetraacetic acid (EDTA) and 1M Sodium 
Hydroxide (NaOH) were prepared using the reagents in Table 2-1, and kept at room 
temperature (RT). 
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Table 2-1. Volume of reagents required for stock solutions of EDTA and NaOH  
Reagent Stock Supplier, Cat. No. Volume for 100ml 
stock 0.5M EDTA 
Volume for 100ml 
stock 1M NaOH 
EDTA (g) Sigma, E5134-
500g 
18.62 0 





Baxter, UK17114 88.95 100 
 
2.1.2.2 Preparation of digestion buffers 
A working solution of an alkaline lysis reagent was prepared by mixing 2.5ml of stock 
NaOH with 40µl of stock EDTA, and made up to 100ml with ddH2O. A working 
solution of a neutralising reagent was prepared by dissolving 630mg of Tris 
(hydroxymethyl) aminomethane (THAM) hydrochloride (Tris-HCL, 40mM) in 100ml 
ddH2O. Working solutions were kept at RT.  
2.1.2.3 DNA extraction from mouse ear biopsy using Hot Sodium Hydroxide 
and Tris (HotShot) method 
The ‘HotShot’ (Sodium Hydroxide and Tris) method was used to extract DNA from 
each mouse ear biopsy. For each reaction, 75µl of the alkaline lysis reagent was added 
to the mouse ear biopsy and heated at 95°C for 30 minutes. Solutions were cooled to 
4°C for 5 minutes and then 75µl of the neutralising reagent was added. Suspensions 
were kept on ice or stored at -20°C until PCR analysis could be completed. The 
combination of the alkaline lysis reagent and neutralising reagent yields a buffer of pH 
8.1, 20mM Tris-HCL and 0.1M EDTA, similar to Tris-EDTA (TE) buffer which is 
commonly used for extracting DNA. 
2.1.2.4 PCR for transgenes in DNA sample from mouse ear biopsy 
PCR (polymerase chain reaction) can be used to target and amplify a specific segment 
of DNA. A typical a reaction requires a DNA template, two primers specific to the 
gene to be amplified, a DNA polymerase, dNTPs and a buffer solution capable of 
providing an optimal chemical environment to maintain the activity and stability of the 
DNA polymerase. During PCR complimentary base pairing primers attach to a 
denatured double stranded template thereby defining a location at the 3’ end of 
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opposite strands facilitating attachment of a thermostable form of DNA polymerase. 
DNA polymerase is a naturally occurring complex of proteins whose function is to 
copy a cell’s DNA before it undergoes division by adding complimentary nucleotides 
(adenine, guanine, cytosine and thymine) to the primers (SantaLucia 2007). 
To genotype the Pdgfrβ-BAC-eGFP knock-in reporter mice and MacGreen reporter 
mice, primers specific to a region of the eGFP transgene were used to identify 
transgenic animals. Fatty acid binding protein 2 (Fabpi) was used as an internal control 
in each reaction, to confirm both the success of the PCR reaction and the quality of the 
resulting DNA. Primer sequences are shown in Table 2-2. To genotype the 
NG2-CreERTM BAC transgenic mice, primers specific to a region of the generic Cre 
transgene were used alongside an internal control, Table 2-2. Primers for each gene of 
interest (GOI) and associated controls were designed using the Universal Probe 
Library Assay Design Centre (Roche Applied Science) and purchased from Eurofins 
(Germany). 
 
Table 2-2. Primer sequences for eGFP, Fabpi, Cre and a control used to genotype 
Pdgfrβ-BAC-eGFP, Macgreen and NG2-CreERTM BAC transgenic mice 
Primer Associated Transgenic Primer Sequence 
eGFP Forward Primer Pdgfrβ-BAC-eGFP, 
MacGreen 
5’ GCA CGA CTT CTT CAA 
GTC CGC CAT GCC 3’ 
eGFP Reverse Primer Pdgfrβ-BAC-eGFP, 
MacGreen 
5’ GCG GAT CTT GAA GTT 
CAC CTT GAT GCC 3’ 
Fabpi Forward Primer Pdgfrβ-BAC-eGFP, 
MacGreen 
5’ CCT CCG GAG AGC AGC 
GAT TAA AAG TGT CAG 3’ 
Fabpi Reverse Primer Pdgfrβ-BAC-eGFP, 
MacGreen 
5’ TAG AGC TTT GCC ACA 
TCA CAG GTC ATT CAG 3’ 
Cre Forward Primer 
(oIMR1084) 
NG2-CreERTM BAC 5’ GCG GTC TGG CAG TAA 
AAA CTA TC 3’ 
Cre Reverse Primer 
(oIMR1085) 
NG2-CreERTM BAC 5’ GTC AAA CAG CAT TGC 
TGT CAC TT 3’ 
Control Forward Primer 
(oIMR7338) 
NG2-CreERTM BAC 5’ CTA GGC CAC AGA ATT 
GAA AGA TCT 3’ 
Control Reverse Primer 
(oIMR7339) 
NG2-CreERTM BAC 5’ GTA GGT GGA AAT TCT 
AGC ATC ATC C 3’ 
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Each PCR reaction was prepared by mixing 2x BioMix Red (Bioline, London, UK) 
with 100µm stocks of primers for the GOI and appropriate control using volumes 
outlined in Table 2-3. 2x BioMix Red is a reaction mix containing a stable Taq DNA 
polymerase and an additional red dye permitting easy visualisation and direct loading 
onto a gel. Using this mix reduces the time required to set up reactions, minimising the 
risk of contamination by reducing the number of pipetting errors that may occur. A 
positive control (known transgenic positive animal), a negative control (known 
transgenic negative animal) and a water control (no DNA) were prepared in parallel 
for each genotyping reaction.  
PCR amplification was carried out on a Peltier Thermal Cycler (PTC-200) under the 
following conditions: 35 cycles of 94°C for 30 seconds (denaturation); 65°C for 30 
seconds (annealing); 72°C for 1 minute (elongation) then 72°C for 7 minutes (final 
elongation) and finally 10°C for ten minutes (final hold). Samples were then put in a 
fridge at 4°C for later processing. Principles of the PCR reaction are outlined in the 
Figure 2-1. 
 
Table 2-3. Final concentration and reaction volumes for each component of the PCR 
master mix. 
Reagent Stock Final 
Concentration 
Volume per 10μl 
reaction (μl) 
2x Biomix Red 1x 5 
GOI Forward Primer 100µm 100nm 0.1 
GOI Reverse Primer 100µm 100nm 0.1 
Control Forward Primer 100µm 100nm 0.1 
Control Reverse Primer 100µm 100nm 0.1 
ddH2O X 3.6 
DNA template X 1 
Total Volume 10 
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Figure 2-1. Schematic representation of the principles of the polymerase chain reaction 
(PCR). Step 1: Denaturation is the first essential step in the reaction and required to disrupt 
the hydrogen bonds between complimentary bases, yielding single stranded DNA molecules. 
Step 2: Thereafter the temperature is reduced to favour annealing of the primers (which are in 
excess) to the DNA strands. Careful design of primers is essential to ensure this read is specific 
to the target of interest. Step 3: Elongations follows governed by the optimal activity 
temperature of the DNA polymerase which synthesizes a new DNA strand complimentary to 
the template by adding dNTPs in the 5’ to 3’ direction. Final elongation ensures that any 
remaining single stranded DNA is fully extended and the final hold is for an indefinite time to 
allow for short term storage of the reaction (based on SantaLucia 2007)) 
 
2.1.2.5 DNA fragment analysis on agarose gels 
PCR products were separated by electrophoresis on a 2% (w/v) agarose gel, prepared 
by heating 1g powdered agarose in 50ml 1xTAE (Tris base, Acetic acid, EDTA mix) 
and setting the gel in a mould and comb with 5μl SYBR safe DNA gel stain 
(Invitrogen, Cat. #S33102) for visualisation. The percentage of agarose gel needs to 
be adjusted depending on the size of product being analysed, in general the smaller 
size of product correlates to a larger percentage agarose. Samples were electrophoresed 
at 120V and 300mA alongside an aliquot (5μl) of DNA Hyperladder IV (1000kb) 
(Bioline, London, UK) in one lane. The size of DNA fragments for each transgenic 
can be seen in Figure 2-2, in each case the detection of two bands was consistent with 
a positive transgenic animal (Figure 2-2). 
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Figure 1-2: Gel image of typical DNA fragment analysis using the agarose gel method for 
(A) Pdgfrβ-BAC-eGFP, (B) MacGreen and (C) NG2-CreERTMBAC transgenic mouse 
lines. Hyperladder IV in lane 1, H20 control in lane 1, negative control in lane 3, positive 
control in lane 4. The remaining lanes show both transgenic positive (+) and transgenic 
negative (-) animals (Author’s own images) 
 
2.2 Investigating uterine tissue in mice 
2.2.1 Collection of uterine tissue from intact/naïve mice 
Normal mouse uterine tissue samples were gathered to investigate cell populations of 
interest in endometrial tissue during homeostasis. Uterine tissues were collected from 
cycling adult female mice (8-10 w/o, all strains) denoted as naïve tissues and, unless 
stated otherwise, used as comparative controls in the experiments of this thesis. Mice 
were culled by asphyxiation by carbon dioxide gas and death confirmed by cervical 
dislocation. Oestrous stage was confirmed by vaginal smears as follows: 
phosphate-buffered saline (PBS) (50μl) was introduced into the vagina and vaginal 
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cells collected onto a glass slide. Vaginal smears were air dried and then fixed by 
immersion in ice cold methanol and air dried four times. Fixed slides were stained with 
haematoxylin and eosin (H&E staining, Section 2.4.1) and the stage of oestrus cycle 
determined by comparing the composition of cells in the smear with a reference figure, 
see Figure 2-3 (Caligioni 2009).  
 
Figure 2-3. Photomicrographs (a-d) and haematoxylin and eosin staining (e-h) of vaginal 
smears taken at various stages of the mouse oestrus cycle. Mice were culled and vaginal 
smears collected to identify the stage of the oestrous cycle. (a/e) Proestrus stage consists 
predominantly of nucleated epithelial cells (N). (b/f) Oestrus stage consists of enucleated 
cornified epithelial cells (C). (c/g) Metoestrus stage consists of nucleated and cornified 
enucleated epithelial cells and leukocytes (L). (d/h) Dioestrus consists predominantly of 
leukocytes (Adapted from Caligioni, 2010 and Mettus & Rane, 2003). 
 
Uteri from naïve female mice were dissected from the peritoneal cavity and separated 
from the ovaries, cervix and surrounding adipose tissue. Uteri were weighed and 
collected into RNAlater (QIAGEN) and stored thereafter at -80°C, or fixed in 4% 
paraformaldehyde (PFA) for two hours followed by overnight storage in 18% sucrose 
and embedding in OCT (optimal cutting temperature) medium for downstream 
histological analysis. Uteri were collected in this way to generate control samples for 
each of the transgenic mouse lines outlined in Section 2.1.1 and also from C57BL/6 
mice for use as transgene negative samples. 
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2.2.2 The Edinburgh menses mouse model 
Laboratory mice do not spontaneously decidualise or menstruate however studies in 
the Saunders group have refined and extended studies by others (Brasted et al. 2003, 
Kaitu'u-Lino et al. 2007, Kaitu'u et al. 2005, Finn and Pope 1984), and established a 
robust mouse model of simulated menstruation in which endometrial breakdown and 
shedding can be detected as overt vaginal bleeding. Briefly, ovariectomised mice are 
treated with a hormonal schedule (exogenouse E2 followed by P4) and decidualisation 
of the endometrial stroma is induced after an intrauterine injection of oil. Thereafter 
endometrial breakdown occurs simulated by the withdrawal of progesterone. 
Validation of this model has confirmed it shares key features with menstruation and 
scarless endometrial repair in women including focal hypoxia (Cousins et al. 2016d), 
tissue breakdown, epithelial repair (Cousins et al. 2014) and dynamic changes in 
immune cell populations (Cousins et al. 2016c).  
All animal procedures carried out in this thesis were done so with assistance from 
Olympia Kelepouri (PIL: IFAF4370C). 
2.2.2.1 Preparation of oestrogen for injections 
A 1mg/ml stock solution of β-oestradiol (E2) was prepared by dissolving 1mg 
crystallised β-estradiol (Sigma, Cat # E8875, Mw 272.38 g/mol) in 100% ethanol 
(VWR Prolabo, France), from which a further 50µg/ml stock solution was made. 
Working solutions of 100µg/100µl and 5µg/100µl were prepared by diluting stock 
solutions by 1/1000 into sesame seed oil (Sigma, Cat # S3547) and mixed overnight at 
RT, Figure 2-4. 
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Figure 2-4. Stock solutions and working solutions of β-oestradiol used in the mouse model 
of endometrial breakdown and repair. Stock solutions (1mg/ml and 0.05mg/ml) were 
prepared by dissolving E2 in 100% ethanol. Working solutions of E2 (100ng/100µl and 
5ng/100µl) were prepared by diluting stock solutions by 1/1000 into sesame seed oil (Author’s 
own image). 
 
2.2.2.2 Preparation of progesterone secreting pellets 
Dow corning silastic tubing (Cat #508-008, 1.57mm ID x 3.18mm OD) was washed 
in 70% ethanol, rinsed in distilled water and air dried, before10mm lengths were cut. 
Multipurpose sealant (Dow Corning multipurpose sealant 732) was used to seal one 
end of each tube and then the pellets were filled with crystalline progesterone (P4, 
Sigma, Cat #P0130) and the other end was sealed; 24 hours prior to insertion, P4 
pellets were incubated in PBS with 1% charcoal stripped foetal calf serum (CSFCS) at 
37℃. 
2.2.2.3 Induction of endometrial tissue proliferation, decidualisation, breakdown 
and repair 
A review of the refined model is shown in Figure 2-5 and the key steps outlined in 
Table 2-4. On day 0, female mice between 8-10 weeks of age were ovariectomised 
under iso-fluorane induced anaesthesia (Merial) and given a post-operative injection 
of an analgesic, buprenorphine (Buprecare, 0.1mg/kg, Alstoe animal health). Mice 
were monitored and allowed to recover for 7d allowing for the complete depletion of 
endogenous ovarian-derived steroids. Mice received daily sub-cutaneous injections 
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(0.1ml) E2 in sesame oil (100ng/100µl) on days 7-9 followed by the sub-cutaneous 
insertion of a P4-secreting pellet on day 13, under iso-fluorane induced anesthesia. 
Mice also received daily sub-cutaneous injections (0.1ml) of E2 in sesame oil 
(5ng/100µl). On day 15, endometrial decidualisation was induced in one uterine horn 
by administering sesame seed oil (20µl) into the uterine lumen via the cervix using a 
non-surgical embryo transfer device (NSET) (Datesand Ltd, Manchester, UK). This 
procedure was performed under iso-fluorane induced anesthesia and the contralateral 
horn was left untreated to act as an unstimulated control (Figure 2-6). P4 ‘withdrawal’ 
was induced 90 hours after decidualisation by removal of the P4-secreting pellet 
(designates time 0 of induced shedding).  
For subsequent tissue recovery, mice were culled by asphyxiation using carbon dioxide 
gas and death confirmed by cervical dislocation. In the majority of slides in this thesis 
tissue was recovered 24hrs after steroid withdrawal but in some cases recovery was at 
other time points (12hrs, 48hrs). Uteri were dissected, weighed and collected into 
RNAlater (QIAGEN) and stored thereafter at -80°C, or fixed in 4% PFA for 2hrs as in 
Section 2.3. In general, uteri collected from this mouse model were either non-
decidualised/unstimulated or fully decidualised/stimulated as displayed in Figure 2-6.  
 
Figure 2-5: The Edinburgh menses mouse model. (A) Schematic of mouse model of 
menstruation. Following ovariectomy (ovex), addition of exogenous hormones mimics the 
human menstrual cycle; ‘proliferative phase’ (pink), ‘secretory phase’ (blue), ‘menstrual 
phase’ (red). Decidualisation is stimulated by introduction of oil into the luminal cavity of the 
uterus. The contralateral uterine horn serves as control (non-decidualised). Menstrual-like 
tissue shedding is induced via removal of P4 pellet on day 19. (B) Induction of menses and 
endometrial shedding can be detected as overt vaginal bleeding. (C) Histological tissue 
morphology of uterine horns 0, 4, 8, 12, 24 and 48hrs following P4 withdrawal. E= oestradiol, 
P= progesterone (adapted from Cousins et al. 2014)). 
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Table 2-4. Summary of key steps in the Edinburgh menses mouse model  
Day of Model Procedure 
0 Ovariectomy 
7 E2 injection 100ng/100µl 
8 E2 injection 100ng/100µl 
9 E2 injection 100ng/100µl 
13 P4 pellet insertion + E2 injection 5ng/100µl 
14 E2 injection 5ng/100µl 
15 E2 injection 5ng/100µl + Oil into lumen for decidualisation 
19 P4 pellet removal 
20 24hrs tissue recovery 
21 48hrs tissue recovery 
 
 
Figure 2-6: Gross Anatomy of mouse uterine tissues after manipulation by the 
Edinburgh menses mouse model. (A) Two non-decidualised/unstimulated (Non) uterine 
horns considered to be the unmanipulated control for this model. (B) One 
decidualised/stimulated (Full) uterine horn and on non-decidualised/unstimulated uterine 
horn. (C) Two decidualised/stimulated uterine horns considered to be experimental tissues 
(Author’s own images). 
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2.3 Tissue processing 
Tissue samples were fixed in 4% (w/v) PFA for 2hrs at 4°C, rinsed thoroughly in PBS 
and stored overnight in 18% (w/v) sucrose at 4°C to replace water in the tissue. 
Approximately 24hrs later samples were rinsed in PBS and snap frozen in optimal 
cutting temperature (OCT) medium, carefully orientated in the cold block so that cross 
sections of the uterine horn could be cut. 
Thin sections (5µm) were cut using a Leica Cryostat CM onto X-tra adhesive 
pre-cleaned micro slides (Surgipath, Leica Biosystems, Peterborough, UK) and left to 
air dry for 2hrs prior to staining at RT, or stored in a freezer at -20°C if required for 
future use. 
2.4 Histological examination of uterine sections 
2.4.1 Haematoxylin and eosin staining 
The most commonly used staining system in histology uses two dyes called 
Haematoxylin and Eosin (H&E). Haematoxylin is a basic dye which binds to acidic 
structures such as DNA and RNA and therefore highlights the nucleus in a purple 
colour, while eosin is an acidic dye while stains basic structures such as proteins, 
intracellular membranes and extracellular fibres in the cytoplasm, highlighting the 
cytoplasmic compartment in red or pink (Fischer et al. 2008). 
H&E staining was carried out on 5µm uterine tissue sections cut on the cryostat and 
left to air dry at RT for 2hrs (Section 2.3). Sections were washed in PBS to remove 
any residual OCT medium and further washed in distilled water before submersion in 
ShandonTM Harris Haematoxylin (ThermoFischer Scientific, Cat. #6765002) for 5 
minutes to stain cell nuclei. Following this, slides were washed in distilled water, 
dipped in 1% acid alcohol (1% hydrochloric acid in 70% ethanol) to remove non-
specific background staining and washed in water again. Slides were submerged in 
Scott’s tap water for 20 seconds to convert haematoxylin to a dark blue colour, washed 
in water and passed through ShandonTM Eosin (ThermoFischer Scientific, Cat. 
#10483750) for 10 seconds to stain non-nuclear elements, before a final wash in water. 
Slides were dehydrated through ascending concentrations of alcohols to remove all 
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traces of water then rinsed in several baths of xylene to remove any residual alcohol. 
Sections were protected using Pertex (CellPath) and coverslips (VWR Prolabo). 
2.4.2 Picrosirius red staining 
Picrosirius red (PSR) staining is a histological technique used to detect collagen I and 
III fibres in tissue sections. PSR stain is viewed using standard light microscopy where 
collagen is red and the background is yellow, or polarised light resulting in 
birefringence of the collagen fibres to distinguish between type I (yellow/orange) and 
type III fibres (green). 
The PSR staining in this thesis was performed by the SuRF Histology and imaging 
laboratory, QMRI. The PSR stain was prepared by mixing one part of 0.5% Direct Red 
(Sigma, Cat. #365548) with nine parts of picric acid, saturated aqueous solutions 
(Sigma, Cat. #P6744-1GA) and stored in a light protected bottle. PSR staining was 
carried out on 5µm uterine tissue sections cut on the cryostat and left to air dry at RT 
for 2hrs (Section 2.3). Sections were washed in PBS to remove any residual OCT 
medium and further washed in distilled water before submersion in the PSR solution 
for 2-4hrs. Sections were rinsed in 100% alcohol, cleared in xylene and mounted using 
a Shandon Thermo ScientificTM ClearVueTM Coverslipper. 
2.4.3 Immunohistochemical staining 
Immunohistochemistry (IHC) is the process used to detect and visualise 
antigens/proteins within cells of a tissue section using the principle of specific 
antibody-antigen binding. The technique was first implemented in 1941 by Albert 
Coons (Coons, Creech and Jones 1941) and since has been widely used in a number 
of applications to: assist in medical diagnoses and prognoses; investigate specific 
cellular events of interest such as proliferation or apoptosis; assess biomarker 
localisation; visualise differentially expressed proteins in different tissues; and 
investigate the pathogenesis of disease (Ramos-Vara and Miller 2014). There are 
various methods of IHC which can be broadly separated into two categories: the direct 
method uses one labelled antibody (fluorescent conjugate) which binds directly to the 
specific antigen on interest; and the indirect method uses a primary antibody which 
binds directly to the specific antigen of interest and a labelled secondary antibody that 
binds to the primary antibody, Figure 2-7. The direct method is rapid and simple 
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however the sensitivity is relatively low whereas the indirect method is more sensitive 
as it allows greater amplification of the signal (Ramos-Vara and Miller 2014). In this 
thesis, IHC was used to visualise cell specific markers used in cell phenotyping and 
cell differentiation using both direct and indirect methods. 
 
Figure 2-7. Schematic representation of the principles of direct and indirect IHC 
methods. The cellular antigen is detected by application of a specific labelled primary 
antibody (direct, I), or a specific unlabelled primary antibody followed by a labelled secondary 
antibody (indirect, II). The detection system can be by chromogenic antigen detection or by 
fluorescently-conjugated antibodies, discussed in Sections 2.4.3.2 and 2.4.3.3 (based on 
Ramos-Vara & Miller, 2013). 
 
2.4.3.1 IHC examination of antigens 
IHC was carried out on 5µm uterine tissue sections cut on the cryostat and air dried 
for approximately 2hrs, according to the protocol outlined in Table 2-5. Unless 
otherwise stated, all wash steps included one 5 minute wash with PBS containing 
0.05% (v/v) tween20 (PBS tween) and two further 5 minute washes in PBS alone. An 
antigen retrieval step was not required for frozen sections as tissue fixation was brief 
and the process would damage the tissues. Controls included a positive tissue control, 
a primary antibody negative control, a secondary antibody negative control where each 
was replaced with normal animal serum (NAS). 
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Table 2-5. IHC protocol for antigen detection in uterine tissue sections 
Step Description Purpose 
Day 1 
1 Wash sections twice in PBS Remove residual OCT 
2 Incubate sections in 3% (v/v) hydrogen 
peroxide in methanol for 30 minutes at 
RT 
Inactivation of any endogenous 
peroxidase enzymes that would 
otherwise interfere with desired 
HRP activity: reduce non-specific 
background staining 
3 Wash sections 
4 Incubate sections in 20% (v/v) normal 
animal serum (NAS: PBS containing 
20% animal serum and 0.05% (w/v) 
bovine serum albumin (BSA)) for 30 
minutes at RT 
Saturate non-specific antigen 
binding sites to prevent non-
specific binding of either primary 
or secondary antibody. Use serum 
from the secondary host 
5 Wash sections 
6 Incubate sections with primary 
antibody at an optimised dilution in 
NAS overnight at 4°C 
Primary detection of antigen of 
interest (unconjugated) 
Day 2 
7 Wash sections 
8 Incubate sections with HRP-
conjugated secondary antibody at an 
optimised dilution in NAS for 30 
minutes at RT 
Secondary detection of primary 
antibody (conjugated). Enzyme 
label is HRP which reacts with a 
substrate to yield a detection signal 
9 Wash sections 
10 Detection systems: see section 2.4.2.2 
and 2.4.2.3 
Amplification of detection signal: 
DAB or Tyramide (see section 
2.4.2.2 and 2.4.2.3) 
11 Wash sections 
12 Nuclear counterstain: see section 
2.4.2.4 
Detection of cell nuclei by 
Haematoxylin or DAPI (see section 
2.4.2.4) 
13 Wash sections 
14 
Protect sections using Pertex for DAB 
detection (CellPath) or permafluor for 
fluorescent detection (Immunotech) 
and mount with coverslips (VWR 
Prolabo). 
Protection of sections for long term 
storage and later microscopy 
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A complete list of primary antibodies and associated working dilutions used in this 
thesis are outlined in Table 2-6 and a complete list of secondary antibodies and 
associated working dilutions are outlined in Table 2-7.  
 
 
Table 2-6. Primary antibodies and associated working dilutions used in the IHC 
detection of antigens in uterine tissue sections 
Antibody Name Supplier and Cat. No. 
(concentration) 
Dilution Serum block 
Polyclonal rabbit anti-
GFP 
Abcam, ab6556 (0.5mg/ml) 1/1000 Goat 
Polyclonal rabbit anti-
MCSF (Csfr1) 













Abcam, 133357 1/1000 Goat 







caspase 3 (Asp175) 















Abcam, ab12905 1/600 Goat 
Monoclonal mouse anti-
αSMA 
Sigma, A-2547 1/10K Horse 
Polyclonal rabbit anti-
CD31 
Abcam, ab28364 (1mg/ml) 1/500 Goat 
Polyclonal rabbit anti-
EpCAM 
Abcam, ab71916 (1mg/ml) 1/2000 Goat 
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Table 2-7. Secondary antibodies and associated working dilutions used in the 
immunohistochemical detection of antigens in uterine tissue sections 
Antibody name Supplier and Catalogue 
No. (concentration) 
Dilution 
Goat F(ab) anti-rabbit IgG 
H&L (HRP) 
Abcam, Ab7171 (1mg/ml) 1/500 
Goat F(ab) anti-mouse IgG 
H&L (HRP) 
Abcam, ab6823 (1mg/ml) 1/500 
ImmmPRESSTM reagent 




N/A (1 drop per slide) 
ImmmPRESSTM reagent 




N/A (1 drop per slide) 
ImmmPRESSTM reagent 




N/A (1 drop per slide) 
 
2.4.3.2 Enzyme mediated chromogenic antigen detection by 3,3' 
diaminobenzidine (DAB)  
The enzyme mediated chromogenic antigen detection method is based on the 
production of a coloured reporter molecule upon interaction of an enzyme and its 
substrate that can be easily visualised by microscopy. The enzymes most commonly 
used as labels are alkaline phosphatase (AP) and horseradish peroxidase (HRP) and a 
variety of substrates are available including DAB which produces a brown staining 
when the enzyme is bound (Ramos-Vara and Miller 2014). In this thesis secondary 
antibodies conjugated to HRP (Table 2-7) and DAB were used as the preferred 
enzyme-substrate interaction. 
Sections were incubated with chromogen DAB (Vector, Peterborough, UK) (Figure 
2-8) for 5 minutes or until the brown colour was detectable. Sections were immersed 
in water to cease the enzymatic reaction. The staining protocol continued as in Table 
2-5, step 11. 
2.4.3.3 Fluorochrome antigen detection  
Fluorochrome antigen detection relies on a fluorescent signal which can be used in 
multiplex immunohistochemistry to detect co-localisation of antigens. The tyramide 
signal amplification (TSA) system (PerkinElmer, Massachusetts, USA) is a method 
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used to amplify the signal to increase sensitivity of detection and spatial resolution, 
whilst keeping background staining to a minimum. In this amplification method, HRP 
(conjugated to the secondary antibody) reacts with the phenolic part of tyramine to 
produce quinone-like structures that carry a radical on the C2 groups. This reactive 
intermediate covalently binds to electron rich amino acids in nearby tissue proteins 
resulting in a localized deposition of the fluorescently-conjugated tyramide derivative 
at the location of the antigen-antibody reaction (Figure 2-8) (Ramos-Vara and Miller 
2014). 
For detection by TSA, sections were incubated with tyramide solution diluted 1/50 in 
the kit diluent for 10 minutes at RT in the dark. Both the red cyanine-3 fluorophore 
and green cyanine-5 fluorophore were used in single and double IHC stains. The 
staining protocol continued as in Table 2-5, step 11, with sections protected from the 
light using aluminium foil to avoid photo bleaching during each subsequent wash and 
incubation steps.  
 
Figure 2-8. Schematic representation of the principles of enzyme mediated chromogenic 
antigen detection and fluorochrome antigen detection used in standard IHC methods. 
The cellular antigen is detected by application of a specific primary antibody followed by a 
HRP-conjugated secondary antibody. Antigen detection can be achieved by application of (I) 
DAB substrate and visualisation of the coloured product or (II) Tyramide and visualisation of 
the fluorescent signal (based on Ramos-Vara and Miller 2014)). 
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2.4.3.4 Nuclear counterstaining 
After chromogenic detection, sections were counterstained with haematoxylin for 5 
minutes, dipped in1% acid alcohol (1% hydrochloric acid in 70% ethanol) and washed 
thoroughly in water. Sections were passed through an increasing alcohol gradient from 
70%, 85%, 95% and 100% before immersion in xylene. Sections were protected using 
Pertex (CellPath) and coverslips (VWR Prolabo).  
After TSA detection, sections were incubated with DAPI (4’, 6-diamidina-2-
phenylindole) (Sigma, D9542) which binds to DNA therefore staining cell nuclei blue. 
Sections were incubated with DAPI diluted to 1/1000 in PBS for 10 minutes at RT. 
The staining protocol continued as in Table 2-5, step 13, with sections protected from 
the light using aluminium foil to avoid photo bleaching during the subsequent wash 
step.  Sections were protected using permaflour (Immunotech, Marseille, France) and 
coverslips (VWR Prolabo).  
2.4.4 Microscopy and Image analysis 
2.4.4.1 Brightfield microscopy 
Bright field images of H&E sections and DAB positive sections were obtained using 
AxioVision 4.8 Software (Carl Zeiss, Cambridge, UK) and a Leica light microscope 
(Olympus Optical, London, UK) with an attached Canon DS126131 camera.  
2.4.4.2 Confocal miscroscopy 
Images of fluorescent sections were obtained using Zen 2009 software (Carl Zeiss, 
Cambridge, UK) and a Zeiss LSM 510 Meta Confocal microscope (Carl Zeiss, 
Cambridge, UK).  
2.4.4.3 Transmission Electron Microscopy (TEM) 
TEM is a very powerful technique where a high energy beam of electrons is shone 
through a very thin layer of tissue and the interactions between the electrons and the 
atoms can be observed and imaged. TEM therefore gives structural information at the 
subcellular level (Burghardt and Droleskey 2006). For TEM, uterine tissue samples 
were fixed in 3% glutaraldehye in 0.1M Sodium Cacodylate buffer (pH 7.3) for 2hrs 
then washed in 0.1M Sodium Cacodylate for 10minutes three times. The following 
steps were carried out by Dr Stephen Mitchell at the Centre Optical Instrumentation 
Laboratory (COIL) in King’s Buildings. Tissues were post-fixed in 1% Osmium 
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Tetroxide in 0.1M Sodium Cacodylate for 45 minutes at RT then washed in 0.1M 
Sodium Cacodylate for 10minutes three times. The tissues were dehydrated through 
increasing concentrations of ethanol: 50%, 70%, 90% and 100% ethanol for 15 
minutes each then immersed in two 10 minute changes in Propylene Oxide.  
Samples were embedded in TAAB 812 resin. Sections (1μm) were cut on a Leica 
Ultracut ultramicrotome, stained with Toluidine Blue, and viewed in a light 
microscope to select suitable areas for investigation.  Ultrathin sections (60nm) thick 
were cut from selected areas, stained in Uranyl Acetate and Lead Citrate then viewed 
in a JEOL JEM-1400 Plus TEM.   Representative images were collected on a GATAN 
OneView camera by thesis author. This technique was carried out with support from 
the Wellcome Trust Multi User Equipment Grant (WT104915MA). 
 
2.5 Flow Cytometry and Fluorescence Activated Cell 
Sorting (FACS) 
Flow cytometry is a powerful method used to interrogate cell characteristics and 
phenotype. Flow cytometry combines fluidics and optics whereby cells are sensed as 
they move in a liquid stream through a laser and can be characterised based on the 
light-scattering property (size, granularity) and colour-discriminated fluorescence 
from antibodies of dyes. In-depth phenotypic information can be gathered based on 
whether a cell is carrying fluorescent molecules conjugated to antibodies designed 
against specific cell surface or intracellular components. Flow cytometry is most 
commonly used therefore to identify different cell types present in a heterogeneous 
population and provides a basis to separate and isolate cells of interest for downstream 
analysis such as an in vitro culture or gene expression analysis (Macey, 2007). 
2.5.1 Uterine tissue digest 
Uterine horns from adult mice were dissected and placed immediately into ice cold 
PBS (2ml per horn) in standard laboratory bijous tubes before being transferred to the 
laboratory for processing. Thereafter uterine tissues were cut into small fragments 
using scalpels (Swann Morten, Cat #0503) in a petri dish with a small volume of PBS 
to avoid the tissues drying out. The dissociated tissue was transferred back to the bijous 
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containing PBS then collagenase (10mg/ml) and DNase (10mg/ml) were added. Tissue 
samples were incubated with digestive enzymes for 30 minutes at 37°C on a rocking 
incubator (Figure 2-9). The tissue samples were further dissociated using an 18G 
needle (BD MicrolanceTM, Cat. #2022-12) and 2ml syringe (BD Plastipak, Cat. #2022-
02). Dissociated tissue samples were passed through a series of cell strainers (70µm 
and 40µm) to remove debris, undigested tissue clumps and large epithelial cells. Each 
cell strainer was rinsed through with ‘FACS’ buffer (PBS Ca2-Mg2-, 5% charcoal 
stripped fetal calf serum (CSFCS), 2mM EDTA) to rinse off any remaining cells. The 
resulting cell suspensions were centrifuged at 400rcf for 5 minutes and the supernatant 
discarded. Cell pellets were re-suspended in 1ml ACK lysing buffer (Gibco, Cat. 
#A10492-01) for 1 minute to remove any residual red blood cells, then by 5ml of 
‘FACS’ buffer was added to stop the reaction. Cell suspensions were centrifuged for a 
second time at 400rcf for 5 minutes and the supernatant discarded. Cell pellets were 
re-suspended in 200µl of ‘FACS’ buffer and transferred to 1.5ml Eppendorf tubes and 
placed on ice for antibody staining (Section 2.5.2).  
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Figure 2-9: Optimised uterine tissue digest protocol to generate single cell suspensions 
for both Flow Cytometry and FACS. Mouse uterine horns were dissected into ice cold PBS 
and manually dissociated before being incubated with Collagenase (10mg/ml) and DNase 
(10mg/ml) for 30minutes at 37°C. Single cell suspensions were generated and stained with 
fluorescently conjugated flow cytometry antibodies as outlined in Table 2-8 and 2-9 (Author’s 
own image)  
 
2.5.2 Flow cytometry antibody staining and analysis 
Flow cytometers are multiparametric so they can record several measurements of each 
cell at once. Different flow cytometer instruments are set up with the capacity to 
analyse a set number of different fluorochromes, with current instruments able to 
detect as many as 18 colours. This allows for the extensive differentiation of specific 
cell types within a heterogeneous population. Flow cytometry antibody panels need to 
be carefully designed with the emission and excitation spectra of each flourochrome 
accounted for to avoid overlap and minimise compensation (Macey, 2007).  
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In the current thesis, two separate flow cytometry antibody panels were designed to 
investigate immune cell populations and mesenchymal cell populations using reagents 
outlined in Table 2.8 and Table 2.9 respectively. Single cell suspensions were prepared 
(Section 2.5.1) and incubated with fluorescently conjugated flow cytometry antibodies 
for 30 minutes on ice.  
Table 2-8. Flow cytometry antibody panel designed to interrogate myeloid immune 
cell populations in uterine tissue 
















496nm 578nm 1/20 
APC anti-mouse 
F4/80 















407nm 650nm 1/100 
 
Table 2-9. Flow cytometry antibody panel designed to interrogate mesenchymal cell 
populations in uterine tissue 































650nm 660nm 1/100 
AF488 anti-mouse 
NG2 
Merck, AB5320A4 495nm 519nm 1/100 




650nm 660nm 1/200 
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Flow cytometry controls included an unstained and fully stained control, single 
antibody stains and fluorescence minus one (FMO) stains for each antibody 
represented in Table 2-10. Controls were set up for each individual experiment using 
both cell samples and OneComp ebeadsTM compensation beads (ThermoFisher 
Scientific, Cat. # 01-1111-41) to ensure reliable adjustment of cytometer 
compensations and consistent set up of the analysis template.  
 
Table 2-10. Representative set up of flow cytometry analysis controls samples 
Control (cells and beads) Antibody 1 Antibody 2 Antibody 3 
Unstained     
All stains    
Single Antibody 1    
Single Antibody 2     
Single Antibody 3    
FMO Antibody 1     
FMO Antibody 2    
FMO Antibody 3    
 
Following antibody incubation, 1ml PBS was added to each suspension and the 
suspensions were centrifuged for 5 minutes at 400rcf at 4°C to pellet the cells. The 
supernatant was discarded and cells were then re-suspended in 500µl PBS and kept on 
ice until analysis by flow cytometry could take place (< 30 minutes). To exclude dead 
cells, DAPI (1/10K) was added prior to flow cytometry analysis. Flow cytometry was 
performed using a BD 5L LSR Fortessa instrument and BD FACSDiva software (BD 
Biosciences). Analysis templates were set up using control samples with guidance 
from core technical staff (Dr Shonna Johnston, Dr William Ramsay, Dr Mari Pattison). 
Data was analysed using FlowJo analysis software (Flowjo LLC, Oregon USA). 
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2.5.3 Uterine cell isolation by Fluorescence Activated Cell Sorting  
Fluorescence activated cell sorting (FACS) is a technique used to separate cells of 
interest from a heterogeneous population based on fluorescent labelling: single cell 
suspensions are stained with fluorescently-conjugated antibodies and are separated 
from each other based on the combination of fluorophores they possess (Macey, 2007). 
The principles of the FACS method are detailed in Figure 2-10. 
 
Figure 2-10. Schematic representation of Fluorescence Activated Cell Sorting (FACS). A 
mixed cell population stained with fluorescently-conjugated antibodies enters a liquid stream 
and each cell becomes encapsulated within a single droplet. Droplets are passed through a 
laser (light amplification by stimulated emission of radiation) and the relative scatter of light 
and colour-discriminated fluorescence of each cell is measured.  Information is passed to a 
computer system that collects data from each droplet. Analysis and differentiation of the cells 
is based on size, granularity and fluorescence and populations of interest defined. Droplets 
pass through a charging collar where all cells containing the same fluorescent signature are 
given the same charge. Cells are then separated by the deflection plates and are collected into 
Eppendorfs for downstream analysis (based on Macey, 2007). 
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Using the principles described in Sections 2.5.1 and 2.5.2, single cell suspensions were 
prepared from mouse uterine tissues and stained with fluorescently-conjugated 
antibodies. FACS was performed using a FACS Aria II instrument and BD FACSDiva 
software (BD Biosciences). Analysis templates were set up using control samples with 
guidance from core technical staff (Dr Shonna Johnston, Dr William Ramsay, Dr Mari 
Pattison). Data files were gathered during FACS and analysed using FlowJo analysis 
software (Flowjo LLC, Oregon USA). 
2.5.4 Immunocytochemical staining 
2.5.4.1 Cytospin 
Cells were isolated from uterine tissues by FACS (Section 2.5.3), sorted into 
Eppendorf’s containing PBS+2% foetal bovine serum (FBS) and placed on ice. 
Eppendorf’s were centrifuged at 400rcf for 5 mins at 4°C and the supernatant 
discarded. Cell pellets were re-suspended in PBS+2% FBS to a concentration of 
approximately 5x105 cells/ml. The cytocentrifuge was prepared with labelled slides, 
cuvettes (chambers) and blotter papers mounted in the metal holders for each sample 
being examined.  Cytospins were carried out by adding 200µl of each cell suspension 
to a slide cuvette and centrifuging at 800rpm for 5 minutes. Slides were carefully 
removed from the cytocentrifuge and allowed to air dry for at least 30 minutes prior to 
staining. 
2.5.4.2 Fixation and immunocytochemical staining 
Slides were air dried for at least 30 minutes then fixed by immersing in ice cold 
methanol and air dried four times. Fixed slides were either stained with H&E, Section 
2.4.1, or taken through an IHC protocol following the method described in Section 
2.4.3. Slides were visualised using brightfield and confocal microscopy, see Section 
2.4.4. 
 
2.6 RNA extraction 
The extraction of ribonucleic acid (RNA) from tissues and cells is a crucial starting 
point for many downstream techniques of molecular biology. RNA is a macromolecule 
that is transcribed from deoxyribonucleic acid (DNA) to produce copies of the genetic 
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information necessary for cell growth, differentiation and survival. Ribosomes 
translate RNA into functional proteins including structural components, enzymes and 
signalling molecules. RNA therefore is responsible for regulating the abundance of 
protein that can be made from a gene at any one time and is a useful readout of gene 
expression profiles in both tissue and cells (reviewed by (Tan and Yiap 2009)). 
2.6.1 RNA extraction using the Qiagen RNeasy mini kit  
The RNeasy Mini Kit offers an efficient RNA extraction method to yield high-quality 
RNA from tissues and cells using silica-membrane RNeasy spin columns (binding 
capacity 100µg RNA) (QIAGEN).  
2.6.1.1 Workspace Preparation 
The workspace and pipettes were cleaned with RNAzap to degrade environmental 
RNase, and new filter pipette tips used throughout the protocol. A lab coat and gloves 
were worn throughout and gloves changed frequently. The RNeasy protocol was 
carried out as per the manufacturer’s instructions (QIAGEN) at RT in a class II fume 
hood and all waste disposed of correctly. Details are given in the following sections. 
2.6.1.2 Tissue homogenisation 
Tissue samples previously preserved in RNAlater were removed from -80°C and 
weighed. Tissues were cut so that approximately 20mg fragments could be placed in a 
tube containing a ball bearing to which 1000µl TriReagent (Sigma, Cat. #T9424) was 
added. Any remaining tissue was stored in RNAlater at -80°C. Tissues were 
homogenised using a tissue lyser (QIAGEN) for two rounds of three minutes at 25Hz 
and then incubated at RT for a further 5 minutes. Samples (1ml) were centrifuged for 
15 minutes at 14,000 rcf at 4°C. Lysates were transferred to 2ml PhaseLock Heavy 
Gel tubes (Invitrogen, Cat #A33248), pelleted at 12,000-16,000 rcf for 20 to 30 
seconds prior to use. Chloroform (200µl) was added to the lysates (1.2ml), and the 
tubes vortexed for 15 seconds. Lysates were incubated for 2 to 3 minutes at RT and 
centrifuged for 15 minutes at 14,000 rcf at 4°C. The aqueous layer (~550µl) was 
aspirated into a new Eppendorf and stored at -80°C. PhaseLock Heavy gel tubes were 
discarded appropriately. 
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2.6.1.3 RNA extraction protocol 
Samples were taken from -80°C and equilibrated to RT. To each sample 1 volume 
(~550µl) of 70% ethanol was added which was then mixed by gentle pipetting. RNA 
extraction was carried out as per manufacturer’s instructions (QIAGEN), briefly 
outlined in Table 2-11. Unless otherwise stated all centrifuge steps were performed at 
8,000 rcf at RT. Resultant RNA samples were stored at -80°C until further use. 
Table 2-11. RNA extraction protocol from RNeasy Mini Kit (QIAGEN).  
Step Description 
1 Transfer approximately 700µl aqueous layer/ethanol mix to RAeasy spin 
columns (QIAGEN) and centrifuge 15 seconds. Discard flow through 
2 Repeat with remaining 400µl of sample 
3 Add 350µl Buffer RW1 and centrifuge 15 seconds. Discard flow through 
4 Add 80µl of DNase mix (10ul DNase and 70ul buffer RDD (QIAGEN)) 
and incubate for 15 minutes at RT 
5 Add 350µl Buffer RW1 and centrifuge 15 seconds. Discard flow through 
6 Add 500µl Buffer RPE and centrifuge 15 seconds. Discard flow through 
7 Add 500µl Buffer RPE and centrifuge 2 minutes. Discard flow through 
8 Place columns in new collection tubes and centrifuge for 1 minute 
9 Place columns were in 1.5ml Eppendorf tubes and add 30µl RNAse-free 
water directly to the membrane  
10 Centrifuge 1 minute to elute RNA. Discard columns 
 
2.6.2 Measuring RNA concentration by Nanodrop 
The total concentration of each RNA sample was determined using a Nanodrop ND-
100 Spectrophotometer (ThermoFischer Sscientific) using nuclease-free water as the 
blank measurement. The Nanodrop measures the absorbance of eluted RNA (1µl of 
each sample) to determine concentration. RNA samples were diluted to a concentration 
of 100ng/µl using nuclease-free water to create standardised stock solutions for 
downstream applications (qPCR). 
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2.6.3 RNA extraction using the SimplyRNA Cells Maxwell® 16 
LEV kit 
For many of the studies in this thesis a small number of cells were isolated from tissues 
by FACS (section 2.5.3) however the quality of RNA extracted using the RNeasy Mini 
Kit (QIAGEN) was not sufficient for downstream applications. A paper by Jeffries et 
al (2014) compared the performance of five commercially available RNA extraction 
kits using small tissue samples (<15mg), the RNeasy Mini Kit from QIAGEN as one 
of them. Results from this paper show that although each kit was capable of extracting 
~5µg RNA from each sample there were noticeable differences in the quality of RNA 
as determined by RNA integrity number (RIN), therefore care needs to be taken when 
selecting extraction methods to generate RNA and should be tailored to the 
requirements of downstream analyses. The study highlighted two superior kits: 
RNeasy Plus Mini Kit (QIAGEN) and SimplyRNA Maxwell® 16 LEV kit (Promega, 
Wisconsin, USA) to yield RNA with consistently higher RIN (>7) than that of the 
other kits (Sellin Jeffries et al. 2014). In this thesis the SimplyRNA Cells Maxwell® 
16 LEV (low elution volume) kit (Promega, Cat. #AS1270) was used as per 
manufacturer’s instructions (Promega), to extract good quality RNA from a small 
number of cells. 
2.6.3.1 Sample preparation 
Cells were isolated from mouse uterine tissue using the tissue digestion and FACS 
isolation protocol described in Section 2.5. To prepare the cells for RNA extraction, 
cells were collected into PBS at 4°C and stored on ice (<2hrs). Cell suspensions were 
centrifuged at 400 rcf for 5 minutes at 4°C and the supernatant carefully aspirated. Cell 
pellets were re-suspended in 200µl homogenisation solution (20µl of 1-Thioglycerol 
per ml of homogenisation solution stock) from the Maxwell® SimplyRNA cells kit 
(Promega, Wisconsin, USA) and lysates stored on ice at 4°C until the RNA extraction 
was performed (<1h). Shortly before adding cell lysates to the Maxwell® cartridge 
(Promega) 200µl of lysis solution was added to each sample and vortexed for 15 
seconds.  
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2.6.3.2 Maxwell® Cartridge preparation  
Maxwell® cartridges were places in the Maxwell® 16 LEV cartridge rack (Cat. 
#AS1251) with the label side facing away from the elution tubes and the seals were 
carefully peeled off. An LEV (low elution volume) plunger was placed in well #8 of 
each cartridge. A 0.5ml elution tube was placed in front of the appropriate cartridge 
for each cell lysate and 30µl of nuclease free water was added. The DNase I solution 
(275µl of nuclease-free H20+lyophilized DNase I+5µl blue dye from Maxwell® 
SimplyRNA cells kit (Cat. #AS1270)) was added to well #5 of each cartridge (5µl). 




Figure 2-11. Schematic of the Maxwell® cartridges placed in the Maxwell® 16 LEV 
cartridge rack. Each cartridge has 8 wells. A LEV plunger is placed in well #8 and a 0.5ml 
elution tube in well #1 with 30µl of nuclease-free water for RNA elution. Cell lysates (400µl) 
are added to well #1 just prior to running the Maxwell® Instrument (Adapted from the 
manufacturer’s instructions, Promega, Wisconsin, USA). 
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2.6.3.3 Maxwell® 16 Instrument Run 
The Maxwell® 16 LEV cartridge rack containing prepared Maxwell® cartridges, was 
transferred to the Maxwell® 16 Instrument (Cat. #AS2000) configured with the 
Maxwell® 16 High Strength LEV Magnetic Rod and Plunger Bar Adaptor (Cat. 
#SP1070). The SimplyRNA cells protocol was run using the Maxwell® 16 firmware 
version 4.95 with the ‘LEV’ hardware configuration and ‘Rsch’ operational mode 
settings. The following selections were made on the instrument: Run > RNA > 
simplyRNA > simplyRNA > OK > Run/Stop. The Maxwell® 16 Instrument 
performed the automated RNA extraction protocol as outlined in Figure 2-12. Upon 
completion of the protocol, elution tubes containing total RNA were removed from the 
Maxwell® cartridge and stored at -80°C. Maxwell® cartridges were discarded. 
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Figure 2-12. Schematic representation of RNA extraction protocol using the Maxwell® 
16 LEV Instrument (Cat. #AS2000) and SimplyRNA Cells kit. The Maxwell® 16 LEV 
simplyRNA Cells Kit(a) (Cat.# AS1270) is used with the Maxwell® 16 Instrument (Cat.# 
AS2000) configured with the Maxwell® 16 High Strength LEV Magnetic Rod and Plunger 
Bar Adaptor (Cat.# SP1070) to purify RNA from cell lysates. This RNA extraction method is 
automated and the LEV is used to generate concentrated high-quality RNA suitable for use in 
downstream applications (based on manufacturer’s instructions, Promega, Wisconsin, USA).   
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2.6.4 Measurement of RNA yield and purity using the LabChip GX 
Touch Nucleic Acid Analyser 
Robust measurement of RNA concentration and quality is an essential requirement for 
many downstream applications. The LabChip GX Touch Nucleic Acid Analyser is an 
automated electrophoresis system which gives precise nucleic acid quantification and 
RNA integrity numbers (RIN) as an assessment of sample quality. This system saves 
time and money by replacing the use of conventional agarose gels and imaging with a 
re-usable LabChip which has a long sample life and an automated data collection. The 
RNA Pico Sensitivity Assay is a rapid and high throughput method which allows the 
detection and quantification of RNA samples as low as 250pg/µl (PerkinElmer). 
 
2.6.4.1 RNA Pico Sensitivity Assay 
Analysis of RNA concentration and quality was determined using the RNA Pico 
Sensitivity Assay Reagent Kit (Perkin Elmer, Cat. #CLS960012) as per 
manufacturer’s instructions, and loaded into the DNA 5K/RNA/Charge Variant Assay 
LabChip (LabChip) (Perkin Elmer, Cat. #760435) to be read using the LabChip GX 
Touch Nucleic Acid Analyser (Perkin Elmer, Cat. #CLS138162). Reagent kit 
components can be seen in Table 2-12. The chip and reagents were allowed to 
equilibrate to RT for 20 minutes before use, RNA samples were thawed on ice. 
 
Table 2-12. RNA Pico Sensitivity Assay Reagent Kit components (Perkin Elmer) 
Reagent Quantity/ Volume 
Pico RNA Dye Concentrate 1 vial, 0.5ml 
Chip Storage Buffer 5 vials, 1.8ml 
RNA Pico Gel Matrix 5 vials, 0.51ml 
RNA Pico Ladder (Part No. CLS760652) 2 vials, 0.04ml 
RNA Pico Marker 1 vial, 0.8ml 
10x RNA Sample Buffer Concentrate 3 vials, 2.0ml 
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2.6.4.2 Preparation of Gel-Dye Solution 
The Pico RNA Dye Concentrate (0.5ml) was vortexed for 20 seconds and then 90µl 
was added to 1 vial of the RNA Pico Gel Matrix (0.51ml). The solution was vortexed 
until it was well mixed and centrifuged for a few seconds to remove any debris. The 
supernatant was transferred into a spin filter and centrifuged at 93,000rcf for 5minutes 
at RT. The filter was removed and the Gel-Dye Solution kept at 4°C on ice. 
2.6.4.3 LabChip Preparation  
The LabChip GX Touch chip has six active wells (1, 3, 4, 7, 8 and 10) and four inactive 
wells (2, 5, 6 and 9). Each active well was rinsed and aspirated twice with nuclease-
free water to clean before use. Using a reverse pipetting technique, 50µl of the prepared 
Gel-Dye was added to wells # 3, 7, 8 and 10 and 50µl of the RNA Pico Marker was 
added to well #4, Figure 2-13 (A). Both sides of the LabChip window were cleaned 
with the clean room cloth supplied with the kit which was dampened with 70% 
isopropanol before loading it onto the LabChip GX Touch Nucleic Acid Analyser, 
Figure 2-13 (B). 
 
 
Figure 2-13. Preparation of the DNA 5K/RNA/Charge Variant Assay LabChip. (A) 
Schematic representation of the LabChip: 50µl Gel-Dye was added to wells 3, 7, 8 and 10 and 
50µl RNA Pico Marker was added to well 4. (B) LabChip loaded into the LabChip GX Touch 
Nucleic Acid Analyser (adapted from the manufacturer’s instructions). 
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2.6.4.4 Sample Preparation 
Sample buffer was prepared by adding 200µl RNA Sample Buffer Concentrate (10x 
solution) to 1800µl to nuclease-free water. 8µl of Sample Buffer was pipetted into each 
well on a 96 well plate that was due to receive samples thereafter. 2µl of each sample 
was added to an individual well and mixed with the sample buffer by pipetting. The 
plate was tightly sealed and centrifuged at 10,000rcf for 2 minutes at RT. The RNA 
samples were denatured by heating to 70°C for 2mins then immediately snap cooled 
on ice for 5 minutes and centrifuged at 10,000rcf for 2 minutes at RT.  
2.6.4.5 Preparation of RNA Ladder 
The RNA Ladder (0.04ml) (Cat. #CLS760652) was centrifuged and heat denatured at 
70°C for 2 minutes. Immediately afterwards, the tubes were snap cooled on ice for 5 
minutes and then aliquoted (4µl) in to nuclease-free tubes and stored at -70°C. Upon 
use, an aliquot of the RNA ladder was thawed and 116µl Sample Buffer was added. 
The resulting solution was mixed thoroughly and transferred to the provided ‘Ladder 
Tube’ while 750µl Sample Buffer alone was transferred to the provided ‘Buffer Tube’. 
2.6.4.6 LabChip GX Touch Nucleic Acid Analyser setup 
The RNA samples (96 well plate), RNA Ladder and Sample Buffer were prepared as 
above and loaded onto the LabChip GX Touch Nucleic Acid Analyser (Perkin Elmer, 
Cat. #CLS138162), to perform the HT RNA Pico Sensitivity Assay, Figure 2-14. 
Electropherograms were obtained for each sample as seen in Figure 2-15. Upon 
completion of the assay, the LabChip was removed from the LabChip GX Touch 
Nucleic Acid Analyser, each well cleaned with nuclease-free water and returned to the 
LabChip storage container. 
LabChip techniques were carried out with assistance from Dr Pamela Brown. 
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Figure 2-14. Preparation of RNA samples, Sample Buffer and RNA Pico Ladder for RNA 
Pico Sensitivity Assay on the LabChip GX Touch Nucleic Acid Analyser. RNA samples 
were prepared as in Section 2.6.4.4 in a 96 well plate and loaded onto the LabChip GX Touch 
Nucleic Acid Analyser. Sample Buffer and the RNA ladder were loaded in the appropriate 
tubes (adapted from manufacturers’ instructions). 
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Figure 2-15: Sample RNA concentration and RNA Integrity Number (RIN /10) as 
determined by LabChip GX Touch Nucleic Acid Analyser and the RNA Pico Sensitivity 
Assay. (A) Example of a high concentration sample with good RNA integrity. Note peaks at 
5S, 18S and 28S corresponding to tRNA and ribosomal RNA. (B) Example of a low 
concentration sample with poor RNA integrity (no ribosomal RNA peaks). (C) Example of a 
low concentration sample with good RNA integrity. The LabChip GX Touch Nucleic Acid 
Analyser was used to assess RNA concentration and quality of every sample (Author’s own 
images). 
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2.7 Synthesis of complimentary DNA  
Reverse transcription is used to synthesis complementary DNA (cDNA) from an RNA 
template using a reverse transcriptase enzyme and short primers complementary to the 
3’ end of the RNA. This method facilitates the cloning of low copy genes and produces 
a cDNA library that can be used directly as a template for quantitative polymerase 
chain reaction (qPCR) thereby obtaining information about corresponding gene 
expression. 
2.7.1 cDNA synthesis using the Superscript VILO cDNA Synthesis 
Kit 
2.7.1.1 RNA sample preparation 
The concentration of stock RNA samples was determined using the Nanodrop 
ND-1000 Spectrophotometer (Section 2.6.2) or the LabChip GX Touch Nucleic Acid 
Analyser (Section 2.6.4). Stock RNA samples were diluted in nuclease-free water to 
obtain a working concentration of 100ng/µl in a final volume of 30µl and kept on ice.  
2.7.1.2 cDNA synthesis master mix preparation 
A master mix solution was prepared, the total volume of which was determined by the 
number of samples to be run in duplicate, using reagents of the Superscript VILOTM 
cDNA Synthesis Kit (InVitrogen, Cat. #11754-250) outlined in Table 2-13. 
Table 2-13. Volumes of reagents used to prepare the cDNA synthesis master mix 
Component Concentration Volume for 1 reaction/sample 
5X VILO mix  1x 4 µl 
10x superscript enzyme mix  0.125x 0.25 µl 
H20 NA 14.75 µl 
Total Volume 19 µl 
 
Individual master mixes were also prepared for each of the three controls using 
reagents in Table 2-13. The positive control contained 5X VILO mix, 10x superscript 
enzyme mix, H20 and control RNA (supplier); the negative control contained 5X VILO 
mix, 10x superscript enzyme mix, H20 and no RNA (replaced by H20); the ‘no enzyme’ 
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control contained 5X VILO mix, H20 and control RNA (10x superscript enzyme 
replaced by water). 
2.7.1.3 cDNA Synthesis 
Nuclease-free PCR tubes (0.2ml) (Applied Biosystems) were labelled appropriately 
and 19µl master mix added to each followed by the addition of 1µl of RNA sample 
(100ng/µl) to make a final volume of 20µl. Tubes were placed in a Peltier Thermal 
Cycler (PTC-200) and the reaction performed using the following parameters: 25°C 
for 1 minute; 42°C for 60 minutes; 85°C for 5 minutes: 4°C ‘hold’. Once completed, 
cDNA samples were stored at -20°C. The concentration of resultant cDNA was 
measured using the Nanodrop ND-1000 Spectrophotometer (Section 2.6.2). 
2.7.2 cDNA synthesis using the NuGEN Ovation RNA-Seq System 
V2 
In some cases, the concentration of RNA was relatively low and therefore standard 
methods of cDNA synthesis could not be used. The NuGEN Ovation RNA-Seq System 
V2 (NuGEN, Cat. #7102-32) provides a rapid and sensitive RNA amplification 
process to make amplified cDNA from a starting RNA concentration as low as 
500pg-100ng, suitable for downstream applications including RNA-Seq and qPCR. 
For RNA-seq studies in this thesis the NuGEN Ovation RNA-Seq System V2 
(NuGEN, Cat. #7102-32) was used as outlined below. 
2.7.2.1 Workspace set up 
Two separate areas were set up: a pre-amplification workspace and a post-
amplification workspace with dedicated consumables and equipment to minimise the 
risk of contamination in the samples. All surfaces, instrumentation and equipment 
were cleaned with RNaseZap (ThermoFischer Scientific, Cat. #AM9780) to reduce 
environmental RNases followed by DNA-OFF (MP Biomedicals, Cat. #QD050) to 
avoid any previously amplified cDNA from contaminating the new amplification. All 
reagents quoted below were from NuGEN Ovation RNA-Seq System V2 (Cat. 
#7102-32). 
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2.7.2.2 Programming the Thermal Cycler 
Programmes were prepared as outlined in Table 2-14 following the operating 
instructions provided by the manufacturer (NuGEN) on a thermal cycler with a heat 
block designed for 0.2ml tubes, equipped with a heated lid and with 100µl reaction 
volume.  
Table 2-14. Thermal Cycler Programming for the NuGEN Ovation RNA-Seq 
System V2 (Cat. #7102-32) 
First Strand cDNA Synthesis 
Programme 1: Primer Annealing 65°C 2 mins, hold at 4°C 
Programme 2: First Strand Synthesis 4°C 1 min, 25°C 10 minx, 42°C 10 
mins, 70°C 15mins, hold at 4°C 
Second Strand cDNA Synthesis 
Programme 3: Second Strand Synthesis 4°C 1 min, 25°C 10 mins, 50°C 30 
mins, 80°C 20mins, hold at 4°C 
SPIA Amplification 
Programme 4: SPIA Amplification 4°C 1 min, 47°C 60 mins, 80°C 20mins, 
hold at 4°C 
  
2.7.2.3 First Strand cDNA Synthesis 
Prior to starting the reaction, the First Strand Primer Mix (A1), First Strand Buffer Mix 
(A2), First Strand Enzyme Mix (A3) and water were retrieved from the -20°C freezer, 
thawed at RT, centrifuged briefly and placed on ice. The nuclease-free water was kept 
at RT; 2µl of A1 and 5µl of total RNA sample (500pg-100ng) was added to each 0.2ml 
PCR tube and mixed by pipetting 5 times, briefly centrifuged and placed on ice. All 
tubes containing samples were placed in a pre-warmed thermal cycler and Programme 
1 was run as outlined in Table 2-14.  
Samples were removed and placed on ice. A master mix was prepared by combining 
the First Strand Buffer Mix (A2: 2.5µl per reaction) and the First Strand Enzyme Mix 
(A3: 0.5µl per reaction) multiplied depending upon the number of samples being 
analysed, in a 0.5ml capped tube. To each sample, 3µl of the master mix was added to 
make a final volume of 10µl, mixed by pipetting 5 times and briefly centrifuged. Tubes 
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were placed in a pre-cooled thermal cycler and Programme 2 was run as outlined in 
Table 2-14. Once complete samples were centrifuged and placed on ice.  
2.7.2.4 Second Strand cDNA Synthesis 
The Second Strand Buffer Mix (B1) and the Second Strand Enzyme Mix (B2) were 
retrieved from -20°C, thawed at RT, centrifuged and placed on ice. A master mix was 
prepared by combining the Second Strand Buffer Mix (B1: 9.7µl per reaction) and the 
Second Strand Enzyme Mix (B2: 0.3µl per reaction) multiplied depending upon the 
number of samples being analysed, in a 0.5ml capped tube. To each sample, 10µl of 
the Second Strand master mix was added to make a final volume of 20µl, mixed by 
pipetting 5 times and briefly centrifuged. Tubes were placed in a pre-cooled thermal 
cycler and Programme 3 was run as outlined in Table 2-14. Once complete samples 
were centrifuged and placed at RT on the bench. 
2.7.2.5 Purification of cDNA 
The Agencourt purification beads (NuGEN, Cat. #7102-32) were retrieved from 4°C 
storage, placed on the bench top and allowed to reach RT. The beads were suspended 
by inverting and tapping the tube several times. At RT 32µl of the resulting bead 
suspension was added to each reaction and mixed by pipetting 10 times, then incubated 
for 10 minutes. The tubes were transferred to a DynaMagTM PCR magnet (Invitrogen, 
Cat. #49-2025) and left to stand for 5 minutes to completely clear the solution of beads. 
Carefully to minimize bead loss, 45µl of the solution was removed and discarded. With 
the tubes still on the magnet, 200µl of freshly prepared 70% ethanol solution was 
added and allowed to stand for 30 seconds. This ethanol ‘wash’ was removed using a 
pipette and the wash step was repeated twice more. Beads were air dried on the magnet 
for 15 to 20 minutes and each tube was inspected carefully to ensure all the ethanol 
was evaporated before continuing with the protocol below. 
2.7.2.6 Single Primer Isothermal Amplification (SPIA) Amplification 
The SPIA Primer Mix (C1), SPIA Buffer Mix (C2) and SPI Enzyme Mix (C3) were 
retrieved from -20°C storage, thawed at RT, centrifuged and placed on ice. A master 
mix was prepared by sequentially combining the SPIA Buffer Mix (C2: 20µl per 
reaction, the SPIA Primer Mix (C1: 10µl per reaction) and the SPIA Enzyme Mix (C3: 
10µl per reaction) multiplied depending upon the number of samples being analysed, 
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in an appropriately sized capped tube. To each sample 40µl of the resulting SPIA 
Master Mix was added which should now contain double stranded cDNA bound to the 
dried beads. Samples were removed from the magnet and mixed thoroughly by 
pipetting at least 8-10 times. Each tube was placed in a pre-cooled thermal cycler and 
Programme 4 was run as outlined in Table 2-14. Once complete samples were 
centrifuged and placed at RT on the bench in the post-amplification workspace. 
Importantly, samples were not take back into the pre-amplification workspace but 
instead all remaining steps were carried out in the post-amplification workspace using 
dedicated post-amplification consumables and equipment. The tubes were transferred 
to the magnet and left to stand for 5 minutes to completely clear the solution of beads; 
thereafter 40µl of cleared supernatant containing the SPIA cDNA was carefully 
transferred to a fresh tube. 
2.7.2.7 Purification of SPIA cDNA 
The QIAGEN QIAquick PCR Purification Kit (QIAGEN, Cat. #28104) was used for 
the purification of the amplified SPIA cDNA produced with the Ovation RNA-Seq 
System V2. Briefly, for each sample 250µl of Buffer PB from the QIAGEN kit was 
added to a clean 1.5ml microcentrifuge tube and the entire volume (40µl) of the 
individual SPIA reaction was added. Samples were vortexed for 5 seconds and 
centrifuged briefly before loading into a QIAquick spin column placed in a collection 
tube. Samples were centrifuged for 1 minute at maximum speed in a microcentrifuge, 
the flow through from the column was discarded and the column replaced in the 
collection tube. To each column, 700µl of freshly prepared 80% ethanol solution was 
added and centrifuged for 1 minute at maximum speed, the flow through again 
discarded and the column replaced in the collection tube. This ethanol ‘wash’ step was 
repeated twice more.  
The column was centrifuged for a further 2 minutes at maximum speed to remove all 
residual ethanol. The flow through and collection tube were discarded and the column 
was blotted onto clean, absorbent paper to remove any residual wash buffer from the 
tip of the column before placing into a clean 1.5ml microcentrifuge tube. 1X TE 
solution (30µl per tube) was added to the centre of each column and left to stand for 5 
minutes at RT. The columns in their microcentrifuge tubes were centrifuged for 1 
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minute at full speed then the columns were discarded and the purified SPIA cDNA in 
each tube (~28µl) was mixed briefly by vortexing, centrifuged and stored at -20°C. 
 
2.7.3 Measuring cDNA concentration and purity by Nanodrop 
The total concentration and quality of each synthesised cDNA sample was determined 
using a Nanodrop ND-1000 Spectrophotometer (ThermoFischer Scientific), as 
outlined in section 2.6.2. The Nanodrop measures the absorbance of synthesised cDNA 
(1µl of each sample) to determine concentration. The A260/280 ratios were 
determined for each sample as a measure of purity and samples were only used for 
further analysis if they were >1.8. 
 
2.8 Quantitative Real Time PCR- TaqMan method  
Quantitative real time polymerase chain reaction (qPCR) is a method which 
determines and monitors the amplification of a chosen DNA molecule in real time. 
PCR consists of a series of temperature changes (repeated ~35 times) that allow for 
the following processes to occur: denaturation of the double stranded DNA molecule; 
annealing of the specifically designed primers with the DNA template of interest; and 
extension of the new transcript by DNA polymerase enzyme.  
In this thesis, the Applied Biosystems TaqMan method (ThermoFischer Scientific) 
was used to detect specific PCR products. This method makes use of a pair of 
unlabelled gene-specific PCR primers (PrimerDesign) and a sequence specific 
TaqMan probe (Universal Probe Library, Roche) labelled with a FAM (6 
carboxy-fluorescein) reporter dye on the 5’ end and a non-fluorescent quencher (NFQ) 
on the 3’ end. This probe hybridises to the complementary sequence defined by the 
primers, quencher activity is released after cleavage by the Taq polymerase resulting 
in release of the reporter dye (Figure 2-16). qPCR by the TaqMan method is carried 
out in a thermal cycler with the capacity to illuminate the sample with a beam of light 
and detect fluorescence emitted by the excited dye in real time. 
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Figure 2-16. Schematic representation of the Applied Biosystems TaqMan qPCR 
method. (A) Components of the assay include template cDNA, Taq DNA polymerase, 
forward and reverse primers and a UPL probe. (B) The first step of qPCR is to raise the 
temperature to denature the double stranded cDNA then the temperature is lowered to allow 
annealing of gene specific forward and reverse primers and sequence specific UPL probe. (C) 
Taq DNA polymerase synthesizes new strands of DNA and when it comes in contact with the 
probe, its endogenous 5’ nuclease activity cleaves the probe separating the FAM dye from the 
quencher and hence a fluorescent signal is generated. Each cycle generates more dye 
molecules resulting in an increase in fluorescence intensity proportional to the amount of 
amplicon synthesised (based on ThermoFisher Scientific). 
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2.8.1 Preparation of the Taqman mastermix 
TaqMan qPCR was used to quantify RNA as a measure of gene expression in samples 
of cells or tissues. A master mix solution was prepared for each gene being tested, the 
total volume of which was determined by the number of samples to be run in duplicate, 
as shown in Table 2-15. Working stock solutions of all primers (20µM) were prepared 
from stock solutions (100µM) by a 1:5 dilution in nuclease-free water. 
 
Table 2-15. Volumes of reagents used to prepare the TaqMan mastermix. 
Stock component Supplier Volume per 1 
reaction (µl) 
2X express Supermix (+ROX) InVitrogen, California 7.5 
Forward primer (20µM) Eurofins, Germany 0.15 
Reverse primer (20µM) Eurofins, Germany 0.15 
UPL probe (10µM) Roche 0.15 
H20  5.55 
Total Volume 13.5 
 
13.5µl of the TaqMan mastermix was pipetted into the appropriate number of wells of 
a 96 well MicroAmp Fast optical reaction plate (Applied Biosystems, California, 
USA) and 1.5µl cDNA sample added in duplicate wells. The plate was centrifuged and 
placed on ice before running the PCR amplification on a real time PCR system 
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Table 2-16. Temperature cycles for the TaqMan qPCR method. 
Denaturation 
Denaturation  95°C 5 min 
cDNA synthesis 
Denaturation 95°C 1 min 
Annealing 58°C 1 min 
Extension 72°C 1 min 
Repeat above three steps 30 cycles 
Extension 
Final extension 72°C 10 min, hold at 4°C 
 
2.8.2 PCR primer design 
Primers for each gene of interest were designed using the Universal probe Library 
Assay Design Centre (Roche Applied Science) and purchased from Eurofins 
(Germany). A complete list of primers used in this thesis can be found in Table 2-17.  
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Table 2-17. Accession numbers, primer sequences and associated UPL probe numbers for genes of interest investigated in this study  
Gene Name Accession Number Forward Primer Sequence Reverse Primer Sequence UPL Probe 
Number 
Cytokines, chemokines and monocyte/macrophage characterisation panel 
Mus musculus chemokine (C-C motif) ligand 2 (Ccl2) NM_011333.3 catccacgtgttggctca gatcatcttgctggtgaatgagt 62 
Mus musculus chemokine (C-C motif) receptor 2 (Ccr2) NM_009915.2 acctgtaaatgccatgcaagt tgtcttccatttcctttgatttg 27 
Mus musculus chemokine (C-C motif) ligand 7 (Ccl7) NM_013654.3 ttctgtgcctgctgctcata ttgacatagcagcatgtggat 89 
Mus musculus chemokine (C-C motif) ligand 8 (Ccl8) NM_021443.3 ttctttgcctgctgctcata gcaggtgactggagccttat 26 
Mus musculus Cxcl1 chemokine (C-X-C motif) ligand 1 NM_008176.3 gactccagccacactccaac tgacagcgcagctcattg 83 
Mus musculus Cxcl2 chemokine (C-X-C motif) ligand 2 NM_009140.2 cagaaaatcatccaaaagatactgaa ctttggttcttccgttgagg 26 
Mus musculus Cxcl3 chemokine (C-X-C motif) ligand 3 NM_203320.3 ccccaggcttcagataatca gggatggatcgcttttctc 69 
Mus musculus chemokine (C-X-C motif) ligand 12 
(Cxcl12), transcript variant 3 
NM_001012477.1 ctgtgcccttcagattgttg taatttcgggtcaatgcaca 41 
Mus musculus colony stimulating factor 1 (macrophage) 
(Csf1), transcript variant 1 
NM_007778 gccattgcactgtgaatactg catagggatggatgggacag 40 
Mus musculus colony stimulating factor 2 (granulocyte-
macrophage) (Csf2) 
NM_009969 gcatgtagaggccatcaaaga cgggtctgcacacatgtta 79 
Mus musculus chemokine (C-X3-C motif) ligand 1 
(Cx3cl1) 
NM_009142.3  ctgccagggtcctttcct gggcaaaggtgagtccttg 108 
Mus musculus chemokine (C-X3-C motif) receptor 1 
(Cx3cr1) 
NM_009987 ggcctagagctcaaagaaatcc cacagaccttcgatcccagt 16 
Mus musculus tumor necrosis factor (Tnf) NM_013693 ttgtcttaataacgctgatttggt gggagcagaggttcagtgat 64 
Mus musculus interleukin 6 (Il6), transcript variant 1 NM_031168 gctaccaaactggatataatcagga ccaggtagctatggtactccagaa 6 
Mus musculus interleukin 10 (Il10) NM_010548 cagagccacatgctcctaga tgtccagctggtcctttgtt 41 
Mus musculus arginase, liver (Arg1) NM_007482 ggcctttgttgatgtcccta acagaccgtgggttcttcac 17 
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Pericyte characterisation panel 
Mus musculus platelet derived growth factor receptor, 
beta polypeptide (PDGFRβ/CD140b) 
NM_001146168.1 tcaagctgcaggtcaatgtc ccattggcagggtgactc 67 
Mus musculus melanoma cell adhesion molecule 
(MCAM/CD146) 
NM_023061.2 aaactggtgtgcgtcttcttg cttttcctctcctggcacac 27 
Mus musculus alpha smooth muscle actin 
(aSMA/Acta2) 
NM_007392.2 ctctcttccagccatctttcat tataggtggtttcgtggatgc 58 




cttggccttgttggtcagat cacctccaggtggttctcc 16 
Wound healing factors 
Mus musculus matrix metallopeptidase 2 (Mmp2) NM_008610.2 taacctggatgccgtcgt ttcaggtaataagcacccttgaa 77 
Mus musculus matrix metallopeptidase 3 (Mmp3) NM_010809.1 ttgttctttgatgcagtcagc gatttgcgccaaaagtgc 7 
Mus musculus matrix metallopeptidase 9 (Mmp9) NM_013599.2 acgacatagacggcatcca gctgtggttcagttgtggtg 19 
Mus musculus tissue inhibitor of metalloproteinase 1 
(Timp1), transcript variant 1 
NM_001044384.1 gcaaagagctttctcaaagacc agggatagataaacagggaaacact 76 
Mus musculus transforming growth factor, beta 1 
(Tgfb1) 
NM_011577.1 tggagcaacatgtggaactc gtcagcagccggttacca 72 
Mus musculus transforming growth factor, beta 3 
(Tgfb3) 
NM_009368 gcagacacaacccatagcac gggttctgcccacatagtaca 1 
Mus musculus collagen, type I, alpha 1 (Col1a1) NM_007742.4 ccgctggtcaagatggtc ctccagcctttccaggttct 1 
Mus musculus collagen, type III, alpha 1 (Col3a1) NM_009930 gaccaggttgcccatcact ggaatggacctgcaaaccta 3 
Mus musculus fibronectin 1 (Fn1), transcript variant 1 NM_010233 ggaatggacctgcaaaccta gtagggcttttcccaggtct 3 
Validation of RNA-sequencing results 
Mus musculus actin, alpha 2, smooth muscle, aorta 
(Acta2) 
NM_007392.2 ctctcttccagccatctttcat tataggtggtttcgtggatgc 58 
Mus musculus myosin, heavy polypeptide 11, smooth 
muscle (Myh11), transcript variant 1 
NM_013607.2 ttgctgggtttgaaatctttg ccctctcgctggtactcttc 1 
Mus musculus olfactory receptor 78 (Olfr78), transcript 
variant 1 
NM_130866 gcttcctccaaccttctgag tggagctcgtttcccaaata 42 
Mus musculus regulator of G-protein signaling 4 (Rgs4) NM_009062 tccctcagttaaacaagatgtgc gtttcatgtcctttgcactcc 4 
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Mus musculus regulator of G-protein signaling 5 
(Rgs5), transcript variant 1 
NM_009063.4 cagacagaggcccctaaaga agacggttccaccaggttc 9 
Mus musculus vascular cell adhesion molecule 1 
(Vcam1) 
NM_011693 tcttacctgtgcgctgtgac actggatcttcagggaatgagt 47 
Mus musculus kit ligand (Kitl), transcript variant 2 NM_001347156.1 cagcgctgcctttccttat ccttggttttgacaagaggatt 68 
Mus musculus potassium inwardly-rectifying channel, 
subfamily J, member 8 (Kcnj8), transcript variant 2 
NM_001330363 gagaaaggcaccatggagaa ggagaagagaaacgcagacg 109 
Mus musculus prostaglandin-endoperoxide synthase 2 
(Ptgs2) 
NM_011198.4 gatgctcttccgagctgtg ggattggaacagcaaggattt 45 
Mus musculus prune homolog 2 (Drosophila) (Prune2) NM_181348.4 tgttgaagagtgagaacaactgg atggcttcaataggaactttgg 69 
Mus musculus chemokine (C-X-C motif) ligand 14 
(Cxcl14) 
NM_019568.2 ttgagaccgttcacagcact ctctctgagcggaagctttg 1 
Mus musculus transforming growth factor, beta induced 
(Tgfbi) 
NM_009369.4 aggtcccaggagagaaaggt cccacaactcccatggtct 3 
Mus musculus runt related transcription factor 1 
(Runx1), transcript variant 1 
NM_001111021.2 ctccgtgctacccactcact atgacggtgaccagagtgc 77 
Mus musculus patched 1 (Ptch1), transcript variant 1 NM_008957.3 cgactacatgccagagacca gggaactgagcgtactcgat 3 
Mus musculus collagen, type VIII, alpha 1 (Col8a1) NM_007739.2 gccagccaagcctaaatgt cagagttcagggaaatgatgaa 3 
Mus musculus prickle planar cell polarity protein 1 
(Prickle1) 
NM_001033217.4 atggattctttggcgttgtc tgacggtcttggcttgct 58 
Mus musculus Wilms tumor 1 homolog (Wt1) NM_144783.2 cagatgaacctaggagctaccttaaa tgcccttctgtccatttca 3 
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2.8.3 Quantification of gene expression 
To quantify gene expression by TaqMan qPCR method, the fluorescence detection is 
plotted against the number of PCR cycles on a logarithmic scale. The threshold cycle 
(Ct) is defined from this graph as the number of cycles required for the fluorescent 
signal to exceed the background signal, Figure 2-17 (A), which is indirectly 
proportional to the amount of PCR product. 
2.8.3.1 Generation of Standard Curve 
Gene expression analysis was performed using the Standard Curve method whereby 
the quantity of each sample was extrapolated from a standard curve and then analysed 
relative to a control sample. Standard curve samples were generated by pooling an 
aliquot of each RNA sample (2µl) in any one experiment and performing four 10-fold 
serial dilutions to produce 4 standard RNA samples of decreasing concentration. The 
concentration of the first pooled standard was determined using the Nanodrop 
ND-1000 (section 2.6.2) and the remaining 4 standards calculated as 1/10 dilutions of 
this value. cDNA synthesis (section 2.7.1) and qPCR (section 2.8) was performed on 
each serial dilution separately to generate corresponding Ct values for each gene of 
interest. Ct values were plotted against log10 (RNA concentration) and a straight line 
fitted. The correlation coefficient on the line was confirmed to be >0.9 (Figure 2-17 
(B-C). From this standard curve the relative expression levels of genes of interest in 
experimental samples can be extrapolated. 
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Figure 2-17. Generation of a standard curve for qPCR analysis. (A) qPCR graph of the 
number of cycles plotted against fluorescence with threshold cycle (Ct) denoted with a green 
arrow. (B) RNA concentration and associated Ct value for 4 exemplar standard samples (C) 
Log10RNA concentration plotted against Ct value of 4 exemplar standard samples. Straight 
line fitted, gradient ~ -3.33 and correlation coefficient >0.9 (Author’s own data). 
 
2.8.3.2 Normalisation to a reference gene 
It is essential to normalise qPCR data to a fixed control reference, one that is not 
affected by the experimental conditions. The Primer Only GeNorm 12 Gene Kit 
(Primer Design, Cat. #ge-SY-12) was used to select the best candidate reference gene 
for the given experimental samples in this thesis (mouse uterine tissues and cells). The 
expression of 12 mouse reference genes (18s, Actb, Atp5b, B2m, Canx, Cyc1, Eif4a2, 
Gapdh, Rpl13a, Sdha, Ubc and Ywhaz) (primers in kit) was assessed in a representative 
set of cDNA samples by qPCR (Section 2.8) and the results analysed using the qbase+ 
analysis software (Primer Design) to generate a list in order of stability (Figure 2-18). 
A report was produced with an output graph which identifies the most stable reference 
gene for the given samples (Actb). 
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Figure 2-18. Average expression stability of top reference genes in experimental samples 
(mouse uterine tissues and cells) as determined by geNorm 12 Gene Kit (Primer Design, 
Cat. #ge-SY-12). Kit included primers against 12 mouse reference genes for including 18s, 
Actb, Atp5b, B2m, Canx, Cyc1, Eif4a2, Gapdh, Rpl13a, Sdha, Ubc and Ywhaz 
(Author’s own data). 
 
The relative quantification result for the gene of interest was normalised to that of the 
house-keeping gene Actb in the same sample. A standard curve was generated for Actb 
and genes of interest normalised to these values. Normalised numbers were then 
compared between experimental samples and displayed as a fold-change in expression. 
2.8.3.3 Statistical Analysis 
Statistical analyses were performed using Graphpad Prism software. In data that was 
normally distributed a student’s t-test was performed to determine the significance of 
a difference between two groups. When comparing the means of more than two groups 
a one-way ANOVA was used followed by a multiple comparisons test such as Sidak’s 
or Tukey’s. All data were presented as mean±SEM and criteria for significance was 
p<0.05.  
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2.9 Next Generation RNA Sequencing by Edinburgh 
Genomics 
In cells, genetic information is stored as DNA, transcribed into RNA which is 
translated into proteins. Transcription of genes regulates a cell’s biological activity and 
characterises the phenotype of the cell, therefore understanding the RNA 
transcriptome gives insight into both development and disease (Wang, Gerstein and 
Snyder 2009). Over the last 50 years, many techniques and technologies have emerged 
to facilitate sequencing of DNA and RNA molecules. Next generation sequencing 
(NGS) or RNA-Seq is a high throughput method that enables RNA analysis through 
sequencing of cDNA. This gives a more detailed and quantitative assessment of gene 
expression and how this changes between physiological and pathological conditions 
(Kukurba and Montgomery 2015). 
RNA-Seq uses deep sequencing technologies. In brief, a sample of RNA is converted 
to a cDNA library with adaptors attached to the ends and these molecules are 
sequenced to obtain short sequences known as reads (generally 30-400bp). Following 
sequencing, the reads are aligned to a reference genome to produce a genome-scale 
transcriptomic map that contains the expression level of each gene (Wang et al. 2009). 
In this thesis, NGS was used to investigate transcriptomic changes in uterine 
mesenchymal cells during endometrial tissue repair.  
2.9.1 RNA and cDNA sample preparation for Next Generation 
Sequencing (NGS)  
Uterine mesenchymal cells were isolated from endometrial tissues dissected from 
cycling Pdgfrβ-BAC-eGFP mice (naïve) and from Pdgfrβ-BAC-eGFP mice at 24hrs 
of the mouse model of endometrial breakdown and repair (section 2.2.2) by FACS, 
protocols described in detail in section 2.5. Cells were centrifuged at 400rcf for 5 
minutes at 4°C and the cell pellet re-suspended in homogenisation solution. RNA 
extraction was performed using the SimplyRNA Cells Maxwell® 16 LEV kit and the 
automated Maxwell® 16 LEV extraction instrument as outlined in section 2.6.3. RNA 
concentration and RNA Integrity Number (RIN) was measured using the LabChip GX 
Touch Nucleic Acid Analyser as outlined in section 2.6.4. As RNA samples met 
minimum quality requirements but failed to reach minimum concentrations, a cDNA 
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amplification step was included in sample preparation, carried out using the NuGEN 
Ovation V2 system as outlined in section 2.7.2 and the quality checked by LabChip 
GX Touch (section 2.6.4) before they were sent to Edinburgh Genomics. 
2.9.2 Truseq mRNA sequencing 
At Edinburgh Genomics (https://genomics.ed.ac.uk/) TruSeq DNA Nano gel free 
libraries (350bp insert) were prepared for each sample. Sequence data was generated 
on the HiSeq 4000 75PE platform to yield at least 290M + 290M reads according to 
the standard protocols at the facility. 
2.9.3 Bioinformatic data analysis 
An in-house bioinformatic analysis of the samples was carried out by Jonathan 
Manning at Edinburgh Genomics and a pdf report outlining the methods used and 
results was provided. In brief, reads were trimmed using Cutadapt version cutadapt-
1.9.dev21. Reads were trimmed for quality at the 3’ end using a quality threshold of 
30 and for adapter sequences of the NuGen Ovation v2 kit (AGATCGGAAGAGC). 
After trimming reads were required to have a minimum length of 50. The Mus 
musculus genome from Ensembl, assembly GRCm38, annotation version 84, was used 
as the reference for mapping. Reads were aligned to the reference genome using 
STAR2 version 2.5.2b specifying paired-end reads. 
Reads were assigned to exon features grouped by gene ID in the reference genome 
using ‘featureCounts‘3, which assigns counts on a ‘fragment’ basis as opposed to 
individual reads such that a fragment is counted where one or both of its reads are 
aligned and associated with the specified features. Strandness was set to ‘unstranded’ 
and a minimum alignment quality of 10 was specified. The raw counts table was 
filtered to remove rows consisting predominantly of near-zero counts, filtering on 
counts per million (CPM) to avoid artefacts due to library depth. Specifically, a row of 
the expression matrix was required to have values greater than 0.1 in at least 3 samples, 
corresponding to the smallest sample group as defined by Group, once any samples 
were removed (where applicable). 
A principal components analysis was undertaken on normalised and filtered expression 
data to explore observed patterns with respect to experimental factors. The cumulative 
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proportion of variance associated with each factor was used to study the level of 
structure in the data, while associations between continuous value ranges in principal 
components and categorical experimental factors was assessed with an ANOVA test. 
Points were assigned as outliers in each component if they occurred outside the 
interquartile range + 1.5. If appropriate due to known experimental difficulties, 
problematic samples were excluded from downstream analysis. Differential analysis 
was carried out with EdgeR4 (version 3.16.5), and the quasi-likelihood (QL) F-test 
using the contrasts desired.  
2.9.4 Validation of RNA Sequencing results by qPCR 
Validation of RNA sequencing results was done using qPCR on an independent set of 
cell samples generated from Pdgfrβ-BAC-eGFP endometrial tissues (naive, Section 
2.2.1 and 24hrs of the mouse model of endometrial breakdown and repair, Section 
2.2.2) by FACS (section 2.5). RNA extraction (section 2.6.3), cDNA amplification 
(section 2.7.1) and qPCR (section 2.8) was performed to analyse the expression of 
candidate genes in validation samples. 
 
2.10 Chromium Single Cell Gene Expression Analysis- 10x 
Genomics 
Single cell RNA sequencing is a technology designed to elucidate heterogeneity within 
cell populations thereby revealing de novo cellular phenotypes and giving a deeper 
understanding of biological systems (Hedlund and Deng 2018). Whereas in bulk 
RNA-Seq subtleties of a heterogeneous cell population are overlooked, single cell 
sequencing provides a platform to identify subpopulations of cells and interrogate 
changes in their individual transcriptome due to physiological or pathological 
conditions (Hedlund and Deng 2018). 
The ChromiumTM Single Cell Gene Expression technique provides a comprehensive 
solution for cell characterisation and gene expression profiling with a simplified 
workflow. In this thesis the ChromiumTM system was used to generate samples for 
single cell sequencing of uterine mesenchymal cells during endometrial tissue repair. 
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2.10.1 . Cell sample preparation for 10x genomics single cell 
sequencing (ScSeq) 
Uterine mesenchymal cells were isolated form endometrial tissues dissected from 
naive Pdgfrβ-BAC-eGFP mice and from Pdgfrβ-BAC-eGFP mice at 24hrs of the 
mouse model of endometrial breakdown and repair (section 2.2) by FACS (section 
2.5). Both naïve and 24hrs samples were pooled from uterine tissues of 4 mice (2 horns 
pooled from each mouse): 25,000 mesenchymal cells (GFP+) from each giving a total 
number of 100,000 mesenchymal cells (GFP+) for downstream application. Cells were 
sorted into a 1.5ml Eppendorf with 500µl of PBS+2%FBS added (the Eppendorf was 
vortexed prior to sorting to ensure the inside was fully coated with buffer). Eppendorfs 
were kept at 4°C during and after FACS. Cells were immediately centrifuged at 400rcf 
for 5 minutes at 4°C and the cell pellet re-suspended in PBS+2%FBS and mixed by 
pipetting. This buffer ‘wash’ was repeated. In each sample, cells were counted using a 
TC20TM Automated Cell Counter (Bio Rad, Cat. #1450102), which also gives a 
viability score (85% threshold value) as determined by a 0.4% trypan blue stain. 
 
2.10.2 ChromiumTM Single Cell 3’ Library and Gel Beads Kits 
The 10x ChromiumTM Controller is an instrument which assigns a 10x barcode to each 
individual cell in a cell suspension by partitioning thousands of cells into 
nanolitre-scale Gel bead-in-EMulsions (GEMs) so that all cDNA molecules generated 
by reverse transcription (RvT) share a common 10x barcode. cDNA libraries are 
generated and sequenced and the 10x barcodes used to associate individual reads back 
to the individual cells (Figure 2-19 (A)) (10x Genomics, USA). 
The Single Cell 3’ Protocol is as follows: during GEM RvT, primers containing an 
Illumina R1 sequence, a 16nt 10x barcode, a 10nt Unique Molecular Identifier (UMI) 
and a poly-dT primer sequence are mixed with cell lysate and a master mix. Incubation 
of the GEMs then produces barcoded, full-length cDNA from poly-adenylated mRNA 
(Figure 2-19). Silane magnetic beads are used to remove leftover biochemical reagents 
and primers from the resulting solution and barcoded cDNA is amplified by PCR. 
Enzymatic fragmentation and size selection are used to optimise the cDNA size prior 
to library construction. The Single Cell 3’ protocol produces sequencing libraries with 
construct structure shown in Figure 2-19 (B). 
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The Single Cell 3’ Reagent Kits used in this thesis were the ChromiumTM Single Cell 
3’ Library & Gel Bead Kit V2. 4 rnx (10x Genomics, Cat. #120267) and the 
ChromiumTM Single Cell A Chip Kit, 16 rnxs (10x Genomics, Cat. #1000009), detailed 




Figure 2-19. Schematic representation of 10x ChromiumTM workflow and generation of 
Single Cell cDNA libraries. (A) GEM production by ChromiumTM Controller, GEM RT 
incubation and generation of 10x barcoded cDNA molecules. (B) Final library construct 
beginning and ending with P5 and P7 primers, read one encoding the 16bp 10x barcode and 
10bp UMI, read two used to sequence the fragment and the i7 Sample Index sequence (adapted 
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Table 2-18. Components of the ChromiumTM Single Cell 3’ Library & Gel Bead Kit 
V2. 4 rnx and ChromiumTM Single Cell A Chip Kit, 16 rxns. 
Product Components Catalogue Number 
ChromiumTM Single Cell 3’ Library Kit V2, 4 rxns (store at -20°C) 
Reagents Module 1 RvT Reagent Mix 220089 
 RvT Enzyme Mix 220127 
Additive A 220074 
RvT Primer 310354 
Buffer Sample Clean Up 1 220020 
Amplification Master Mix 220129 
cDNA Primer Mix 220106 
cDNA Additive 220067 
Reagents Module 2 Fragmentation Enzyme Blend 220130 
 Fragmentation Buffer 220108 
Ligation buffer 220109 
DNA Ligase 220131 
Adaptor Mix 220026 
SI-PCR Primer 220111 
ChromiumTM Single Cell 3’ Gel Bead Kit V2, 4rxns (store at -80°C) 
 Single Cell 3’ Gel Beads 220104 
ChromiumTM Single Cell A Chip Kit, 16 rxns (store at ambient temperature) 
 Single Cell A Chip (x2) 2000019 
Gaskets 3000072 
Partitioning Oil (x2) 220088 
Recovery Oil (x2) 220016 
 
2.10.3 Preparation of Single Cell Master Mix  
Before use (>30mins), Single Cell 3’ Gel Beads, the reverse transcriptase (RvT) 
Reagent Mix and Additive A were equilibrated to RT. Lyophilized RvT Primer was 
briefly centrifuged and re-suspended in 40µl of low TE buffer, vortexed and 
centrifuged and left at RT for >30mins prior to use. RvT Enzyme Mix was placed on 
ice. All reagents used in the following protocol are outlined in Table 2-18. 
A master mix was prepared using the reagents in Table 2-19, added in the order shown 
and mixed by pipetting 15 times and centrifuged briefly. To each well of a PCR 8-tube 
strip, 66.2µl of the master mix was added and the strip placed on ice. 
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Table 2-19. Volume of reagents used to prepare the Single Cell Master Mix  
Master Mix Component 1 rxn (µl) 4 rxns + 10% xs (µl) 
RT Reagent Mix 50.0 220.0 
RT Primer 3.8 16.7 
Additive A 2.4 10.6 
RT Enzyme Mix 10.0 44.0 
Total Volume 66.2 291.3 
 
2.10.4 Loading the ChromiumTM Single Cell A Chip 
A Single Cell A Chip was placed in a 10xTM Chip Holder (Cat. #330019). As fewer 
than 8 samples were being processed, a 50% glycerol solution was added to each 
unused well as follows: 90µl in row #1; 40µl in row #2; and 270µl in row #3 (Figure 
2-21). 
The appropriate volume of nuclease-free water and single cell suspension of each 
sample (washed, diluted and mixed well by pipetting), determined from the Cell 
Suspension Volume Calculator Table (Figure 2-20), was added to the PCR tube strip 
containing master mix (on ice) (total volume 100µl). Each tube was mixed gently by 
pipetting and 90µl of the resulting solution was transferred to a corresponding well in 
row #1 of the ChromiumTM Single cell A Chip taking care not to introduce any bubbles 
(Figure 2-21 (A)).  
The Single Cell 3’ Gel beads were vortexed for 30 seconds then 40µl was slowly 
aspirated and dispensed into the bottom of the ‘active’ wells in row #2 of the 
ChromiumTM Single cell A Chip taking care not to introduce any bubbles (Figure 2-21 
(B)). 
A total volume of 270µl (2x135µl ) of Partitioning Oil was added to the ‘active’ wells 
in row #3 of the ChromiumTM Single cell A Chip (Figure 2-21 (C)). The 10xTM Gasket 
(Cat. #3000072) was attached with the notched cut at the top left corner ensuring the 
holes were aligned with the wells (Figure 2-22 (A)). 
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Figure 2-20. Cell Suspension Volume Calculator Table. Grey boxes- volumes that would 
exceed the allowable water volume in each reaction. Yellow boxes- indicate a low transfer 
volume that may result in higher cell load variability. Blue boxes- optimal range of cell stock 
concentration to maximise the likelihood of achieveing the desired cell recovery target 
(manufacturer’s instructions, 10x Genomics, USA) 
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Figure 2-21. Loading the ChromiumTM Single Cell A Chip. (A) 90µl of Master Mix and 
Cell Suspension solution is added to row #1 of the Chip. (B) 40µl of the Single Cell 3’ Gel 
beads solution is added to row #2 of the Chip. (C) 270µl of Partitioning Oil is added to row 
#3 of the Chip (adapted from manufacturer’s instructions, 10x Genomics, USA). 
 
2.10.5 Running the ChromiumTM controller 
The assembled Chip, 10x Chip Holder and 10x Gasket was placed on the tray of the 
ChromiumTM Controller (Figure 2-22 (B)) and the tray retracted. It was confirmed that 
the Chromium Single Cell A programme was shown on the screen and the ‘play’ 
button pressed to begin the run (Figure 2-22 (C)). After completion of the run (~6.5 
mins) the Chip was removed from the ChromiumTM Controller, the gasket removed 
and the next step of the protocol was immediately undertaken. 
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Figure 2-22. Set up of the ChromiumTM Controller. (A) ChromiumTM Single Cell A Chip 
with gasket covering. (B) Chip placed into the ChromiumTM Controller (adapted from 
manufacturer’s instructions, 10x Genomics, USA). 
 
2.10.6 GEM-RvT Incubation 
An emulsion-safe PCR 8-tube strip was placed on ice. The 10x Chip Holder was 
opened and the lid folded back to expose the wells at a 45° angle. As they have a high 
viscosity, 100µl GEMs was aspirated slowly from the lowest points of the Recovery 
Wells with care taken not to introduce bubbles (Figure 2-23 (A)). Samples were 
verified to have no air in the tips and be uniformly opaque across all channels (Figure 
2-23 (B)) and then dispensed into the PCR 8-tube strip and capped. The Single Cell A 
Chip was discarded. The capped tube strip was loaded into a BioRad C1000 Touch 
Thermal Cycler and the incubation protocol in Table 2-20 was carried out. Upon 
completion the tube strip was stored at -4°C (<24hrs) before proceeding to the Post 
GEM-RvT Clean-up. 
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Figure 2-23. Transfer of GEMs for RvT incubation. (A) Aspiration of GEMs from recovery 
wells. (B) Opacity is indicative of a successful ChromiumTM Controller run (adapted from 
manufacturer’s instructions, 10x Genomics, USA). 
 
Table 2-20. Temperature cycles for GEM RvT incubation 
Specifications 
Lid Temperature Reaction Volume Run Time 
53°C 125µl ~55 mins 
Protocol 
Step Temperature Time 
1 53°C 45 mins 
2 85°C 5 mins 
3 4°C Hold 
 
Sections 2.10.2-2.10.5 were carried out with assistance from Dr Ross Dobie, affiliated 
with Professor Neil Henderson. 
 
2.10.7 Post GEM-RvT Cleanup  
Before use (>30mins), DynaBeads® MyOneTM Silane Beads , Additive A, cDNA 
Additive and cDNA Primer Mix were equilibrated to RT. Buffer Sample Clean Up 1 
was thawed at 65°C and kept at RT. An 80% ethanol solution was prepared and the 
Amplification Master Mix was placed on ice. All reagents used in the following 
protocol are outlined in Table 2-18. 
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Recovery Agent (125µl) was added to each well of the PCR 8-tube strip containing 
post RvT incubation GEMS and incubated for 60 seconds without mixing. The 
recovered biphasic mixture contained distinct Recovery Agent/Partitioning Oil (Figure 
2-24, (A) pink) and aqueous (Figure 2-24, (A) clear) phases with no persisting 
emulsion. 125µl of the Recovery Agent/Partitioning Oil (pink) was slowly removed 
from the bottom of the tubes and discarded with care to avoid the clear aqueous sample 
(Figure 2-24, (B)). DynaBeads MyOne Silane beads were vortexed until fully 
re-suspended and a DynaBeads Cleanup mix was prepared using reagents in Table 2-
21. To each sample, 200µl of amplification master mix was added, mixed by pipetting 
and incubated at RT for 10 mins (Figure 2-24, (C)). 
 
Figure 2-24. Visualisation of Recovery Agent and DynaBeads. (A-B) The biphasic mixture 
of Recovery Agent/Partitioning Oil (pink) and aqueous sample (clear). (C) Sample re-
suspended with DynaBeads MyOne Silane beads (adapted from manufacturer’s instructions, 
10x Genomics, USA). 
 
Table 2-21. Volume of reagents used to prepare the DynaBeads Cleanup mix 
Reagents 1 rxn (µl) 4 rxns +10% xs (µl) 
Nuclease-free water 9 39 
Buffer Sample Clean up 1 182 801 
DynaBeads MyOne Silane 4 18 
Additive A 5 22 
Total Volume 200 880 
 
After incubation, the tube strip was placed into the 10xTM Magnetic Separator (Cat. 
#230003) (magnet) in the high position until the solution was clear. The supernatant 
was carefully removed and discarded and 300µl of 80% ethanol added to wash the 
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pellet for 30 seconds. This ethanol wash was repeated. Ethanol was carefully removed 
and the samples allowed to air dry for 1 minute.  
The Elution Solution I was prepared using reagents in Table 2-22. The tube strip was 
removed from the magnet and 35.5µl Elution Solution I was added and mixed 
thoroughly to fully re-suspend the beads. Beads were incubated for 1 minute then 
returned to the magnetic separator until the solution was clear. A new tube strip was 
obtained and 35µl of the purified GEM-RT product was transferred into it. 
Table 2-22. Volume of reagents used to prepare the Elution Solution I 
Reagents 1 rxn (µl) 4 rxns +10% xs (µl) 
Buffer EB 98 392 
10% Tween 20 1 4 
Additive A 1 4 
Total 100 400 
 
2.10.8 cDNA Amplification Reaction  
A cDNA Amplification Reaction Mix was prepared using reagents in Table 2-23, 
mixed thoroughly and briefly centrifuged. The Amplification Reaction Mix (65µl) was 
added to each tube containing 35µl of purified GEM-RvT product, mixed by pipetting 
15 times and briefly centrifuged. The capped tube strip was loaded into the thermal 
cycler and the incubation protocol in Table 2-24 was carried out. 
Table 2-23 Volume of reagents used for the cDNA Amplification Reaction Mix 
Reagent 1 rxn (µl) 4 rxns + 10% xs (µl) 
Nuclease-free water 8 35 
Amplification Master Mix 50 220 
cDNA Additive 5 22 
cDNA Primer Mix 2 9 
Total 65 286 
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Table 2-24. Temperature cycles for the cDNA Amplification Reaction by PCR 
Specifications 
Lid Temperature Reaction Volume Run Time 
105°C 100µl ~30-45 mins 
Protocol 
Step Temperature Time 
1 98°C 3 mins 
2 98°C 15 secs 
3 67°C 20 secs 
4 72°C 1 mins 
5 Go to Step 2 for 15 cycles 
6 72°C 1 min 
7 4°C Hold 
 
 
2.10.8.1 Post cDNA Amplification Reaction Cleanup- SPRIselect 
To carry out the post cDNA Amplification Reaction Cleanup, the SPRIselect Reagent 
was vortexed until fully re-suspended and 60µl (0.6x) was added to each sample in the 
tube strip and mixed. Unless otherwise stated, solutions were mixed gently by pipetting 
15 times. The tube strip was incubated for 5 mins at RT and then placed on the magnet 
until the solution was clear. The supernatant was carefully removed and discarded and 
200µl 80% ethanol was added to the pellet for 30 seconds. This ethanol wash was 
repeated. Ethanol was carefully removed and the samples allowed to air dry for 2 
minutes. The tube strip was removed from the magnet and 40.5µl Buffer EB was 
added, mixed and incubated at RT for 2 minutes. The tube strip was returned to the 
magnet until the solution was clear and 40µl of the sample transferred to a new tube 
strip and capped and placed on ice. cDNA concentration and quality was measured 
using a Qubit Fluorometer. 
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2.10.9 cDNA Library Construction  
2.10.9.1 Fragmentation, End Repair and A-tailing 
Before use (>30mins) the Fragmentation Buffer, Ligation Buffer, Adaptor Mix, 
SI-PCR Primer and ChromiumTM i7 Sample Index Plate were equilibrated to RT. The 
Fragmentation Enzyme Blend, DNA Ligase and Amplification Master Mix were 
placed on ice. All reagents used in the following protocol are outlined in Table 2-18. 
The Fragmentation Mix was prepared on ice using reagents in Table 2-25, mixed 
thoroughly and briefly centrifuged then 15µl was added to each well of a new PCR 
8-tube strip. To individual wells, 35µl of purified cDNA was added and mixed by 
pipetting 15 times. The tube strip was placed in a pre-cooled thermal cycler and the 
incubation protocol in Table 2-26 was carried out.  
Table 2-25. Volume of reagents used to prepare the Fragmentation Mix 
Reagent 1 rxn (µl) 4 rxns + 10% xs (µl) 




Total 15 66 
 
Table 2-26. Temperature cycles for Fragmentation, End-Repair and A-tailing 
Specifications 
Lid Temperature Reaction Volume Run Time 
65°C 50µl ~35 mins 
Protocol 
Step Temperature Time 
1. Pre-cool block 4°C Hold 
2. Fragmentation 32°C 5 mins 
3. End Repair & A-
tailing 
65°C 30 mins 
4. Hold 4°C Hold 
 
2.10.9.2 Double Sided Size Selection- SPRIselect 
The SPRIselect Reagent was vortexed until fully re-suspended and 30µl (0.6x) added 
to each sample in the tube strip, mixed and incubated at RT for 5 mins. The tube strip 
was placed on the magnet until the solution was clear. The supernatant (75µl) was 
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added to a new tube strip and 10µl SPRIselect Reagent (0.8x) was added to each 
sample, mixed and incubated at RT for 5 minutes. The tube was placed on the magnet 
until the solution was clear. The supernatant (80µl) was carefully removed and 
discarded and 125µl 80% ethanol was added to the pellet for 30 seconds. This ethanol 
wash was repeated twice more. Ethanol was carefully removed and the tube strip was 
removed from the magnet. Buffer EB (50.5µl) was added, mixed and incubated at RT 
for 2 minutes. The tube strip was returned to the magnet until the solution was clear 
and 50µl of sample was transferred to a new tube strip which was capped. 
2.10.9.3 Adaptor Ligation 
The Adaptor Ligation Mix was prepared by adding the reagents in Table 2-27 and 50µl 
was added to each tube containing 50µl sample, mixed by pipetting 5 times and briefly 
centrifuged. The sample was placed in a thermal cycler and the incubation protocol in 
Table 2-28 was carried out.  
 
Table 2-27. Volume of reagents used to prepare the Adaptor Ligation Mix 
Reagent 1 rxn (µl) 4rxns + 10% xs (µl) 
Nuclease-free water 17.5 77 
Ligation Buffer 20 88 
DNA Ligase 10 44 
Adaptor Mix 2.5 11 
Total 50 220 
 
Table 2-28. Temperature cycles for Adaptor Ligation 
Specifications 
Lid Temperature Reaction Volume Run Time 
30°C 100µl 15 mins 
Protocol 
Step Temperature Time 
1 20°C 15 mins 
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2.10.9.4 Post Ligation Cleanup- SPRIselect 
The SPRIselect Reagent was vortexed until fully re-suspended and 80µl (0.8x) was 
added to each sample, mixed and incubated at RT for 5 minutes. The tube strip was 
placed on the magnet until the solution was clear. The supernatant was carefully 
removed and discarded and 200µl 80% ethanol was added to the pellet for 30 seconds. 
This ethanol wash was repeated twice more. Ethanol was carefully removed and the 
samples allowed to air dry for 2 minutes. The tube strip was removed from the magnet 
and 30.5µl Buffer EB added, mixed and incubated at RT for 2 minutes. The tube strip 
was returned to the magnet until the solution was clear and 30µl of the sample was 
transferred to a new tube strip. 
2.10.9.5 Sample Index PCR 
A Sample Index PCR Mix was prepared by adding the reagents in Table 2-29, mixed 
thoroughly and briefly centrifuged and 60µl added to each tube containing 30µl 
purified Post Ligation sample. To each sample an individual Chromium i7 Sample 
Index (10µl) was added and the assignment recorded. Samples were mixed by 
pipetting 15 times, centrifuged briefly and placed in a thermal cycler and the 
incubation protocol in Table 2-30 was carried out.  
 
Table 2-29. Volume of reagents used to prepare a Sample Index PCR Mix 
Reagent 1 rxn  (µl) 4 rxns + 10% xs (µl) 




SI-PCR Primer 2 9 






Chapter 2: Materials and Methods  153 
 
Table 2-30. Temperature cycles for the Sample Index PCR incubation  
Specifications 
Lid Temperature Reaction Volume Run Time 
105°C 100µl ~25-40 mins 
Protocol 
Step Temperature Time 
1 98°C 45 secs 
2 98°C 20 secs 
3 54°C 30 secs 
4 72°C 20 secs 
5 Go to Step 2 for 16 cycles 
6 72°C 1 min 
7 4°C Hold 
 
2.10.9.6 Post Sample Index PCR Double Sided Size Selection- SPRIselect 
The SPRIselect Reagent was vortexed until fully re-suspended and 60µl (0.6x) was 
added to each sample, mixed and incubated at RT for 5 minutes. The tube strip was 
placed on the magnet until the solution was clear. The supernatant (150µl) was 
carefully removed and transferred to a new tube strip. 20µl SPRIselect Reagent (0.8x) 
was added to each sample, mixed and incubated at RT for 5 minutes. The tube strip 
was placed on the magnet until the solution was clear. The supernatant (165µl) was 
carefully removed and discarded and 200µl 80% ethanol was added to the pellet for 
30 seconds. This ethanol wash was repeated twice more. The tube strip was removed 
from the magnet and 35.5µl Buffer EB added, mixed and incubated at RT for 2 
minutes. The tube strip was returned to the magnet until the solution was clear and 
35µl of the sample was transferred to a new tube strip and capped. Purified cDNA 
samples were stored at -20°C. 
2.10.9.7 Post Library Construction Quantification 
cDNA concentration and quality was measured using the LabChip GX Touch Nucleic 
Acid Analyser as outlined in section 2.6.4 with assistance from Pamela Brown. cDNA 
samples met the minimum requirements and were sent to Edinburgh Genomics.  
Sections 2.10.7-2.10.10 were carried out with assistance from Dr Beth Henderson, 
affiliated with Professor Neil Henderson. 
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2.10.10  10x genomics single cell RNA-seq library sequencing 
At Edinburgh Genomics (https://genomics.ed.ac.uk/) quality control of the cDNA 
libraries was performed and sequence data generated on the Illumina NovaSeq 
platform using an S1 flowcell using the bespoke 10x parameters (28/8/91 cycle setup) 
to yield a minimum of 350M reads per library, according to the standard protocols at 
the facility. 
2.10.11 Bioinformatic analysis  
An in-house bioinformatic analysis of the samples was carried out by Frances Turner 
at Edinburgh Genomics and a pdf report outlining the methods used and results was 
provided. An additional analysis was carried out by Dr Richard Taylor, affiliated with 
Professor Neil Henderson.  
In brief, Commands from 10X Genomics’ ‘Cellranger’ tool (version 2.0.1) were 
executed as follows: FASTQ files were generated using ‘Cellranger mkfastq’ 
specifying ‘SI-GA’ indices associated with each sample. ‘Cellranger count’ was 
performed for each sample, using the ‘Cellranger mkfastq’ files, the ‘SI-GA’ indices 
and the transcriptome ‘refdata-cellranger-mm10-1.2.0’ as supplied by 10x genomics. 
An aggregated final dataset was created using the ‘Cellranger aggr’ command, 
supplying a .cvs file describing the outputs of ‘Cellranger count’ and the associated 
sample groups.  
Summary tables of the basic statistics, quality control statistics and mapping statistics 
were delivered with the pdf report. Other output files included LoupeTM Cell Browser 
files (files for input to the 10x ‘Loupe’ browser), clustering analysis results, differential 
expression analysis results, principle components analysis (PCA) results and t-SNE 
(t-distributed Stochastic Neighbour Embedding) projection results. Loupe files were 
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Chapter 3 Investigation of the relationship between 
tissue resident and transient immune cell 
populations during endometrial repair  
3.1 Introduction 
3.1.1 Inflammation and the endometrium 
Inflammation is a regulator of normal wound healing in most tissues with macrophages 
being implicated in regulation of repair processes (Cash and Martin 2016, Vannella 
and Wynn 2017). Excessive and prolonged inflammation is associated with fibrosis, 
chronic wounds, abnormal wound healing and deposition of scar tissue (Zhao et al. 
2016, Qian et al. 2016). When recruitment of immune cells is ablated in experimental 
mouse models, for example mice which lack macrophages and neutrophils, rapid and 
scar-free wound healing of the skin occurs.  Notably physiological wound healing of 
human foetal skin (Martin and Leibovich 2005) and the oral mucosa (Szpaderska et al. 
2003) is also scar-free and characterised by a significantly reduced inflammatory 
component. In contrast, repair of endometrium during menstruation does not fit neatly 
into these categories as although the tissue undergoes rapid and scar-free wound 
healing this is accompanied by a substantial inflammatory response characterised by a 
large number of immune cells (Salamonsen et al. 2002, Kats et al. 2005, Maybin and 
Critchley 2015). Although menstruation has been cited as ‘a model of self-limiting 
inflammation’ by Maybin and Critchley (2015) the role played by these inflammatory 
processes/immune cells in restoration of tissue homeostasis remains poorly 
understood. 
 
3.1.2 Immune cells in the endometrium 
The endometrium hosts a diverse population of immune cells, the abundance and 
composition of which changes throughout the menstrual cycle. Some immune cell 
types can proliferate within the tissue and are considered resident populations, while 
others are recruited from the circulation in response to chemotactic stimuli (Evans and 
Salamonsen 2012, Maybin and Critchley 2015). Immune cells are present in relatively 
low numbers during the proliferative phase but there is a striking increase in leucocyte 
numbers in both the secretory and menstrual phases of the cycle (Kamat and Isaacson 
1987, Salamonsen et al. 2002, King and Critchley 2010, Andreotti et al. 2018).   
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During the secretory phase there is an increase in the numbers of a unique population 
of CD56++ natural killer cells (uNK) that play a key role in regulation of vascular 
remodelling and regulation of menstruation (Bulmer and Lash 2005). These cells 
appear responsive to steroids (Henderson et al. 2003, Gibson et al. 2015) and some 
studies have claimed their distribution is altered in women suffering from heavy 
menstrual bleeding (Biswas Shivhare et al. 2015). Another prominent immune cell 
population that shows a dramatic change in numbers during the human menstrual cycle 
are neutrophils which are the most prominent leucocyte present during decidual tissue 
breakdown (Kamat and Isaacson 1987), reported as 6-15% of total cell number 
perimenstrually (Lathbury and Salamonsen 2000).  In a recent study immunostaining 
of human endometrial tissue sections using an antibody directed against neutrophil 
elastase reported immunopostive staining restricted to samples recovered during active 
menses (Armstrong et al. 2017). Using a mouse model of simulated ‘menstruation’ 
Kaitu’u-Lino et al used anti Ly6B2 antibodies to identify putative neutrophils and 
reported they were most abundant at 24h after progesterone withdrawal. They also 
reported in vivo depletion of putative neutrophils using an anti-GR-1 antibody delayed 
endometrial repair processes suggesting that the neutrophils are essential for 
endometrial repair (Kaitu'u-Lino et al. 2007). 
Macrophages have also been detected in the endometrium throughout the menstrual 
cycle (Bonatz et al. 1992) with important roles in preparation of the receptive 
endometrium and subsequent decidualisation of the endometrial stroma being 
proposed (Lea and Clark 1991, Kats et al. 2005). Given the huge increase in expression 
of macrophage-derived cytokines and proteases (MMPS) that has been reported in the 
late secretory phase endometrium, macrophages have also been implicated in the 
initiation of decidual breakdown (Salamonsen and Woolley 1999, Critchley et al. 
2001a). It has been suggested that macrophages, as active phagocytes, could have a 
role in apoptotic cell clearance and glandular remodelling (Garry et al. 2010). Studies 
on human endometrium complemented by in vitro analysis of macrophages 
differentiated from peripheral blood monocytes showed they were able to synthesise 
and release CXCL2 and CXCL8 (Evans and Salamonsen 2012) with these and other 
results postulating a role in tissue repair (Maybin and Critchley 2012) which required 
further exploration. 
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3.1.3 Macrophages and endometrial repair 
Macrophages are cells of the innate immune system that derive from myeloid 
progenitors and are largely responsible for engulfing and destroying pathogens and 
apoptotic cellular debris (Reviewed by Biswas et al. 2012). In recent years the simple 
view that all macrophages arise through differentiation of circulating monocytes after 
they extravasate from the blood stream and enter peripheral tissues (Van Furth and 
Thompson 1971) has been challenged with data from lineage tracing experiments in 
mice indicating there are at least three lineages of macrophages arising at varying 
stages of development from different origins: the yolk sac, the foetal liver and bone 
marrow (Wynn et al. 2013). Macrophages have been found to be capable of 
phagocytosis, maintaining tissue homeostasis, regulating wound healing and the 
function of other immune cell populations (Wynn and Barron 2010). In wound healing 
in particular, macrophages have several roles including defence against pathogens, 
clearance of apoptotic cellular debris, regulation of the inflammatory response and 
support of tissue proliferation and restoration (Mosser and Edwards 2008, Koh and 
DiPietro 2011). Using an inducible transgenic mouse model (LysM-Cre/DTR), 
administration of diphtheria toxin was shown to reduce BM-derived macrophage 
numbers in the skin (CD11b+F4/80high cells) but did not affect circulating monocytes 
(CD11b+Ly6Chigh cells). When macrophages were depleted it was reported that skin 
wounds exhibited both impaired neoangiogenesis and delayed wound closure 
associated with an increase in neutrophils (Goren et al. 2009). This study suggests that 
macrophages playing a key role in efficient tissue repair in this species in part due to 
regulation of neutrophil persistence.  
Macrophages identified in human endometrium by immunostaining for CD68 are most 
abundant during the late secretory and menstrual phases of the cycle (Garry et al. 
2010). During the menstrual phase macrophages account for ~10% of cells in the tissue 
(Nowak, Borkowska and Pawlowski 2016): their presence is paralleled by a marked 
increase in immunoexpression of CXCL2 (Evans and Salamonsen 2012). It has also 
been postulated that macrophages in the decidua can secrete both pro- and anti-
inflammatory cytokines which may represent a phenotype unique to the endometrial 
tissue (Houser et al. 2011). In the endometrium of normal cycling mice, F4/80 
immunopositive macrophages were located throughout the stroma (Shimada-
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Hiratsuka et al. 2000, Mackler et al. 2000). Using a mouse model of simulated 
‘menstruation’ it was reported that F4/80 expressing macrophages do not associate 
with areas undergoing tissue remodelling but instead were located distal to the lumen 
and the authors concluded that macrophages did not contribute to endometrial repair 
(Kaitu'u-Lino et al. 2007). It is therefore a subject of debate whether macrophages have 
a role in endometrial tissue repair. 
3.1.4 Importance of understanding macrophage contribution to 
endometrial repair 
Abnormalities in endometrial repair processes are thought to underpin a number of 
gynaecological pathologies including heavy menstrual bleeding. Women with HMB 
most often complain of unscheduled bleeding which is thought to be due to problems 
in the differentiation of the endometrial tissue and its associated vasculature (Maybin 
and Critchley 2011, Munro et al. 2011). Clark et al, 1996 found that there was an 
increase in the number of macrophages in the endometrium of women presenting with 
unscheduled bleeding (Clark et al. 1996). Endometriosis is a condition where 
endometrial-like tissue embeds in regions out with the uterus causing pelvic pain and 
infertility (Giudice 2010). Bacci et al, 2009 reported that macrophages in patients with 
endometriosis were alternatively activated and likely to support lesion growth 
(expressed high levels of CD163/CD206). When macrophages were depleted using 
clodronate liposomes, blood vessels did not populate the lesions which substantially 
reduced their growth. Additionally, the adoptive transfer of alternatively activated 
BM-derived macrophages (mouse) enhanced lesion formation in mice while 
classically activated macrophages impaired lesion establishment (Bacci et al. 2009). 
In another study using a syngeneic mouse model of endometriosis in combination with 
MacGreen reporter mice as donors and recipients Greaves et al reported that 
macrophages from both the peritoneum and donor (menses) endometrium can 
contribute to lesions (Greaves et al. 2014). Similarly, endometrial cancer is the most 
common gynaecological cancer in the UK (Ryan et al. 2005) and tumour tissue has 
been shown to be infiltrated with pro-tumorigenic macrophages which may enhance 
tumour angiogenesis (Sivridis et al. 2002, Harris et al. 2007). 
In each of these conditions a link to the malfunction of macrophage behaviour has been 
suggested and characterisation of macrophage phenotype and function in physiological 
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endometrial repair may therefore inform understanding of normal tissue regulation. 
This may lead to the development of therapies to manage or treat such gynaecological 
conditions. Further to this, if the contribution of macrophages to scarless wound 
healing can be determined, then the macrophage population in tissues suffering from 
chronic inflammation might be a target to induce scarless healing in other tissues.  
3.1.5 Transgenic mouse lines to study macrophages  
A variety of cell surface markers are used in the identification of myeloid immune 
cells. In the MacGreen (Sasmono et al. 2003, Sasmono and Williams 2012) and 
MacApple (Hawley et al. 2018) transgenic reporter mice, eGFP and RFP (respectively) 
are expressed under control of the Csf1r gene promoter, though the insertion locus of 
the transgene is slightly different for each. CSF1R is a tyrosine-protein kinase that acts 
as a cell surface receptor for CSF1 and IL34 and regulates proliferation, differentiation 
and survival of haematopoietic precursor cells, in particular mononuclear phagocytes 
including monocytes and macrophages (Sasmono and Williams 2012). Therefore these 
transgenic mice were considered suitable to identify and characterise sub-populations 
of mononuclear phagocytes in endometrial tissue. In addition the CD68eGFP 
transgenic reporter mouse was also used, in these mice eGFP is expressed under 
control of the human CD68 gene promoter (Iqbal et al. 2014). CD68 is a 
transmembrane glycoprotein highly expressed by monocytes and tissue macrophages 
(Iqbal et al. 2014) thought to be involved in phagocytic activity, and therefore this 
mouse line offers an additional way to target mononuclear phagocytes in the 
endometrium using a discrete marker system.  
3.1.6 Summary 
Menstruation in women involves concurrent shedding and repair of the inner lining of 
the endometrium (Garry et al. 2009) and is associated with an increase in both immune 
cells and inflammatory mediators. Endometrial macrophages are reported to be 
abundant in endometrial tissue during menstruation but their role if any in regulating 
repair is not well understood. Tissue resident populations of macrophages exhibit 
diverse phenotypes depending upon their localisation and we therefore postulated that 
an in-depth characterisation of endometrial macrophage phenotype and location could 
lead to new insights into the role of macrophages in the regulation of endometrial tissue 
repair and scarless healing. 
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3.2 Aim 
To characterise the myeloid immune cell populations in endometrial tissue and to 
investigate changes in phenotype and location during endometrial tissue repair using 
a mouse model of endometrial breakdown and repair. 
 
3.3 Experimental Approach 
3.3.1 Mouse model of endometrial breakdown and repair 
The Edinburgh menses mouse model established and refined in the Saunders’ group 
(Cousins et al. 2014), was used to investigate the dynamic changes in immune cell 
populations in endometrial tissue during a defined period that included breakdown, 
repair and restoration of homeostasis (0-48hrs after progesterone withdrawal. The full 
protocol is outlined in Section 2.2.2 and described in Table 2-4 and Figure 2-5. 
3.3.2 Transgenic mouse lines 
The results in this chapter were generated using the MacGreen, MacApple and 
CD68-eGFP reporter mouse lines as detailed in Sections 2.1.1.2, 2.1.1.3 and 2.1.1.4 
respectively, to specifically identify cells of the myeloid lineage in endometrial tissue. 
3.3.3 Tissue processing and immunohistochemistry 
Uterine tissue samples were fixed in 4% PFA for 2 hrs at 4°C, rinsed in PBS and stored 
overnight in 18% sucrose at 4°C before being embedded in OCT medium and stored 
at -80°C, as described in Section 2.3. H&E staining and IHC was carried out as in 
Section 2.4.1 and 2.4.3 respectively. Antibodies used for IHC in this Chapter are 
outlined in Table 3-1. Images were obtained by both brightfield and confocal 
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Table 3-1. Antibodies used in IHC to interrogate immune cell populations in mouse 
endometrial tissue 
Antibody Name Supplier and Cat. No. 
(concentration) 
Dilution Serum block 
Polyclonal rabbit anti-
GFP 
Abcam, ab6556 (0.5mg/ml) 1/1000 Goat 
Polyclonal rabbit anti-
Mcsf (Csf1r) 












caspase 3 (Asp175) 





Abcam, 133357 1/1000 Goat 
Polyclonal rat anti-GR1 
r1 
AbD Serotec, MCA2387PET 1/500 Goat 
 
3.3.4 Flow Cytometry and FACS 
Flow cytometry analysis was used to interrogate the phenotype and proportions of 
immune cell populations in endometrial tissue using protocols detailed in Section 2.5 
and flow cytometry antibodies outlined in Table 3-2. Specific immune cells were 
isolated from the endometrial tissue using FACS according to the protocol detailed in 
Section 2.5.3. ICC was carried out as in Section 2.5.4 to confirm their identity. 
Table 3-2. Flow cytometry antibody panel designed to interrogate myeloid immune 
cell populations in uterine tissue 
Antibody 
name 
















496nm 578nm 1/20 
APC anti-
mouse F4/80 
















407nm 650nm 1/100 
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3.3.5 RNA extraction and cDNA synthesis 
RNA was extracted from isolated cell samples using the Qiagen RNeasy mini kit as 
outlined in Section 2.6.1 followed by synthesis of cDNA using the standard method as 
in Section 2.7.1. 
3.3.6 Quantitative real time PCR 
Quantitative real time PCR (qPCR) was used to determine mRNA expression of 
specific genes used to characterise immune responses and immune cell phenotypes as 
detailed in Section 2.8 using primers detailed in Table 2-17. Quantification of gene 
expression and statistical analysis was performed as outlined in Section 2.8.3. 
 
3.4 Results 
3.4.1 Validation of transgenic mouse lines by IHC: MacGreen, 
MacApple and CD68-eGFP 
3.4.1.1 Expression of reporter proteins in MacGreen, MacApple and CD68-
eGFP transgenic mouse endometrium 
IHC on fixed tissue sections was used to detect the expression of specific antigens on 
immune cells within the endometrial stroma. To validate each of the transgenic mouse 
reporter lines (MacGreen, MacApple and CD68-eGFP) the expression of the 
fluorescent reporter proteins (GFP/RFP) and the native proteins (CSF1R/CD68) was 
examined in adult uterine tissue sections. In the MacGreen uterus, cells that expressed 
GFP were dispersed throughout the endometrial stroma and GFP co-localised with 
expression CSF1R protein (Figure 3-1, arrows). Similarly in the MacApple uterus, 
cells that expressed RFP were dispersed throughout the stroma and co-localised with 
expression CSF1R protein (Figure 3-2, arrows). The results from these two transgenic 
lines appeared identical confirming that the different locus of insertion of the reporter 
gene had no impact on CSF1R promoter activity and appropriate expression of the 
reporter proteins. 
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Figure 3-1. Expression of GFP and CSF1R in naïve MacGreen uterine tissue. IHC reveals 
the expression of the reporter GFP (green) reliably identifies cells that express CSF1R (red) 
in MacGreen transgenic uterine tissue. GFP/ CSF1R double positive cells (white arrows) are 
located throughout the endometrial stroma of uterine tissues. Stroma (S), glands (G) 
(representative image, n=10).  
 
 
Figure 3-2. Expression of RFP and CSF1R in naïve MacApple uterine tissue. IHC reveals 
the expression of the reporter GFP (green) reliably identifies cells that express CSF1R (red) 
in MacApple transgenic uterine tissue. GFP/ CSF1R double positive cells (white arrows) are 
located throughout the endometrial stroma of uterine tissues. Stroma (S), glands (G) 
(representative image, n=6). 
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In CD68-eGFP uterine tissue cells that expressed GFP co-expressed CD68 protein and 
were dispersed throughout the endometrial stroma (Figure 3-3, arrows) however the 
staining pattern of the GFP reporter was less distinct than that of MacGreen and 
MacApple tissues. In this line, it appeared that there were also some reporter+ cells 
that did not express CD68 (yellow arrows) which may be indicative of background 
staining due to non-specific reporting. With this in mind, it was concluded that the 
MacGreen and MacApple lines showed the most reliable reporting of the antigen of 
interest and since both are based on expression of CSF1R, the MacGreen mouse was 
chosen for preliminary investigation of mononuclear phagocytes in the endometrium. 
 
 
Figure 3-3. Expression of GFP and CD68 in naïve cD68-eGFP uterine tissue. 
Immunohistochemistry reveals the expression of the reporter GFP (green) identifies cells that 
express CD68 (red) in CD68-eGFP transgenic uterine tissue. GFP/CD68 double positive cells 
(white arrows) are located throughout the endometrial stroma of uterine tissues. Cells that 
express the GFP reporter but not CD68 were also identified (yellow arrows). Stroma (S), 
glands (G) (representative image, n=4). 
 
 
Chapter 3: Investigation of the relationship between tissue resident and transient 
immune cell populations during endometrial repair 165 
 
3.4.2 Characterisation of myeloid immune cell populations in 
MacGreen uterine tissue 
3.4.2.1 Expression of myeloid cell markers by GFP+ cells in MacGreen uterine 
tissue  
Having established that all GFP+ cells in MacGreen uterus were CSF1R+ and 
therefore of the myeloid lineage, additional IHC was performed to analyse the 
expression of other immune cell surface markers CD45, GR1 and CD11b to further 
characterise the GFP+ cells in uterine tissues from naive MacGreen mice. In line with 
expectations, all GFP+ cells were CD45+ (Figure 3-4 (A) white arrows). CD45, 
lymphocyte common antigen, is expressed on all leucocytes (Martin and Leibovich 
2005) and therefore the additional presence of GFP-CD45+ cells (Figure 3-4 (A) 
yellow arrows) was likely to be identifying other immune subtypes in the tissue. 
Similarly all GFP+ cells were CD11b+ (Figure 3-4 (B) white arrows). CD11b is an 
integrin involved in various cellular interactions between monocytes, macrophages, 
granulocytes and other cells and is believed to have a role in phagocytosis (Schulz et 
al. 2012), therefore the presence of this protein identified GFP+ cells as mononuclear 
phagocytes. 
Interestingly when tissues were stained with an antibody specific for GR1, a 
granulocyte-associated marker (Yang et al. 2014), two populations were detected. 
Whilst some cells were GFP+ GR1+ there were also GFP+ GR1- cells (Figure 3-4 (C), 
white versus yellow arrows). In addition, a sub-population of GFP- GR1+ cells were 
also detected (Figure 3-4 (C), red arrows). The Gr1 antigen is composed of both Ly6C 
and Ly6G proteins which are expressed individually by monocytes and neutrophils 
respectively (Yang et al. 2014, Rose, Misharin and Perlman 2012) therefore it is likely 
that heterogeneity in expression of Gr1 with respect to GFP expression is related to 
the identification of different cells types: GFP+ GR1+ monocytes, GFP+ GR1- 
monocyte/macorphages and GFP- GR1+ neutrophils.  
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Figure 3-4. The expression of GFP, CD45, GR1 and CD11b in MacGreen uterine tissue. 
(A) Staining for GFP (green) and CD45 (red) identifies GFP+CD45+ cells (white arrows) and 
GFP-CD45+ cells (yellow arrows). (B) Staining for GFP (green) and CD11b (red) identifies 
GFP+CD11b+ cells (white arrows) and GFP-CD11b+ cells (yellow arrows) (C) Staining for 
GFP (green) and Gr1 identifies GFP+Gr1+ cells (white arrows) GFP+Gr1- cells (yellow 
arrows) and GFP-Gr1+ cells (red arrows) (representative images, n=4). 
 
3.4.2.2 Expression of myeloid cell markers by GFP+ cells in MacGreen and CD68-
eGFP uterine tissues identified by flow cytometry  
To further characterise and to quantify GFP+ cell sub-populations in the endometrium, 
MacGreen and CD68-eGFP uterine tissues were digested and analysed by flow 
cytometry. Cells were sequentially gated to be within the ‘All cells’ gate followed by 
the ‘Single cells’ gate and then the ‘Live’ gate as detailed in Figure 3-5 (A). Cells were 
further analysed for expression of GFP, CD45 and CD11b. In MacGreen and 
CD68-eGFP uterine tissues GFP+ cells accounted for approximately 49.3±9.38% and 
53.1±10.23% of the CD45+ immune cell populations respectively, and all GFP+ cells 
were CD45+ (Figure 3-5 (B) (D) respectively, upper right quadrant). Furthermore 
93.1±3.03% and 98.1±1.23% of GFP+ cells in MacGreen and CD68-eGFP uterine 
tissues respectively were CD11b+ (Figure 3-5 (C) (E) respectively). Flow cytometry 
analysis was performed using analytic gates based on an unstained, single stain 
controls and FMO (fluorescence minus one) controls. Flow cytometry results were in 
agreement with results of IHC (Figure 3-4) confirming a comparable identity of GFP+ 
cells in both MacGreen and CD68-eGFP uterine tissues as mononuclear phagocytes. 
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Figure 3-5. Flow cytometry analysis and phenotyping of GFP+ cell populations in naïve 
MacGreen and CD68-eGFP uterine tissues. (A) Gating strategy employed to analyse GFP+ 
cell populations in naïve mouse uterine tissue: 1. All cells > 2. Single cells > 3. Live cells > 
CD45+GFP+ cells > CD11b+ cells, percentages displayed are frequencies of the parent gate. 
All gates drawn using single stained, unstained and FMO control samples. The proportion of 
CD45+ leucocytes that are GFP+ in naïve (B) MacGreen and (C) CD68-eGFP uterine tissues. 
(D) Approximately 49.3±9.38% and 53.1±10.23% of the CD45+ immune cell population is 
GFP+ in naïve MacGreen and CD68-eGFP uterine tissues respectively. The proportion of 
GFP+ cells that express CD11b in naïve (E) MacGreen and (F) CD68-eGFP uterine tissues. 
(G) Approximately 93.1±3.03% and 98.1±1.23% of GFP+ cells in naïve MacGreen and 
CD68-eGFP uterine tissues respectively are CD11b+ (representative plots, MacGreen; n=4, 
CD68-eGFP; n=5).  
 
Chapter 3: Investigation of the relationship between tissue resident and transient 
immune cell populations during endometrial repair 168 
 
3.4.2.3 Assessment of morphology of GFP+ cells isolated from MacGreen uterine 
tissue by FACS  
Following analysis by Flow cytometry, the optimised parameters were used to isolate 
CD45+GFP+ cells from MacGreen uterine tissue by FACS. To confirm the identity of 
the cells, a cytospin was performed on the isolated cells which were then fixed and 
stained by H&E or IHC using an antibody against GFP. Isolated cells were found to 
be mononuclear by H&E (Figure 3-6 (A)) and confirmed to express GFP reporter 
protein by IHC (Figure 36 (B)) further supporting the identity of the GFP+ cells in the 
naïve mouse endometrium as mononuclear phagocytes. 
 
 
Figure 3-6. Investigation of cell morphology of CD45+GFP+ immune cells isolated from 
naïve MacGreen uterine tissue. (A) H&E staining of CD45+GFP+ cells indicate the cells 
are mononuclear. (B) IHC of CD45+GFP+ cells show expression of reporter protein GFP 
(representative images, n=3). 
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3.4.3 Investigation of myeloid immune cell populations during 
endometrial breakdown and repair 
3.4.3.1 Distribution of GFP+ cells in MacGreen endometrial tissue at various time 
points during endometrial tissue breakdown and repair   
To investigate immune cell dynamics during endometrial repair processes, IHC was 
used to assess the distribution of GFP+ cells in uterine tissue from MacGreen 
transgenic mice recovered across the time course of endometrial breakdown and repair 
(0, 12, 24 and 48hrs). Before tissue breakdown (before P4 withdrawal; 0hrs) very few 
GFP+ cells were present in the tissue (Figure 3-7 (A), arrows) suggesting that an 
inflammatory response had not been stimulated. During active tissue breakdown at 
12hrs there was a striking increase in the number of GFP+ cells (Figure 3-7 (B), 
arrows) which were predominantly detected in the endometrial stromal layer in close 
proximity to the border of decidualised tissue that was undergoing tissue breakdown 
(Figure 3-7 (B), blue dashed line). 
At 24hrs when the endometrial tissue was undergoing synchronous tissue breakdown 
and repair, an abundance of GFP+ cells was detected in the tissue (Figure 3-7 (C), 
arrows). Examination of multiple tissue sections generated from different blocks/mice 
revealed that the majority of the GFP+ cells were located in regions undergoing repair 
but with some cells also present in the shed tissue (Figure 3-7 (C) arrows) suggesting 
the cells may have dual roles to play in this process. At 48hrs when tissue repair was 
complete detected by the fully re-epithelialised lumen (L in Figure 3-7 (D)), there were 
very few GFP+ cells detected in the endometrial tissue (Figure 3-7 (D), arrows) but a 
few were present in the shed tissue (Figure 3-7 (D), blue dashed line).  
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Figure 3-7. Distribution of GFP+ immune cells in MacGreen uterine tissue during 
endometrial breakdown and repair. IHC reveals dynamic changes in the location and 
number of GFP+ cells (white arrows) prior to endometrial breakdown (0hrs), during 
endometrial breakdown (12hrs), and during endometrial repair (24hrs) and the remodelling 
phases (48hrs). The blue dashed line represents the boundary between decidualised 
endometrial tissue/shed tissue and the underlying layer of residual endometrial stroma. Stroma 
(S), lumen (L) (representative image, n=10).  
 
 
3.4.3.2 Quantification of GFP+ cells in MacGreen endometrial tissue at 24hrs 
following P4 withdrawal during active tissue repair   
As results presented above showed that GFP+ immune cells were most abundant in 
uterine tissue collected 24hrs following P4 withdrawal (Figure 3-7) further analysis 
was carried out by flow cytometry at this time point (tissue samples as above). Cells 
were gated to be within the ‘All cells’ gate followed by the ‘Single cells’ gate and then 
the ‘Live’ gate as described previously (Figure 3-5 (A)). Analysis of the side scatter 
profile and GFP expression by live single cells confirmed that whilst there were very 
few GFP+ cells present in the non-decidualised control uterine horns, i.e. tissue 
stimulated by hormones but not exposed to oil (Figure 3-8 (A)) there was a prominent 
GFP+ population in the actively repairing (decidualised) endometrial tissue samples 
(Figure 3-8 (compare A with B)). The proportion of GFP+ cells in the repairing tissues  
(24hrs, n=8) accounted for 23.36±3.5% of the live cells whilst in the control tissue 
(adjacent undecidualised horn) they accounted for only 0.66±0.21% (mean±SEM). 
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This striking increase in GFP+ cells was significant as determined using an unpaired 
t-test giving a p value of 0.0033 (Figure 3-8 (C)). 
 
Further phenotyping of the GFP+ cells by analysing expression of F4/80 (a mature 
macrophage marker) revealed that in naïve endometrial tissue the majority of GFP+ 
cells were F480+ while there was also a population of GFP-F4/80+ cells (Figure 3-8 
(D) Q2 and Q1 respectively). In repairing tissues (24hrs) there was a shift in 
populations with the majority of the GFP+ cells being F4/80- (Figure 3-8 (E) Q3) and 
an apparent increase in the numbers of GFP+F4/80+ cells, which appeared to be 
composed of two subpopulations: F4/80high and F4/80low (Figure 3-8 (E) Q2). There 
was also a GFP-F4/80+ cell population present in the repairing tissue (Figure 3-8 (E) 
Q1). Analysis of this additional flow cytometry data confirmed that there was a highly 
significant increase in GFP+F4/80- cells (16.83±3.27% versus 0.10±0.02%, p<0.0001) 
as well as an increase in GFP+F4/80+ cells (7.35±0.59% versus 1.27±0.15%, p=0.016) 
in the repairing (n=7) versus the non-repairing (n=4) uterine horns. In contrast there is 
no significant change in the GFP-F4/80+ cell population (0.20±0.06% versus 
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Figure 3-8. Characterisation of GFP+ immune cell populations in MacGreen uterine 
tissues recovered from control (non-decidualised), naïve and repairing (decidualised) 
horns 24hrs following progesterone withdrawal by flow cytometry. (A-B) Very few GFP+ 
cells were detected in the control horns whereas they were abundant in the repairing tissue. 
(C) Summary data showed GFP+ cells represent around 0.66±0.21% of live singlets in control 
tissue but this increases to 23.36±3.5% of live singlets in repairing tissues (n=8, p<0.001). (D-
E) The expression of the mature macrophage marker F4/80 was assessed in both naïve and 
repairing tissues. Three subpopulations of cells were identified: GFP+F4/80- cells (Q3); 
GFP+F4/80+ cells (Q2); and GFP-F4/80 (Q1), distributed differently when comparing niave 
and repairing samples. (F) Quantification of data showed that the majority of influxing GFP+ 
cells are F4/80- (~60%) while the remaining cells are F4/80+ (~30%). F4/80+GFP- cell 
populations were unchanged in niave and repairing tissues (data presented as mean±SEM, 
representative plots, control: n=4, repairing: n=7).  
 
 
3.4.3.3 Distribution of GFP and F4/80 expressing immune cell populations in 
MacGreen uterine tissue at 24hrs 
To examine the distribution of discrete immune cell subpopulations as defined by flow 
cytometry in repairing endometrial tissue, IHC was used to stain MacGreen uterine 
sections (24hrs after P4 withdrawal) for both GFP and F4/80. Results confirmed the 
presence of three subpopulations based on these two markers and revealed different 
patterns of distribution within the repairing tissue (Figure 3-9). GFP+F4/80- cells were 
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clustered mainly in the shed tissue (Figure 3-9 (A) white arrows) but also abundant in 
the residual stromal layer (Figure 3-9 (B-C) white arrows). GFP+F4/80+ cells were 
solely located in the residual stromal layer undergoing tissue repair and not in the shed 
tissue nor in regions of the tissue already re-epithelialised/repaired (Figure 3-9 (B-C), 
yellow arrows). In contrast GFP-F4/80+ cells were found to be dispersed throughout 
the endometrial tissue and the myometrium, seemingly irrespective of regions 
associated with tissue breakdown and repair (Figure 3-9 (B-C), arrow heads).  
 
Figure 3-9. Distribution of GFP and F4/80 expressing immune cell populations in 
MacGreen uterine tissue 24hrs following progesterone withdrawal. (A) H&E cross section 
of a fully decidualised and actively repairing uterine horn with shed tissue undergoing 
breakdown in the centre: myometrium (M), residual endometrium (RE). (B) IHC looking at 
the distribution of cells expression GFP and/or F4/80 reveals that (C) an influx of GFP+F4/80- 
cells (white arrows) clustered in regions of shed tissue undergoing breakdown and (D) 
GFP+F4/80+ cells (yellow arrows) are solely located in the underlying residual endometrial 
layer undergoing active tissue repair. GFP-F4/80+ cells (white arrow heads) are dispersed 
throughout the residual endometrium and myometrium irrespective of regions associated with 
tissue breakdown and repair (representative image, n=10).  
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3.4.3.4 Distribution of subpopulations of GFP and F4/80 expressing immune cells 
in MacGreen endometrial tissue at various time points of endometrial tissue 
breakdown and repair   
Having identified a heterogeneous population of GFP and F4/80 expressing immune 
cells in actively repairing tissue (24hrs), the spatio-temporal distribution of these cells 
was investigated using dual fluorescence across the time course of tissue repair (0-
48hrs). At 0hrs (before tissue breakdown) very few GFP+F4/80- cells were present in 
the tissue and these were only detectable in association with blood vessel structures 
and not integrated into the tissue (Figure 3-10 (A), white arrows). At this time point 
GFP-F4/80+ cells were abundant and dispersed throughout the basal layer of 
endometrium but not so prominent in the decidualised tissue (Figure 3-10 (B), arrows 
heads). At 12hrs, during active tissue breakdown, these two cell populations were still 
detectable however there was a greater proportion of GFP+F4/80- cells detectable 
which appeared to be clustering predominantly near regions of decidual tissue 
breakdown (Figure 3-10 (C), white arrows). Notably, at this time point the GFP-
F4/80+ cell population appeared to be unchanged and was still dispersed throughout 
the residual endometrium and myometrium (Figure 3-10 (D), arrow heads).  
As above, during active tissue repair at 24hrs there was a visible increase in the 
GFP+F4/80- cells detected in both regions of active breakdown in shed tissue and 
active tissue repair (Figure 3-10 (E), white arrows). Notably there was also an increase 
in GFP+F4/80+ cells at 24hrs which had not been detected at earlier time points and 
these were solely located in the residual endometrium undergoing tissue repair (Figure 
3-10 (E), yellow arrows). In the same tissue, but in regions of resolved repair (intact 
epithelium) there were very few GFP+F4/80+ cells although GFP+F4/80- cells were 
detected (Figure 3-10 (F), white arrows and white arrow heads respectively). 
Throughout the tissue GFP-F4/80+ cells were detected and these were distributed as 
in naive tissues and in tissues from the other time points (Figure 3-10 (F), arrows 
heads), suggesting they were relatively homeostatic. At 48hrs when tissue repair was 
complete (intact lumen), there were few detectable GFP+F4/80- cells (shed tissue) and 
GFP+F4/80+ cells while there was still a prominent GFP-F4/80+ cell population 
distributed throughout the residual endometrium (Figure 3-10 (G-H)). These IHC 
results show dynamic changes in the number and location of immune cell populations 
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during endometrial repair and suggested that GFP+F4/80- monocytes and 
GFP+F4/80+ monocyte-derived macrophages may have an important role to play in 
endometrial tissue repair. 
 
 
Figure 3-10. Spatio-temporal distribution of GFP+ immune cell subpopulations in 
Macgreen uterine tissues at various phases of endometrial breakdown (0 and 12hrs) and 
repair (24 and 48hrs).  Note upper panels show a low power view of H&E stained tissue to 
give an overview of the gross appearance of the decidualised horn in cross section. IHC 
revealed dynamic changes in populations of immune cells at various phases of endometrial 
breakdown (A-D) and repair (E-H) based on the expression of GFP (green) and F4/80 (red) 
and their location. Three populations of cells exist in the tissue: GFP+F4/80- cells (white 
arrows), GFP+F4/80+ cells (yellow arrows) and GFP-F480+ cells (white arrow heads). 
Residual endometrium (RE), Decidualised tissue (D), shed tissue (ST) lumen (L) 
(representative images, n=10).  
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3.4.4 Confirmation of the existence of three monocyte/macrophage 
immune cell subpopulations 
Flow cytometry and IHC identified three distinct immune cell populations based on 
expression of GFP and F4/80 however it was surprising to find cells that were GFP-
F4/80+ as the literature states that all populations of macrophages express Csf1r and 
absolutely require it for cell survival (Dai et al. 2002, Wei et al. 2010, Luo et al. 2013, 
MacDonald et al. 2010, Jones and Ricardo 2013). In the current study it was initially 
unclear whether GFP-F4/80+ cells were a true population of macrophages, or whether 
there was a problem with reporting efficiency in the MacGreen transgenic line in 
uterine tissues or even if these cells expressed GFP at such a low level it was too 
difficult to detect using standard methods. Further investigations were therefore 
undertaken to confirm that GFP-F4/80+ cells were truly CSF1R negative using triple 
staining and additional transgenic lines (MacApple, CD68-eGFP). 
3.4.4.1 Expression of GFP, Csf1r and F4/80 in naïve MacGreen endometrium 
Triple IHC was used to analyse the expression of GFP, Csf1r and F480 in naïve 
MacGreen uterine tissue. Results revealed that cells which expressed GFP also 
expressed Csf1r (Figure 3-11, white and yellow arrows) and that there was a subset of 
these which also expressed F4/80 (Figure 3-11, white arrows only). Additionally, the 
existence of a population of F4/80+ cells which did not express either GFP or Csf1r 
was confirmed (Figure 3-11, red arrows). This was in agreement with results reported 
above and consistent with an endometrial macrophage population that existed within 
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Figure 3-11. Expression of GFP (green), Csf1r (blue) and F4/80 (red) in naive MacGreen 
uterine tissue.  IHC reveals the expression of GFP reliably identifies cells that express Csf1r 
(white and yellow arrows) with a subset co-expressing F4/80 (red) (white arrows). A 
population of GFP-Csf1r-F4/80+ cells was detectable (red arrows) (representative image, 
n=4).  
 
3.4.4.2 Comparison of Reporter+ and F4/80+ cell distribution in MacGreen, 
MacApple and CD68-eGFP endometrial tissues 
To further interrogate the existence of discrete immune cell subpopulations based on 
expression of GFP and F4/80, additional analysis was carried out using two further 
transgenic reporter mouse lines: MacApple and CD68-eGFP (described in Section 
2.1). The mouse model of endometrial breakdown and repair was performed using 
both additional lines: MacApple mice (reporter: RFP) and CD68-eGFP mice (reporter: 
GFP). Uterine tissues were collected at 24hrs in order to draw direct comparisons with 
results from MacGreen mice (reporter: GFP). In all cases IHC was performed to 
compare locations of reporter (presented in green for direct comparison of transgenic 
output) and F4/80 (presented in red) expressing immune cells in the tissues.  
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In uterine tissues from each transgenic line, collected 24hrs after P4 withdrawal, the 
same heterogeneity in immune cell populations existed based on detection of 
fluorescent reporter protein (GFP/RFP) and F4/80 immunoexpression. As before, three 
populations could be detected, outlines in Figure 3-12 (A-C): Reporter+F4/80- cells 
(white arrows), Reporter+F4/80+ cells (yellow arrows) and Reporter-F4/80+ (red 
arrows) cells with similar spatial arrangements in the repairing tissue in all three lines. 
These discrete populations were also detected in uterine tissues collected from normal 
cycling adult mice (naïve) of the MacGreen, MacApple and CD68-eGFP transgenic 
lines (Figure 3-13 (A-C). Taken together, these data support the conclusion that there 
is a heterogeneous monocyte/macrophage population present in both cycling and 
repairing endometrial tissues. 
 
 
Figure 3-12. Expression of Reporter proteins (green) and F4/80 (red) in MacGreen, 
MacApple and CD68-eGFP uterine tissues 24h after progesterone withdrawal. IHC 
confirms that three populations of cells exist in (A) MacGreen (n=10), (B) MacApple (n=5) 
and (C) CD68-eGFP (n=8) uterine tissues: Reporter+F4/80- cells (white arrows), 
Reporter+F4/80+ cells (yellow arrows) and Reporter-F480+ cells (red arrows). Residual 
endometrium (RE).  
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Figure 3-13. Expression of Reporter proteins (green) and F4/80 (red) in naive MacGreen, 
MacApple and CD68-eGFP uterine tissues. IHC confirms that three populations of immune 
cells exist within the stromal compartment in (A) MacGreen (n=8), (B) MacApple (n=4) and 
(C) CD68-eGFP (n=4) uterine tissues: Reporter+F4/80- cells (white arrows), 




3.4.4.3 Comparison between GFP+ cells in MacGreen and CD68-eGFP 
endometrial tissue during active tissue repair (24hrs)   
To compliment previous findings, flow cytometry was also used to accurately assess 
changes in GFP+ immune cell populations during endometrial tissue repair (24hrs) 
comparing data from MacGreen (Section 3.4.3.2) with data generated using uterine 
tissues from CD68-eGFP mice. Analysis of the side scatter profile and GFP expression 
by live single cells from MacGreen uterus showed very few GFP+ cells present in the 
control (non-decidualised) horn and a distinct GFP+ population present in the samples 
recovered from the repairing (decidualised) horn after P4 withdrawal (Figure 3-14 
(A)). Analysis of cells from the CD68-eGFP uteri showed similar changes between 
naive and repairing tissues: very few GFP+ cells in the control samples and many 
GFP+ cells in repairing samples (Figure 3-14 (B)). Analysis of tissues from both 
reporter lines demonstrated that in MacGreen repairing tissues (24hrs, n=10) GFP+ 
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cells account for 23.36±3.5% of the live cells whilst in the control tissue they account 
for only 0.66±0.21% (unpaired t-test p=0.003) (Figure 3-14 (C)) and in CD68-eGFP 
repairing tissues (24hrs, n=8) GFP+ cells account for 23.96±2.59% of the live cells 
whilst in the control tissue they account for only 1.67±0.39% (unpaired t-test, 




Figure 3-14. Flow Cytometry analysis of MacGreen and CD68-eGFP uterine tissues 
collected at 24hrs following P4 withdrawal at the time of active tissue repair and 
compared to non-decidualised control tissues. (A) Flow cytometry plots of control and 
repairing uterine tissues from MacGreen mice at 24hrs (n=10). (B) Flow cytometry plots of 
control and repairing uterine tissues from CD68-eGFP mice at 24hrs (n=8). (C) Assessment 
of the GFP+ immune cell influx in MacGreen transgenic mice at 24hrs. (D) Quantification of 




Chapter 3: Investigation of the relationship between tissue resident and transient 
immune cell populations during endometrial repair 181 
 
3.4.5 Spatio-temporal analysis of immune cells and apoptotic cells in 
endometrial tissue during repair  
A primary function of mononuclear phagocytes is to engulf (phagocytose) pathogens, 
dying/dead cells or cellular debris. To analyse whether GFP+ immune cells were 
associated with areas of cell death (apoptosis) in the endometrium, double fluorescent 
IHC was used to identify whether co-expression of cleaved caspase 3 (CC3), an 
enzyme activated in apoptotic cells, and GFP occurred in MacGreen uterine tissues. 
Analysis of uterine horns recovered at 0, 12, 24 and 48hrs after progesterone 
withdrawal revealed dynamic time-dependent changes in expression/co-expression of 
the proteins. At 0hrs very few CC3+ cells were detected in the tissue consistent with 
an intact decidualised stroma (Figure 3-15 (A), yellow arrows); as previously 
described, at 0hrs there were also very few GFP+ immune cells present in the tissue 
(Figure 3-15 (A), white arrows). By 12hrs after P4 withdrawal active tissue breakdown 
was underway and CC3+ apoptotic cells could be detected in the decidualised tissue 
mass which was starting to break down (Figure 3-15 (B), yellow arrows). In areas of 
tissue with CC3+ cells there was an apparent association with GFP+ immune cells 
(Figure 3-15 (B) white arrows) although there was no evidence for co-expression of 
the two proteins in individual cells suggesting active phagocytosis had not yet taken 
place. 
At 24hrs, CC3+ cells were detected throughout the shed tissue consistent with active 
tissue breakdown and apoptosis (Figure 3-15 (C) yellow arrows). Many GFP+ immune 
cells were found in close proximity to CC3+ cells (Figure 3-15 (C) white arrows) but 
there was no evidence for co-expression of the proteins. At 48hrs when tissue repair 
was complete, CC3+ cells were still present detected within the newly formed 
epithelium (Figure 3-15 (D)). Notably, the GFP+ immune cells still detected in the 
residual endometrial stroma co-expressed CC3 (Figure 3-15 (D), white and yellow 
arrows). GFP+CC3+ cells are either GFP+ immune cells that had phagocytosed CC3+ 
apoptotic cells or were GFP+ cells that were undergoing apoptosis themselves. With 
the completion of repair and resolution of inflammation apparent in the endometrial 
tissue, the latter is considered more likely as it would be a mechanism to explain the 
rapid reduction in GFP+ cells at 48hrs compared with 24hrs based on previous IHC 
results (Figures 3-7 and 3-10). 
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Figure 3-15. Spatio-temporal distribution of GFP+ immune cells and CC3+ apoptotic 
cells in MacGreen uterine tissues before (0hrs) and at various phases of endometrial 
breakdown (12hrs) and repair (24-48hrs).  IHC reveals dynamic changes in numbers of 
cells undergoing apoptosis (CC3+) and varying degrees of association with GFP+ immune 
cells. (A) At 0hrs few GFP+ cells (white arrows) and few apoptotic cells (yellow arrows) are 
present. (B) At 12hrs numbers of GFP+ cells increase (white arrows) and apoptotic cells can 
be detected in the decidua (yellow arroes). (C) At 24hrs GFP+ cells peak in numbers (white 
arrows) and there is a definite association with apoptotic decidual cells (yellow arrows). (D) 
At 48hrs there is evidence for GFP+CC3+ (white and yellow arrows) cells which could be 
macrophages engulfing apoptotic bodies or undergoing apoptosis themselves. Residual 
endometrium (RE), shed tissue (ST), lumen (L) (representative images, n=6). 
 
 
To investigate if the different GFP+ immune cell populations have different 
phagocytic activities IHC was used to perform a triple stain of MacGreen uterine 
tissues for GFP, F4/80 and CC3. Notably this more refined examination suggested that 
in regions of endometrium undergoing active tissue repair there were GFP+F4/80+ 
cells that were apparently engulfing CC3+ cells (Figure 3-16 (A), yellow arrows) and 
there was also evidence for GFP-F4/80+ cells engulfing CC3+ cells. No evidence for 
GFP+F4/80- cells engulfing CC3+ cells (Figure 3-16 (A), red versus white arrows) 
was found. In regions of shed tissue (undergoing breakdown) there was no evidence 
for immune cell populations engulfing apoptotic cells however there was a close 
association of GFP+F4/80-  cells with CC3+ (presumptive apoptotic) decidual cells 
(Figure 3-16 (B), white versus orange arrows). These data suggest that GFP+F4/80- 
inflammatory monocytes might have a role to play in inducing apoptosis in decidual 
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cells but that it is only GFP+F4/80+ and GFP-F4/80+ cells (macrophages) that appear 





Figure 3-16. Association of immune cells with apoptotic cells in MacGreen uterine tissues 
during active tissue repair. (A) Expression of GFP, F4/80 and CC3 in residual endometrial 
tissue (B) Expression of GFP, F4/80 and CC3 in shed tissue. Orange arrows represent CC3+ 
apoptotic cells, white arrows represent GFP+F4/80- cells, yellow arrows represent 
GFP+F4/80+ cells engulfing a CC3+ cell and red arrows represent GFP-F4/80+ cells engulfing 
a CC3+ cell. (representative image; n=4). 
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3.4.6 Expression of signalling molecules and receptors with known 
roles in monocyte/macrophage function in endometrial tissue 
3.4.6.1 qPCR analysis of cytokines and chemokines in endometrial tissue 
To investigate mechanisms by which the heterogeneous population of GFP+ immune 
cells were recruited to the regions of repairing tissue, qPCR was used to analyse 
mRNA expression of key cytokines and chemokines. mRNA was extracted from 
whole uterine tissue samples recovered from both the hormone-treated 
non-decidualised (control) and the decidualised (repairing) uterine horns retrieved 
between 0 and 48hrs. Results were normalised to mRNA expression of the reference 
gene Actb (Figure 3-17, black versus grey bars respectively). 
In uterine tissues mean Ccl2 mRNA was higher in the decidualised horn compared 
with the control horn at 0, 12 and 24hrs (Figure 3-17 (A)). However Ccr2, a receptor 
for Ccl2 which may mediate monocyte chemotaxis to sites of inflammation was 
reduced at 0 and 12hrs and only higher at 24hrs in the decidualised samples (Figure 
3-17 (B)). Cx3cl1 (fractalkine) mRNA was upregulated in the decidualised horn at 12, 
24 and 48hrs suggesting the chemokine will only be secreted after tissue breakdown 
is initiated but may persist throughout repair (Figure 3-17 (C)). The corresponding 
receptor Cx3cr1 was also upregulated in the decidualised tissue at 12hrs and even more 
so at 24 and 48hrs (Figure 3-17(D)). Ccl7 (Mcp3) mRNA was upregulated in the 
decidualised horn at 12hrs and further increased at 24hrs (Figure 3-17 (E)). Ccl8 
(Mcp2) mRNA was upregulated in the decidualised tissue both before (0hrs) and 
during tissue breakdowns (12hrs) but no different to controls at 24 and 48hrs (Figure 
3-17 (F)). Interestingly, Csf1 mRNA was upregulated in the decidualised horn at all 
time points 0, 12, 24 and 48hrs (Figure 3-17 (G)). In contrast, Csf2 mRNA was 
exclusively upregulated in the decidualised horn at 24hrs (Figure 3-17 (H)) and 
comparable to control samples at all other time points.  
In uterine tissues both Cxcl1 and Cxcl2 mRNA were markedly upregulated only at 
24hrs in the decidualised horn (Figure 3-17 (I-J)) which paralleled the time point when 
there was the highest number of macrophages present in the tissue consistent with 
these cells being a source of these chemokines. Similarly, Cxcl3 and Cxcl12 mRNA 
were significantly upregulated in decidualised horns exclusively at 24hrs (Figure 3-17 
(K-L), ****p<0.0001). Il10 was upregulated in the decidualised horn at 24 and 48hrs 
Chapter 3: Investigation of the relationship between tissue resident and transient 
immune cell populations during endometrial repair 185 
 
while Arg1 was only upregulated at 24hrs (Figure 3-17 (M-N)). Notably, both Il6 and 
Tnfa were significantly upregulated at 24hrs in decidualised uterine horns compared 
with controls (Figure 3-17 (O-P), ****p<0.0001). All mRNA values (AU) normalised 
to Actb expression are detailed in Table 3-3. 
 
Figure 3-17. qPCR analysis of mRNA encoding key cytokines and chemokines in whole 
uterine tissue homogenates assessed 0-48hrs in control and decidualised uterine tissues. 
mRNA expression of (A) Ccl2, (B) Ccr2, (C) Cx3cl1, (D) Cx3cr1, (E) Ccl7, (F) Ccl8, (G) 
Csf1, (H) Csf2, (I) Cxcl1, (J) Cxcl2, (K) Cxcl3, (L) Cxcl12, (M) Il10, (N) Arg1, (O) Il6, (P) 
Tnfα in control (hormone treated, non-decidualised) and repairing tissues (hormone treated, 
decidualised) (n=5 for each condition and time point). All values normalised to mRNA 
expression of reference gene (Actb). Black bars represent non decidualised uterine tissues, 
grey bars represent fully decidualised uterin tissues (two-way ANOVA, Sidak’s multiple 
comparison’s test, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).
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Table 3-2. Gene expression values (mRNA; AU) as normalised to Actb in control (non-decidualised) and decidualised (repairing) uterine tissues at 0, 
12, 24 and 48hrs of the Edinburgh menses mouse model. P values demonstrated significance as analysed using a two-way ANOVA and Sidak’s 
multiple comparison’s test. 
Gene 0hrs 12hrs 24hrs 48hrs 
Control Decidualised p value Control Decidualised p value Control Decidualised p value Control Decidualised p value 
Ccl2 0.42±0.21 2.13±0.83 0.027 0.55±0.08 2.17±0.46 0.039 0.39±0.15 2.38±0.50 0.008 0.35±0.17 1.63±0.42 0.143 
Ccr2 1.81±0.24 0.69±0.11 0.014 1.56±0.29 0.36±0.06 0.005 1.97±0.22 3.27±0.24 0.002 2.11±0.27 1.79±0.11 0.832 
Cx3cl1 0.95±0.13 1.16±0.11 0.704 0.74±0.06 2.11±0.11 <0.0001 0.73±0.04 1.71±0.62 <0.0001 0.63±0.06 1.43±0.15 0.001 
Cx3cr1 1.08±0.24 1.53±0.07 0.771 0.73±0.08 2.26±0.49 0.005 0.53±0.10 3.32±0.63 <0.0001 0.68±0.03 2.84±0.12 <0.0001 
Ccl7 0.26±0.03 0.27±0.06 0.999 0.31±0.07 1.44±0.16 <0.0001 0.20±0.03 2.23±0.35 <0.0001 0.31±0.06 0.56±0.15 0.669 
Ccl8 0.12±0.02 1.35±0.37 0.001 0.08±0.03 1.04±0.41 0.007 0.14±0.05 0.32±0.09 0.954 0.12±0.02 0.34±0.07 0.904 
Csf1 0.27±0.04 0.72±0.07 0.009 0.15±0.02 0.67±0.19 0.002 0.17±0.03 1.08±0.14 <0.0001 0.16±0.04 0.58±0.09 0.018 
Csf2 0.17±0.09 0.13±0.02 0.999 0.48±0.15 2.03±0.44 0.779 0.13±0.04 11.03±3.01 <0.0001 0.19±0.04 2.04±0.11 0.654 
Cxcl1 0.20±0.07 0.04±0.01 0.971 0.16±0.08 0.28±0.09 0.991 0.10±0.05 1.78±0.54 <0.0001 0.13±0.04 0.09±0.03 0.999 
Cxcl2 0.16±0.06 0.07±0.04 0.999 0.16±0.13 0.83±0.39 0.982 0.34±0.21 13.15±2.71 <0.0001 0.30±0.09 0.33±0.08 0.999 
Cxcl3 0.02±0.01 0.03±0.01 0.999 0.16±0.15 0.53±0.23 0.999 0.17±0.11 18.52±3.41 <0.0001 0.27±0.08 1.22±0.54 0.971 
Cxcl12 1.96±0.51 0.61±0.12 0.012 1.45±0.12 0.70±0.09 0.298 1.01±0.14 4.20±0.52 <0.0001 1.84±0.25 2.45±0.22 0.489 
Il10 0.43±0.08 1.38±0.29 0.782 0.58±0.11 1.72±0.16 0.643 0.43±0.07 5.02±1.34 <0.0001 0.81±0.14 4.32±1.23 0.003 
Arg1 0.04±0.01 0.12±0.02 0.989 0.23±0.06 0.08±0.02 0.905 0.13±0.02 2.27±0.33 <0.0001 0.62±0.15 1.16±0.08 0.029 
Il6 0.08±0.03 0.29±0.08 0.817 0.17±0.14 0.78±0.28 0.044 0.07±0.03 2052±0.31 <0.0001 0.07±0.02 0.04±0.01 0.999 
Tnfα 0.14±0.03 0.98±0.28 0.159 0.56±0.13 1.55±0.18 0.069 0.24±0.03 4.38±0.69 <0.0001 0.17±0.04 0.64±0.16 0.671 
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3.4.6.2 Isolation and characterisation of myeloid immune cell populations during 
endometrial repair 
To further characterise the distinct monocyte/macrophage cell populations identified 
in repairing endometrial tissue, GFP+F4/80- cells, GFP+F4/80+ cells and GFP-F4/80+ 
cells were isolated by FACS from MacGreen uterine tissues recovered 24hrs after P4 
withdrawal. RNA extraction and cDNA synthesis were performed and qPCR was used 
to analyse the expression of genes used in previous studies to identify distinct 
monocyte and macrophage phenotypes in mice (Evans and Salamonsen 2012, 
Thiruchelvam et al. 2013, Mackler et al. 2000, Martin and Leibovich 2005, 
Salamonsen et al. 2002, Kamat and Isaacson 1987, Van Furth and Thompson 1971). 
Cells were isolated from six mice. Total isolated cell numbers are presented in Table 
3-4. Notably in all cases the largest number of cells was detected as being in the 
GFP+F4/80- cell population consistent with results detailed in previous sections (see 
Figure 3-8). 
Table 3-4. Cell numbers of each monocyte/macrophage population isolated by FACS 
Sample GFP+F4/80- cells GFP+F480+ cells GFP-F480+ cells 
1 97,302 33,025 13,557 
2 102,156 52,971 22,988 
3 99,373 40,071 24,195 
4 218,121 64,579 32,541 
5 101,096 42,456 22,222 
6 106,430 58,431 22,608 
 
As summarised in Table 3-5, each of these three populations of cells had a distinct 
gene expression profile. Specifically GFP+F4/80- cells, in agreement with 
immunohistochemistry (Figure 3-1), expressed Csf1r mRNA and also contained 
readily detectable mRNAs encoded by Cx3cr1, CD14, and CD16 all known monocyte 
markers but had low expression of Ccr2, Arg1 and Il6. For ease of comparison 
macrophages are often considered as having a M1 (classically 
activated/proinflammatory) or a M2 (alternatively activated/anti-inflammatory) 
phenotype although it is acknowledged that these are not likely to be discrete 
phenotypes within a tissue context (Shapouri-Moghaddam et al. 2018, Biswas et al. 
2012). Notably, in addition to Cx3cr1 the GFP+F4/80- cells also expressed some 
markers considered typical of M2-like macrophages including Tgfβ1, Csf1 and Il10 
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and interestingly a high amount of Tnfα mRNA (Table 3-5). These results suggest that 
the GFP+F4/80- cell population may be heterogeneous, predominantly composed of 
Ccr2lowCx3cr1+ alternative monocytes. 
 
The GFP+F4/80+ cells also expressed high levels of Cx3cr1 mRNA and lower levels 
of Ccr2, CD14 and CD16 mRNA. Notably the GFP+F4/80+ cells also expressed high 
levels of Arg1, Tgfβ1 and Il10 mRNAs which usually considered as being M2 
macrophage markers (Biswas et al. 2012, Shapouri-Moghaddam et al. 2018). 
Reassuringly, the purified GFP-F4/80+ cells did not express mRNAs encoded by Csf1r 
in agreement with the IHC and flow cytometry data detailed above. GFP-F4/80+ cells 
expressed Ccr2 and showed mixed expression of mRNAs considered typical of M1 
(Il6, Tnfα) and M2 (Arg1, Tgfβ1, Csf1) macrophage phenotypes (Table 3-5), again 
consistent with a non-typical/intermediate phenotype. In summary, these qPCR results 
show that although three subpopulations have been identified based on cell surface 
expression of Csf1r (cytoplasmic GFP) and F4/80, functional heterogeneity exist 
within each population which requires further investigation.  
 
Table 3-5. Summary of gene expression in three distinct monocyte/macrophage 
populations in endometrium recovered 24hrs after progesterone withdrawal. All values 
normalised to mRNA expression of Actb (reference gene) 
Cell Marker GFP+F4/80- cells GFP+F4/80+ cells GFP-F4/80+ cells 
Csf1r + + + + - 
Ccr2 - + + + + 
Cx3cr1 + + + + + + + + - 
CD14 + + + + + + - 
CD16 + + + + + + - 
Arg1 - + + + + + 
Tgfβ1 + + + + 
Csf1 + + + - + + 
Csf2 - - - 
Il10 + + - 
Ifnγ - - + 
Il6 - - + + 
Tnfα + + + + + + 
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3.5 Discussion 
3.5.1 Mouse model of endometrial breakdown and repair 
During the normal human menstrual cycle, the inner section of the endometrium 
breaks down and is shed and at the same time a rapid process of scar-free tissue 
repair takes place (Garry et al. 2009). Menstruation is considered an inflammatory 
event associated with the sequential recruitment of neutrophils and macrophages 
that are believed to play key roles in the controlled break down of the tissue and its 
subsequent shedding (Evans and Salamonsen 2012). We and others have focused on 
macrophages as one of the immune cells most likely to play a role in regulation of 
endometrial inflammation and tissue breakdown during menses in part because of the 
evidence that their numbers peak during menstruation where they account for up to 
15% of the total leucocyte population (Salamonsen and Woolley 1999, 
Thiruchelvam et al. 2013).  Macrophages are able to adapt their phenotype so that 
they can regulate both pro- and anti-inflammatory responses depending upon the 
tissue environment (Biswas et al. 2012). 
 
Menstruation only occurs naturally in women and a few other species including some 
higher primates (e.g. macaques: (Brenner and Slayden 2012, Brenner et al. 1996)), 
some bat species, the elephant shrew and as most recently discovered, the Cairo spiny 
mouse (Bellofiore et al. 2018, Bellofiore et al. 2017). In order to study mechanisms 
responsible for breakdown of endometrial tissue a number of models have been 
developed including the use of human tissue xenografted into immune-suppressed 
mice (Coudyzer et al. 2013). Whilst this model has the merit of using human tissue it 
is not suitable for studying the impact of immune cells on the process. A number of 
investigators have therefore developed protocols to simulate ‘menses’ in non-
menstruating rodent species including rats and mice with two approaches most widely 
used: ovariectomy combined with hormone treatment and mechanical induction of 
decidualisation (Finn and Pope 1984, Brasted et al. 2003, Kaitu'u et al. 2005); or 
induction of pseudopregnancy (Rudolph et al. 2012).  
 
In the current study, a mouse model of endometrial breakdown and repair that was a 
refined and revalidated protocol based on that of the Salamonsen group (Kaitu'u et al. 
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2005, Kaitu'u-Lino et al. 2007, Kaitu'u-Lino et al. 2009, Kaitu'u-Lino et al. 2010, 
Kaitu'u-Lino et al. 2012) was used. Using the ‘Edinburgh model’ we have already 
demonstrated key parallels with the process of menstruation in women including local 
hypoxia (Cousins et al. 2016d) which occurs in parallel to simultaneous shedding and 
repair, expression of matrix metalloproteinases, active angiogenesis and epithelial 
proliferation and migration in the absence of oestrogen stimulation (Cousins et al. 
2014, Cousins et al. 2016b). Given the evidence that monocyte-derived macrophages 
and paracrine factors secreted by these cells play a key role in regenerating tissues 
(Das et al. 2015) and in wound repair we used transgenic mice in which these cells 
could be identified by fluorescent reporter proteins in combination with our mouse 
model to interrogate their role in endometrial wound healing. 
3.5.2 Harnessing the power of mouse transgenics to reveal different 
subpopulations of endometrial mononuclear phagocytes in the 
endometrium 
Myeloid progenitor cells differentiate into macrophages in situ in peripheral tissues, a 
process that is regulated by macrophage colony-stimulating factor (Csf1) which binds 
to cells expressing Csf1 receptor (Csf1r) (Dai et al. 2002, Wei et al. 2010, Luo et al. 
2013, MacDonald et al. 2010, Jones and Ricardo 2013). Two transgenic mouse lines 
used in this study are based around this biology: the MacGreen (Sasmono et al. 2003) 
and MacApple (Hawley et al. 2018) lines express the fluorescent reporter proteins 
eGFP and RFP (respectively) under control of the Csf1r promoter. Similarly CD68 is 
expressed by myeloid cells, specifically monocytes and macrophages and another 
transgenic line, CD68-eGFP, expresses eGFP under control of the CD68 gene 
promoter (Iqbal et al. 2014).  
In the MacGreen endometrium GFP+ cells were found to express CD45 the leucocyte 
common antigen which is expressed on almost all haematopoietic cells except mature 
erythrocytes (Martin and Leibovich 2005), confirming their identity as leucocytes. 
Similarly all GFP+ cells expressed CD11b which is an integrin expressed on the 
surface of a number of leucocytes including monocytes, natural killer cells and 
macrophages and in some cases it is believed that varied expression of CD11b relates 
to diverse functions (Schulz et al. 2012), although both IHC and flow cytometry results 
in this characterisation did not display this. Interestingly when analysing 
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immunoexpression of Gr1, an inflammatory monocyte marker, a proportion of the 
GFP+ cells were GR-1+ while some were Gr1-. It is known that mouse monocyte 
subsets can be characterised by differential expression of Gr1 where Gr1+ monocytes 
are CD11b+Csf1r+ and considered to be ‘classical’ monocytes, while Gr1- monocytes 
are also CD11b+Csf1r+ but considered to be ‘alternative/patrolling’ monocytes (Yang 
et al. 2014).  
GFP+ cells were determined to have low granularity as determined by side scatter in 
flow cytometry analysis, and were mononuclear when examined on cytospins. Taken 
together these results suggest that GFP+ cells in the MacGreen endometrium represent 
two subsets of mononuclear phagocytes: Csf1r/GFP+CD11b+Gr1+ ‘classical’ 
monocytes and Csf1r/GFP+CD11b+Gr1- ‘alternative’ monocytes. Notably some 
previous studies have used Gr1 as a neutrophil specific marker to elucidate essential 
roles in endometrial physiology (Hestdal et al. 1991, Daley et al. 2008, Menning et al. 
2012a, Armstrong et al. 2017). The current dataset suggests the conclusions from those 
studies may require reinterpretation. 
3.5.3 Characterisation of mononuclear phagocytes during 
endometrial breakdown and repair 
Analysis of MacGreen uterine tissue revealed that there was a striking increase in the 
numbers of GFP+ cells 24hrs after progesterone withdrawal at a time when previous 
validation studies suggested active decidual tissue breakdown as accompanied with 
basal endometrial repair (Cousins et al. 2014), shown to parallel with studies in human 
tissues recovered on day 28/1 of the menstrual cycle (Armstrong et al. 2017). In the 
current study the use of flow cytometry provided a powerful way of quantifying 
changes in cell content and revealed that the proportion of GFP+ cells increased from 
0.66±0.21% to 23.26±3.46% of live cells in digests of tissue recovered at 24hrs. These 
findings would appear to be consistent with the extravasation of inflammatory 
monocytes from the circulation in response to an ‘injury’ stimulus (Van Furth and 
Thompson 1971, Das et al. 2015, Hampton et al. 2001, Jones et al. 2004, Yang et al. 
2014).  
Further characterisation using the mature macrophage marker F4/80, widely used to 
detect macrophage populations in mouse tissues, identified three putative 
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subpopulations of monocyte/macrophage present during endometrial repair: 
GFP+F4/80-, GFP+F4/80+ and GFP-F4/80+ cells. The majority of cells were 
GFP+F4/80- previously described as inflammatory monocytes while there was also 
a population of GFP+F480+, which also showed a significant increase in the 
repairing endometrial tissue with detection of the latter consistent with the 
differentiation of monocytes into macrophages following extravasation into the 
endometrial tissue (Van Furth and Thompson 1971, Battersby et al. 2002, Das et al. 
2015, Hesketh et al. 2017, Mantovani et al. 2013, Yang et al. 2014). On the basis of 
flow cytometry alone these subpopulations were therefore characterised as influxing 
inflammatory monocytes (GFP+F4/80-) and monocyte-derived macrophages 
(GFP+F4/80+). Notably a third population of GFP-F4/80+ cells were identified the 
numbers of which appeared to be relatively unchanged during endometrial repair 
leading to the assumption that these cells would represent a stable tissue-resident 
macrophage population. 
Complementary studies using fixed tissue sections showed the GFP+F480- monocytes 
were most prominent in areas of decidual tissue breakdown and in areas of repairing 
tissue. Notably, GFP+F480+ cells were only detected in the regions of residual 
(unshed) endometrium undergoing active repair and were not associated with regions 
of repaired tissue. The GFP-F480+ cells, putative tissue-resident macrophages were 
detected throughout the tissue independent of areas of tissue breakdown and repair. 
Such distinct locations of immune subpopulations may have significant impacts on 
their phenotype and function (Schulz et al. 2012). Further analysis of subpopulations 
revealed dynamic changes in abundance and location across the full time course of 
endometrial breakdown and repair. Specifically GFP+F480- monocytes were rare 
before the onset of tissue breakdown (0hrs), increased moderately by 12hrs during 
tissue breakdown and were highly abundant at 24hrs in regions of both tissue 
breakdown and repair. By 48hrs these cells were diminished, consistent with 
successful resolution of inflammation. Interestingly it was noted that the GFP+F4/80+ 
monocyte-derived macrophage population was abundant at the 24hrs time point but 
relatively low at all other time points. The GFP-F480+ tissue-resident macrophage 
population was detected across the time course and appeared relatively homeostatic.  
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These novel findings documenting for the first time both the temporal and spatial 
association of three phenotypically identifiable populations of 
monocytes/macrophages during dynamic endometrial shedding and repair is 
entirely consistent with the highly plastic nature of these cells and the ability of the 
local microenvironment to imprint their phenotypic and functional characteristics . 
An interpretation of these result is summarised in Figure 3-18 showing the most 
abundant populations of monocytes and macrophages are detected in the mouse 
endometrium at 24hrs during active endometrial tissue repair. 
 
 
Figure 3-18. Schematic interpretation of changes in immune cell subpopulations during 
endometrial tissue breakdown and repair based on IHC and flow cytometry results. 
Before tissue breakdown at 0hrs there are few GFP+F4/80- cells and GFP+F4/80+ cells. 
GFP+F4/80- cells are more abundant at 12hrs during tissue breakdown and peak at 24hrs 
during tissue repair. GFP+F4/80+ cells are not detectable at 12hrs but also peak at 24hrs. By 
48hrs both GFP+F4/80- and GFP+F4/80+ cells are diminished. GFP-F4/80+ cells are 
relatively unchanged throughout the cycle of tissue breakdown and repair although show a 
modest increase in abundance at 24hrs. At 24hrs during active tissue repair GFP+F4/80- cells 
represent ~ 16%, GFP+F4/80+ cells represent ~7% and GFP-F4/80+ cells represent ~1% of 
live single cells in the endometrium. 
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In the case of endometrial repair, monocyte recruitment occurs in response to ‘sterile’ 
inflammation. This is similar to the injury response seen in the cardiovascular system 
where Ly6Chigh monocytes initially influx into the tissue, postulated to regulate 
removal of cellular debris, then Ly6Clow monocytes influx later to promote tissue repair 
in a linear bi-phasic progression (Nahrendorf et al. 2007) with the critical difference 
that during menstruation, simultaneous breakdown and repair is observed. With this 
in mind it is postulated that inflammatory monocytes (GFP+F4/80-) initially influx 
into the endometrium and repair-associated monocyte-derived macrophages 
(GFP+F4/80+) may either arise from this population over time, or differentiate from 
a second wave of influxing monocytes of the ‘alternative’ phenotype to take part in 
repair. This hypothesis requires further investigation. Current results have 
highlighted clear spatio-temporal regulation of monocytes and macrophage 
subpopulations, each of which may have distinct functions in endometrial repair. 
3.5.4 Confirming the existence of tissue-resident macrophages 
In contrast to most tissues in the MacGreen mouse where expression of eGFP 
corresponds to all F4/80 expressing cells (Sasmono et al. 2003), the endometrium had 
a population of cells identified as GFP-F4/80+ that were dispersed throughout the 
tissue and seemingly were not affected by simulated menstrual tissue breakdown and 
repair. This result was unexpected as it has been reported that macrophages require 
expression of Csf1r/ Csf1-dependent signalling to proliferate, differentiate and survive 
(Dai et al. 2002, Wei et al. 2010, Luo et al. 2013, MacDonald et al. 2010, Jones and 
Ricardo 2013). To confirm that detection of this population was not due to any 
technical issues with reporting efficiency in the MacGreen transgenic line additional 
analyses were undertaken. A triple stain revealed that all GFP+ cells were Csf1r+ and 
a subset of these expressed F4/80. Notably a population of GFP-Csf1r-F4/80+ cells 
were clearly identified. In addition, using additional transgenic lines, the same three 
subpopulations of monocyte/macrophage lineage cells were detected in both 
MacApple and CD68-eGFP endometrial tissue during the repair phase 
(Reporter+F480-, Reporter+F4/80+, Reporter-F4/80+).  
These additional analyses confirmed that GFP-F4/80+ expression identified a true cell 
population which is consistent with studies suggesting that macrophages are not solely 
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dependent on Csf1 signalling. For example in mice lacking functional Csf1 (op/op 
mice) (Cecchini et al. 1994) and in mice where Csf1r has been deleted (Dai et al. 2002) 
there is an incomplete depletion of macrophages (defined as F4/80+). The results of 
the current study suggest that endometrial tissue-resident macrophages (GFP-F4/80+ 
cells) do not express Csf1r and given that they appear relatively unchanged during 
endometrial repair, it is reasonable to speculate that these may represent a quiescent 
population that persists in the tissue independently of Csf1, although this alternative 
mechanism is yet to be investigated. This hypothesis can be supported by the fact that 
a reduction of Csf1 in vitro promotes quiescence of BM-derived macrophages 
(Tushinski and Stanley 1985) and that antibody depletion of Csf1r in MacGreen mice 
has been shown to diminish GFP expressing macrophages in several tissues but not 
the uterus (MacDonald et al. 2010). These results suggest that monocytes, monocyte-
derived macrophages and tissue-resident macrophages, all present simultaneously in 
the endometrium during tissue repair, may be phenotypically and functionally distinct 
from monocyte/macrophage populations in other tissues of the body. 
3.5.5 Analysis of immune cells and apoptosis during endometrial 
repair  
To assess the function and fate of the GFP+ immune cells, cellular apoptosis was 
examined using expression of cleaved caspase 3 (CC3) which plays a central role in 
cell apoptosis as a key marker. In this study apoptosis was confined to the decidualised 
tissue undergoing active tissue breakdown at 12 and 24hrs and there was a clear 
association with GFP+ cells although no clear evidence for phagocytosis 
(co-expression of GFP and CC3). Additional analysis using triple IHC revealed that in 
the basal endometrium some GFP+F4/80+ monocyte-derived macrophages and GFP-
F4/80+ tissue-resident macrophages did appear to be engulfing CC3+ apoptotic bodies 
while GFP+F4/80- cells were often associated with CC3+ cells but no colocalisation 
was detected. At 48hrs, some evidence of apoptotic GFP+CC3+ cells was detected 
which might be consistent with remaining immune cells undergoing apoptosis to 
resolve the inflammatory response, perhaps by signals generated by the remodelling 
tissue itself. 
It is well documented that monocytes and macrophages are capable of directing 
apoptosis in various tissues (Jaffe, Ruggiero and Falcone 1985, Arantes et al. 2000) 
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however evidence from studies in the human and mouse endometrium suggests that 
neutrophils are the key functional player in inducing apoptosis of decidual cells during 
tissue breakdown (Armstrong et al. 2017). Armstrong et al detected neutrophils using 
an anti-Gr1 antibody however Gr1 has been shown by others to be expressed by both 
granulocytes and monocytes (Rosas et al. 2010, Sasmono and Williams 2012), a result 
supported by the current study where Gr1 was detected on GFP+ 
monocyte/macrophages. As Gr1 is composed of both Ly6C and Ly6G proteins (Yang 
et al. 2014, Rose et al. 2012) it is likely that Amstrong et al detected a missed 
population of cells and therefore results may need to be reinterpreted. Additionally 
although an increase in Il6 and Tnfα was noted and attributed to neutrophil function by 
Armstrong et al, these cytokines are often secreted by inflammatory monocytes 
(Agarwal et al. 1995).  
It has been documented that two subsets of macrophages exist in the human decidua 
during pregnancy: CD14+CD11chi macrophages (~67%) predominantly involved in 
inflammation, antigen processing, induction of apoptosis and immune regulation; and 
CD14+CD11clo (~33%) macrophages predominantly involved in smooth muscle cell 
regulation, ECM formation, tissue remodelling and phagocytosis (Houser et al. 2011). 
Although CD11c expression was not examined in the current study, it can be 
hypothesised that functional heterogeneity exists in the current data set which may 
reflect that seen by Houser et al: the induction of apoptosis (GFP+F4/80- cells) and 
subsequent clearance of apoptotic bodies (GFP+F4/80+ cells). 
3.5.6 Regulation of monocyte/macrophage trafficking and 
differentiation 
To complement the studies on the immune cell populations, the expression of 
cytokines and chemokines reported to be involved in the regulation of monocyte 
and macrophage trafficking and differentiation was measured across the time course 
of endometrial breakdown and repair. Ccr2 and Cx3cr1 are monocyte cell surface 
receptors which respond to Ccl2 and Cx3cl1 respectively to regulate the adhesion 
and migration of monocytes (Yang et al. 2014). Although Ccl2 mRNA was 
upregulated in the endometrium throughout the time course, the corresponding 
receptor was only upregulated at 24hrs. In contrast both Cx3cl1 and Cx3cr1 mRNAs 
were upregulated in the endometrium at both 12 and 24hrs during tissue breakdown 
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and repair. These results would suggest that monocyte trafficking in the 
endometrium might be regulated predominantly through the Cx3cl1/Cx3cr1 
alternative axis as opposed to the classic inflammatory axis of Ccr2/Ccl2 (Yang et 
al. 2014, Ino et al. 2014). 
Additional factors examined included: Ccl7 and Ccl8 which are cytokines involved in 
monocyte trafficking; Csf1 and Csf2 which are involved in the proliferation, 
differentiation and survival of monocytes and macrophages; Cxcl1 and Cxcl2 which 
are secreted by macrophages and regulate the function of other immune cells; and 
Cxcl3 and Cxcl12 which are stromal derived factors which control migration, adhesion 
and activation of monocytes and other leucocytes. Dynamic changes in gene 
expression of each of these factors were noted in relation to time points of active tissue 
repair and may be important in orchestrating an immune response associated with scar-
free repair. Analysis of anti-inflammatory cytokines (Il10, Arg1) associated with M2 
or alternative macrophages and pro-inflammatory cytokines (Il6, Tnfα) associated with 
M1 or classical macrophages (Thiruchelvam et al. 2013), indicated that signals 
associated with pro-repair or alternative monocyte/macrophage populations were more 
predominant in endometrial tissue during scar-free tissue repair. As qPCR was carried 
out on whole tissue homogenates however, the spatial regulation of production and 
secretion of these factors was not realised. 
3.5.7 Gene expression profiling of isolated immune cell 
subpopulations 
To complement the analysis of whole tissue homogenates described above, gene 
expression analysis was carried out on the three isolated immune cell 
subpopulations uniquely identified in repairing endometrial tissue from MacGreen 
mice with the results summarised in Table 3-3. Interestingly both monocytes and 
monocyte-derived macrophages expressed Csf1r mRNA while tissue resident 
macrophages showed minimal expression which is in line with them being GFP- 
and further reinforces the novel results presented in this chapter. Monocytes  
(GFP+F4/80-) did not express Ccr2 mRNA but highly expressed Cx3cr1 mRNA. 
Monocytes have been phenotyped by differential expression of Ccr2 with Ccr2+ 
monocytes having a higher capacity for migration and infiltration and therefore 
considered to be pro-inflammatory (Yang et al. 2014). More recently the expression 
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of Cx3cr1 has been used to further stratify subsets where Ccr2highCx3CR1low cells are 
considered to be inflammatory monocytes and Ccr2lowCx3cr1high cells are 
considered to be alternative monocytes (Yang et al. 2014, Ino et al. 2014). 
Similarly GFP+F4/80- cells were found to express equal amounts of CD14 mRNA 
and CD16 mRNA, the ratios of which can also be used to determine monocyte 
phenotype, with a balance being indicative of intermediate monocytes which 
differentiate into M2-like macrophages (Mandl et al. 2014). With this in mind, the 
results of the current study suggest that GFP+F4/80- cells, previously denoted as 
inflammatory monocytes may represent alternative monocytes that give rise to 
macrophages with a pro-repair, M2-like phenotype (Thiruchelvam et al. 2013, 
Biswas et al. 2012, Das et al. 2015, Mantovani et al. 2013). Notably GFP+F4/80- 
cells expressed both anti-inflammatory (Tgfβ1, Csf1, Il10) and pro-inflammatory 
(Tnfα) cytokines. The use of IHC revealed that GFP+F4/80- cells were located in 
both the shed tissue and the repairing endometrium consistent with the relative 
diversity in function that may be attributed to signals in the microenvironment. 
Furthermore, Tnfα which was highly expressed in this subpopulation, is able to 
induce apoptotic cell death (Agarwal et al. 1995, Oróstica et al. 2016) and thus 
GFP+F4/80- cells may function in inducing apoptosis of decidualised stromal cells. 
Monocyte-derived macrophages (GFP+F4/80+) expressed high levels of Cx3cr1 
mRNA and lower levels of Ccr2, CD14 and CD16 mRNA, suggesting that they have 
differentiated from their monocyte precursors as described above. Interestingly 
these cells also express Arg1, Tgfβ1, Csf1 and Il10 mRNAs which is indicative of a 
pro-repair, M2-like macrophage phenotype. Tissue resident macrophages expressed 
Ccr2 mRNA and mRNAs for both anti-inflammatory (Arg1, Tgfβ1, Csf1) and 
pro-inflammatory (Ifnγ, Il6, Tnfα). Taken together, qPCR analysis has shown that 
although three distinct GFP/F4/80 subpopulations can be identified and isolated 
from endometrial tissue during repair based on surface marker expression, 
functional heterogeneity may exist within each population, likely to be related to their 
in vivo localisation. This requires further investigation.  
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3.5.8 Future prospects 
To confirm if GFP+ cell become part of the tissue-resident macrophage population, 
lineage tracing studies are required and care must be taken when choosing which 
cell markers to use. Further characterisation of the phenotype and function of each 
subpopulation present in the MacGreen tissue will inform this decision although 
with current results in mind, Cx3cr1 can be put forward as a potential target for 
these technologies. Additional phenotypic characterisation of the same cell 
populations during earlier (12hrs) and later (48hrs) time points may help uncover 
the origins of specific cell types and laser capture microdissection would help 
address the effects of spatial localisation on monocyte/macrophage cell phenotype 
and function.  Studies using isolated cell populations including a comparative 
phagocytosis assay; phenotypic assessment of the cells using a flow cytometry 
antibody panel that interrogates multiple immune cell types; and more extensive 
analysis gene expression profiles and secreted proteins could be employed. 
Ultimately a single cell sequencing study would be useful in determining subtleties 
in the heterogeneity of the endometrial monocyte/macrophage population and how 
these respond during repair processes, not only informing endometrial physiology 
but also directing future experimentation. 
Future functional studies are imperative to confirm if distinct immune cell 
populations are essential to endometrial repair. This might be achieved using 
transgenic knock out mice for example by comparison of Ccr2 KO and Cx3cr1 KO 
or by pharmacological inhibition of each subpopulation. It is hoped these studies 
may inform the development of cell-specific or cell-based therapies for a variety of 
gynaecological conditions and pathologies in other tissue systems where excessive 
scar formation is a problem. 
3.5.9 Concluding remarks 
The novel results obtained in the current study supports the hypothesis that a simple 
classification of monocytes and macrophages does not accurately reflect the 
diversity of these populations during tissue homeostasis and following injury, and 
highlights the limitation of using ‘definitive’ markers described in the literature for 
identification of immune cell subpopulations. Notably, analysing the inflammatory 
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response associated with endometrial tissue breakdown and repair in an established 
mouse model has uncovered novel immune cell subpopulations. A transient 
population of influxing ‘alternative’ monocytes and repair-specific monocyte-
derived macrophages have been shown to associate with spatio-temporal regulation 
of endometrial repair and remodelling. In-depth characterisation and phenotyping 
of these uterine macrophage populations could lead to new insights into the role of 
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Chapter 4 Identification and characterisation of a 
population of putative mesenchymal 
progenitor cells in mouse endometrium 
4.1 Introduction 
The extensive regenerative capacity of the endometrium led to the development of a 
hypothesis proposing that a population of stem/progenitor cells exists in the tissue 
which may have a role to play in tissue regeneration (Dimitrov et al. 2008). The 
concept of stem cells in the endometrium was first introduced by Prainishnikov in 1978 
however, the first evidence for their existence was only presented in 2004 by Chan et 
al (Chan et al. 2004). Since then, a growing body of work has identified 
stem/progenitor cells in the endometrium (both human and rodent) which have been 
shown to have functions important for maintaining tissue homeostasis (Gargett and 
Masuda 2010). A recent review by Gargett and colleagues highlighted a range of 
studies and different markers used to identify them (Gargett et al. 2016) highlighting 
both their potential as a therapeutic target and gaps in our knowledge. 
4.1.4 Do mesenchymal stem cells (MSCs) exist in the endometrium? 
Mesenchymal stem cells (MSCs) are a rare population of undifferentiated cells that 
have the ability to self-renew, proliferate and differentiate into several mesodermal 
lineages including adipocytes, chondrocytes and osteocytes (Cervelló et al. 2007). 
MSCs have been identified in many adult tissues including the heart, liver, dental pulp, 
umbilical cord, adipose tissue and the amniotic fluid and found to be crucial for the 
maintenance of tissue homeostasis (Dimitrov et al. 2008, Marquez-Curtis et al. 2015, 
Hass et al. 2011, Gargett et al. 2016, Kalinina et al. 2011). MSCs undergo asymmetric 
cell division to both maintain their own populations whilst also giving rise to more 
differentiated progenitor cells which are capable of rapid proliferation. These 
progenitor cells are then responsible for producing more differentiated and mature 
progeny known as transit-amplifying cells (Kalinina et al. 2011).  
MSC are broadly defined as plastic adherent cells which can differentiate into 
adipocytes, osteoblasts and chondrocytes in vitro (Crisan et al. 2008), and express the 
following markers: CD29, CD44, CD73, CD90 and CD105 (Dimitrov et al. 2008). To 
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be classified as a MSC, cells must exhibit a capacity for self-renewal, proliferation, 
migration and multi-lineage differentiation (Spitzer et al. 2012, Phinney and Prockop 
2007, Hwang et al. 2009, Takahashi et al. 2018). 
Various techniques have been employed in an attempt to identify and characterise cells 
with a MSC-like phenotype in endometrial tissue and to determine if they represent a 
resident stem-cell like population (Deane, Gualano and Gargett 2013). These have 
included assays focussing on clonogenicity and self-renewal; the Hoechst exclusion 
assay to identify side population cells; the BrdU label retention system to identify 
label-retaining cells; tissue reconstruction by xenografting techniques; and in vitro 
differentiation assays (Gargett and Masuda 2010). 
In 2004, Chan et al, identified small populations of both epithelial and stromal cells 
that had colony forming (CFU) ability in vitro (0.22% and 1.25% respectively). 
Notably their culture media were supplemented by the addition of TGFα, EGF and 
PDGF-BB (Chan et al. 2004).  These clonal cells were found to have properties of 
self-renewal, a high proliferative potential and capacity for multilineage differentiation 
in vitro (Gargett et al. 2009). Gargett et al, suggested that this rare population of 
clonogenic cells should be identified as the endometrial MSC population. 
In other studies, the Hoechst exclusion assay has been used identify side population 
(SP) cells: this assay relies on the fact that stem cells have the ability to extrude the 
DNA binding dye Hoechst 33342 due to expression of via the ATP-binding cassette 
transporter protein ABCG2/Bcrp1 (Cervelló et al. 2011, Hu et al. 2010, Kato et al. 
2007). SP cells have been identified in both the epithelial and stromal compartment of 
the endometrium throughout the basalis and functionalis (Kato et al. 2007). Further 
characterisation of endometrial SP cells confirmed that SP cells expressed markers of 
undifferentiated cells including c-kitD/CD117 and Oct-4, could undergo multilineage 
differentiation and were able to reconstitute endometrial tissue in vivo after being 
engrafted under the kidney capsule of NOD-SCID mice (Cervelló et al. 2011). 
A well-known method to identify stem/progenitor cells and their in vivo location in 
rodents is the label retaining cell (LRC) approach. This method is based on the finding 
that stem/progenitor cells undergo less cell divisions and retain labels integrated into 
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nuclear DNA (e.g BrdU) for longer than ‘fast cycling’ cell populations which include 
many differentiated cell types (e.g. glandular epithelium). LRC have been identified 
in the mouse endometrium in both the epithelial and stromal cell compartments (Chan 
and Gargett 2006b, Kaitu'u-Lino et al. 2012, Cao et al. 2015, Patterson and Pru 2013) 
and have been found to express markers of undifferentiated cell types including c-kit 
and Oct-4 (Cervelló et al. 2007). Unfortunately, the LRC approach does not 
definitively identify stem/progenitor cells and functional studies are hindered by the 
fact that BrdU detection assays require tissue fixation precluding FACS isolation 
(Gargett et al. 2016). Thus although SP cells and LRCs have been identified in the 
human and mouse endometrium respectively (Figure 4-1), a definitive MSC could not 
be identified using these approaches. 
 
 
Figure 4-1. Hypothesised location of stem/progenitor cells in human and mouse 
endometrium. (A) In human endometrium epithelial progenitor cells identified by clonogenic 
and side population techniques, are located in the base of glands in the basalis while MSCs are 
located near blood vessels. (B) In mouse endometrium, LRC hypothesised to be 
stem/progenitor cells are located in the luminal epithelium and near blood vessels in the stroma 
(based on Gargett and Masuda 2010). 
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4.1.5 Endometrial MSC cell surface markers 
To more reliably investigate endometrial MSCs specific cell markers were sought to 
discriminate between putative MSCs and other cell types in the endometrial tissue.  
Typical stem cell markers including Oct4, c-kit, CD90, CD44, CD73, and CD166 (Cho 
et al. 2004, Cervelló et al. 2007, Indumathi et al. 2013, Cheng et al. 2017) and MSC 
markers CD29, SUSD2 and CD105 (Schwab and Gargett 2007, Dimitrov et al. 2008, 
Phinney and Prockop 2007, Hwang et al. 2009, Marquez-Curtis et al. 2015) were used 
to identify putative endometrial MSCs in human (using clonogenic and SP techniques) 
and mouse endometrium (using LRC technique) through IHC and flow cytometry. A 
limitation of the results obtained was that these putative MSC specific proteins were 
also expressed by other cell types and therefore a combination of different markers 
was required to identify MSC. The challenge therefore was to detect cell surface or 
other proteins that would specifically identify endometrial MSCs so that they could be 
purified and separated from other endometrial cell types some of which are detailed 
below. 
The RNA binding protein Musashi-1, known to be associated with control of 
asymmetric cell division of neural and epithelial progenitor cells, was found to be more 
highly expressed in the human endometrium than the myometrium (Götte et al. 2008). 
Further investigation reported that Musashi-1 was co-localised with Notch1 and 
telomerase (stem cell markers) and concluded that Musashi-1 could be used to identify 
endometrial MSCs in the human endometrium (Gotte et al, 2008). The same group 
reported an upregulation of putative endometrial stem-cell numbers expressing 
Musashi-1 in endometriosis and endometrial carcinoma (Götte et al. 2008). 
It was also noted that human stromal cells only formed colonies in vitro in the presence 
of PDGF-BB and so it was hypothesised that endometrial MSCs may express Pdgfrβ 
(Chan et al. 2004, Schwab et al. 2005). To investigate this, Schwab and Gargett 
assessed the expression of PDGFRβ and the adhesion molecule CD146 (a well-known 
MSC marker) in human endometrium using IHC and identified cells that co-expressed 
PDGFRβ and CD146. They isolated these cells by FACS and performed in vitro assays 
to show they had clonogenic and multilineage differentiation potential. Furthermore, 
some perivascular cells were positive for PDGFRβ and CD146 which led to the 
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proposal that some or all endometrial MSCs may be perivascular pericytes which may 
have MSC activity. The lack of cell markers exclusive to pericytes has to date hindered 
definitive confirmation (Schwab and Gargett 2007). In a subsequent study profiling of 
CD146+/PDGFRB+cells, putative endometrial MSCs revealed gene signatures 
associated with self-renewal, multi-potency, differentiation, migration and 
immunomodulation. Expression of genes related to Notch, TGFB, IGF, Hedgehog, 
and G-protein-coupled receptor signalling pathways were increased (Spitzer et al. 
2012).  
The protein SUSD2 (sushi domain containing-2) identified by the W5C5 antibody, was 
identified as a novel marker for MSCs in the human endometrium (Masuda et al. 
2012). Notably co-localisation studies (IHC) and FACS studies showed that W5C5+ 
cells were comparable to PDGFRβ+CD146+ cells when analysed, demonstrating 
clonogenicity, multilineage differentiation and self-renewal consistent with an MSC 
identity (Masuda et al. 2012, Gargett et al. 2016). Furthermore, these cells also had a 
perivascular location in both the basal and functional layer of endometrial stroma and 
when isolated and xenografted under the kidney capsule of NOD-SCID mice, these 
cells gave rise to endometrial stromal tissue in vivo (Masuda et al. 2012). This study 
was the first to report a single marker (SUSD2) for the identification of MSCs in 
human endometrial tissue.  
Compared to the human tissue, cell surface markers for stem/progenitor cells in the 
mouse endometrium are less well characterised. Putative MSCs in the mouse 
endometrium have largely been identified using the LRC method in both the stromal 
and epithelial cell compartment (Chan and Gargett 2006b, Cervelló et al. 2007, Chan, 
Kaitu'u-Lino and Gargett 2012, Kaitu'u-Lino et al. 2012, Cao et al. 2015). LRCs have 
been further characterised by IHC and confirmed to express stem cell markers Oct4 
and c-kit (Cervelló et al. 2007) as well as CD44, CD90, Pdgfrβ, CD146 and Sall4 
(Chan and Gargett 2006b). Chan and Gargett, (2006) also described LRC as having a 
close association with CD31 expressing endothelial cells (IHC) in the stroma with their 
expression of α-SMA (IHC) indicative of a vascular smooth muscle cell or pericyte 
phenotype. The perivascular location of some of the stromal LRCs (Schwab and 
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Gargett 2007, Kaitu'u-Lino et al. 2012) parallels results from human eMSCs and to be 
consistent with a perivascular phenotype in mouse as well as human. 
Pericytes are supportive cells that sit in close contact with endothelial cells of blood 
vessels in most tissues and have functions in regulating blood flow, perfusion of fluids, 
cells and proteins between capillaries and tissues, and supporting vascular 
development (Mills et al. 2013). It has been suggested that pericytes may also represent 
an adult tissue MSC as they are clonogenic and capable of giving rise to other types of 
mesenchymal cells including chondrocytes, adipocytes, osteoblasts and phagocytes 
following in vitro culture (Mills et al. 2013, Murray et al. 2014). In support of this 
hypothesis, pericytes express Pdgfrβ and CD146 as well as a number of other markers 
such as Rgs5, Acta2, Angpt2, Igf, Ngf and Pdgf also identified in stem and progenitor 
cells (Spitzer et al. 2012). It has been suggested that endometrial MSCs may be similar 
to vSMC, pericytes or endothelial cells since MSC progeny appear to share common 
markers with all these cell types (Schwab and Gargett 2007) however, further studies 
are needed to confirm their identity and function. 
4.1.6 Summary 
The endometrium experiences cyclical episodes of rapid repair and regeneration. A 
population of stem/progenitor cells has been identified in human endometrium as 
clonogenic cells and in mouse endometrium as LRC. These populations which have 
similar characteristics to MSCs in other tissues and can be further identified by 
expression of Pdgfrβ and CD146. Endometrial MSCs may have future beneficial 
implications when used in cell-based therapies for gynaecological pathologies and in 
regenerative medicine. Recently it has been proposed that MSCs in the human 
endometrium may be perivascular pericytes however further studies are needed to 
validate this identity. Various markers have been used to identify stem/progenitor cells 
in the endometria of women and mice and although SUSD2 (W5C5) has been 
identified as a specific marker to detect stromal progenitor cells in human 
endometrium (Masuda et al. 2012), to date no single marker has been found that 
exclusively identifies putative progenitor cells in the mouse endometrium. 
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4.2 Aim 
To identify and characterise a population of mesenchymal stem/progenitor cells in the 
endometrium using the Pdgfrβ-BAC- eGFP transgenic mouse. 
4.3 Experimental Approach 
4.3.1 Transgenic mouse lines 
The results in this chapter were generated using the Pdgfrβ-BAC-eGFP reporter mouse 
line as detailed in Section 2.1.1.1: in these mice GFP reporter protein is expressed 
under control of the Pdgfrβ gene promoter element. In mice Pdgfrβ is expressed by 
mesenchymal cells therefore using these mice facilitates identification and isolation of 
mesenchymal cells. 
Further results were gathered using the NG2-CreERTM BAC tamoxifen-inducible 
mouse line as detailed in section 2.1.1.5. In this line Cre-recombinase is expressed in 
NG2-expressing cells: results presented in Chapter 4 using the Pdgfrβ-BAC-eGFP 
reporter mouse line, identified NG2+ cells as GFPbright pericytes. When crossed with 
the Ai14 reporter mouse line (Section 2.1.1.6), TdTomato is expressed in NG2 
expressing cells and therefore this mouse allows pericytes to be identified by 
expression of TdTomato. 
4.3.2 Tissue processing and Immunohistochemistry 
Uterine tissue samples from Pdgfrβ-BAC-eGFP transgenic mice were briefly fixed in 
4% PFA for 2 hours at 4°C, rinsed in PBS and stored overnight in 18% sucrose at 4°C 
before being embedded in OCT medium and stored at -80°C, as described in Section 
2.3. H&E staining was carried out as in Section 2.4.1 and IHC performed following 
the protocols described in Section 2.4.3. Antibodies used for IHC in this Chapter are 
outlined in Table 4-1. Images were obtained by both brightfield and confocal 
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Table 4-1. Antibodies used to interrogate mesenchymal progenitor cells in Pdgfrβ-
BAC-eGFP mouse endometrial tissue 















Polyclonal Rabbit anti-NG2 
(Cspg4) 
Abcam, ab12905 1/600 Goat 
Monoclonal mouse anti-
αSMA 
Sigma, A-2547 1/10K Horse 
Polyclonal rabbit anti-CD31 Abcam, ab28364 (1mg/ml) 1/500 Goat 
Polyclonal rabbit anti-
EpCAM 
Abcam, ab71916 (1mg/ml) 1/2000 Goat 
 
4.3.3 Flow Cytometry and FACS 
Flow cytometry analysis was used to interrogate the endometrial mesenchyme using 
protocols detailed in Section 2.5 and flow cytometry antibodies outlined in Table 4-2. 
FACS was used to isolate specific mesenchymal cell populations from the endometrial 
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Table 4-2. Flow cytometry antibody panel designed to interrogate mesenchymal cell 
populations in uterine tissue 































650nm 660nm 1/100 
AF488 anti-mouse 
NG2 
Merck, AB5320A4 495nm 519nm 1/100 




650nm 660nm 1/200 
 
4.3.4 Cytospin and Immunocytochemistry  
A cytospin was carried out on isolated mesenchymal cells, outlined in Section 2.5.4.1 
and immunocytochemical staining performed (Section 2.5.4.2) to analyse expression 
of key cell surface markers used in the isolation method. 
4.3.5 RNA extraction methods and cDNA synthesis 
Two RNA extraction methods were used on isolated cell samples: the Qiagen RNease 
mini kit outlined in Section 2.6.1; and the SimplyRNA Cells Maxwell 16 LEV kit 
outlined in Section 2.6.3. The resulting yield of RNA from each method was compared 
using the LabChip GX Touch Nucleic Acid Analyser (Section 2.6.4) and the RNA 
Pico Sensitivity Assay (Section 2.6.4.1). cDNA samples for qPCR were synthesised 
from RNA samples using the superscript VILO cDNA Synthesis kit (Section 2.7.1) 
while cDNA samples for NGS were synthesised using the NuGEN Ovation RNA-Seq 
System V2 (Section 2.7.2). 
4.3.6 Quantitative real time PCR 
Quantitative real time PCR (qPCR) was used to determine mRNA expression of 
specific genes used to identify mesenchymal progenitor cells as detailed in Section 2.8 
using primers detailed in Table 2-17. Quantification of gene expression and statistical 
analysis was performed as outlined in Section 2.8.3. 
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4.3.7 Next Generation Sequencing 
Mesenchymal cells were isolated from Pdgfrβ-BAC-eGFP uterine tissues. RNA 
extraction and cDNA synthesis was carried out as described in Section 2.9.1. Samples 
were sent to Edinburgh Genomics for sequencing on the HiSeq 4000 75PE platform 
according to standard protocols at the facility (Section 2.9.2). Bioinformatic analysis 
of the NGS data was largely carried out by Jonathan Manning at the Edinburgh 
Genomics facility, as described in Section 2.9.3. Validation of the results was achieved 
using qPCR on an independent set of cell samples generated from naïve Pdgfrβ-BAC-
eGFP endometrial tissues (Section 2.9.4). 
 
4.4 Results 
4.4.1 Validation of Pdgfrβ-BAC-eGFP transgenic mouse line by 
immunohistochemistry  
In the transgenic Pdgfrβ-BAC-eGFP reporter mouse, eGFP (green fluorescent protein) 
is expressed under control of the Pdgfrβ gene promoter element. In previous studies 
Pdgfrβ has been identified as a putative progenitor cell marker in human endometrium 
(Schwab and Gargett 2007, Spitzer et al. 2012, Bhartiya 2016) therefore the Pdgfrβ-
BAC-eGFP reporter mouse was considered an ideal choice for these studies to identify 
putative progenitor cell populations and their distribution in mouse endometrial tissue.  
4.4.1.1 Expression of eGFP reporter protein in Pdgfrβ-BAC-eGFP endometrial 
tissue 
In uterine tissues from cycling Pdgfrβ-BAC-eGFP transgenic mice (n=8), GFP was 
expressed exclusively in stromal cells distributed throughout all layers of the 
endometrium and was absent from epithelial cells (glandular and luminal) and 
myometrial smooth muscle cells of the myometrium (Figure 4-2 (A-D). Based on the 
intensity of the GFP there appeared to be two subpopulations: GFPdim cells dispersed 
throughout the stromal compartment and GFPbright cells located in more specific 
clusters (Figure 4-2, yellow versus white arrows).  
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Figure 4-2. Expression of GFP in naïve mouse endometrium from Pdgfrβ-BAC-eGFP 
adult females. (A-D) IHC reveals that GFP is expressed exclusively by cells of the stromal 
compartment (S) and not expressed by cells of the epithelial compartment be that glandular or 
luminal (E and G respectively) in the Pdgfrβ-BAC-eGFP transgenic uterus. Epithelium (E, 
yellow dashed line), Glands (G), Stroma (S), and Myometrium (M), stroma-myometrial 
junction (white dashed line). Two GFP+ cell populations are apparent: GFPdim cells dispersed 
throughout the stroma (yellow arrows) and GFPbright cells which appear to be more specifically 
clustered (white arrows) (representative image, n=8, Scale bar 20µm).  
 
4.4.1.2 Expression of Pdgfrβ native protein in Pdgfrβ-BAC-eGFP endometrial 
tissue 
As an additional validation of the Pdgfrβ-BAC-eGFP transgenic line a double IHC 
stain was used to detect co-localisation of GFP and endogenous Pdgfrβ expression in 
endometrial tissues from adult cycling females. As above, two distinct subpopulations 
of GFP+ cells were apparent: GFPdim and GFPbright cells. Pdgfrβ was detected 
exclusively in cells of the stromal compartment although in contrast to GFP there was 
no apparent difference in intensity of Pdgfrβ detected by the antibody in different 
stromal subpopulations. As there was 100% co-incidence between expression of GFP 
and Pdgfrβ in cells of the stromal compartment it was concluded GFP is acting as a 
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reliable reporter for Pdgfrβ gene promoter activity and gene expression in the Pdgfrβ-
BAC-eGFP transgenic line (Figure 4-3).  
 
 
Figure 4-3. Expression of GFP and Pdgfrβ in naive Pdgfrβ-BAC-eGFP endometrial 
tissue. Immunohistochemistry revealed that the expression of the reporter GFP (green) 
exclusively identifies cells that express Pdgfrβ (red) in cycling Pdgfrβ-BAC-eGFP transgenic 
mouse uterus. Notably the GFP/Pdgfrβ double positive cells (yellow) are located throughout 
the endometrial stroma (S) but not detected in epithelial cells of the glands (G) in adult cycling 
uterine tissues. There is not an apparent difference in the expression of Pdgfrβ between GFPdim 
cells (yellow arrows) and GFPbright cells (white arrows) (representative image, n=8, Scale bar 
50µm). 
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4.4.2 Characterisation of mesenchymal cells in Pdgfrβ-BAC-eGFP 
transgenic endometrial tissue   
4.4.2.1 Characterisation of mesenchymal cells based on cell surface marker 
expression by IHC 
Having established that all GFP+ cells were Pdgfrβ+, IHC with antibodies chosen to 
detect a range of cell marker proteins was used to characterise the two subpopulations 
of stromal GFP+ cells in Pdgfrβ-BAC-eGFP endometrial tissue. The following 
markers were used based on previous reports of their patterns of expression: CD146 
(Mcam) expressed by endothelial cells and smooth muscle cells; NG2 (Cspg4) 
expressed by smooth muscle cells and pericytes; αSMA (Acta2) expressed by smooth 
muscle cells; CD31 (Pecam-1) expressed by endothelial cells; and EpCAM (CD326) 
expressed by epithelial cells. All GFP+ cells were found to be CD31- and EpCAM- 
distinguishing them from both endothelial and epithelial cells respectively (Figure 4-
4 (E-F)). GFPdim cells were confirmed as Pdgfrβ+, CD146-, NG2- and aSMA- 
indicative of a stromal fibroblast phenotype while GFPbright cells were found to be 
Pdgfrβ+, CD146+, NG2+ and aSMA+ a phenotype consistent with that of putative 
pericytes (Figure 4-4 (A-D)). 




Figure 4-4. Characterisation of GFPbright cells and GFPdim cells in Pdgfrβ-BAC-eGFP uterine tissue. (A-D) Immunofluorescent staining reveals 
GFPbright cells (white arrows) to be Pdgfrβ+, CD146+, aSMA+, and NG2+ consistent with a perivascular pericyte phenotype while GFPdim cells are 
Pdgfrβ+, CD146-, aSMA- and NG2- indicative of a stromal fibroblast phenotype. (E-F) All GFP+ cells are CD31- and EpCAM- distinguishing them from 
endothelial and epithelial cells respectively (representative images, n=8, Scale bars 50µm).  
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4.4.2.2 Investigation of endometrial mesenchymal cell types in the perivascular 
niche 
To complement and extend these findings, GFP expression in cells associated with 
endometrial vasculature was compared to that of the endothelial cell marker CD31 and 
the putative pericyte marker CD146 using IHC. Notably, GFPbright cells were revealed 
to be CD146+CD31- and were located in close proximity to CD31+CD146+ 
endothelial cells. This confirmed their perivascular location and further supported their 
identity as pericytes which reside in the perivascular niche (Figure 4-5, white arrows). 
Figure 4-5. Expression of blood vessel markers in association with GFP positive cells in 
Pdgfrβ-BAC-eGFP uterine tissue. Immunohistochemistry using CD31 as an endothelial cell 
marker, CD146 as a putative pericyte marker and Pdgfrβ as a mesenchymal cell marker reveals 
(A) CD31+CD146+ endothelial cells surrounded by CD31-CD146+ cells (white arrows), (B) 
CD31+GFP- endothelial cells surrounded by CD31-GFPbright cells (white arrows) and (C) 
CD146+GFP- endothelial cells surrounded by CD146+GFPbright cells (white arrow) 
(representative images, n=8, Scale bars 50µm). 
 
Transmission Electron Microscopy (TEM) was used to look at higher magnifications 
to examine the ultrastructure of endometrial blood vessels. Blood vessels were 
identified by the presence of red blood cells in the vessel lumen (Figure 4-6 (A-A’)). 
In the mouse uterine tissues the endometrial blood vessels were found to be composed 
of endothelial cells that were closely surrounded by perivascular cells that were 
embedded within a collagenous basement membrane (Figure 4-6), a hallmark of 
perivascular pericytes (Bergers and Song 2005). 
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Figure 4-6. Transmission Electron Microscopy (TEM) of naïve murine endometrial 
tissue. (A) Blood vessel structures can be located in endometrial stromal tissue by the presence 
of red blood cells which appear as easily identifiable black shapes in the section. (A’) Blood 
vessels are composed of endothelial cells (blue overlay) and have red blood cells present in 
the vessel lumen (red overlay) with perivascular cells (green overlay) surrounding the 
endothelial cells and perivascular fibroblasts (orange overlay) on close association. (B-C) 
Perivascular cells are located within the collagenous basement membrane of the blood vessel 
(representative images, n=4, Scale bars 5µm). 
 
4.4.2.3 Semi-quantitative analysis of putative pericytes in mouse endometrial 
tissue by IHC 
Having confirmed that Pdgfrβ was expressed by both stromal fibroblasts (GFPdim) and 
perivascular pericytes (GFPbright) while CD146 was expressed by both pericytes and 
endothelial cells (CD31+ cells), it was clear that neither could be used in isolation to 
identify pericytes. Characterisation by IHC revealed that NG2 was expressed by 
GFPbright cells (Figure 4-5) and further IHC revealed that NG2+ cells were located in 
close association with blood vessels, composed of CD31+ endothelial cells (Figure 4-
7).  
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Figure 4-7 IHC analysis of CD31 and NG2 expressing cells in endometrial tissue. (A-D) 
CD31+ endothelial cells (red) surrounded by NG2+ pericytes (green; white arrows) located in 
various regions of the endometrial stromal compartment. Stroma (S), Epithelium (E), Lumen 
(L), Myometrium, (M) and Glands (G) (representative images, n=8, scale bar = 50µm). 
 
To analyse the relationship between pericytes and endothelial cells, cell counting was 
performed on immunostained sections of mouse uterus to determine the numbers of 
both CD31+ endothelial cells and NG2+ pericytes per field of view (FOV) in uterine 
tissue sections. Cells were only counted if there was a visible nucleus associated with 
positive staining, and distinguished by staining for CD31 and NG2, as outlined in 
Figure 4-8 (A). In naïve mouse endometrium there was significantly more pericytes 
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per FOV (38±1.36) than endothelial cells (28.5±1.43) (paired t-test, p<0.0001) (Figure 
4-8 (B), resulting in a pericyte:endothelial cell ratio of 1.25±0.02 (Figure 4-7 (C)). 
Notably all the NG2+ pericytes were found in a perivascular location in close 
associated to CD31+ endothelial cells (100±0.24%) (Figure 4-8 (D)). 
 
Figure 4-8 Analysis of pericytes and endothelial cells in endometrial tissue. (A) Method 
employed to count pericytes and endothelial cells: red ‘N’ represents the nucleus of a CD31+ 
cell; green ‘N’ represents the nucleus of an NG2+ cell; numbers are assigned to blood vessel 
structures identified through presence of CD31+ staining. Uterine tissues were collected from 
four naïve mice (n=4) and two tissue sections were analysed per mouse (n=8). In each tissue 
section, two fields of view (FOV) were imaged (n=16). (B) CD31+ cells (red N) and NG2+ 
cells (green N) were counted and presented as the number of cells per FOV (n=4, paired t-test, 
p<0.001). (C) The ratio of pericytes: endothelial cells and (D) the proportion of NG2+ 
pericytes associated with blood vessel structures (determined by positive CD31 staining) was 
calculated for each FOV (n=4, paired t-test, p<0.0001). 
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4.4.2.4 Analysis of GFP+ subpopulations in Pdgfrβ-BAC-eGFP transgenic 
endometrial tissue by Flow cytometry 
To assess the relative proportions of each GFP+ subpopulations to the stromal 
compartment, Pdgfrβ-BAC-eGFP uterine tissues were digested and flow cytometry 
performed on single cell suspensions. Flow cytometry analysis was carried out using 
analytical gates detailed in Figure 4-9.  
The unstained control was a single cell suspension generated from age-matched naïve 
C57BL/6 mouse (GFP-) which was not incubated with any flow cytometry antibodies 
therefore allowing for the detection of the negative population when assessing the 
signal for each fluorochrome. The stained control was a single cell suspension 
generated from a Pdgfrβ-BAC-eGFP mouse (GFP+) incubated with all the flow 
cytometry antibodies to assess the positive population of each and any overlap in 
signal. Cell suspensions were also prepared for single antibody stains to analyse the 
positive signal of each fluorochrome. The‘fluorescence-minus-one’ (FMO) controls 
contained all the antibodies in a given panel except one which ensured that any spread 
of the fluorochromes into the channel of interest was properly identified, allowing for 
the true identification of the negative population. A representation of the setup of flow 
cytometry controls can be found in Chapter 2, Section 2.5.2, Table 2-10. 
Following the establishment of gates from the single and FMO analyses to specifically 
analyse mesenchymal cells in uterine tissue, a gate was set to exclude both CD31+ and 
CD45+ cells therefore excluding endothelial and immune cells respectively (Figure 4-
9 B lower right). GFP expression was used to identify mesenchymal cells (Figure 4-9 
(B,C,D)) and to compare this to the expression of CD146 and EpCAM to determine 
the proportions of cells with pericyte and epithelial cell phenotypes (Figure 4-9 (C, D).  
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Figure 4-9. Parameters employed to draw analytical gates for flow cytometry analysis of 
mouse endometrial tissue. A gating strategy was devised to exclude and/or analyse cell 
populations in naïve Pdgfrβ-BAC-eGFP uterine tissues based on unstained, fully stained, 
singlestained and ‘fluorescence minus one’ (FMO) controls. (A) Antibodies against CD31 and 
CD45 had similar fluorophores and were used to exclude endothelial cells and immune cells 
from the analysis. To capture the CD31-CD45- cell population a gate was drawn excluding 
positive signals derived from the single stains, FMOs and fully stained controls. Analytical 
gates to capture (B) GFP+ cells, (C) EpCAM+ cells and (D) CD146+ cells were determined 
against unstained, fully stained, single stained and FMO controls respective to each marker 
(representative plots, n=3). A full set of controls was prepared for each flow cytometry analysis 
undertaken in this thesis to ensure accurate gating. 
 
To complement and extend IHC analysis of GFP+ uterine tissues with respect to 
CD146 and EpCAM, further flow cytometry analysis was undertaken. A sequential 
gating strategy (Figure 4-10 (A)) was employed to target live and single cells only. 
Specifically, an ‘All cells’ gate was drawn to remove data points with low side and 
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forward scatter (SSC-A and FSC-A respectively) identified as cell debris (Figure 4-10 
(A)). A ‘Single cell’ gate was drawn to capture data points representing single entities 
and remove potential doublets (Low FSC-H high FSC-A) (Figure 4-10 (B)) and the 
DAPI signal was used to exclude dead cells (DAPI+) from the data (Figure 4-10 (C)). 
To further exclude endothelial cells and immune cells from the analysis, a gate was set 
to capture data points that were both CD31- and CD45- respectively. The antibodies 
for these two proteins expressed a similar fluorochrome therefore used as an exclusion 
signal (Figure 4-9 (A) and 4-10 (D)). To analyse mesenchymal cells within the 
remaining dataset, the expression of GFP was analysed against SSC-A: based on GFP 
intensity alone two subpopulations of cells were detected: GFPdim and GFPbright cells 
(Figure 4-10 (E)), confirming IHC results described previously. Further analysis of the 
relative expression of CD146 by GFP+ cell populations confirmed that GFPdimcells 
were CD146- while GFPbright cells were CD146+ (Figure 4-10 (F)) identifying them as 
stromal fibroblasts and pericytes respectively. Plotting these results in histograms 
displayed the difference in the intensity of GFP expression by mesenchymal sub-
populations (Figure 4-10 (G)) and confirmed that GFPbright cells expressed CD146 
while GFPdim cells did not express CD146 (Figure 4-10 (H)). Plots in Figure 4-9 (I) 
and (J) summarise the data showing that in uterine tissue the GFPbrightCD146+ cell 
population accounts for a smaller proportion of total GFP+ mesenchymal cells than 
the GFPdimCD146- cell population. 
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Figure 4-10. Flow cytometry analysis and phenotyping of GFP+ cell populations in naïve 
Pdgfrβ-BAC-eGFP endometrial tissue. Sequential gating strategy employed to analyse 
GFP/PDGFRβ+ cell populations in mouse uterine tissue: (A) All cells > (B) Single cells > (C) 
Live cells > (D) CD31-CD45- cells > (E) GFP+ cells > (F) CD146-/+ cells, percentages 
displayed are frequencies of the parent gate. All gates drawn using single stained, unstained 
and ‘fluorescence minus one’ (FMO) control samples (Figure 4-9) (representative plots, n=8). 
(G) Analysis of GFP expression by GFP+, GFPdim and GFPbright cells in Pdgfrβ-BAC-eGFP 
uterus (blue) when compared to C57Bl/6 control uterus (red). (H) Analysis of CD146 
expression by GFP+, GFPdim and GFPbright cells in Pdgfrβ-BAC-eGFP uterus (blue) when 
compared to C57Bl/6 control uterus (red). (I) Summary of GFP expression by GFPdim and 
GFPbright cells in Pdgfrβ-BAC-eGFP uterus. (J) Summary of CD146 expression by GFPdim and 
GFPbright cells in Pdgfrβ-BAC-eGFP uterus (representative plots, n=8). 
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Following this detailed flow cytometry analysis, quantification of the specific cell 
populations from multiple tissue isolations (8 naïve mice; pooled uterine horns) 
revealed that GFPbright cells accounted for 17.22±1.26% of the GFP+ mesenchymal 
cell population while the remaining 82.78±1.29% were GFPdim cells (Figure 4-11 (A)). 
When results were reanalysed as a frequency of live cells in the tissue, GFPbright cells 
accounted for 8.33±0.36% while GFPdim cells accounted for 40.05±2.25% (Figure 4-
11 (B)).  
 
 
Figure 4-11. Analysis of mesenchymal cell populations in naïve Pdgfrβ-BAC-eGFP 
endometrial tissue by flow cytometry. Uterine tissues were collected from naïve Pdgrβ-
BAC-eGFP mice (n=8), digested and incubated with flow cytometry antibodies. Based on the 
gating strategy outlined in Figure 4-10, the proportion of GFP+ subpopulations was calculated. 
(A) Pie chart analyssi of the relative proportions of GFPdim and GFPbright cell populations 
determined as a frequency of total GFP+ mesenchymal cells. (B) Relative proportion of GFPdim 
and GFPbright cell populations calculated as a frequency of live single cells in naïve mouse 
endometrium. Data representative of n=8 mice. 
 
4.4.3 Isolation and characterisation of GFPdim and GFPbright cells 
from Pdgfrβ-BAC-eGFP transgenic endometrial tissue  
4.4.3.1 Characterisation of GFP+ subpopulations isolated by fluorescent 
activated cell sorting (FACS) and cytospin 
Following the detailed analysis by flow cytometry that identified GFPdim and GFPbright 
cell populations (stromal fibroblasts and pericytes respectively) the same previously 
Chapter 4: Identification and characterisation of a population of putative 
mesenchymal progenitor cells in the mouse endometrium 224 
 
validated parameters (Figures 4-9, 4-10) were used to isolate GFP+ subpopulations 
using a Fluorescence Activated Cell Sorter (FACS), based on their relative expression 
of GFP and CD146. To confirm the identity of the isolated cells, a cytospin was 
performed and immunocytochemistry used to stain for GFP, Pdgfrβ and CD146 using 
an independent set of antibodies to those used for Flow and FACS. The cytospins 
confirmed that the GFPbright cells were GFP+/Pdgfrβ+/CD146+ while GFPdim cells 
were GFP+/Pdgfrβ-/CD146- in line with previous results (Figure 4-12 (B)). The 
appearance of the two cell populations was also distinct with the GFPdim cells adopting 
a clear fibroblastic phenotype (Figure 4-12 (B) lower panels). 
 
 
Figure 4-12. Isolation and characterisation of GFPdim stromal fibroblasts and GFPbright 
pericytes from naive Pdgfrβ-BAC-eGFP endometrial tissue. (A) GFPdim and GFPbright cells 
can be isolated from adult Pdgfrβ-BAC-eGFP mouse uterus (Immunohistochemistry, scale bar 
50µm) by a fluorescence activated cell sorter (FACS) based on intensity of GFP expression. 
(B) Cytospin and IHC on isolated cells confirms that GFPbright cells are GFP+Pdgfrβ+CD146+ 
while GFPdim cells are GFP+Pdgfrβ+CD146-, as determined with an independent set of 
antibodies (n=3).  
 
4.4.3.2 Optimisation of techniques for RNA extraction from isolated cells 
RNA extraction was performed using two different techniques to identify the optimal 
method for a small number of input cells (<20,000): Qiagen RNeasy Mini Kit (manual) 
and Promega SimplyRNA Cells Maxwell® 16 LEV kit (automated) as described in 
Chapter 2: Sections 2.7.3 and 2.7.4. The concentration (ng/μl) and integrity (RIN 
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score) of the RNA samples were analysed by LabChip technology (Chapter 2: Section 
2.7.5) to compare the efficiency of each technique. The RNA yield from both GFPdim 
cells (n=4) and GFPbright cells (n=4) was significantly more with the automated method 
when compared to the manual method of RNA extraction (GFPdim cells: 14.05±6.15 
ng/µl versus 2.65±0.36 ng/µl, unpaired t-test, p=0.02; GFPbright cells: 4.07±0.51 ng/µl 
versus 2.12±0.31 ng/µl, unpaired t-test, p=0.006) (Figure 4-13 (A)). When analysing 
RNA yield against input cell number, there was a positive correlation (factor) between 
the two parameters and the automated method yielded more RNA that the manual 
method (Figure 4-13 (B)). All GFPdim samples exceeded the minimum RIN 
requirement (RIN >7) regardless of the RNA extraction method whereas only GFPbright 
samples where the RNA concentration was >4ng/µl had a suitable RIN score for 
further analysis (Figure 4-13 (C)).  
Based on data obtained it was concluded that the automated system using the 
SimplyRNA Cells Maxwell® 16 LEV kit with freshly isolated cells was the optimal 
way to extract RNA from the isolated cell populations that was of sufficient quality 
for further downstream analysis (Figure 4-13). 
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Figure 4-13. Optimisation of RNA extraction techniques. (A) Comparison of RNA yield 
from GFPdim and GFPbright cells isolated from uterine tissues of naïve Pdgfrβ-BAC-eGFP mice 
(n=4) after manual or automated RNA extraction (Paired t-test, *p<0.05, **p<0.01). (B) RNA 
yield plotted against starting cell number of both GFPdim and GFPbright cells, comparing manual 
and automated RNA extraction methods. (C) RNA yield plotted against RNA Integrity 
Number (RIN score) for both GFPdim and GFPbright cells, comparing manual and automated 
RNA extraction methods, dotted line represents acceptable cut-off score (RIN=7). 
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4.4.3.3 Analysis of mRNA expression by isolated cells using qPCR 
To further investigate the molecular phenotype of GFP+ subpopulations qPCR was 
used to analyse mRNA expression of the key cell markers Pdgfrβ, Mcam (CD146), 
Acta2 (αSMA) and Cspg4 (NG2) in both GFPdim and GFPbright cells isolated from 
endometrial tissue collected from naïve transgenic Pdgfrβ-BAC-eGFP mice (n=4). As 
detailed in Figure 4-14 (A) both GFPbright cells and GFPdim cells expressed Pdgfrβ as 
expected, however GFPbright cells expressed significantly higher mRNA levels 
(3.65±0.16 versus 1.51±0.19, p=0.0005). qPCR further revealed that GFPbright cells 
expressed significantly higher mRNA levels of Mcam (CD146) than GFPdim cells 
(6.14±0.37 versus 0.13±0.01, p=0.0005) (Figure 4-14 (B)). This difference between 
GFPbright and GFPdim cells was also apparent for the expression on Acta2 (αSMA) 
(5.89±0.46 versus 0.01±0.00, p=0.0011) (Figure 4-14 (C)) and Cspg4 (NG2) 
(5.25±0.50 versus 0.01±0.00, p=0.0019) (Figure 4-14 (D)). It was notable that in this 
analysis Pdgfrβ mRNA was significantly higher in the isolated GFPbright cells a finding 
consistent with the intensity of the reporter protein which had not been detected by 
IHC using antibodies against the native protein on tissue sections (see Figure 4-3). 
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Figure 4-14. qPCR analysis of pericyte marker expression in GFPdim and GFPbright cells 
isolated from naïve Pdgfrβ-BAC-eGFP endometrial tissues by FACS. Expression of (A) 
Pdgfrβ (B) Mcam (CD146) (C) Acta2 (αSMA) (D) Cspg4 (NG2) in isolated GFPdim and 
GFPbright cells. GFPbright cells; n=4 expressed significantly higher mRNA levels of Pdgfrβ, 
Mcam (CD146), Acta2 (αSMA) and Cspg4 (NG2) than GFPdim cells; n=4 (paired t-test, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
 
4.4.4 Profiling GFPdim and GFPbright cells from Pdgfrβ-BAC-eGFP 
endometrial tissue by next generation sequencing (NGS) 
4.4.4.1 RNA and cDNA sample preparation 
To generate a more comprehensive transcriptomic profile of endometrial pericytes, 
NGS was undertaken on GFP+ mesenchymal cells isolated from normal adult cycling 
Pdgfrβ-BAC-eGFP mice (naïve). The concentration of RNA extracted from GFPbright 
pericytes was too low for downstream sequencing applications due to a low numer of 
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sorted cells. Therefore, total GFP+ cells (GFPdim stromal fibroblasts and GFPbright 
pericytes combined) and GFPdim cells (stromal fibroblasts alone) were chosen as the 
comparative samples from which the profile of GFPbright pericytes could be inferred. 
For presentation of the following results these two samples are labelled as ‘naïve’ and 
‘stromal’, with only the former containing RNA from pericytes. 
RNA concentration and quality were analysed by LabChip GX Touch technique as 
described previously (Chapter 2: Section 2.6.4). The mean RNA concentration of the 
naive samples was 12.34±1.651 ng/µl while the mean RNA concentration of the 
stromal samples was 7.125±2.42 ng/µl and all samples had an RNA Integrity Number 
(RIN) greater than 8.7. As concentrations did not meet the minimum requirements 
requested by Edinburgh Genomics (>20ng/µl) a cDNA amplification step was 
performed as outlined previously (Chapter 2: Section 2.7.2). Following this the mean 
cDNA concentration of the naïve samples was 123.1±5.342 ng/µl and the mean cDNA 
concentration of the stromal samples was 137.9± 9.195 ng/µl and all samples had an 
A260/280 ratio greater than 1.8 (Figure 4-15).  
4.4.4.2 TruSeq mRNA Sequencing 
All samples were confirmed to meet the minimum criteria for both concentration and 
quality before being sent to Edinburgh Genomics for RNA sequencing which was 
conducted by staff within the Genomics Facility (http://genomics.ed.ac.uk/). TruSeq 
DNA Nano gel free libraries (350bp inserts) were prepared from each of the cDNA 
samples and sequence data was generated on the HiSeq 4000 75PE platform to yield 
at least 290M + 290M reads. 
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Figure 4-15.  LabChip GX Touch analysis of RNA/cDNA quantity and quality for 
samples generated for RNA sequencing by Edinburgh Genomics. (A) RNA concentrations 
(ng/ul) of naive and stromal samples. (B) RIN score of the naive and stromal samples, dashed 
line represents the minimum score required by Edinburgh Genomics (8.7). (C) cDNA 
concentrations (ng/µl) of naive and stromal samples after performing cDNA amplification 
using the NuGEN Ovation V2 system. (D) A260/A280 ratios of the naive and stromal samples, 
dashed line represents the minimum ratio required by Edinburgh Genomics (1.8). (E) LabChip 
GX touch read out gel results for the naïve and stromal (stro) samples: red band represents 
18S, green band represents 28s and the blue band represents 5S. 
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4.4.4.3 Bioinformatic data handling  
Initial bioinformatic analysis was performed by Jonathan Manning at Edinburgh 
Genomics as described in Chapter 2: Section 2.9.3). In brief, reads were trimmed using 
Cutadept version cutadept-1.9.dev21 at the 3’ end using a quality threshold of 30 and 
for adaptor sequences of the NuGen Ovation V2 kit. Reads were required to have a 
minimum length of 50. The reference used for mapping was the Mus musculus genome 
from Ensembl, assembly GRCm38, annotation version 84. Reads were aligned to the 
reference genome using STAR2 version 2.5.2b specifying paired-end reads. Reads 
were assigned to exon features grouped by gene ID in the reference genome using 
‘featureCounts‘3. Strandness was set to ‘unstranded’ and a minimum alignment 
quality of 10 was specified. Gene names and other fields were derived from input 
annotation and added to the counts matrix. The raw counts table was filtered to remove 
rows consisting predominantly of near-zero counts, filtering on counts per million 
(CPM) to avoid artefacts due to library depth. A summary of key statistics associated 
with read pair mapping and counting supplied by Edinburgh Genomics can be seen in 
Table 4-3. 
 
Table 4-3. Summary of key statistics associated with read pair mapping and counting. 
Read Mapping 
Total read pairs 28.9-65.2M  
Read pairs after trimming 26.8-60.7M (90.7 – 94.1%) 
Mapped trimmed read pairs 20.7-51.9M (73.2 – 88.5%) 
Mapped read pairs assigned to features for 
counting 
5.5-18.4M (26.3 – 42.9%) 
Derived insert size 
Median 319bp-365bp  
SD 83bp-94bp  
Uncounted mapped reads 
Mapping quality below threshold (10) 0-0M (0 – 0%) 
Not uniquely mapped 0.6-1.4M (2.3 – 4.4%) 
Not mapped to feature 11.4-34.3M (50.8 – 69.5%) 
Ambiguous feature mapping 0.2-0.7M (0.9 – 2.2%) 
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4.4.4.4 Principle component analysis  
A principal component analysis (PCA) was undertaken by Jonathan Manning on 
normalised and filtered expression data to explore observed patterns with respect to 
experimental factors. The cumulative proportion of variance associated with each 
factor was used to study the level of structure in the data, assessed with an ANOVA 
test. As seen in Figure 4-16 (A), naïve (GFPdim plus GFPbright cells) and stromal 
(GFPdim cells only) samples clustered together on the PCA plot reflecting a degree of 
similarity in the transcriptomic profile of both sample groups which was expected 
given both contained stromal cells. However this preliminary analysis also hinted at 
the additional complexity of the naïve group as reflected in them clustering separately 
to the stromal samples which gave hope that comparisons would reveal differences in 
gene signatures (Figure 4-16 (A)).  
As an extension of this initial PCA analysis I also undertook additional analysis of the 
data using BioLayout Express 3D software; the correlation between sample groups 
was determined based on individual gene expression levels. Sample cluster graphs 
generated (both 2D and 3D) confirm a high correlation in the transcriptomic profiles 
of both groups (naïve and stromal) (Figure 4-16 (C)). 
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Figure 4-16. Exploratory analysis of the relatedness between the transcriptome of total 
GFP+ cells (naïve samples) and GFPdim cells (stromal samples).  (A) Principle component 
plot of the first and second components from PCA analysis using selected naive and stromal 
samples (n=7 and n=5 respectively). (B) Boxplots showing expression distributions among 
samples at different stages of pre-processing (log2 scale), using selected samples. Note that 
raw and filtered values are expressed in counts, while normalised values are in counts per 
million (CPM). Points outside whiskers are outliers at 1.5 x IQR where IQR is the inter-quartile 
range. (C) The correlation of RNASeq datasets between naïve and stromal samples was 
determined in BioLayout Express3D based on individual gene expression levels and a sample 
cluster graph generated (Pearson’s correlation of R>0.8 and intensity >1 of dataset with fold 
change >2 or <-2 and FDR <0.05). Nodes represent individual samples and edges represent 
the degree of correlation between them, colour/thickness is equivalent to how similar the 
samples are. (C) 3D sample cluster graph and (D) 2D sample cluster graph displaying a high 
correlation between the groups (naive n=6; stromal n=5). 
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4.4.4.5 Differential gene expression analysis 
Differential gene expression analysis was carried out with EdgeR4 (version 3.16.5) 
and the quasi-likelihood (QL) F-test using the contrast between naïve and stromal 
sample groups (Jonathan Manning, Edinburgh Genomics). The total numbers of 
differentially expressed genes are outlined in Table 4-4 according to the thresholds on 
minimum fold-change (2) and maximum false discovery rate (0.05).  
 
Table 4-4. Total numbers of differentially expressed genes between naïve and stromal 
sample groups 
Contrast  Upregulated Downregulated 
Naïve vs Stromal  143 11 
 
Gene expression data can also be visualised as a heatmap, fold change plot or a volcano 
plot and all of these were used to illustrate the 154 differentially expressed genes 
between samples (Figure 4-17 (A-C). In the fold change and volcano plots 
differentially regulated genes are identified as red dots (Figure 4-17 (B-C)). As the 
naïve sample group was composed of total GFP+ cells while the stromal sample group 
was composed of a subset of this, GFPdim cells, it was postulated that the 143 genes 
which appeared to be upregulated in the naïve samples could be attributed to GFPbright 
cells previously identified as putative pericytes. To confirm this hypothesis the 
expression data was further analysed to determine whether the candidate pericyte 
genes already identified in the GFPbright cells were present. Notably in further 
validation of the RNASeq analysis a clear increase in the mean CPM and LogFC of 
Mcam (CD146), Cspg4 (NG2), Acta2 (αSMA) and Pdgfrβ was confirmed in naïve 
compared to stromal samples (Figure 4-17 (D)). The top 100 most significantly 
upregulated genes in the naïve samples when compared to stromal samples are 
summarised in Appendix 1. 
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Figure 4-17. Differential gene expression analysis between the transcriptome of GFP+ 
cells (naïve samples) and GFPdim cells (stromal samples). (A) Heatmap showing the top 50 
most differentially expressed genes by false discovery rate (FDR <0.05) between the naïve 
and ntromal groups (11 upregulated genes and 143 downregulated genes in total). (B) Fold 
change and (C) volcano plot illustrating differential expression between groups naive and 
stromal as defined by group. Volcano plots illustrate log(2) fold change vs –log(10) false 
discovery rate. The horizontal dashed line represents the specified FDR threshold for 
significance (0.05), dotted lines in both plots represent the specified fold change threshold (2) 
in both the positive and negative directions. Points passing both thresholds are coloured red 
and are differentially expressed. (D) Table outlining the mean CPM and logFC of target genes 
previously used to identify and characterise endometrial pericytes, gene expression is validated 
in the differential gene set. 
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4.4.4.6 Gene ontology (GO) and Gene Set Enrichment Analysis (GSEA) 
Expression data was also analysed using BioLayout Express 3D software and a 
network map generated based on individual gene expression levels in naïve and 
stromal samples. Using this methodology three clusters of genes were identified: 
cluster 1 correlated to genes upregulated in naïve samples while cluster 2 and 3 
correlated to genes downregulated in naïve samples when compared to stromal cells 
alone (Figure 4-18 (A)). Cluster 1 therefore represented putative pericyte associated 
genes which was further analysed using the online Gene Ontology Consortium to find 
gene ontology (GO) terms that were over-represented in the differential gene 
expression data to identifying potential functions of this gene set. GO terms associated 
with the 143 putative pericyte associated genes included: extracellular matrix 
assembly; muscle contraction; regulation of blood vessel diameter; angiogenesis; 
blood vessel morphogenesis; negative regulation of immune system process; cell 
adhesion; negative regulation of signal transduction; tissue development; and 
regulation of cell proliferation. This preliminary analysis suggests these key biological 
processes can be attributed to putative pericytes in the mouse endometrium (Figure 4-
18 (B)).  
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Figure 4-18. Gene ontology analysis of putative pericyte genes. (A) Markov clustering 
(MCL, inflation= 1.7) was used to identify clusters related to putative pericyte genes (RNASeq 
results comparing naive’ and stromal’ samples). Clusters were analysed to create a network 
map where each node is a gene and each edge the similarity in expression levels between 
genes, colours of nodes represents membership in a cluster. (B) Gene ontology analysis of the 
putative pericyte genes identifies several key biological processes including blood vessel 
morphogenesis, regulation of blood vessel diameter, angiogenesis, muscle contraction, 
regulation of immune cell processes and cell adhesion attributed to pericytes (cluster 1). 
 
Further ontology analysis was performed using the Gene Set Enrichment Analysis 
(GSEA) software to identify pathways enriched by putative pericyte genes associated 
with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, Canonical 
Pathways (CP), Biological Process (BP) and Molecular Function (MF). Results of 
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these analyses are summarised in Figure 4-19 (A-D) respectively. A comparison 
between the various functions shared between these different pathway analyses 
highlighted some relevant pathways which included those associated with vasculature 
function such as vascular smooth muscle contraction (Enrichment score (ES): 2.04), 
complement and coagulation cascade (1.96), platelet homeostasis (2.28), blood vessel 
morphogenesis (2.20) and angiogenesis (2.14). Roles in cell adhesion were also 
highlighted including ECM receptor interaction (2.16), collagen binding (2.26), 
integrin binding (2.24), cell matrix adhesion (2.20), extracellular structure organisation 
(2.19), cell adhesion molecule binding (2.01) and ECM glycoproteins (2.07). 
Functions associated with regulation of the immune system were also noted including 
integrin cell surface interaction (2.30), regulation of leucocyte migration (2.17), 
regulation of inflammatory response (2.13), chemokine activity (1.89) and cytokine 
receptor interactions (1.58).  
In summary, simple gene ontology analysis revealed that RNAs over-represented in 
endometrial pericytes were likely to encode proteins associated with functions of blood 
vessel regulation, cell adhesion and immune responses all of which would appear 
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Figure 4-19. Gene Set 
Enrichment Analysis 
(GSEA) of putative 
pericyte genes. Gene 
ontology analysis as 
performed using the 
Gene Set Enrichment 
Analysis (GSEA) 
software. Analysis of 
pathways enriched by 
putative pericyte genes 
assessing (A) Kyoto 
Encyclopedia of Genes 
and Genomes (KEGG) 
pathways (B) Canonical 
Pathways (CP) (C) 
Biological Process (BP) 
and (D) Molecular 
Function (MF). 
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4.4.5 Validation of putative endometrial pericyte-associated gene 
signature 
To provide the platform for further validation of the gene analysis results a ranked 
gene list was generated using GSEA software to identify the most differentially 
expressed genes identified as putative pericyte genes (Figure 4-20). This method 
highlighted 37 genes which had been identified as differentially expressed in the 
analysis performed by Edinburgh Genomics (LogFC <-2 and FDR <0.05). Taken 
together these two forms of analysis provided a target list of putative pericyte-
associated genes to specifically identify pericytes in the endometrium (Figure 4-20).  
 
Figure 4-20. Ranked gene list generated using GSEA based on transcript abundance, as 
determined by CPM, in naïve samples (total GFP+ cells) and stromal samples (GFPdim 
subset) generated from Pdgfrβ-BAC-eGFP uterus. Genes, except for those identified with 
an *, were also found to be differentially expressed in the dataset by Edinburgh Genomics 
(logFC >2 and FDR <0.05). Genes highlighted in bold/red were chosen for validation studies. 
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4.4.5.1 Primary validation of putative endometrial pericyte-associate genes by 
qPCR 
Following identification of a short list of putative mouse endometrial pericyte RNAs 
validation using qPCR was performed using a new set of samples different to those 
sent to Edinburgh Genomics. Cells of interest were isolated using FACS and RNA 
extracted using the Promega SimplyRNA Cells Maxwell® 16 LEV kit as described in 
Chapter 2: Section 2.6.3. cDNA amplification and qPCR using the Taqman method 
was performed as described in Chapter 2: Section 2.7.1 and Section 2.8 respectively, 
using primers designed against ten genes detailed in Table 4-5. In this set of 
experiments genes were selected for validation based on the LogFC >2, FDR <0.05, 
mean CPM in naïve samples >5 and mean CPM in stromal samples <4. The availability 
of reliable primer sequences and antibodies was also used to narrow down genes from 
the 37 genes considered a priority for validation (Figure 4-20). 
Table 4-5. Putative pericyte genes identified through RNA sequencing to be more 
highly expressed in the naïve samples (total GFP+ cells) than the stromal samples 
(GFPdim subset) as determined by LogFC (>2) in mean counts per million (CPM). 







Actin, alpha 2 smooth 
muscle 
48.62480465 1.059755434 5.508426009 
Myh11 Myosin heavy 
polypeptide 11 
112.3382175 1.871607608 5.915143007 
Cspg4 
(NG2) 
Neural glial antigen 2 7.623761625 0.572417667 3.710645725 
Olfr78 Olfactory receptor 78 13.14954306 0 10.64494967 
Rgs4 Regulator of G-protein 
signalling 4 
30.59502037 1.376631718 4.463932917 
Rgs5 Regulator of G-protein 
signalling 5 
659.6824379 3.541085656 7.545825823 
Vcam1 Vascular cell adhesion 
molecule 1 





7.13375629 0.463077708 3.925662267 
Kitl Kit ligand 16.11201615 0.682810577 4.552554094 
Kcnj8 Potassium channel, 
subfamily J, member 8 
11.43342976 0.028477121 8.418738739 
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The first set of experiments assessed the expression of mRNAs encoded by these genes 
in the new set of samples, both naïve (GFPdim and GFPbright cells) and stromal (GFPdim 
subset) isolated from normal adult Pdgfrβ-BAC-eGFP endometrium (Figure 4-21). 
This validation set was identical to that of the samples sent to Edinburgh Genomics 
for RNA sequencing. qPCR results were analysed by comparing expression of key 
genes in naïve samples; n=4 to those of stromal samples; n=4, normalised to a 
reference gene (Actb).  
The expression of 6 of the 10 mRNAs were significantly upregulated in the naïve 
samples when compared to the stromal samples: Acta2 (0.25±0.003 versus 
0.0005±0.0002, p=0.0034), Myh11 (0.04±0.006 versus 0.0002±6.24E-006, p=0.0027), 
Cspg4 (0.53±0.13 versus 1.42E-005± 7.58E-006, p=0.0192), Rgs4 (0.53±0.13 versus 
0.018±0.009, p=0.0218), Rgs5 (0.15±0.02 versus 0.0002±9.15E-005, p=0.0007) and 
Kcnj8 (0.89±0.23 versus 0.002±0.001, p=0.025). There was a trend for the remaining 
4 mRNAs to be to be upregulated in naïve samples when compared to stromal samples 
however these values did not reach significance: Olfr78 (0.35±0.12 versus 
0.0001±1.7E-005), Vcam1 (0.18±0.03 versus 0.08±0.03), Mcam (0.16±0.05 versus 
0.001±0.001) and Kitl (0.03±0.01 versus 0.001±0.0002) (Figure 4-21). These results 
were in line with expectations based on the sequencing data and it was notably that 
only Vcam1 appeared to be expressed much above baseline in the stromal cells. 
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Figure 4-21. Expression of ten putative pericyte genes by qPCR in naïve (total GFP+ 
cells) and stromal samples (GFPdim subset) generated from Pdgfrβ-BAC-eGFP 
endometrial tissue as samples to validate NGS results. Acta2 (αSMA), Myh11, Cspg4 
(NG2), Rgs4, Rgs5 and Kcnj8 are all significantly upregulated in naïve samples; n=4 when 
compared to stromal samples; n=4. Olfr78, Vcam1, Mcam (CD146) and Kitl have a trend for 
a decrease although this did not reach significance (unpaired t-test,*p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001).  
 
4.4.5.2 Further analysis of primary validation of putative endometrial pericyte-
associate genes by qPCR 
Acta2, Myh11, Cspg4 (NG2), Olfr78, Rgs4, Rgs5, Vcam1, Mcam (CD146), Kitl and 
Kcnj8 were identified through RNA sequencing to be overexpressed in naive samples 
(total GFP+ cells) when compared to stromal samples (GFPdim cell subset) and 
therefore formed a putative pericyte-specific gene set (GFPbright cells). To provide 
additional independent verification of cell specific gene expression, qPCR was used to 
assess the expression of key genes in RNA from purified populations of FACS sorted 
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cells: GFPdim cells (stromal fibroblasts; n=3); GFPbright cells (pericytes, n=3); and 
CD31+ cells (endothelial cells, n=4) all of which were isolated from naive Pdgfrβ-
BAC-eGFP endometrial tissue. 
It was notable that all the putative pericyte associated genes identified using the 
different approaches described in the previous sections were confirmed as being 
expressed in purified GFPbright cells (pericytes). A key finding was that mRNAs 
encoded by Acta2 (αSMA) (3.7±1.6 mRNA (AU) normalised to  Actb; reference gene), 
Myh11 (3.25±0.76) and Cspg4 (NG2) (1.79±0.38) were expressed exclusively by the 
GFPbright cells (pericytes) and undetectable in RNA from either stromal fibroblasts 
(GFPdim) or endothelial cells. In contrast some expression of Olfr78 (0.15±0.03), Rgs4 
(0.36±0.08), Rgs5 (0.07±0.02) and Kcnj8 (0.36±0.08) was detected in the CD31+ 
endothelial cells although in all cases expression in this cell type was significantly 
lower than in the pericytes (Figure 4-22). In contrast three genes were expressed by 
both GFPbright cells (pericytes) and CD31+ cells (endothelial cells) although RNA 
levels appeared consistently higher in pericytes: Vcam1 (4.12±1.61 versus 1.6±0.39), 
Mcam (CD146) (3.79±0.37 versus 2.57±0.20) and Kitl (2.15±0.65 versus 0.92±0.18). 
Importantly none of these genes were expressed by GFPdim cells (stromal fibroblasts) 
providing further validation for the strategy employed to identify a pericyte-specific 
gene signature (Figure 4-22). 
In summary, RNA sequencing and qPCR validation identified Acta2, Myh11, Cspg4, 
Olfr78, Rgs4, Rgs5, and Kcnj8 as genes expressed specifically in endometrial pericytes 
in Pdgfrβ-BAC-eGFP mice which may be useful in downstream studies to specifically 
target pericytes. Cspg4 (NG2) was identified as a pericyte specific marker in 
endometrial tissues by IHC, NGS and qPCR and was therefore chosen as the marker 




Chapter 4: Identification and characterisation of a population of putative 
mesenchymal progenitor cells in the mouse endometrium 245 
 
 
Figure 4-22. Expression of putative pericyte genes by qPCR in GFPdim stromal cells, 
GFPbright pericytes and CD31+ endothelial cells isolated from naive Pdgfrβ-BAC-eGFP 
endometrial tissue to further validate NGS results. Acta2, Myh11, Cspg4 (NG2), Olfr78, 
Rgs4, Rgs5, Vcam1, Mcam (CD146), Kitl and Kcnj8 are all expressed by GFPbright pericytes 
(n=3) and not expressed by GFPdim stromal cells (n=3) while Vcam1, Mcam (CD146) and Kitl 
were also expressed by CD31+ endothelial cells (n=4) (One-way ANOVA, Holm-Sidak’s 
multiple comparisons test,*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).  
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4.4.6 Identification of NG2+ pericytes using an inducible transgenic 
mouse line 
Lineage tracing is a biological technique for tracing the progeny of a single cell or 
group of cells over time; a cell is ‘marked’ (tattooed) in such a way that this mark will 
be transmitted to all progeny. Transgenic mice have been developed to exploit this 
technique using the Cre/lox site-specific recombination system which allows spatial 
control of gene activity in a cell type of interest. With the development of ligand-
dependent induction of specific Cre recombinases, temporal control was gained as Cre 
recombinase expression was only stimulated by administration of the ligand.  
In the preceding sections GFP expression in the Pdgfrβ-BAC-eGFP was not pericyte 
specific, however further analysis suggested that NG2 (encoded by Cspg4) was 
identified as a pericyte-specific gene. To advance studies on the role of endometrial 
pericytes we purchased an NG2-CreERTM BAC tamoxifen-inducible mouse line 
(available from Jackson Laboratories detailed in Section 2.1.1.5). These mice were 
cross-bred with an Ai14 reporter mouse line engineered to contain a loxP-flanked 
STOP cassette upstream of a TdTomato (DsRed fluorescent protein) sequence, 
detailed in Section 2.1.1.6. Mice were given injections of tamoxifen (TMX), and the 
expression of the red fluorescent protein TdTomato examined.  
4.4.6.1 Expression of TdTomato in NG2-CreERTM BAC uterine tissue after 
tamoxifen administration 
To investigate the efficiency of recombination by the NG2-CreERTM BAC tamoxifen-
inducible mouse line, it was crossed with the Ai14 reporter mouse line (Chapter 2; 
Section 2.1.1.6). NG2-Cre/Ai14 offspring were generated in which TdTomato is only 
expressed in NG2 expressing cells. To assess this reporting, uterine tissues were 
collected from adult cycling mice after administration of TMX and tissue sections 
observed for TdTomato expression. TdTomato was expressed by cells located within 
the endometrial stromal compartment (Figure 4-23 (A-B) arrows) and was not 
expressed by epithelial cells of the lumen (L) (Figure 4-23 (A-B), dashed line). 
Observation at a higher magnification showed that TdTomato+ cells had cellular 
morphology consistent with a pericyte phenotype: fat cell bodies and long 
membranous processes wrapping around blood vessel structures (Figure 4-23 (C) 
arrows).  
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Figure 4-23. TdTomato expression in naïve NG2-Cre/Ai14 uterine tissue after 
administration of tamoxifen. (A-B) TdTomato expressing cells (arrows) were located 
throughout the endometrial stromal compartment and not associated with the epithelium 
(cream dashed line). (C) TdTomato expressing cells (arrows) exhibit pericyte-like 
morphology. Stroma (S), gland (G), lumen (L) (representative images, n=4). 
 
4.4.6.2 Characterisation of TdTomato expressing cells in naïve NG2-Cre/Ai14 
uterine tissue by IHC 
To confirm that TdTomato+ cells in naïve NG2-Cre/Ai14 uterine tissue were 
pericytes, IHC was used with antibodies raised against a range cell marker proteins. 
The following markers were used based on previous reports and the results outlined in 
Figure 4.24: NG2 (Cspg4) expressed by smooth muscle cells and pericytes; CD146 
(Mcam) expressed by endothelial cells and smooth muscle cells; Pdgfrβ expressed by 
mesenchymal cells; CD31 (Pecam-1) expressed by endothelial cells; and EpCAM 
(CD326) expressed by epithelial cells. TdTomato+ cells were confirmed as NG2+, 
CD146+ and Pdgfrβ+ a phenotype consistent with that of pericytes (Figure 4-24 (A-
C) arrows). All TdTomato+ cells were CD31- and EpCAM- distinguishing them from 
both endothelial and epithelial cells respectively (Figure 4-24 (D-E) arrows). These 
results are consistent with TdTomato expressing cells being identified at pericytes. 




Figure 4-24. Characterisation of TdTomato+ cells in naïve NG2-Cre/Ai14 uterine tissue by IHC. Expression of TdTomato (red; white arrows) and 
(A) NG2 (B) CD146 (C) Pdgfrβ (D) CD31 and (E) EpCAM (green) in uterine tissue. Co-localisation of TdTomato with NG2, CD146 and Pdgfrβ was 
detected. TdTomato positive cells did not express CD31 or EpCAM (representative images; n=4 mice, scale bar = 50μm). 
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To assess the contribution of TdTomato+ cells to the stromal compartment, naïve 
NG2-Cre/Ai14 uterine tissues were collected from adult mice after tamoxifen 
administration and analysed by flow cytometry. Analytical gates were set up using an 
unstained controls, single stains and FMO’s of all the included antibodies and single 
live cells analysed (Figure 4-25 (A)). There was a population of TdTomato + cells that 
accounted for 4.12±0.23% of the total live cells in the tissue (Figure 4-25 (B and E). 
When analysed further it was found that 85.71±1.79% of the TdTomato+ cells 
expressed CD146 and 58.82±3.87% expressed NG2 (Figure 4-25 (C) and (F)) while 
TDTomato+ cells did not express either CD31 (2.46±0.36%) or EpCAM 
(4.85±1.09%) (Figure 4-25 (D) and (F)). TdTomato+ cells were however located in 
close proximity to CD31+ blood vessels indicative of a perivascular phenotype (Figure 
4-25 (D)). These results were in line with the characterisation by IHC and further 
confirm the pericyte phenotype of TdTomato+ cells. 
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Figure 4-25. Characterisation of TdTomato+ cells in NG2-Cre/Ai14 uterine tissue by 
flow cytometry. (A) Gating strategy to analyse live single cells: All cells > Single cells > Live 
cells. (B) Plot showing TdTomato against SSC-A and the presence of the TdTomato+ cell 
population. (C) Expression of NG2 and CD146 by TdTomato+ cells. (D) Expression of CD31 
and EpCAM by TdTomato+ cells. (E) Quantification of TdTomato+ cells as a frequency of 
live single cells (F) Quantification of cell marker expression by TdTomato+ cells as a 
frequency of TdTomato+ cells (representative plots, n=4). 
 
 
In summary, IHC and flow cytometry have confirmed that TdTomato expressing cells 
in the NG2-Cre/Ai14 uterus can be identified as perivascular pericytes. The results 
mirror data generated from Pdgfrβ-BAC-eGFP transgenic mouse line, where GFPbright 
cells were previously characterised as perivascular pericytes. This confirms use of the 
a rationale for using these mice in future studies related to endometrial repair although 
the further work is needed to determine the independent impact of tamoxifen (an anti-
oestrogen) on uterine responsiveness before these can be undertaken.  
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4.5 Discussion 
4.5.1 Characterisation of endometrial mesenchymal cells 
Current knowledge on the characterisation of endometrial stem/progenitor cells has 
been gathered from in vitro studies on heterogeneous populations of stromal cells, 
however this method does not exclude contamination from other cell types and both 
gene expression and cellular function are likely to be altered by culture conditions 
(Masuda et al. 2012). It is therefore imperative that new studies focus on use of 
methods that can identify progenitor cell specific markers using cells recovered from 
their native environment to provide the tools necessary for reliable isolation of pure 
cell populations for studies that will enable them to be properly characterised. In the 
human endometrium, co-expression of Pdgfrβ and CD146 (Schwab and Gargett 2007) 
and specific expression of SUSD2 (previously known as W5C5) (Masuda et al. 2012) 
have been used to identify and isolate stromal MSCs consistent with Pdgfrβ+CD146+ 
cells representative of putative pericytes, while SUSD2+ cells representing true MSCs 
(Gargett et al. 2016)  
Based on these previous findings in the human endometrium, the current study started 
by identifying and locating cells that co-expressed Pdgfrβ and CD146 in the mouse 
endometrium and by capitalising on the opportunity to conduct studies in the Pdgfrβ-
BAC-eGFP transgenic mouse line, previously used to identify pericytes in the liver 
and kidney (Henderson et al. 2013). Before embarking on studies to isolate putative 
pericytes a variety of methods were used to demonstrate that in the Pdgfrβ-BAC-eGFP 
transgenic mouse line the promoter-dependent expression of GFP mirrored that of the 
native Pdgfrβ protein. GFP and Pdgfrβ were both exclusively detected in the stromal 
compartment. A novel finding during this analysis was that there were two 
subpopulations present in the endometrial tissue based on the intensity of GFP 
expression alone: GFPdim cells and GFPbright cells. As GFP expression is a readout of 
Pdgfrβ gene promoter activity (Henderson et al. 2013) this indicated that the Pdgfrβ is 
more active in the GFPbright cells and that Pdgfrβ protein would be more abundant in 
these cells and that two populations of stromal GFP+ cells could be easily 
distinguished. These results confirmed the use of the Pdgfrβ-BAC-eGFP transgenic 
mouse in investigating cells of the endometrial mesenchyme (Pdgfrβ+), and suggested 
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that there was previously unknown functional heterogeneity within this cell population 
in the endometrium based on Pdgfrβ signalling. 
Further characterisation of the GFP positive cell populations revealed that GFPbright 
cells expressed Pdgfrβ, CD146, αSMA and NG2 suggesting they had a pericyte 
phenotype as these markers have been used to identify pericytes in a variety of other 
tissues including heart, skeletal muscle, brain, spinal cord, retina, adipose tissue, bone 
marrow, lymph node, skin, aorta, lungs, kidney and pancreas (Guimarães-Camboa et 
al. 2017). In contrast, GFPdim cells expressed Pdgfrβ but did not express CD146, 
αSMA or NG2 consistent with a stromal fibroblast phenotype (Schwab and Gargett 
2007). Flow cytometry confirmed that two GFP+ subpopulations were present in naive 
Pdgfrβ-BAC-eGFP endometrial tissue and showed that they could be separated based 
on relative expression of CD146: GFPdim cells were CD146- and GFPbright cells were 
CD146+ once again confirming a pericyte phenotype (Spitzer et al. 2012).  
These results appear in agreement with previously published papers in which 
co-expression of Pdgfrβ and CD146 has been detected in human endometrial pericytes 
which may have MSC-like functions (Schwab and Gargett 2007, Kaitu'u-Lino et al. 
2012, Spitzer et al. 2012). However it is notable that Pdgfrβ and CD146 are apparently 
expressed by more than one cell type so cannot be described as pericyte specific and 
therefore a combination of these markers is required. In the current study αSMA and 
NG2 appeared to be pericyte specific markers although further investigation showed 
αSMA was not detected in every pericyte and was also expressed by smooth muscle 
cells of the myometrium. Notably, this is the first report of increased expression of 
Pdgfrβ by GFPbright cells (pericytes) compared with stromal cells had not been 
previously described and warrants further investigation into cell-specific regulation of 
the promoter. 
4.5.2 Investigating the perivascular niche 
Both IHC and flow cytometry showed GFP+ cells did not express EpCAM or CD31 
demonstrating they were distinct from epithelial and endothelial cells. This is in line 
with previous data from studies in human endometrial tissue which describes 
endometrial MSCs as expressing CD29, CD44, CD73, CD90, CD102 and CD146 but 
not STRO-1, CD31, CD45 or EpCAM (Gargett and Masuda 2010, Guimarães-Camboa 
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et al. 2017). In the current study the GFPbright cells were located in close proximity to 
CD31+ cells surrounding blood vessels, and could therefore be described as 
‘perivascular’. This fits with LRC studies where many endometrial LRCs were located 
near to blood vessels in the stroma and hypothesised to be either pericytes or vascular 
smooth muscle cells (Cervelló et al. 2007, Chan and Gargett 2006a, Patterson and Pru 
2013). Similarly in other studies where human endometrial MSCs were detected in 
tissue sections by either co-expression of Pdgfrβ and CD146 (Kaitu'u-Lino et al. 2012, 
Bergers and Song 2005) or sole expression of SUSD2 (Masuda et al. 2012), they were 
described as occupying a perivascular niche.  
The perivascular location of endometrial pericytes in the mouse endometrium was also 
investigated using transmission electron microscopy (TEM): endothelial cells were 
directly adjacent to the vessel lumen with large nuclei, and perivascular cells with 
smaller nuclei and evidence for membranous processes were found wrapping around 
these vessel structures. The latter were identified as pericytes and shown to be 
encapsulated within the collagenous basement membrane of the vasculature, a 
hallmark of the pericyte phenotype (Bergers and Song 2005). Further studies are 
needed to confirm their identity using immunogold labelling with an antibody against 
a pericyte specific marker such as NG2.  
Analysis of CD31+ and NG2+ revealed that every NG2+ pericyte in the endometrial 
tissue was located in close proximity to a CD31+ endothelial cell (100±0.24%) thereby 
occupying a perivascular niche in endometrial tissue. The ratio of pericytes:endothelial 
cells was calculated to be 1.25:1 (±0.02). In the literature, pericyte coverage is 
described as dense or sparse and is thought to be related to the extent of substance 
transfer between blood vessels in different tissues. For example the retina has a high 
ratio of 1:1 while the peripheral vasculature has a low ratio of 1:100 (Andersson et al. 
2015). A higher ratio is believed to be related to greater regulation of blood flow and 
more frequent remodelling of microvessels, as well as being a sign of vessel maturity 
(Andersson et al. 2015). Similarly in vitro co-culture studies using a decreasing 
pericyte (primary human muscle) to endothelial cell (dHMECs) ratio (1:1, 10:1, 20:1) 
have shown that pericytes ‘home’ to endothelial cells and there is a decrease in 
endothelial cord area as pericyte:endothelial cell ratio decreases. At a ratio of 1:1 there 
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was an inhibition of endothelial cell proliferation which decreased as the ratio 
decreased believed to be due to an inability of pericytes to communicate with the 
increasing number of endothelial cells (Bodnar et al. 2016).  
Various studies conclude that all endometrial vessels consist of endothelial cells with 
supporting basal lamina and pericytes (Hickey and Fraser 2000, Hickey et al. 2003). 
In a paper studying the role of pericyte coverage in endometrial tissue from women 
suffering from HMB, control subjects were rarely found to exhibit endothelial tubes 
without associated pericytes while those with HMB had greatly reduced numbers 
(Andersson et al. 2014). Similarly it has been shown that HRT users have reduced 
pericyte coverage which coincides with increased vascular fragility and associated 
unexplained bleeding (Hickey et al. 2003). The current study has demonstrated that 
endometrial vasculature has a dense coverage of pericytes and this would be consistent 
with an important role in the regulation of blood flow and control of substance transfer. 
Considering the endometrium is a highly dynamic tissue that is constantly undergoing 
regeneration and degeneration with associated changes in vasculature (Gargett et al. 
2016) a substantial pericyte population is probably required for regulation of 
endothelial cell function during angiogenesis and tissue remodelling (Chan et al. 
2004). Interestingly it has been shown that while pericytes are associated with all 
vascular capillaries and post-capillary venules in the human endometrium, there are 
spatially organised differences in pericyte phenotype (based on vSMC differentiation 
markers) however the functional significance of this has yet to be determined (Rogers 
and Abberton 2003). Results of the current study are in agreement that all endometrial 
vessels (mouse) have a close association with perivascular pericytes which likely have 
various influences over vascular function in the endometrium. 
Pericytes associated with spiral arteries have been found to be more highly 
proliferative than those of other vessels, likely to reflect an active role in spiral artery 
remodelling essential for embryo implantation and placentation (Rogers and Abberton 
2003, Elia et al. 2011). Additionally, during decidual shedding, vasoconstriction is 
important in limiting blood loss during menstruation (Chan et al. 2004) and as 
pericytes are contractile cells this could be a primary role in endometrial physiology. 
Notably in their paper Andersson et al, (2014) reported finding low pericyte coverage 
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of vessels in the endometrium of women suffering from HMB, confirming a role for 
pericytes in regulating blood loss during menstruation. Finally, if pericytes have MSC 
functions (Spitzer et al. 2012), high pericyte coverage provides the endometrium with 
a reliable source of progenitor cells for tissue turnover and regeneration. 
4.5.3 Assessing endometrial mesenchymal cell populations 
Flow cytometry combined with tissue from the transgenic reporter mice offered a 
unique opportunity to analyse the numbers of GFPbright pericytes revealing that they 
were 17.22±1.26% of the total stromal GFP+ cell population (CD31-CD45-GFP+ 
cells, Figure 4-10) and approximately 8.33±0.36%  of total live cells (DAPI- cells, 
Figure 4-10) present in the tissue. This population of pericytes appears to be higher 
than the numbers of putative MSC reported by other investigators suggesting not all 
pericytes are MSC or that there are species differences.  
For example, in 2004, Chan et al did clonogenic studies on isolated endometrial 
stromal cells (EpCAM- cells) from human hysterectomy tissues and found that a small 
population was clonogenic: 1.25%, generating both large (0.02%) and small (1.23%) 
colonies (Chan et al. 2004). Similarly using the Hoescht exclusion assay on cells 
isolated from human endometrial tissue, SP cells accounted for between 0-5% of the 
total cell population, that this was highest in the proliferative phase samples (up to 
0.7%) and highly variable between subjects (Kato et al. 2007). Results from other 
studies using antibodies in combination with flow cytometry reported that 
Pdgfrβ+CD146+ cells accounted for 1.5±0.2% of the CD45-EpCAM- stromal cell 
population (Schwab and Gargett 2007). In a separate study screening with antibodies 
raised against putative MSC identified W5C5 (subsequently found to be encoded by 
the gene SUSD2) identified a population of clonogenic multipotent cells that were 
4.2±0.6% of a purified stromal cells population (Masuda et al. 2012). Finally LRC 
studies in mice have shown that between 6-9% of the stromal cells can be identified 
as LRC and that these are mainly located near blood vessels (Chan and Gargett 2006b, 
Cervelló et al. 2007). 
When comparing current results to those gathered in the aforementioned studies it must 
be appreciated that displayed values are calculated as frequencies of different starting 
populations. The flow cytometry results discussed in this chapter excludes both 
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endothelial cells and immune cells from the analysis, then calculates the contribution 
of pericytes (GFPbrightCD146+ cells), confirmed to be EpCAM- and calculated as a 
percentage of total live cells in the suspension. In contrast, in the clonogenic and SP 
studies mentioned above the isolation technique does not exclude endothelial or 
immune cells from the analysis and therefore a more heterogeneous population has 
been examined. It is of note that the CFU and SP techniques are focussed on 
identifying a specific MSC population in the endometrial tissue and the difference in 
value suggests not all Pdgfrβ+CD146+ pericytes are MSC. Similarly when comparing 
current results with SUSD2/W5C5+ cells as a proportion of stromal cells from human 
endometrium (Masuda et al. 2012) it is possible that a larger cell population is being 
captured when analysing co-expression of Pdgfrβ and CD146, while a smaller 
population expresses SUSD2 alone. 
When comparing current results to those by Schwab & Gargett 2007 where they 
calculated the Pdgfrβ+CD146+ cells as a percentage of CD45-EpCAM- cells, this 
should be relatively comparable to CD31-CD45- population in this study it is 
presumed that Pdgfrβ+CD146+ cells are both EpCAM- and CD31-. Discrepancies 
between these results could be due to differences in the preparation of the single cell 
suspension, the use of different flow cytometry antibodies, the advantage of the 
intrinsic GFP reporter protein over the use of an antibody or a true difference in the 
proportion of pericytes in endometrial tissue in human versus mouse tissue. 
Interestingly the current results show most similarity to the results gained when using 
the technique of LRC to identify cells in mouse endometrium (Chan and Gargett 
2006b, Cervelló et al. 2007) further highlighting a potential difference in the cellular 
composition of the endometrium between human and mouse species. Although one 
caveat is that the LRC method examines all cellular compartments while the current 
results solely analysed mesenchymal cells.  
In summary, the GFPbright cells in the Pdgfrβ-BAC-eGFP endometrium were 
characterised as Pdgfrβ+CD146+ perivascular pericytes by a variety of techniques. 
4.5.4 Isolation of endometrial pericytes  
Pericytes were purified from endometrial tissue using FACS based on their 
co-expression of GFP and CD146. Approximately 20,000 GFPbright cells and 400,000 
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GFPdim cells could be isolated from two naïve Pdgfrβ-BAC-eGFP uterine horns using 
a refined digest protocol (Chapter 2: Section 2.5). A cytospin of the cells was 
confirmed GFPbright cells were GFP+/Pdgfrβ+/CD146+ while GFPdim cells were 
negative for CD146. These results were in agreement with the literature where 
pericytes are Pdgfrβ+CD146+ while stromal fibroblasts are Pdgfrβ+CD146- (Schwab 
and Gargett 2007, Kaitu'u-Lino et al. 2012, Spitzer et al. 2012). 
Different RNA extraction techniques were compared and it was found that for a small 
cell input, the automated Maxwell extraction method with the SimplyRNA cell kit 
yielded the best quality RNA. When a molecular characterisation was carried out on 
RNA extracted from the different cells using primers directed against candidates 
identified by immunohistochemistry as pericyte/stromal associated GFPbright cells 
(pericytes) were confirmed as Pdgfrβ+, CD146+, αSMA+ and NG2+ while GFPdim 
cells (stromal fibroblasts) were Pdgfrβ+, CD146-, αSMA- and NG2-. These results 
confirmed Pdgfrβ is more highly expressed in pericytes than stromal fibroblasts in the 
mouse. Notably NG2 was confirmed to be a marker expressed specifically in mouse 
endometrial pericytes. 
Using FACS allowed us to exploit a multi-colour panel of antibodies generating 
detailed analysis of the expression of multiple cell surface markers in a single sample. 
In terms of clinical application, magnetic bead sorting has been suggested to be optimal 
for MSC isolation as it is rapid and simple, yields greater cell numbers, maintains cell 
viability to a higher degree and results in extracted RNA with better integrity (Masuda 
et al. 2012). However, the resulting cell population is not 100% pure and multiple cell 
markers cannot be used and it is dependent upon identification of a cell surface protein 
that can be bound by antibodies and which is not expressed in other cell types: in 
human tissue the W5C5 antigen appears to be promising for isolation of stromal 
clonogenic cells (Masuda et al. 2012).  
The current study is the first to describe a robust method to isolate a pure population 
of pericytes from mouse uterus based on co-expression of Pdgfrβ and CD146. This 
provided a platform for further molecular characterisation of the cells and an 
opportunity to expand both the range of pericyte specific genes as well as increase our 
understanding of their function. 
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4.5.5 Profiling endometrial pericytes  
Next generation sequencing (NGS) was performed on cells isolated from 
Pdgfrβ-BAC-eGFP mouse uterus. In the current study the samples groups compared 
were total mesenchymal cells (all GFP+ cells) and stromal fibroblasts (GFPdimCD146- 
cells), as the RNA generated from the GFPbrightCD146+ cells had poor quality 
(determined by LabChip GX Touch technology) and was therefore removed from the 
initial analysis although RNA from purified pericytes was used in validation 
experiments. It was postulated that differences in gene expression between the total 
GFP+ cell population (GFPdimCD146-/GFPbrightCD146+) and isolated GFPdimCD146- 
stromal cells might be due to the presence of the GFPbrightCD146+ cells. Anaylsis of 
results identified 143 putative pericyte associated genes including several previously 
reported in the literature as being expressed in pericytes including Mcam (CD146), 
Acta2 (αSMA), Cspg4 (NG2), Pdgfrβ, Myh11, Olfr78, Rgs4, Rgs5, Vcam1, Kitl and 
Kcnj8 (Spitzer et al. 2012, Gaafar et al. 2014, Cheng et al. 2017, He et al. 2016).  
Spitzer et al carried out transcriptomic analysis (by gene array) of human endometrial 
MSCs isolated by FACS as Pdgfrβ+CD146+ cells in comparison to Pdgfrβ+CD146- 
stromal fibroblasts which revealed a gene signature they concluded to be similar to 
that of pericytes (Spitzer et al. 2012). Similarities can be drawn with the current data 
set and suggest human endometrial MSCs and mouse endometrial pericytes express 
some of the same genes including: Pdgfrβ, Mcam, Acta2, Rgs5, Angpt2, Scl38a, 
Mef2c, Serpin1, Tagl, Abcc9 and Slit3. Differences in the results may be because the 
expression of Pdgfrβ and CD146 identifies slightly different cell populations in human 
and mouse endometrial tissue, the comparisons drawn in each study were different or 
the parameters used to filter the resulting data were different. Nevertheless both studies 
suggest that Pdgfrβ+CD146+ cells in both human and mouse endometrium can be 
identified as perivascular pericytes. 
This conclusion is further supported when comparing current NGS data to a study 
which analysed the transcriptome of mural cells in the mouse brain. Sequencing of 
Pdgfrβ+NG2+ cells isolated from brain tissue identified several pericyte-asssociated 
genes including Acta2, Kcnj8, Pdgfrβ, Des, Abcc9, Rgs5 and Cspg4 (He et al. 2016). 
However, in that study NG2 (Cspg4) was found to be expressed by both mural cells 
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(Pdgfrβ+NG2+) and olidodendrocyte progenitor cells (OPCs: Pdgfrβ-NG2+) whereas 
in the current study detailed analysis showed NG2 was only expressed in endometrial 
cells that co-expressed Pdgfrβ. Whether this is an important tissue specific difference 
is yet to be investigated. He et al concluded that mural cells (Pdgfrβ+NG2+) in the 
brain represented a heterogeneous population of cells but this has not yet been 
investigated in the endometrial pericytes. 
Gene Set Enrichment Analysis (GSEA) of genes identified in the current study as 
being expressed by endometrial pericytes has highlighted several biological processes 
and signalling pathways relevant to the function of pericytes during homeostasis. 
Several processes were associated with vascular functioning such as regulation of 
blood vessel diameter, angiogenesis, vascular smooth muscle contraction and blood 
vessel morphogenesis which represent the well-known pericyte function of vasculature 
support, also highlighted by other transcriptomic studies (Spitzer et al. 2012: 
vasculogenesis, angiogenesis; He et al, 2016: angiogenesis, smooth muscle 
contraction). Additional functions included extracellular matrix assembly, negative 
regulation of signal transduction, tissue development and regulation of cell 
proliferation all of which were confirmed in other studies (Spitzer et al. 2012, Gaafar 
et al. 2014, He et al. 2016). Interestingly, a link to regulation of inflammatory process 
was also identified such as negative regulation of immune system process, cytokine 
receptor interactions, regulation of leucocyte migration and regulation of 
inflammatory response. This function has been identified by others and it has been 
suggested that endometrial pericytes have immunomodulatory functions which may 
have therapeutic potential (Spitzer et al. 2012). 
Signalling pathways found to be enriched in endometrial perciytes included calcium 
signalling, Wnt signalling and Hedgehog signalling which have been previously 
implicated in the MSC properties of self-renewal and multipotency (Spitzer et al. 2012, 
Gaafar et al. 2014). In a study by Gaafar et al, human endometrial MSCs and BM-
MSCs were compared by gene expression profiling. They found 52 core genes that 
were shared including those associated with stemness, self-renewal and members of 
the TGFβ, Notch and Wnt signalling however differentially expressed genes were 
associated with vasculogenesis, cell adhesion, smooth muscle contraction and 
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migration, processes which were identified in endometrial pericytes in the current 
study by GSEA. 
In the current study RNA sequencing confirmed the transcriptomic profile of 
GFPbrightCD146+ cells was consistent with a pericyte phenotype. Notably, when 
validation of the sequencing data was carried out using RNA purified from isolated 
cell populations of GFPbrightCD146+ and GFPdimCD146- the expression of NG2 
(Cspg4) was confirmed as being exclusive to GFPbrightCD146+ pericytes and not 
detectable in either stromal or endothelial cells. Building on this information mice in 
which transcription of a TdTomato fluorescent transgene was induced specifically in 
mice expressing an NG2 promoter were generated and their uteri recovered for 
analysis. In addition to confirmation that TdTomato was exclusive to a cell population 
with a perivascular phenotype Flow cytometry of tissue digests showed tdTomato+ 
pericytes represented 4.12±0.23% of the total live cells in the endometrial tissue which 
is comparable to numbers of LRC studies previously identified in mice (Chan and 
Gargett 2006b, Cervelló et al. 2007). Notably, this proportion was also similar to the 
numbers of W5C5+ MSCs in human tissues (Masuda et al. 2012). These results were 
in contrast to those obtained using GFP and CD146 co-expression to identify pericytes 
in Pdgfrβ-BAC-eGFP tissues by flow cytometry which suggested pericytes 
represented 8.33±0.36% of total live cells. The discrepancy in these values suggests 
that the co-expression of Pdgfrβ and CD146 may identify a broader population of cells 
than NG2. These novel findings suggest that the endometrial pericyte population is 
heterogeneous which may have associated functional heterogeneity. This was further 
investigated in Chapter 5.  
4.5.6 Future prospects 
In the current study, in depth characterisation of the cellular and molecular phenotype 
of endometrial pericytes using IHC, flow cytometry, qPCR and NGS was achieved 
using various transgenic reporter mice. However functional studies (both in vitro and 
in vivo) are required to compliment this data and definitively confirm pericytes as 
MSCs. To analyse whether endometrial pericytes have true MSC properties both 
clonogenicity and multilineage differentiation assays need to be performed (Gargett 
and Masuda 2010), using single expanded cell colonies from isolated cells (Schwab 
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and Gargett 2007). Additionally, a scratch assay could be performed to study their 
capacity for migration and potential role in wound healing. Transplanting purified 
endometrial pericytes (GFPbrightCD146+) from Pdgfrβ-BAC-eGFP mouse 
endometrium under the kidney capsule of a recipient mouse could be used to compare 
their capacity to reconstruct endometrial tissue in vivo as has been described for human 
MSC (Masuda et al. 2015). Such analyses are required to further characterise 
endometrial pericytes before they can be identified as a true stem/progenitor cell 
population. 
4.5.7 Conclusions 
GFPbrightCD146+ cells in Pdgfrβ-BAC-eGFP endometrial tissue can be identified as 
perivascular pericytes which exclusively express NG2. A full characterisation of 
endometrial pericytes in the mouse uterus has identified novel targets which could be 
used to specifically target pericytes in future experiments. These results provide a 
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Chapter 5 Investigation of the role of mesenchymal 
progenitor cells in endometrial tissue 
breakdown and repair  
5.1 Introduction 
5.1.1 Menstruation and endometrial repair 
In women tissue repair of the normal endometrium is relatively rapid being 
characterised by complete restoration of the epithelial cell layer within 2-3 days 
(Ferenczy 1976). Recent morphological investigations have revealed that tissue 
breakdown occurs simultaneously with tissue repair processes which include 
neoangiogenesis, re-epithelialisation and stabilisation of basal blood vessels (Garry et 
al. 2009, Garry et al. 2010, Cousins et al. 2016b). It has been postulated that the basal, 
unshed, endometrial layer can serve as a regenerative compartment from which a new 
functional layer is generated (Spencer et al. 2005, Gargett and Masuda 2010, Spencer, 
Dunlap and Filant 2012). Several processes are known to be involved in endometrial 
tissue repair, however, the precise cellular and molecular mechanisms responsible for 
‘scarless’ healing are yet to be fully elucidated (Jabbour et al. 2006b, Henriet et al. 
2012, Garry et al. 2010).  
Notably, studies in mice suggest endometrial repair can occur in a steroid hormone 
depleted environment (Kaitu'u et al. 2005) although the increase in depth recorded 
during the proliferative phase is oestrogen-dependent. Explant studies in which tissue 
was cultured in the presence or absence of hormonal support (E2 and P4) have reported 
that hormone deprived explants increased expression of genes associated with a 
signature of ‘wound healing and inflammation’ (Gaide Chevronnay et al. 2012). 
Progesterone withdrawal is reporter to be associated with tissue-restricted hypoxia and 
increased biosynthesis of prostaglandins and angiogenic factors including VEGF 
(Maybin et al. 2011a, Maybin et al. 2011b, Cousins et al. 2016d).  
5.1.2 Mechanisms of re-epithelialisation 
One of the most fundamental processes of endometrial repair is restoration of the 
epithelial cell layer after decidual shedding, so-called re-epithelialisation (Cousins et 
al. 2014). In women this process is reported to begin on day 2 of menses will full 
epithelial coverage of denuded stromal surfaces achieved by day 5, occurring in 
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parallel with tissue shedding. Originally it was believed that new epithelial cells arose 
from glandular epithelium retained in the basal layer (Novak 1946).  This hypothesis 
was updated in the 1970s when Ferenczy suggested that new epithelial cells arose from 
proliferation of both basal glandular epithelium and intact surface epithelium 
bordering regions of denuded stromal tissue (Ferenczy 1976, Evans et al. 2011, 
Kaitu'u-Lino et al. 2010). More recently it has been proposed that three synchronous 
mechanisms contribute to re-epithelialisation: luminal epithelial cell proliferation, 
glandular epithelial cell migration and a mesenchymal to epithelial transition (MET) 
of cells in the endometrial stroma (Garry et al. 2009, Patterson et al. 2013, Cousins et 
al. 2014).  
Key evidence for trans-differentiation of stromal cells so that they gain an epithelial 
phenotype (MET) has been documented in mouse models of simulated ‘menses’ using 
transgenic reporter strains and detailed IHC (Krull et al. 2010, Patterson et al. 2013, 
Cousins et al. 2014). For example, Cousins et al, using the Edinburgh menses mouse 
model and IHC identified cells in the stromal compartment adjacent to areas of 
denuded epithelium that expressed both vimentin (stromal marker) and pan cytokeratin 
(epithelial marker) in samples recovered 12 and 24hrs following P4 withdrawal. This 
study also highlighted evidence for stromal cell proliferation in regions close to 
denuded surfaces and found dynamic changes in gene expression implicated in EMT 
and MET in uterine tissues across a time course of repair including Wt1, Snai1, Snai2, 
Snai3, Cdh1, cytokeratin, Wnt1, osteopontin and Vim (Cousins et al. 2014). Although 
these studies suggest that the stromal cells in the residual unshed endometrium can 
contribute to reepithelialisation they used total tissue extracts to assess gene expression 
and did not provide information on what proportion of the stromal cell population are 
capable of MET. 
5.1.3 Myofibroblasts during endometrial repair 
During a classical wound healing response, e.g. in the skin, fibroblasts differentiate 
into myofibroblasts through the fibroblast to myofibroblast transition (FMT) 
characterised by an increase in the expression of αSMA (Leavitt et al. 2016). 
Myofibroblasts play a key role in dermal wound contraction however their persistence 
at a site of injury results in the formation of scar tissue (Hantash et al. 2008, Haldar et 
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al. 2016, Greenhalgh et al. 2013). Myofibroblasts may also arise through 
transdifferentiation of epithelial cells into cells with a fibroblast phenotype (EMT) 
which gives them heightened migration properties (Kothari et al. 2014). The role, if 
any, of FMT in endometrial repair is unknown.  
5.1.4 Stem/progenitor cells and endometrial repair 
As discussed in Chapter 4, the striking regenerative capacity of the endometrium has 
led to the hypothesis that a population of stem/progenitor cells exist that can 
differentiate into multiple cell lineages in response to ‘damage’ at the time of menses 
(Gargett and Masuda 2010, Kaitu'u-Lino et al. 2012). In primates, it was reported an 
entire endometrium could be regenerated from only a few remaining cells, after 
performing an experimental endometriectomy (Bickers 1944). Populations of 
stem/progenitor cells have been identified in the human endometrium using 
clonogenic stem cell assays (Chan et al. 2004, Dimitrov et al. 2008, Gargett et al. 2009) 
and Hoechst exclusion assay to identify side population cells (Kato et al. 2007, Hu et 
al. 2010, Cervelló et al. 2011).  In mice, pulse-chase experiments have identified label-
retaining cells (LRC) in both epithelial and stromal cell compartments (Chan and 
Gargett 2006, Cao et al. 2015, Kaitu'u-Lino et al. 2012). The exact contribution of 
these cells to physiological endometrial repair and remodelling remains unclear 
(Schwab et al. 2005, Schwab and Gargett 2007, Cervelló et al. 2007). 
5.1.5 A role for perivascular pericytes in endometrial repair? 
Pericytes are cells that reside in close proximity to blood vessels and there is a growing 
body of evidence that they have functions in vascular development and stability with 
a specific role in regulating endothelial cell proliferation and migration (Crocker et al. 
1970, Mills et al. 2013, Murray et al. 2014). Pericytes have been shown to have MSC 
like properties including multilineage differentiation, with the ability to 
transdifferentiate into chondrocytes, adipocytes and osteocytes in vitro (Cervelló et al. 
2007, Murray et al. 2014, Ansell and Izeta 2015). Pericytes have also been implicated 
in the process of wound healing and shown to interact with multiple cell types 
including platelets, inflammatory cells, connective tissue cells and endothelial cells 
(Bodnar et al. 2016, Khosrotehrani 2013). It has been shown that pericytes detach from 
blood vessels and migrate into the surrounding tissue to guide the process of 
angiogenic sprouting (Stratman et al. 2009): this is reported to be driven by Pdgfrβ-
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dependent signalling (Rajkumar et al. 2006). Within the skin it has been found that 
pericytes promote angiogenesis and epithelial cell proliferation and skin regeneration 
by modifying their ECM environment (Paquet-Fifield et al. 2009)). Further to this 
pericytes have been described to play a role in modulating the inflammatory response 
by secreting chemokines which stimulate the migration of leucocytes through vascular 
walls (Pober and Tellides 2012, Stark et al. 2013) and in the brain it has even been 
suggested that pericytes can differentiate into macrophages (Monteiro, Rocha and 
Marini-Abreu 1996, Sakuma et al. 2016). 
Pericytes have also been implicated in pathological fibrosis. Fibrosis is characterised 
by an excessive accumulation of ECM proteins produced by activated fibroblasts and 
myofibroblasts (Bodnar et al. 2016). Myofibroblasts are thought to arise from pre-
existing fibroblasts, BM-MSCs and pericytes (Hinz 2007). Pericyte-derived 
myofibroblasts have been implicated in kidney fibrosis as collagen-producing cells 
(Ballhause et al. 2014, Duffield 2014, LeBleu et al. 2013) and in dermal fibrosis where 
the majority of collagen producing cells were generated from a Pdgfrβ+NG2+ 
subpopulation (Dulauroy et al. 2012). It has been suggested that nestin and ADAM12 
may be key regulators that determine the pericyte to myofibroblast transition (Bodnar 
et al. 2016, Dulauroy et al. 2012). However the precise signals that regulate the 
functions of pericytes in wound healing and fibrosis are yet to be deciphered and 
additional complexity comes from recent papers that pericytes may represent a 
heterogeneous population of cells which have functional subclasses (Ansell and Izeta 
2015) 
Understanding the role of mesenchymal progenitor cells in physiological endometrial 
repair may inform the mechanisms responsible for gynaecological disorders including 
heavy menstrual bleeding, endometriosis and Asherman’s syndrome (Dimitrov et al. 
2008, Deane et al. 2013). These conditions are all associated with abnormal 
endometrial function which may in part be attributed to abnormalities in the number, 
function, location and/or regulation of stem/progenitor cells (Gargett and Chan 2006, 
Du and Taylor 2007, Dimitrov et al. 2008). A better understanding of the role(s) of 
stem/progenitor cells in endometrial pathologies is seen as a key goal in developing 
new treatment options. 
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5.1.6 Summary 
The endometrium is a complex multicellular tissue that exhibits ECM remodelling, an 
inflammatory response, hypoxia, vasculature changes and tissue remodelling in 
response to menstruation all of which have roles to play in its regeneration without 
scarring (Spitzer et al. 2012). In Chapter 3 dynamic changes in immune cell 
populations, including the emergence of a unique population of monocyte-derived 
macrophages were identified during dynamic shedding and remodelling of 
endometrium in mice induced to experience artificial ‘menses’. Studies described in 
Chapter 4 have identified a population of putative stem/progenitor cells in the mouse 
endometrium that were identified as perivascular pericytes. In the studies described in 
the current Chapter capitalise on the use of the Edinburgh menses mouse model 
building on previous characterisation of the putative stem cells (pericytes; Chapter 4) 
as a platform to investigate their role in scar-free tissue healing and restoration of 
homeostasis.  
5.2 Aim 
To characterise the phenotype of endometrial pericytes during endometrial tissue 
repair.  
5.3 Experimental Approach 
5.3.1 The Edinburgh menses mouse model  
To investigate the mesenchymal cell contribution to endometrial tissue repair the 
Edinburgh menses mouse model was used. The full protocol is outlined in Section 
2.2.2 and described in Table 2-4 and Figure 2-5 (Cousins et al. 2014, Cousins et al. 
2016b, Cousins et al. 2016d). 
5.3.2 Transgenic mouse lines 
The results in this chapter were generated using the Pdgfrβ-BAC-eGFP reporter mouse 
line, detailed in Section 2.1.1.1, in which GFP reporter protein is expressed under 
control of the Pdgfrβ promoter element: studies detailed in Chapter 4, demonstrated 
that GFP/Pdgfrβ was exclusively expressed in the endometrial stromal compartment. 
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5.3.3 Tissue processing and Immunohistochemistry 
Uterine tissue samples were fixed in 4% PFA for 2 hours at 4°C, rinsed in PBS and 
stored overnight in 18% sucrose at 4°C before being embedded in OCT medium and 
stored at -80°C, as described in Section 2.3. H&E staining and IHC was carried as in 
Section 2.4.1 and 2.4.3 respectively using antibodies in Table 5-1.  
Table 5-1. Antibodies used to interrogate the role of mesenchymal cells in endometrial 
repair using the Edinburgh mouse model of endometrial breakdown and repair. 
Antibody Name Supplier and Cat. No. 
(concentration) 
Dilution Serum block 
Polyclonal rabbit anti-
GFP 













Abcam, ab12905 1/600 Goat 
Monoclonal mouse anti-
αSMA 
Sigma, A-2547 1/10K Horse 
Polyclonal rabbit anti-
CD31 
Abcam, ab28364 (1mg/ml) 1/500 Goat 
Polyclonal rabbit anti-
EpCAM 
Abcam, ab71916 (1mg/ml) 1/2000 Goat 
 
Picrosirius stain (PSR) was carried out as in Section 2.4.2. Images were obtained using 
both brightfield and confocal microscopy as in Section 2.4.4. 
5.3.4 Flow cytometry and FACS 
To interrogate mesenchymal cell populations flow cytometry analysis was performed 
using protocols detailed in Section 2.5 and flow cytometry antibodies outlined in Table 
5-2. FACS was used to isolate specific mesenchymal cell populations from the 
endometrial tissue as detailed in Section 2.5.3. 
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Table 5-2. Flow cytometry antibody panel designed to interrogate mesenchymal cell 
populations in uterine tissue 































650nm 660nm 1/100 
AF488 anti-mouse 
NG2 
Merck, AB5320A4 495nm 519nm 1/100 




650nm 660nm 1/200 
 
5.3.5 RNA extraction and cDNA synthesis 
RNA extraction from cells was carried out using the SimplyRNA Cells Maxwell® 16 
LEV kit (Section 2.6.3) and run on the automated Maxwell® 16 Instrument (Section 
2.6.3.2). The resulting yield of RNA was measured using the LabChip GX Touch 
Nucleic Acid Analyser (Section 2.6.4) and the RNA Pico Sensitivity Assay (Section 
2.6.4.1). 
cDNA samples for qPCR were synthesised using the Superscript VILO cDNA 
Synthesis kit (Section 2.7.1). cDNA samples for NGS were synthesised using the 
NuGEN Ovation RNA-Seq System V2 (Section 2.7.2) while cDNA samples for single 
cell sequencing were synthesised using the ChromiumTM Single Cell 3’ Library & Gel 
Bead Kit V2 (Section 2.10.2). 
5.3.6 Quantitative PCR 
qPCR was used to determine mRNA expression of genes specific to endometrial tissue 
repair as detailed in Section 2.8 using primers detailed in Table 2-17. Quantification 
of gene expression and statistical analysis was performed as outlined in Section 2.8.3. 
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5.3.7  Next Generation Sequencing 
To complement and extend data detailed in Chapter 4 mesenchymal cells were isolated 
from Pdgfrβ-BAC-eGFP uterine tissues at 24hrs of the mouse model of endometrial 
breakdown and repair. RNA extraction and cDNA synthesis was carried out as 
described in Section 2.9.1. Samples were sent to Edinburgh Genomics for sequencing 
on the HiSeq 4000 75PE platform according to standard protocols at the facility 
(Section 2.9.2). Bioinformatic analysis of the NGS data was carried out by Jonathan 
Manning at the Edinburgh Genomics facility, as described in Section 2.9.3. To validate 
sequencing results qPCR was performed on an independent set of RNA samples 
generated from cells isolated from Pdgfrβ-BAC-eGFP endometrial tissues (Section 
2.9.4). 
5.3.8  Single Cell Sequencing 
Single cell sequencing was carried out on two populations of mesenchymal cells 
isolated from Pdgfrβ-BAC-eGFP uterine tissues: a) at 24hrs of the mouse model of 
endometrial breakdown and repair and b) from cycling adult females (naïve). Pooled 
samples (n=4 from either (a) or (b)) were analysed using Single Cell Sequencing 
technology on the 10x Genomics platform as detailed in Section 2.10. Samples were 
sent to Edinburgh Genomics (https://genomics.ed.ac.uk/) for sequencing on the 
Illumina NovaSeq platform (Section 2.10.10) and an in-house bioinformatic analysis 
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5.4 Results 
5.4.1 Dynamic changes in mesenchymal cell populations during 
endometrial repair 
Having identified a population of endometrial stromal pericytes (putative 
mesenchymal progenitors) in naïve female mice and characterised their gene 
expression profile (Chapter 4), in the current Chapter their contribution to mechanisms 
underpinning rapid, synchronous, endometrial breakdown and repair was investigated. 
5.4.1.1 Expression of known pericyte markers, Pdgfrβ and CD146, at various time 
points of endometrial breakdown and repair. 
To investigate spatial and temporal changes in location/phenotype of pericyte 
populations during endometrial breakdown and repair, IHC was used to analyse 
expression of two known pericyte identification markers (Pdgfrβ and CD146) in 
endometrial tissues collected at 0, 4, 12 and 24hrs following P4 withdrawal. At 0hrs, 
before decidual tissue breakdown, Pdgfrβ was immunolocalised to cells throughout 
the stromal compartment and to decidual cells: in agreement with results in Chapter 4 
the myometrial and epithelial cells were immunonegative. CD146+ endothelial cells 
surrounded blood vessels that were dense in the decidualised tissue and more evenly 
dispersed in the residual endometrium (Figure 5-1 (A)). Pdgfrβ+/CD146+ pericytes 
could be identified in perivascular locations consistent with a pericyte phenotype as 
discussed in depth in Chapter 4 (Figure 5-1 (A) arrows). At 4hrs, during initiation of 
decidual breakdown, Pdgfrβ+ cells were readily detected in the residual 
(non-decidualised) endometrium however expression by decidualised cells was 
decreased (Figure 5-1 (B)). CD146 expressing endothelial cells were abundant 
throughout the tissue which displayed a dense vasculature in the decidua however there 
was no association with Pdgfrβ expression in the decidualised tissue (Figure 5-1 (B). 
Notably, Pdgfrβ+/CD146+ (pericytes) were exclusive to the residual endometrium and 
could not be detected in the decidualised tissue (Figure 5-1 (B) arrows).  
At 12hrs active tissue breakdown was occurring and apoptosis of decidual cells could 
be detected by altered nuclear morphology (chromatin condensation, nuclear 
shrinkage, DNA fragmentation as determined by DAPI staining). At this time, Pdgfrβ 
was expressed predominantly by cells of the residual endometrium with some cells in 
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the shed tissue expressing Pdgfrβ (Figure 5-1 (C)). CD146 expressing endothelial cells 
(and vessels) were present throughout the tissue but there was evidence of vessel 
degeneration in the shed tissue (Figure 5-1 (C) arrow heads). As noted at 4hrs, cells 
co-expressing Pdgfrβ and CD146 (pericytes) were only located in the residual 
endometrium and could not be detected in the shed tissue (Figure 5-1 (C) arrows). 
During active tissue repair (24hrs), Pdgfrβ was exclusively expressed by stromal cells 
in the residual endometrium and not detected in cells of the shed tissue creating a clear 
distinction between the two tissue regions (Figure 5-1 (D) dashed line). In contrast to 
12hrs, no CD146 expressing endothelial cells were detected in the shed tissue 
indicating that full vessel degeneration had occurred (Figure 5-1 (D)). In the residual 
endometrium Pdgfrβ+/CD146+ pericytes were located around blood vessels and in 
close proximity to edge of the detached shed tissue (Figure 5-1 (D) arrows). In 
summary, these results demonstrate dynamic changes in both the vasculature and 




















Is Figure 5-1. IHC detection of Pdgfrβ and CD146 expression in mouse uterine tissues before (0hrs after P4 withdrawal) and during tissue 
breakdown (4 and 12hrs) and repair (24hrs). The expression of Pdgfrβ (red) and CD146 (green), co-expression of which identifies pericytes (arrows), 
was examined in uterine tissues collected from the Edinburgh menses mouse model at various time points of the breakdown and repair phases. Pdgfrβ is 
expressed by stromal fibroblasts and pericytes while CD146 is expressed by endothelial cells and pericytes. (A) At 0hrs Pdgfrβ and CD146 were expressed 
throughout the decidualised tissue and residual endometrium and double positive cells (arrows) could be detected in association with blood vessel 
structures. (B) At 4hrs, during the initiation of tissue breakdown Pdgfrβ expression was decreased in the decidualised tissue while CD146 was expressed 
throughout the tissue. Blood vessesl in the decidualised tissue did not have double positive cells (arrows) associated with them. Double positive cells were 
located in the residual endometrium (C) At 12hrs, during active tissue breakdown, Pdgfrβ and CD146 were expressed in the residual endometrium and 
there was evidence for vascular degeneration in the shed tissue as (arrow heads) where CD146 expressing blood vessels appear smaller and broken. Again 
double positive cells were confined to the residual endometrium (arrows). (D) At 24hrs, during active tissue repair Pdgfrβ and CD146 were exclusively 
expressed in the residual endometrium while the shed tissue was completely negative. Double positive cells (arrows) were located along the stromal 
surface denuded of epithelium. Decidua (D), residual endometrium (RE), myometrium (M), lumen (L), shed tissue (ST) blue dashed line= boundary 
between decidualised/shed tissue and residual endometrium (representative images, n=4 for each time point).  
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5.4.1.2 Association of pericytes with vasculature in the endometrium during 
endometrial repair 
To better understand the relationship between pericytes and the vasculature during 
endometrial repair processes, IHC was used to assess the location endothelial cells 
(CD31+) and NG2+ cells which were previously identified as endometrial pericytes in 
naïve mice (see results in Chapter 4). Expression was compared between naïve uterine 
tissue and uterine tissues collected at the 24hrs time point of the Edinburgh menses 
mouse model (actively repairing). 
In naïve samples CD31+ endothelial cells could be identified dispersed throughout the 
basal endometrial stroma. The NG2+ pericytes were closely associated with these 
structures (Figure 5-2 (A) yellow arrows) and were not located anywhere else in the 
tissue. In repairing samples (24hrs) blood vessel structures (CD31+ endothelial cells) 
were still detected in the residual endometrial stroma with NG2+ pericytes surrounding 
them (Figure 5-2 (B) yellow arrows) as in naïve tissue. Notably however, in these 
tissues there were also NG2+ cells that were not associated with CD31+ blood vessel 
structures (Figure 5-2 (B) white arrows) but were instead located in close proximity to 
the denuded stromal surface and degrading decidual edge (Figure 5-2 (B), dashed line).  
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Figure 5-2. Investigation of the distribution of CD31 (red) expressing endothelial cells 
and NG2 (green) expressing pericytes in naïve uterine tissue (control) and uterine tissue 
collected at 24hrs following P4 withdrawal (repairing) from C57BL/6 mice. (A) CD31+ 
endothelial cells are closely surrounded by NG2+ pericytes in naïve tissue. (B) CD31+ 
endothelial cells are closely surrounded by NG2+ pericytes in residual endometrium of 
repairing tissue while NG2+ cells can also be detected in close proximity to the repairing 
stromal surface (white dashed line) (representative images, n=6 for each, scale bar = 50µm). 
 
To further analyse these novel findings, cell counting was performed to determine the 
number of blood vessel structures per field of view (FOV) and then the number of 
endothelial cells (CD31+ with visible nucleus) and pericytes (NG2+ with visible 
nucleus) per FOV. Two FOVs were imaged for each tissue section (n=4 mice, n=16 
FOV). Representative images of naïve and 24hrs tissue sections can be seen in Figure 
5-3 (A-B respectively) outlining the method used to distinguish cell types for counting.  
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Figure 5-3. Assessment of CD31 (red) expressing endothelial cells and NG2 (green) 
expressing pericytes in naïve uterine tissue (control) and uterine tissue collected at 24hrs 
(repairing). Expression of CD31 and NG2 in (A) naïve and (B) repairing uterine tissues 
(representative images, n=4). (A’-B’) Numbers are assigned to each blood vessel structure 
denoted as having CD31+ endothelial cells present. Red ‘N’ represent nuclei of CD31+ cells 
and yellow ‘N’ represent nuclei of NG2+ cells. Blue dashed line is the border between residual 
endometrium and shed tissue undergoing breakdown (scale bar = 50µm). 
 
Based on the criteria outlined in Figure 5-3, a number of parameters were counted in 
both naïve and repairing uterine tissue samples (n=4). There was a significant decrease 
in the number of blood vessels present in the endometrial stroma at 24hrs (naïve: 
26.44±1.39; repairing: 16.25±0.85, unpaired t-test, p<0.0001) (Figure 5-4 (A)) 
consistent with the fact that a large amount of the tissue has been lost during decidual 
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breakdown and shedding. Similarly the number of CD31+ endothelial cells was 
reduced while there was a small increase in the number of pericytes (Figure 5-4 (B)). 
This resulted in a shift in the pericyte:endothelial cell ratio from a mean of 1.27±0.02 
in naïve tissues to a mean of 2.03±0.06 in repairing tissues (Figure 5-4 (C)). Notably 
in the naïve tissue 99.5±0.24% of the NG2+ pericytes were associated with CD31+ 
blood vessel structures however in the repairing tissue this decreased to 67.48±1.76% 
(Figure 5-4 (D)) while there was a corresponding increase in the percentage of NG2+ 
cells located in the endometrial stromal tissue that were not associated with blood 
vessel structures (0.5±0.24 versus 32.52±1.75) (Figure 5-4 (E)). 
  
 
Figure 5-4. Quantification of blood vessels, endothelial cells and pericytes in naïve and 
repairing uterine tissue. (A) Number of blood vessels per FOV. (B) Number of blood vessel 
associated cells: endothelial cells (CD31+) and pericytes (NG2+) per FOV. (C) 
Pericyte:endothelial cell ratio. (D) Number of pericytes associated with blood vessels and (E) 
number of pericytes not associated with blood vessels. # = number (n=4, unpaired t-test, 
*p<0.05, ***p<0.001 ****p<0.0001).  
 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   278 
 
5.4.1.3 Flow cytometry analysis of GFP+ cell populations in Pdgfrb-BAC-eGFP 
transgenic mouse uterus at various time points of endometrial breakdown and 
repair 
To more accurately assess changes in mesenchymal cell populations during 
endometrial breakdown and repair, flow cytometry analysis of Pdgfrb-BAC-eGFP 
transgenic mouse uterine tissue was performed. A full characterisation of this 
transgenic mouse line and associated mesenchymal subpopulations was discussed in 
Chapter 4. Briefly, in Pdgfrb-BAC-eGFP uterus GFP expression is a readout of Pdgfrβ 
promoter activity, and as outlined in Section 4.4.2.3, two GFP expressing 
subpopulations can be identified in uterine tissue recovered from naïve females using 
flow cytometry based on both GFP intensity and relative expression of CD146: 
GFPdimCD146- stromal fibroblasts and GFPbrightCD146+ pericytes.  
Using parameters validated in Chapter 4 the same subpopulations were quantified in 
Pdgfrb-BAC-eGFP uterine tissue 12hrs (tissue breakdown), 24hrs (tissue repair) and 
48hrs (tissue remodelling) after P4 withdrawal using the parameters and analytical 
gates described in Figure 4-6 and 4-7. As before, GFP+ subpopulations in naïve 
samples were distinguished by relative expression of CD146: GFPdim cells were 
CD146- and GFPbright cells were CD146+ (Figure 5-5 (A)). At 12hrs, the same two 
populations could be detected but there was a further population identified as being 
GFPdimCD146mid (Figure 5-5 (B)). At 24hrs, these three subpopulations were present 
with an apparent increase in the numbers of GFPdim CD146mid (intermediate) cells 
(Figure 5-5 (C)). By 48hrs, the subpopulations once more mirrored those seen in naïve 
tissues: GFPdimCD146- and GFPbright CD146+ and the third GFPdimCD146mid 
(intermediate) population (Figure 5-5 (D)) was no longer detectable consistent with 
the completion of tissue repair and return to homeostasis.  
Analysis of the flow cytometry data revealed that there was no significant difference 
in the proportions of GFPdimCD146- (stromal fibroblasts) at any time point of tissue 
breakdown and repair, although there was a trend for a decrease at 24hrs (Figure 5-5 
(I)). In contrast, there was a significant increase in the number of GFPbrightCD146+ 
(pericytes) at 24hrs when compared to both naïve and 12hrs samples (naïve: 
16.84±1.23%; 12hrs: 12.38±1.57% versus 24hrs: 23.97±2.05%, p=0.0299 and 
p=0.0002 respectively). At 48hrs the proportion of GFPbrightCD146+ was comparable 
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to naïve samples and decreased relative to 24hrs (23.97±2.05% versus 16.98±1.28%, 
p=0.0343) (Figure 5-5 (J)). 
Flow cytometry provided evidence for a population of stromal cells characterised as 
GFPdim CD146mid (intermediate cells) that were unique to repairing tissue and 
significantly increased between naïve and 24hrs (1.31±0.15% versus 14.73±2.49%, 
p<0.0001) and between 12 and 24hrs (4.388±0.97% versus 14.73±2.49%, p=0.0023) 
but less abundant at 48hrs (24 hours 14.73±2.49%, 48hours 3.536±0.62%, p=0.0009) 
(Figure 5-5 (K)). Although these novel results identified a population of transient 
intermediate cells that are specific to repairing endometrial tissue further investigation 
was required to better understand their location and phenotype. 
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Figure 5-5. Flow Cytometry analysis of GFP+ subpopulations in Pdgfrβ-BAC-eGFP 
uterus at various time points of endometrial tissue breakdown (12hrs), repair (24hrs) 
and remodelling (48hrs). (A) Flow cytometry plots analysing expression of CD146 (y-axis) 
in different GFP+ cell populations (x-axis) in naïve uterine tissue and uterine tissues 12, 24 
and 48hrs following P4 withdrawal (Pdgfrβ-BAC-eGFP). Parent gates: All cells > Single cells 
> Live cells > CD31-CD45- cells > GFP+ cells (see Chapter 4, Figure 4-6). (B) Pie charts 
summarising the composition of the GFP+ cell compartment and changes in relative 
abundance of each GFP+ subpopulation during endometrial breakdown and repair (frequency 
of total GFP+ cells). (C) Quantification of GFP+ subpopulations represented as a frequency 
of total GFP+ cells in uterine tissue 12, 24 and 48hrs following progesterone withdrawal 
(naïve: n=8; 12hrs: n=8 , 24hrs: n=13, 48hrs: n=8) (1 way ANOVA, Tukey’s multiple 
comparisons test, *= p<0.05, **= p<0.01 ***= p<0.001 ****= p<0.0001). 
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5.4.2 Investigation of the potential of mesenchymal cells to undergo 
a mesenchymal to epithelial transition (MET) during 
endometrial repair  
Re-epithelialisation is a fundamental aspect of endometrial tissue repair. Previous 
results in the Saunders group generated using mice identified three synchronous 
mechanisms that could contribute to re-establishment of an intact epithelial cell layer: 
epithelial cell proliferation, epithelial cell migration and a mesenchymal to epithelial 
transition (MET) (Cousin et al, 2014). Although MET has been identified as a potential 
mechanism, the contribution of cells in the mesenchymal compartment that may have 
the ability to trans differentiate as well as the signals that govern METare not known.  
5.4.2.1 Flow cytometry analysis of epithelial cell markers by GFP+ cells 
populations in Pdgfrβ-BAC-eGFP transgenic mouse uterus at various time points 
of endometrial breakdown and repair 
To investigate if GFP+ mesenchymal cells in the Pdgfrb-BAC-eGFP mouse uterus 
undergo MET and contribute to re-epithelialisation during endometrial repair, flow 
cytometry analysis was performed on uterine tissues collected at 12hrs (breakdown), 
24hrs (repair) and 48hrs (remodelling) following P4 withdrawal. Flow cytometry 
histograms in Figure 5-6 (A) display expression of EpCAM in each of the GFP+ 
subpopulations defined in Figure 5-9 (A): GFPdimCD146- cells (stromal fibroblasts), 
GFPbrightCD146+ cells (pericytes) and GFPdimCD146mid  cells (novel intermediate 
cells). In naïve uterine tissue, the intermediate cell population was not detectable and 
neither stromal fibroblasts nor pericytes expressed EpCAM consistent with their 
mesenchymal phenotype, and distinguishing them from epithelial cells in normal 
tissue (Figure 5-6 (A)). 
Assessment of these data has shown changes in the expression of EpCAM by GFP+ 
mesenchymal cells in naïve; n=8 uterine tissues and uterine tissues at 12hrs; n=8, 
24hrs; n=14 and 48hrs; n=8 of the Edinburgh menses mouse model. There was a 
significant increase in EpCAM expression by stromal fibroblasts at 24hrs when 
compared to either naïve tissue or samples recovered at 12hrs (naïve: 0.27±0.04%, 
12hrs: 1.49±0.44%, 24hrs: 7.73±2.08%, p=0.026 and p=0.045 respectively) (Figure 
5-6 (B)). In pericytes there was a significant increase in EpCAM expression when 
comparing: naive with 12hrs (0.178±0.04% versus 14.93±1.89%, p<0.0001); naïve 
with 24hrs (0.178±0.04% versus 34.12±2.07%, p<0.0001); and naïve with 48hrs 
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(0.178±0.04% versus 8.94±1.17%, p=0.017). There was also a significant increase in 
expression of EpCAM between 12hrs and 24hrs (14.93±1.89% versus 34.12±2.07%, 
p<0.0001) followed by a significant decrease between 24hrs and 48hrs (34.12±2.07% 
versus 8.94±1.17%, p<0.0001) (Figure 5-6 (C)). When assessing EpCAM expression 
by intermediate cells there was a significant increase between naive and 12hrs 
(0.017±0.01% versus 23.45±1.34%, p<0.0001) and naive and 24hrs (0.017±0.01% 
versus 34.03±2.27%, p<0.0001); a significant increase between 12hrs and 24hrs 
(23.45±1.34% versus 34.03±2.27%, p=0.001); and a significant decrease between 
12hrs and 48hrs (23.45±1.34% versus 0.434±0.08%, p<0.0001) and 24hrs and 48hrs 
(34.03±2.27% versus 0.434±0.08%, p<0.0001) (Figure 5-6 (D)). Results demonstrate 
an increase in EpCAM expression by all three mesenchymal subpopulations, 
suggesting they can undergo an MET during endometrial repair.  
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Figure 5-6. Flow Cytometry analysis of the expression of epithelial cell marker EpCAM 
by GFP+ cell populations in Pdgfrβ-BAC-eGFP mouse uterus at various time points 
endometrial breakdown and repair (12hrs: breakdown, 24hrs: repair, 48hrs: 
remodelling). Flow cytometry analysis of GFP+ cells was achieved by employing the gating 
strategy defined in Figure 5-9: All cells > Single cells > Live cells > CD31-CD45- cells > GFP+ 
cells. (A) Histograms displaying the expression of EpCAM (x-axis) in GFP+ cell populations: 
GFPdimCD146- stromal fibroblasts; GFPbrightCD146+ pericytes and GFPdimCD146mid 
intermediate cells in naïve Pdgfrβ-BAC-eGFP uterine tissue and at 12, 24 and 48hrs of the 
Edinburgh menses mouse model. Analytical gates to examine each population are defined in 
Figure 5-9 (A)). Analysis of EpCAM expression calculated as a percentage of each cell 
subpopulation: (B) Stromal fibroblasts (GFPdimCD146-), (C) pericytes (GFPbrightCD146+) and 
(D) intermediate cells (GFPdimCD146mid) (naïve: n=8; 12hrs: n=8 , 24hrs: n=13, 48hrs: n=8) 
(one way ANOVA, Tukey’s multiple comparisons test, *= p<0.05, **= p<0.01 ***= p<0.001 
****= p<0.0001). 
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5.4.2.2 Expression of GFP and EpCAM in uterine tissue during endometrial 
repair determined by IHC 
To complement flow cytometry data, IHC was used to generate spatio-temporal 
information about GFP+EpCAM+ cells in repairing Pdgfrβ-BAC-eGFP uterine tissue. 
In naïve tissue, GFP was expressed exclusively by mesenchymal stromal cells, both 
GFPdim stromal fibroblasts and GFPbright pericytes (Figure 5-7 (A) white arrows) while 
EpCAM was expressed exclusively by epithelial cells both luminal and glandular 
(Figure 5-7 (A), red arrows), distinguishing between the two cellular compartments. 
Interestingly, in the experimental animals at 24hrs, while the GFP+EpCAM- stromal 
cells and GFP-EpCAM+ epithelial cells were still present in the tissue (Figure 5-7 (B) 
white and red arrows respectively), there was also a population of GFP+EpCAM+ cells 
that were located on the luminal edge of the endometrium that displayed an 
epithelial-like morphology (Figure 5-7 (B), yellow arrows). At 48hrs no 
GFP+EpCAM+ cells were detected in the tissue and the two distinct cell compartments 
were again apparent: GFP+EpCAM- stromal cells and GFP-EPCAM+ epithelial cells 
(Figure 5-7 (C), white and red arrows respectively).  
These results provided further evidence to support our original findings that suggested 
mesenchymal cells undergo MET to re-instate the epithelial cell layer during 
endometrial repair (Cousins et al. 2014) however they do not allow us to determine 
whether these transdifferentiating cells are stromal fibroblasts or pericytes. 
Specifically, as the reporter in the Pdgfrβ-BAC-eGFP transgenic mouse is a knock-in, 
GFP is only expressed when the Pdgfrβ gene promoter is active and GFP is being 
actively synthesised. This means that when the Pdgfrβ gene promoter is no longer 
active, as will be the case in a fully transdifferentiated ‘epithelial’ cell, GFP expression 
will reduce according to the half-life of the protein (~25hrs) with further dilution in 
actively proliferating cells.  
Therefore in follow up studies efforts were made to validate an alternative transgenic 
strategy to use a lineage tracing system which would allow for persistence of labelling 
in pericyte derived cell type(s). 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   285 
 
 
Figure 5-7. Expression of GFP and EpCAM in Pdgfrβ-BAC-eGFP uterine tissue during 
endometrial repair. (A) In naïve tissue there are distinct populations of GFP+ mesenchymal 
cells (white arrows) and EpCAM+ epithelial cells (red arrows). (B) At 24hrs there are GFP+ 
mesenchymal cells (white arrows), EpCAM+ epithelial cells (red arrows) and GFP+EpCAM+ 
cells (yellow arrows) located in an area of active re-epithelialisation. (C) By 48hrs no 
GFP+EpCAM+ cells were detected and there are only distinct populations of GFP+ 
mesenchymal cells (white arrows) and EpCAM+ epithelial cells (red arrows) as in the naïve 
tissues. Residual endometrium (RE), shed tissue (ST), myometrium (M), epithelium (E), 
lumen (L) (representative images, n=8-10 mice per group, scale bar H&E=500µm, scale bar 
IHC=50µm). 
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5.4.3 Profiling mesenchymal cells from Pdgfrβ-BAC-eGFP 
endometrial tissue during endometrial repair (24hours) by 
next generation sequencing  
Studies using Flow cytometry described above identified dynamic changes in the 
intensity of GFP and co-expression of EpCAM with the apparent emergence of a 
transient population at 24hrs after progesterone withdrawal. As this time point has 
emerged in the studies in both this chapter and Chapter 3 as the most dynamic time 
in endometrial remodelling/wound repair further transcriptional analysis was 
undertaken on 24hrs samples.  
5.4.3.1 RNA and cDNA sample preparation 
To characterise the transcriptomic profile of mesenchymal cells during endometrial 
repair, total GFP+ cells were isolated from Pdgfrβ-BAC-eGFP uterine tissues collected 
at 24hrs: RNA concentration and quality were analysed using LabChip GX Touch 
technology (Chapter 2; Section 2.6.4). This sample set was prepared at the same time 
as the naïve (control/cycling) samples the analysis of which was described in detail in 
Chapter 4. In the current chapter we sought insights into the transcriptomic phenotype 
of the different GFP+ cells in the repairing tissue by comparing the previously 
described dataset (naïve) with the ‘repairing’ gene set. To provide a direct comparison 
between these sample sets the naïve samples (Chapter 4) are reproduced in Figure 5-8. 
The repairing samples had a mean RNA concentration of 0.98±0.13ng/µl and all 
samples had an RNA Integrity Number (RIN) greater than 8.7 (Figure 5-8 (A)). As 
described in Chapter 4 these concentrations however did not meet the minimum 
requirement requested by Edinburgh Genomics (>20ng/µl) therefore cDNA synthesis 
and amplification was performed (Chapter 2; Section 2.7.2). Following this the 
repairing samples had a mean cDNA concentration of 86.62±4.61ng/µl and all samples 
had an A260/280 ratio greater than 1.8 (Figure 5-8 (B)).  
5.4.3.2 TruSeq mRNA Sequencing 
All samples were sent to Edinburgh Genomics for RNA sequencing within the 
Genomics Facility (http://genomics.ed.ac.uk/). TruSeq DNA Nano gel free libraries 
(350bp inserts) were prepared from each of the cDNA samples and sequence data was 
generated on the HiSeq 4000 75PE platform to yield at least 290M + 290M reads. 
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Figure 5-8. LabChip GX Touch analysis of RNA/cDNA quantity and quality for samples 
generated for RNA sequencing by Edinburgh Genomics. (A) RNA concentrations (ng/ul) 
of naive and repairing samples. (B) RIN score of the naïve and repairing samples, dashed line 
represents the minimum score required by Edinburgh Genomics (8.7). (C) LabChip GX touch 
read out gel results for the naïve and repairing samples. (D) cDNA concentrations (ng/ul) of 
naïve and repairing samples after performing cDNA amplification using the NuGEN Ovation 
V2 system. (E) A260/A280 ratios of the naïve and repairing samples, dashed line represents 
the minimum ratio required by Edinburgh Genomics (1.8) (naïve: n=8; repairing: n=8). 
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5.4.3.3 Bioinformatic data handling 
Bioinformatic analysis was performed by Jonathan Manning at Edinburgh Genomics 
as described in Chapter 2: Section 2.9.3. A summary of the key statistics associated 
with read pair mapping and counting is outlined in Table 4-3 (Chapter 4). 
5.4.3.4 Principle component analysis 
As part of the initial analysis, a PCA on normalised and filtered expression data was 
carried out by Jonathan Manning to explore observed patterns with respect to 
experimental factors. Briefly, the cumulative proportion of variance associated with 
each factor was used to study the level of structure in the data, assessed with an 
ANOVA test. As seen in Figure 5-9 (A), individual naive and repairing samples 
clustered together showing a large degree of similarity between samples of the same 
experimental group however when comparing groups there was a large separation on 
the PCA demonstrating that the transcriptomic profiles of each group were very 
different (Figure 5-9 (A)). As an extension of the PCA I analysed expression data using 
BioLayout Express 3D software which determines the correlation between sample 
groups based on individual gene expression levels. Sample cluster graphs generated 
(both 2D and 3D) confirmed a high correlation in the transcriptomic profiles of 
samples within a group but low correlation between naive and repairing groups (each 
node represents a sample and each line represents similarity between them) (Figure 5-
9 (C)). 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   289 
 
 
Figure 5-9. Exploratory analysis of the relatedness between naive and repairing sample 
groups.  (A) Principle component plot of the first and second components from PCA analysis 
using selected naive and repairing samples (n=7 and n=5 respectively). (B) Boxplots showing 
expression distributions among samples at different stages of pre-processing (log2 scale), 
using selected samples. Note that raw and filtered values are expressed in counts, while 
normalised values are in counts per million (CPM). Points outside whiskers are outliers at 1.5 
x IQR where IQR is the inter-quartile range. (C) The correlation of RNASeq datasets between 
naïve and repairing samples was determined in BioLayout Express3D based on individual 
gene expression levels and a sample cluster graph generated (Pearson’s correlation of R>0.8 
and intensity >1 of dataset with fold change >2 or <-2 and FDR <0.05). Nodes represent 
individual samples and edges represent the degree of correlation between them, 
colour/thickness is equivalent to how similar the samples are. 3D sample cluster graph 
displaying a high disparity and little correlation between the groups (naive: n=6; repairing: 
n=5). 
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5.4.3.5 Differential gene expression analysis 
Differential gene expression analysis was carried out with EdgeR4 (version 3.16.5) 
and the quasi-likelihood (QL) F-test using the contrast between naïve and repairing 
sample groups (Jonathan Manning, Edinburgh Genomics). The total numbers of 
differentially expressed genes are outlined in Table 5-3 according to the thresholds on 
minimum fold-change (2) and maximum false discovery rate (FDR<0.05). 
 
Table 5-3. Total numbers of differentially expressed genes between naïve and 
repairing sample groups 
Contrast  Upregulated Downregulated 
Naive vs repairing  616 1013 
 
Gene expression data can be visualised as a heatmap, fold change plot and volcano 
plots which illustrate the most differentially expressed genes between samples (Figure 
5-10). Note panel A shows a clear separation between the two datasets based on the 
top 50 differentially expressed genes. In panels B and C red dots highlight differential 
expression. As both sample groups were generated following sorting of total GFP+ 
cells this Figure gives a striking illustration of the changed of patterns of expression in 
the mesenchymal cell population(s) in response to endometrial ‘injury’. Lists of the 
top 20 most significantly upregulated and downregulated genes in repairing samples, 
as determined by FDR<0.05, are presented in Tables 5-4 and Table 5-5 respectively.  
The full list of the top 100 genes is presented in Appendices 5-1; 5-2. 
 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   291 
 
 
Figure 5-10. Differential gene expression analysis between naïve and ‘repairing’ sample 
groups. (A) Heatmap showing the top 50 most differentially expressed genes by false 
discovery rate (FDR <0.05) between the naïve and repairing groups (616 upregulated genes 
and 1013 downregulated genes in total. (B) Fold change and (C) volcano plot illustrating 
differential expression between groups naive and repairing as defined by group. Volcano plots 
illustrate log(2) fold change vs –log(10) false discovery rate. The horizontal dashed line 
represents the specified FDR threshold for significance (0.05), dotted lines in both plots 
represent the specified fold change threshold (2) in both the positive and negative directions. 
Points passing both thresholds are coloured red and are differentially expressed.  
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Table 5-4. Top 20 most significantly upregulated genes in repairing samples when 
compared to naïve samples as determined FDR <0.05. Table displays the mean CPM 
for each gene in naïve and repairing tissues and the associated LogFC and p-value. 




LogFC P-value FDR <0.05 
Mmp10 0.192611314 495.95818 11.2432086 9.71E-06 0.001359377 
Erv3 0.045257809 84.0704655 10.71748135 6.49E-06 0.001024937 
Mmp12 0.112752673 154.8354046 10.3423004 1.04E-06 0.000252339 
Mmp13 0.255816556 231.8863547 9.800783712 0.00017493
1 
0.009061145 
Sprr2h 0 7.674410321 9.660603129 9.79E-05 0.006430275 
Cd177 0 7.251583962 9.575453439 0.00125461
6 
0.028421027 
Jakmip1 0.008520914 11.10935265 9.187891507 1.44E-06 0.000338097 
Tnfrsf9 0.01261252 11.4483069 9.164302927 1.98E-05 0.002174383 
Slpi 0 5.283499957 9.129152766 0.00043000
7 
0.016091638 
Cxcl5 0.145989044 83.00211007 8.998444358 7.58E-08 4.63E-05 
Parvb 0.024675058 13.62585254 8.521122087 0.00020797
2 
0.01010534 
Onecut3 0.018492264 9.958627792 8.437463465 0.00030168
9 
0.012868605 
Gpr55 0 2.800546567 8.204691479 0.00086368
9 
0.023524625 
Tnf 0.009246132 5.640869553 8.197978843 1.24E-05 0.001582367 
Tnc 5.473751472 1555.833241 8.151385875 1.28E-07 6.48E-05 
Abca13 0 2.284936928 7.896652941 0.00064176
2 
0.0201544 
Gareml 0 2.03374187 7.727634526 0.00217357
4 
0.037626717 
Olfr505-ps1 0 1.715232757 7.487670018 0.00187094
8 
0.035214312 
Tph1 0 1.675092592 7.471207085 0.00029689
5 
0.012702769 
Lama1 0.579926874 96.79574453 7.402468391 1.94E-06 0.000397164 
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Table 5-5. Top 20 most significantly downregulated genes in repairing samples when 
compared to naive samples as determined by FDR <0.05, Table displays the mean 
CPM for each gene in naïve and repairing tissues and the associated LogFC and p-
value. 




LogFC P-value FDR <0.05 
Vcam1 18.87612 0 -10.9576 7.70E-08 4.63E-05 
Ces2g 14.98131 0 -10.6217 1.00E-05 0.001384095 
Clca1 13.28959 0 -10.4559 4.51E-06 0.000767291 
Asb4 13.12932 0 -10.4326 6.08E-07 0.000174188 
Zcchc16 11.60277 0 -10.2586 2.75E-05 0.002711056 
Tmod1 25.90097 0.015361301 -9.92398 2.48E-09 2.76E-06 
Sphkap 24.39947 0.014478712 -9.84058 2.95E-08 2.26E-05 
Crabp1 8.041571 0 -9.73353 0.000312 0.01311522 
Aldh1a1 123.7077 0.128831026 -9.72553 5.78E-12 6.43E-08 
Ltf 7.409469 0 -9.6104 5.98E-05 0.004668477 
Il31ra 7.352368 0 -9.59967 2.02E-06 0.000409847 
Ube2t 7.344575 0 -9.59774 7.67E-06 0.001154335 
Lgr6 96.94894 0.116242478 -9.53581 3.91E-07 0.000138064 
Adamtsl3 6.880863 0 -9.50374 0.000138 0.007983703 
Pcdh12 6.161984 0 -9.34644 8.06E-06 0.001196664 
Arsi 5.815426 0 -9.27028 2.38E-05 0.002495151 
Fhl5 5.00413 0 -9.04249 9.94E-05 0.006472006 
Gfra1 32.28628 0.049495506 -9.042 2.12E-07 8.59E-05 
Prss23os 4.505037 0 -8.89254 3.64E-05 0.003290656 
Olfr78 13.14954 0.019749985 -8.89158 1.51E-06 0.000342751 
 
5.4.3.6 Gene Ontology and Gene Set Enrichment Analysis (GSEA) 
To gain insights into the processes that might be altered in the mesenchymal 
compartment of the repairing endometrium an initial gene ontology analysis was 
carried out using the online Gene Ontology Consortium platform 
(http://www.geneontology.org/) inputting the top 100 up and down regulated genes as 
summarised in Table 5-6. This analysis suggested processes enriched by upregulated 
genes were associated with smooth muscle cell function, blood vessel function and 
regulation of the inflammatory response. Interestingly there were a number of genes 
that have previously been identified as involved in myofibroblast differentiation and 
smooth muscle contraction consistent with FMT and the morphogenesis of an 
epithelial sheet consistent with MET which would be in agreement with other data 
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described in this Chapter. Processes enriched by downregulated genes were associated 
with collagen organisation, cell adhesion and developmental process. 
Table 5-6. Gene Ontology associated with the top 100 up- and down-regulated genes 
in mesenchymal cells during endometrial repair, fold enrichment scores and associated 
gene list for each term. 
Top 100 upregulated genes in mesenchymal cells during endometrial repair 
Gene Ontology Term Fold Enrichment Associated Genes 
Smooth muscle 
contraction 
6.06 Smad5. Cacna1c, Kcnma1, Rgs2, Ednra, 
Gatm 
Response to wounding 5.66 Mmp12, Tnc, Mmp2, Gli1, Serpine2, Notch2, 
Dpysl3, Cd44 
Relaxation of vascular 
smooth muscle 
5.56 Kcnma1, Rgs2, Dock5, Ptgs2, Cacna1c, Stc1, 
Hdac4, Pde4b 
Morphogenesis of an 
epithelial sheet 
5.47 Mmp12, Notch2, Lama1, Cd44, Hoxd11, Tnc, 
Ptch1, Lef1, Ednra, Prickle1, Lmo4 
Blood vessel 
maturation 
5.21 Prickle1, Smad5, Ptgs2, Tmem2, Cdh5, 
Mmp2, Stra6, Lef1, Ednra, Col8a1, Zmiz1, 
Notch2, Prdm1, Lama1 
Regulation of 
vasoconstriction 
5.08 Dock5, Cacna1c, Ptgs2, Mmp2 
Regulation of myoblast 
differentiation 
4.91 Prickle1, Cxcl14, Tnf, Dock5, Smad5, Neo1, 
Rgs2, Igf2, Foxp4, Ptgs2 
Smooth muscle cell 
proliferation 
4.79 Kalrn, Stc1, Tnf, Ptch1, Tgfbi, Ifgbp4, Lef1, 
Ednra, col8a1, Fst, Nothc2, Prdm1 
Neutrophil chemotaxis 4.53 Cxcl5, Itga9, Pde4b, Spp1, Neo1, Nav1, 
Kalrn, Tnf, Cd44, Mmp12 
Regulation of myeloid 
leucocyte 
differentiation 
4.34 Tnf, Lef1, Runx1, Notch2, Zmiz1, Prdm1, 
Inhba  
Top 100 downregulated genes in mesenchymal cells during endometrial repair 
Gene Ontology Term Fold Enrichment Associated Genes 
Collagen fibril 
organisation 
5.06 Col5a1, Col1a2, Adamts2, Col1a1, Col3a1, 
Tmod1, Gdn, Ccl11, Vim, Gdpd2 
Cell adhesion 4.70 Pcdh12, Flrt2, Col6a6, Col15a1, Negr1, 
Cadm2, Col6a1, Col5a1, Col6a5, Bves, 
Adam12, Cd34, Col6a4, Vcam1, Lsamp 
Regulation of cell 
localisation 
4.26 Flrt2, Cacnb2, Lgr6, Gpm6b, Olfr78, Sema3b, 
Dcn, Ptrf, Synpo2, Gsn, Bves, Grin2b, Sparc, 
Anxa1, Per2, Crp, Npy1r, Vim, Col1a1 
Regulation of 
developmental process 
3.85 Flrt2, Gpm6b, Negr1, Dcn, Adam12, Ccl11, 
Vldlr, Dcx, Anxa1, Vim, Col1a1, Asb4, Ptpn5, 
Gdpd2, Crp, Cd34, Sox5 
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Further ontology analysis of the differentially expressed genes dataset was carried out 
using the Gene Set Enrichment Analysis (GSEA) software to identify pathways 
enriched in mesenchymal cells during endometrial repair associated with Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways, Biological Process, 
Canonical Pathways (CP) and Molecular Function (MF) (Figure 5-11 (A-D) 
respectively).  
Signalling pathways identified using this methodology included the Wnt signalling, 
Hedgehog signalling, TGFβ signalling, Notch signalling and Hippo signalling. Other 
prominent pathways included the BMP pathway, HDAC Class I pathway, HIF1 
pathway and β-catenin pathway.  
Biological processes identified were cell junction assembly, adherens junctions, T-cell 
receptor signalling and processes involving trans-differentiation such as osteoblast 
differentiation, blood vessel morphogenesis, angiogenesis and epithelial cell 
morphogenesis. Notably, the data set was also associated with female reproductive 
processes including maternal process involved in female pregnancy, embryo 
implantation and decidualisation. These preliminary gene ontology analyses 
highlighted several processes and pathways that may be essential to regulating 
endometrial repair several of which are in line with previous results but have generally 
broadened the range of genes worthy of further study and drive future hypotheses. 
Looking in more detail at GO terms of interest, enrichment plots and gene lists were 
generated to summarise genes in these groups. The top gene targets associated with 
selected KEGG pathways were identified as follows: Wnt signalling (Lef1, Prkx, 
Prickle 1), Hedgehog Signalling (Ptch1, Gli1, Smo) and TGFβ signalling (Fst, Smad5, 
Inhba).  
Figure 5-12 summarises the top targets associated with regulation of Biological 
Processes which were identified as: blood vessel morphogenesis (Tgfβi, Col8a1, Lef1), 
epithelial cell morphogenesis (Basp1, Wt1, Frmd6) and osteoblast differentiation 
(Lef1, Hdac9, Gli1) respectively. Examples of canonical pathways included: BMP 
signalling (Fst, Smad5, Ski), and collagens (Col8a1, Col26a1, Col18a1). Figure 5-13 
summarises the top targets associated with molecular functions which included were 
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all associated with the Wnt signalling pathway: Wnt protein binding (Sfrp2, Fzd1, 
Sfrp1), Wnt activated receptor activity (Sfrp2, Fzd1, Smo) and β-catenin binding (Lef1, 
Cdh5, Esr1).  
The primary value of this analysis was to identify genes that appeared to play key 
role(s) in more than one pathway including Lef1, Smo, Gli-1, Fst and Fzd1 which 
therefore merit further study and validation of their role(s) in regulation of the 
mesenchymal cell phenotype it was also notable that processes highlighted included 
those which appeared to reflect previously identified changes in tissue architecture 
during endometrial repair including blood vessel and epithelial cell morphogenesis.  
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial tissue breakdown and repair   297 
 
 
Figure 5-11. Gene Set 
Enrichment Analysis 
(GSEA) of genes 
enriched in 
mesenchymal cells in the 
repairing endometrium. 
Gene ontology analysis as 
performed using the 
GSEA software. Analysis 
of pathways enriched by 
putative pericyte genes 
assessing (A) Kyoto 
Encyclopedia of Genes 
and Genomes (KEGG) 
pathways (B) Biological 
Process (BP) (C)  
Canonical Pathways (CP) 
and (D) Molecular 
Function (MF). 
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Figure 5-12. Exploration of gene ontology terms enriched by genes upregulated in 
mesenchymal cells during endometrial repair. Enrichment plots map the relative abundance 
of each gene associated with a gene ontology term in the dataset (green line). A peak towards 
the left shows a positive correlation with the repairing samples while a peak towards the right 
shows a positive correlation with the naïve samples. Heatmaps list the genes associated with 
each gene ontology term and display expression patterns in naïve and repairing samples. 
Enrichment plots and heatmaps for the GO terms (A) Blood vessel morphogenesis, (B) 
epithelial cell morphogenesis and (C) osteoblast differentiation showing strong positive 
correlation to the repairing samples. 
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Figure 5-13. Exploration of gene ontology terms enriched by genes upregulated in 
mesenchymal cells during endometrial repair. Enrichment plots map the relative abundance 
of each gene associated with a gene ontology term in the dataset (green line). A peak towards 
the left shows a positive correlation with the repairing samples while a peak towards the right 
shows a positive correlation with the naïve samples. Heatmaps list the genes associated with 
each gene ontology term and display expression patterns in naïve and repairing samples. 
Enrichment plots and heatmaps for the GO terms (A) Wnt protein binding, (B) Wnt activated 
receptor activity and (C) beta-catenin binding showing strong positive correlation to the 
repairing samples. 
 
5.4.4 Validation of differentially expressed genes in mesenchymal 
cells during endometrial repair 
To narrow the focus of studies to validate the RNAseq results a ranked gene list was 
generated using GSEA software to identify the most differentially expressed genes in 
mesenchymal cells in repairing endometrial tissues when compared to those of naïve 
tissues (Figure 5-14). This method highlighted 48 genes which were also identified as 
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differentially expressed by the analysis performed by Edinburgh Genomics (LogFC <-
2 and FDR <0.05). Taken together these analyses provide a list of genes which may 
be essential to endometrial tissue repair.   
 
 
Figure 5-14. Ranked gene list generated using GSEA based on transcript abundance, as 
determined by CPM, in mesenchymal cells (total GFP+ cells from Pdgfrβ-BAC-eGFP 
uterus) in naïve and repairing samples. Genes, except for those identified with an *, were 
also found to be differentially expressed in the dataset by Edinburgh Genomics (logFC >2 and 
FDR <0.05). Genes highlighted in bold/red were chosen for validation studies. 
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5.4.4.1 Primary validation of mesenchymal cell genes associated with endometrial 
repair 
A new set of RNA samples were generated from cells sorted from naïve and 24 hour 
repairing uteri to provide a validation of the sequencing dataset: qPCR was performed 
using the TaqMan method as described in Chapter 2: Section 2.8 using primers 
designed against nine of the most differentially expressed genes summarised in Table 
5-7. In these experiments genes were selected for validation based on the LogFC >2, 
FDR <0.05, mean CPM in naïve samples >70 and mean CPM in repairing samples 
<100. The availability of reliable primer sequences and antibodies further vindicated 
the choice of target. 
 
Table 5-7. List of highly expressed genes that were significantly upregulated by 
mesenchymal cells (total GFP+ cells from Pdgfrβ-BAC-eGFP uterus) in repairing 
samples when compared to naïve samples as determined by LogFC (>2) in mean 
counts per million (CPM). 








9.702824 598.7562 5.952372 
Prune2 Prune homolog 2 64.69977 414.1897 2.671154 
Cxcl14 CXC Motif chemokine ligand 14 7.475004 116.655 3.958206 
TGFBi Transforming growth factor beta-
induced 
1.289687 112.7243 6.421906 
Runx1 Runt related transcription factor 1 28.23202 308.234 3.445607 
Ptch1 Patched 1 30.71477 341.2435 3.468907 
Col8a1 Collagen type VIII alpha 1 4.055594 235.9686 5.868561 
Prickle1 Prickle homolog 1 16.32713 115.2596 2.812171 
Wt1 Wilms tumor 1 63.55119 159.1044 1.316639 
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The first validation experiment assessed the amount of mRNA encoded by the selected 
genes using RNA extracted from GFP+ cells (GFPbright+GFPdim) isolated from normal 
adult Pdgfrβ-BAC-eGFP endometrial tissues (‘control’) and from Pdgfrβ-BAC-eGFP 
endometrial tissues at 24hrs after progesterone withdrawal (‘repairing). Results 
confirmed that mRNAs encoded by all genes (normalised to reference gene Actb and 
displayed as arbitrary units (AU)) were significantly upregulated in the GFP+ 
mesenchymal cells isolated from repairing; n=5 endometrial tissue when compared to 
naïve samples; n=5 (Figure 5-15): Ptgs2 (0.33±0.04 versus 0.002±0.002, p=0.0001), 
Prune2 (0.97±0.04 versus 0.09±0.03, p<0.0001), Cxcl14 (1.25±0.14 versus 0.37±0.11, 
p=0.0027), Tgfβi (4.16±0.93 versus 0.02±0.01, p=0.0043), Runx1 (4.58±0.60 versus 
0.17±0.05, p=0.0003), Ptch1 (4.20±0.69 versus 0.37±0.22, p=0.002), Col8a1 
(5.71±0.44 versus 0.004±0.002, p<0.0001), Prickle1 (4.53±0.67 versus 1.38±0.45, 
p=0.008), and Wt1 (1.15±0.09 versus 0.63±0.096, p=0.0073). The results were 
therefore in agreement with the sequencing data. 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   303 
 
 
Figure 5-15. Expression of genes upregulated in GFP+ mesenchymal cells generated 
from Pdgfrβ-BAC-eGFP endometrial tissue during homeostasis (naïve) and repair 
(24hrs; repairing) to validate NGS results. Total GFP+ cells were isolated from naïve 
Pdgfrβ-BAC-eGFP uterine tissues and tissues from 24hrs of the Edinburgh menses mouse 
model (24hrs; repairing). RNA was extracted and qPCR used to analyse expression of key 
genes chosen to validate the RNA sequencing results, normalised to Actb and displayed as 
AU. Expression of Ptgs2, Prune2, Cxcl14, TGFβi, Runx1, Ptch1, Col8a1, Prickle1 and Wt1 
were all found to be significantly upregulated in cells of repairing tissue; n=4 when compared 
to naive tissue; n=4. (unpaired t-test,*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).  
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5.4.4.2 Subset validation of mesenchymal cell genes associated with endometrial 
repair 
To extend these findings expression of the same gene set was investigated in RNA 
extracted from subpopulations of GFP+ cells: GFPdim cells (stromal fibroblasts) and 
GFPbright cells (pericytes) isolated independently from both control and repairing 
Pdgfrβ-BAC-eGFP endometrial tissues. qPCR revealed that mRNA of some of the 
genes were significantly upregulated in GFPdim cells isolated from repairing tissues 
when compared to naïve tissues (Figure 5-16): Prune2 (0.71±0.08 versus 0.15±0.05, 
p<0.0001), Cxcl14 (0.8±0.13 versus 0.27±0.03, p=0.0044), Tgfβi (1.96±0.46 versus 
0.04±0.03, p=0.0036), Runx1 (5.52±1.24 versus 0.12±0.003, p=0.0028), Ptch1 
(5.83±0.91 versus 0.58±0.25, p=0.0002), Col8a1 (14.74±0.92 versus 0.001±0.001, 
p=0.0009) and Prickle1 (6.16±0.86 versus 1.17±0.38, p=0.0001), while other genes 
were not significantly upregulated: Ptgs2 (0.11±0.03 versus 0.004±0.001, p=0.1592) 
and Wt1 (1.39±0.47 versus 0.63±0.18, p=0.1718) 
Notably some genes were also significantly upregulated in the GFPbright pericytes cells 
in repairing tissue when compared to naïve tissue: Ptgs2 (0.3±0.06 versus 0.05±0.01, 
p=0.0024), Tgfβi (1.9±0.29 versus 0.02±0.005, p=0.0041), Runx1 (6.21±0.79 versus 
2.16±0.15, p=0.0166) and Col8a1 (20.37±3.33 versus 0.03±0.01, p<0.0001), while 
other genes were not upregulated: Prune2 (0.19±0.04 versus 0.04±0.001, p=0.1664), 
Cxcl14 (0.29±0.05 versus 0.24±0.08, p=0.9173), Ptch1 (2.62±0.34 versus 0.65±0.08, 
p=0.0741), Prickle1 (1.65±0.18 versus 1.23±0.06, p=0.8389), and Wt1 (0.17±0.04 
versus 0.05±0.01, p=0.9437) (Figure 5-16). These results hihglight different responses 
in the two cell populations that merited further study. 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   305 
 
 
Figure 5-16. Expression of genes upregulated in in isolated subpopulations of 
mesenchymal cells (GFPdim stromal fibroblasts and GFPbright pericytes) generated from 
Pdgfrβ-BAC-eGFP endometrial tissue during homeostasis (naïve) and repair (24hrs; 
repairing). GFPdim and GFPbright cells were isolated from naïve Pdgfrβ-BAC-eGFP uterine 
tissues and tissues from 24hrs of the Edinburgh menses mouse model (repairing). RNA was 
extracted and qPCR used to analyse expression of key genes, normalised to Actb and displayed 
as AU. Expression of Prune2, Cxcl14, TGFβi, Runx1, Ptch1, Col8a1, Prickle1 and were all 
found to be significantly upregulated in GFPdim cells of repairing tissue; n=4 when compared 
to naive tissue; n=4. Expression of Ptgs2, Tgfβi, Runx1 and Col8a1 were significantly 
upregulated in GFPbright cells of repairing tissue; n=4 when compared to naïve tissue; n=4 
(unpaired t-test,*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
 
 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   306 
 
5.4.5 Profiling mesenchymal cells from Pdgfrβ-BAC-eGFP 
endometrial tissue from controls and during endometrial repair 
(24hours) by single cell sequencing  
Next generation sequencing of RNA extracted from pooled GFP+ endometrial cells 
identified transcriptomic changes in the total mesenchymal cell population during 
endometrial repair. To extend these findings, with the specific aim of determining 
changes in gene signatures of specific mesenchymal subpopulations, single cell 
sequencing was performed on cells from Pdgfrβ-BAC-eGFP uterine tissues. 
5.4.5.1 Sample validation 
Total GFP+ cells (GFPdim stromal fibroblasts plus GFPbright pericytes) were isolated 
using FACS from normal adult cycling Pdgfrβ-BAC-eGFP (naïve) and from Pdgfrβ-
BAC-eGFP uterine tissues collected 24hrs after progesterone withdrawal (repairing): 
cDNA libraries were prepared for single cell sequencing as outlined in Chapter 2; 
Section 2.10. Each sample was a pool of uterine tissues from four mice to control for 
variation. For presentation of results the samples are labelled as ‘naive and ‘repairing’. 
Prior to sending the samples, QC was carried out using the LabChip GX Touch 
instrument (Chapter 2; Section 2.6.4) to assess both the quantity and quality of cDNA. 
As outlined in Figure 5-17, the naive sample had a concentration of 30.95 ng/µl while 
the repairing sample had a concentration of 45.56ng/µl, both of which exceeded the 
minimum QC requirements set by Edinburgh Genomics (https://genomics.ed.ac.uk/). 
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Sample Concentration (ng/ul) 
Naïve  30.95 
Repairing 45.56 
 
Figure 5-17. LabChip GX Touch analysis of cDNA quantity and quality for samples 
generated for single cell sequencing by Edinburgh Genomics. (A) LabChip GX Touch read 
out gel results for the naive and repairing samples. (B) Electrogram results for both naive and 
repairing samples. (C) Concentration of cDNA in both naïve and repairing samples. 
 
 
5.4.5.2 Bioinformatic data handling 
Following generation of the sequence data the initial bioinformatic analysis (as 
outlined in Chapter 2; Section 2.10.11) was carried out by Frances Turner at the 
Edinburgh Genomics facility (https://genomics.ed.ac.uk/). Thereafter a secondary 
analysis was carried out by Dr Richard Taylor affiliated with Professor Neil 
Henderson’s group. A summary of the basic statistics generated by Frances Turner 
using the Cellranger software can be found in Table 5-8. All values were above 
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Table 5-8. Basic statistics of single cell sequencing data generated for total GFP+ 
cells isolated from naïve and repairing Pdgfrβ-BAC-eGFP uterine tissue using 
Cellranger (by Frances Turner). Number of reads, estimated cell number, total genes 
detected, mean reads per cell, median genes per cell and sequencing saturation values 
all exceeded threshold requirements, indicating the success of the sequencing.  
 













Naïve  453,334,959 5,363 18,422 84,530 1,986 84.70% 
Repairing 481,132,039 4,515 17,989 106,563 2,773 81.90% 
 
 
5.4.5.3 t-distributed stochastic neighbour embedding (t-SNE) analysis of control 
uterine tissue 
Loupe files for the naïve and repairing single cell datasets were provided by Frances 
Turner and Richard Taylor. Subsequent analysis outlined in this Chapter was 
performed by the author of this thesis. The Cell Loupe Browser software provided by 
Cellranger (10x Genomics; https://www.10xgenomics.com/) was used to analyse the 
single cell data sets. The first round of analysis focussed on the results from the naïve 
uterine tissue to assess heterogeneity within the mesenchymal cell population during 
homeostasis to extend and complement results detailed in Chapter 4. 
The t-SNE analysis is a technique that visualises high-dimensional data by assigning 
each data point (single cells) a location in a two dimensional space based on similarity 
to other data points. The Cell Loupe Browser software uses this technique to reveal 
structures in the data based on similarities and differences in the transcriptomic profiles 
of each cell. This analysis revealed that the naïve mesenchymal cell population (all 
GFP+ cells) was composed of five individual clusters based on tSNE-1 and tSNE-2, 
revealing a high degree of heterogeneity within the population which was a novel 
finding compared with our previous datasets that had identified 2 populations based 
only on GFP intensity using IHC, FC and qPCR techniques (Figure 5-18).  
As the mesenchymal cell population was isolated from Pdgfrβ-BAC-eGFP tissues 
based on GFP expression (reporter for Pdgfrβ promoter activity) it was predicted that 
all cells should express Pdgfrβ. To confirm this Pdgfrβ expression was mapped onto 
the t-SNE plot leading to the identification of two populations: cells that had low 
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Pdgfrβ expression were located in clusters 1 and 4, cells that had high Pdgfrβ 
expression located in clusters 2 and 3 and cells that had minimal Pdgfrβ expression 
located in cluster 5 (Figure 5-19). From this analysis it was concluded that Clusters 1 
and 4 were the equivalent of the GFPdim stromal cells while Cluster 2 and 3 represented 
GFPbright cells previously identified as perivascular pericytes. The use of single cell 
analysis identified heterogeneity within each of these subpopulations that had not 
previously been detected and further analysis has therefore focused on profiling the 
five clusters to elucidate their phenotype. 
 
Figure 5-18. Visualisation of the single cell dataset naive uterine mesenchymal cells. A t-
SNE plot where each dot represents a single cell. Cells cluster together based on the similarity 
in their transcriptomic profile: note this software identified 5 discrete cell clusters in the naïve 
endometrial mesenchymal cell population. 
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Figure 5-19. Expression of Pdgfrβ in naive uterine mesenchymal cells. Cluster 1 and 4 had 
low expression of Pdgfrβ while cluster 2 and 3 had high expression of Pdgfrβ and cluster 5 
had minimal expression of Pdgfrβ: based on this single gene cluster 1+4 appeared to be 
representative of GFPdim fibroblasts and 2+3 were GFPbright putative pericytes. 
 
5.4.5.4 Differential gene expression analysis of control uterine tissue 
To more thoroughly investigate transcriptomic differences between each cell cluster, 
a heat map summarising the differential gene expression was generated to identify 
genes that were more highly expressed in one cell cluster when compared to the others. 
The heat map in Figure 5-20 displays transcriptomic differences between each cell 
cluster confirming that there was a degree of similarity between clusters 1 and 4 and 
between clusters 2 and 3 but a very distinct profile in cluster 5. A list of the top 100 
genes differentially expressed by each cell cluster is outlined in Appendix 5-3.   
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Figure 5-20. Heat map of differentially expressed genes that distinguish five 
mesenchymal cell clusters in naïve uterine tissue as determined by single cell sequencing. 
Clusters 1 and 4 show a degree of similarity as do Clusters 2 and 3. Cluster 5 has a very distinct 
gene signature that does not show a degree of similarity to other cell clusters 
 
To expand the understanding of the differences between clusters, several of the most 
differentially expressed (DE) genes that distinguished each cluster (identified by 
bold/highlighting in Appendix 5-3) were mapped to the t-SNE plot to assess their 
distribution patterns and to start to identify the distinct phenotypes of each cell type, 
outlined in Figure 5-21.  
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Figure 5-21. tSNE plots exhibiting the distribution of differentially expressed genes that 
distinguish each cell cluster in the single cell sequencing dataset of naïve endometrial 
mesenchyme (5 clusters as outlined in Figure 5-18). Gene expression is displayed where 
increasing intensity of colour (red) correlates to increasing abundance of gene transcripts. 
Cluster 1 exclusively expressed Pdgfrα, Cdh11, Cd34 and Fbln2. Cluster 2 expressed Abcc98, 
Cspg4, Endrb, Kcnj8, Rgs5, Vtn, Thy1 and Pdgfrβ and cluster 3 expressed Acta2, Cnn1, Rgs5, 
Tagln, Olfr558, Myh11, Mcam and Pln although there was some overlap between these cell 
clusters with expression of Rgs5, Vtn, Pdgfrβ, Rgs4, Olfr588 and Mcam detected in both 
cluster 2 and 3. Cluster 5 exclusively expressed Cdh1, EpCAM, Krt18 and Muc1. 
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Differential gene expression analysis revealed that Cluster 1 had 439 genes that were 
significantly up-regulated when compared to other clusters. These up-regulated genes 
included Wt1, Cdh11, Fbln2, Pdgfrα, Fn1, Igf1 and CD34, in line with a stromal 
fibroblast phenotype. Cluster 4 had 423 significantly upregulated genes some which 
such as CD34, Pdgfrα, and Igf1 were shared with Cluster 1 (fibroblast-like) whilst 
others included CD55, Fbln1, Col14a1, Clec3b, and Cald1 (Figure 5-21). Many of the 
genes that appeared to characterised Cluster 4 encoded collagens suggesting that these 
cells could be considered as a subpopulations of fibroblast-like cells clustering 
separately due to a specialised function such as the synthesis of matrix proteins.  
Cluster 2 had 577 genes that were significantly upregulated including Kcnj8, Abcc9, 
Vtn, Ednrb, Rgs5, Thy1, Olfr588, Pdgfrβ, Cspg4, Rgs3, Rgs4 and Des. Cluster 3 had 
539 significantly upregulated genes including Pln, Cnn1, Tagln, Acta2, Myh11, Kitl, 
Pdgfa, Rgs4, Mcam, Des, Olfr588 and lmna (Figure 5-21). Notably Clusters 2 and 3 
appeared to express a number of the same genes which including several previously 
use to identify and characterise perivascular pericytes in endometrial tissue – such as 
Mcam, Rgs5 and Olfr588 (list of top 100 DE genes per cluster in Appendix 5-3). 
However Cluster 3 also uniquely expressed genes associated with vascular smooth 
muscle cells.  
Finally, Cluster 5 which appeared to have relatively few cells compared with the other 
clusters had 438 genes that were significantly upregulated including EpCAM, Krt8, 
Cdh1, Krt19, Krt18, Kft7 and MUC1 (Figure 5-21) which were epithelial associated 
genes suggesting that Cluster 5 is made of epithelial cells. 
These results have highlighted complex heterogeneity that has not previously been 
defined in endometrial stromal cell populations that are summarised in Figure 5-22: 
Cluster 1 and 4 have been identified as the stromal fibroblast population, composed of 
subpopulations with discrete functions; Cluster 2 and Cluster 3 have been identified as 
perivascular pericytes and vascular smooth muscle cells respectively however these 
populations may represent a spectrum of cells in relation to functions; and Cluster 5 
has been identified as a small amount of epithelial cells which is believed to be due to 
contamination as only GFP+ cells were isolated (usually EpCAM negative) (Figure 5-
22).  
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Figure 5-22. Hypothesised phenotypes of each cell cluster identified in the mesenchyme 
of the naïve mouse endometrium based on differentially expressed genes. Cluster 1 and 4: 
stromal fibroblasts, Cluster 2: perivascular pericytes, Cluster 3: vascular smooth muscle cells, 
Cluster 5: epithelial cells (contamination). 
 
 
5.4.5.5 Comparison between mesenchymal cell populations in naïve and repairing 
uterine tissue as determined by t-SNE analysis  
Having identified complex heterogeneity within the mesenchymal cell population of 
naive endometrial tissues, the contribution of distinct cell types to the endometrial 
repair processes was assessed by creating an aggregate file of the single cell 
sequencing datasets from the naïve and repairing uterine tissues. The tSNE plot 
generated in Figure 5-23 is colour coded by library ID to identify cells from control 
(orange) versus repairing (blue) uterine tissues. Two discrete clusters were seen, 
attributed to global gene expression changes in mesenchymal cells in response to 
endometrial repair (Figure 5-23, heat map). The t-SNE plot in Figure 5-24 displays the 
results of cluster analysis on the aggregate file, revealing a striking amount of 
heterogeneity within the total mesenchymal populations. Nine distinct clusters were 
identified suggesting that distinct genomic profiles exist in the mesenchymal cells 
during repair. Combined tSNE analysis showed that Cluster 1, 3, 4 and 8 were cells of 
control mesenchyme while Cluster 2, 5, 6, 7 and 9 were cells of repairing mesenchyme. 
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Figure 5-23. Cluster analysis based on Library ID separating mesenchymal cells from 
naive (orange) and repairing (blue) uterine tissue. Global gene expression changes separate 
the two experimental datasets distinctly. The heatmap displays striking transcriptomic 
differences between mesenchymal cells from naïve and repairing endometrium. 
 
Figure 5-24. Cluster analysis based on DE gene expression profiles of mesenchymal cells 
in the aggregate file containing both naïve and repairing single cell datasets. A t-SNE plot 
where each dot represents a single cell and cells cluster together based on the similarity in their 
transcriptomic profile. Cluster analysis reveals nine distinct cell clusters present in the 
aggregate file of naïve and repairing endometrial tissues. 
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Further examining the expression of Pdgfrβ in the aggregate tSNE plot, three 
prominent populations were once again identified: cells that had high expression of 
Pdgfrβ (Cluster 3, 4, 6, 7 and 9), cells that had low expression of Pdgfrβ (Cluster 1, 2 
and 5), and cells with minimal Pdgfrβ expression (Cluster 8) although it could be 
argued that Cluster 5 contained some cells with an intermediate expression level 
(Figure 5-25). Combining the information from Figure 5-23, 5-24 and 5-25 it can be 
concluded that Cluster 1 represents GFPdim cells and Clusters 3 and 4 represent 
GFPbright cells from naive uterine tissues, while Clusters 2 and 5 represent GFPdim cells 
and Clusters 6 and 7 represent GFPbright cells from repairing uterine tissues. Cluster 8 
of the naïve data set represents epithelial cells, as previously determined, and cluster 
9 of the repairing dataset is unknown.  
 
Figure 5-25. Expression of Pdgfrβ mapped onto the t-SNE plot of mesenchymal cells fron 
naïve and repairing uterine tissue. Pdgfrβ expression is displayed where increasing intensity 
of colour (red) correlates to increasing abundance of gene transcripts. Cluster 1, 2 and 5 have 
low expression of Pdgfrβ while Cluster 3, 4, 6, 7 and 9 have high expression of Pdgfrβ. Cluster 
8 has minimal expression of Pdgfrβ. 
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5.4.5.6. Differential gene expression analysis of control and repairing uterine 
tissue 
Differential gene expression analysis was carried out to characterise each cell cluster 
identified in the tSNE analysis. The heat map in Figure 5-26 displays the most 
significant transcriptomic differences between each cell cluster when compared to the 
other clusters. Clusters 1, 2, 5 and 8 have very distinct transcriptomic signatures with 
their most significantly upregulated genes not expressed in other clusters. In contrast 
Clusters 3 and 4 have similar expression patterns as do Clusters 6 and 7 which even 
show some similarities to Clusters 3 and 4. This suggests that there may be a degree 
of similarity between these cell types. A list of the top 100 genes differentially 
expressed by each cell cluster are summarised in Appendix 5-5, with previously 
identified characteristic genes highlighted in bold print. 
 
 
Figure 5-26. Heat map of differentially expressed genes that distinguish the nine cell 
clusters in the aggregate file containing both naïve and repairing mesenchyme single cell 
datasets. Striking transcriptomic differences between cell clusters can be detected. Clusters 1, 
2, 5 and 8 have very distinct transcriptomic profiles. Clusters 3 and 4 show a high degree of 
similarity. Clusters 6 and 7 show a high degree of similarity and also share expression of genes 
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To expand analysis beyond cluster analysis, genes previously identified as specific to 
the five cell clusters in naïve tissue (Section 5.4.5.4) were mapped to the extended 
merged 9 cluster dataset (Figure 5-27). The stromal fibroblast markers Cd34, Cdh11, 
Fbln2 and Pdgfrα mapped to Clusters 1, 2 and 5. Similarly, the expression of Cd55, 
Clec3b, Col14a1 and Fbln1 prominent in a subset of stromal fibroblasts mapped to a 
subset of both Clusters 1 and 2. Notably Cd55 was also expressed by Cluster 5 and 
Fbln1 was noticeably upregulated in Cluster 2 when compared with Cluster 1. These 
results were consistent with the identification of clusters 1, 2 and 5 having low Pdgfrβ. 
In comparison clusters 3, 4, 6, 7 and 9 had high Pdgfrβ and were considered to be 
putative pericytes. Analysis showed genes identified in control pericytes including 
Abcc9, Ednrb, Kcnj8, Thy1 and Vtn were expressed predominantly in Clusters 3, 6 and 
7 while others including Cspg4 and Rgs5 were expressed in Clusters 3, 4, 6 and 7. 
Notably the expression of vascular smooth muscle cell markers Mcam, Olfr558 and 
Rgs4 mapped to Clusters 3, 4, 6 and 7 while Acta2, Cnn1, Mhy1, Pln and Tagln were 
predominantly expressed in Clusters 4 and 6. Cspg4, Thy1, Mcam and Tagln were also 
expressed by Cluster 5 and there was an apparent increase in expression of several 
genes in Cluster 2 including Kcnj8, Thy1, Acta2 and Tagln.  
Cluster 9 expressed cell associated with progression of the cell cyle such as Mki67, 
Cdk1 and Pcna but also showed similarities to each of the other cell clusters. Therefore 
this cluster was identified as a mixed population of cells undergoing proliferation. 
Finally looking at epithelial cell gene expression is was seen that Cluster 8 expressed 
Cdh1, Epcam, Krt8 and Krt18 consistent with a small amount of contamination 
previously identified in naïve samples (Figure 5-21) and the distinct profile apparent 
in the heat map. 
One of the most interesting Clusters was number 5 which was found to express genes 
that were otherwise used to identify a range of cells types such as Cdh11, Fbln2, 
Pdgfrα and Cd55 used to identify stromal fibroblasts, Cspg4, Pdgfrβ and Thy1 used to 
identify perivascular pericytes and Acta2 and Tagln used to identify vascular smooth 
muscle cells. Notably Cluster 5 also expressed genes attributable to epithelial cells 
including Epcam, Krt8 and Krt18 (Figure 5-27).  
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Figure 5-27. tSNE plots exhibiting the distribution of genes used to identify different cell 
types present in the naïve endometrial mesenchyme (Figure 5-21) amongst cell clusters 
in the repairing endometrial mesenchyme. To identify the phenotype of the 9 cell clusters 
in the aggregate single cell dataset (Figure5-24), genes previously found to identify distinct 
clusters in the naïve uterus were mapped to the t-SNE plot. Genes associated with stromal 
fibroblasts include Cd34, Cdh11, Fbln2, Pdgfrα, CD55, Clec3b, Col14a1 and Fbln1. Genes 
associated with pericytes include Abcc9, Cspg4, Ednrb, Kcnj8, Pdgfrβ, Rgs5, Thy1 and Vtn. 
Genes associated with vascular smooth muscle cells include Acta2, Cnn1, Mcam, Myh11, 
Olfr558, Pln, Rgs4 and Tagln. Genes associated with epithelial cells include Cdh1, Epcam, 
Krt8 and Krt18. 
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The assessment of gene expression profiles associated with specific cell types in the 
control uterine tissue clearly identified four clusters of mesenchymal cells (plus minor 
contamination by epithelial cells) and in the combined analysis these were once more 
present (although their position in the map produced by the software was slightly 
altered the stromal fibroblasts appeared as a single cluster) – these are numbered as 
clusters 1, 3, 4 and 8 in Figure 5-28.  Strikingly the gene expression profile of the 
repairing tissue was sufficiently distinct from the control sample to generate additional 
clusters – 2, 6, 7 and 5 with cluster 5 having a phenotype that appears unique to the 
repairing tissue. This provides a platform for the investigation of how each cell 
population specifically contributes to endometrial repair processes. 
Figure 5-28. Hypothesised phenotypes of each cell cluster identified in the aggregate file 
containing both naïve and repairing single cell datatsets of endometrial mesenchyme. 
Identification of cell clusters was determined by the relative expression of DE genes that 
distinguished cell clusters in the naïve mesenchyme, outlined in the table. Clusters 1 and 2: 
stromal fibroblasts, Clusters 3 and 7: perivascular pericytes, Clusters 4 and 6: vascular smooth 
muscle cells, Cluster 8: epithelial cells, Cluster 5: repair-specific cluster of unknown 
phenotype. Cluster 9: proliferating cells of mixed phenotypes. 
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5.4.5.7. Investigation of differential gene expression in mesenchymal cell 
populations during endometrial repair 
To augment the initial cluster analysis a comparison was made between expression of 
genes in the putative stromal fibroblasts, vascular smooth muscle cells and pericytes 
in the repairing samples and the same cell type in the control samples. For example 
genes that are upregulate in Cluster 2 when compared to Cluster 1 represent those 
higher in stromal fibroblasts during endometrial repair. Results for the top 100 genes 
based on fold change are summarised in (Appendix 5-5).  
Gene ontology analysis was carried out using the online Gene Ontology Consortium 
platform (http://www.geneontology.org/) to investigate processes associated with the 
top 100 upregulated genes in each cell type during endometrial repair, outlined in 
Table 5-9. Processes enriched by genes upregulated in stroma cells were associated 
with ECM production, Wnt signalling and epithelial cell function. Processes enriched 
by genes upregulated in vascular smooth muscle cells were associated with smooth 
muscle cell function, regulation of fibroblasts, blood vessel function and the 
inflammatory response. Processes enriched by genes upregulated in pericytes were 
associated with ECM production, blood vessel function, regulation of the 
inflammatory response and mesenchymal cell differentiation. This preliminary 
analysis suggest some of the processes to which the different cell types might be 
contributing during the active phase of endometrial repair. 
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Table 5-9. Gene Ontology associated with the top 100 upregulated genes in 
mesenchymal cell types during endometrial repair 
Stromal Fibroblasts 
Gene Ontology Term Fold Enrichment Associated Genes 
Regulation of cGMP-
mediated signalling 
5.33 Thbs1, Pde10a, Xbp1, Sod2, Hspb1, Pde10a, 
Mmp3, Sfrp1, Serpine2, Sfrp4, Gsto1, Socs3 
Regulation of neutrophil 
mediated killing 
4.06 Cxcl1, Cxcl5, Ccl2, Spp1 
Connective tissue 
replacement involved in 
inflammatory response 
wound healing 
7.97 Timp1, F2r, Cyr61, Sod2, Tpm1, Serpine2, 
Pdpn, Ccl2, Fbln1, Ighf1,  
Regulation of endothelial 
cell chemotaxis 
4.60 Thbs1, Lgn, Hspb1, Rhob, Igf1, Pfn2, Pfn1 
Collagen catabolic 
process 
4.72 Mmp10, Mmp13, Mmp3, Mmp14, Mmmp2, 
Adamts2 
TGFβ signalling pathway 5.06 Pdcd5, Col4a1, Fos, Fermt2, Col1a2, Tgfbr2, 
Jun, Cilp, Zfp36l1, Col3a1, Ccl2, Actr3 
VEGFr signalling 
pathway 
4.47 Xbp1, Hsbp1, Ccl2, Pdcd6, Nrp1, Sulf1 
Non-canonical Wnt 
signalling pathway 
3.80 Fzd1, Frzb, Sfrp1, Sfrp4, Smo, Ptch1, Rac1, 
Sfrp2 
Regulation of epithelial 
cell proliferation 




4.97 Rhob, Igf1, Tnc, Fzd1, Aldh1a2, Ednra, Sfrp1, 
Cfl1, Mgp, Pfn1 
Vascular Smooth Muscle Cells 
Gene Ontology Term Fold Enrichment Associated Genes 
Muscle cell cellular 
homeostasis 
6.52 Hif1a, Lamp2, Cfl2, Il6, Aldoa 
Regulation of focal 
adhesion assembly 
5.78 Thy1, Nrp1, Rac1, s100a10, Cfl1, Mmp14, 
Pten 
Angiogenesis 5.36 Trp53, Sod2, Mif, App, Calr, Scp2, Romo1, 
Picalm, Rwdd1, Serp1, Cisd2, Pebp1 
Cellular response to 
glucocorticoid stimulus 
5.34 Eif4ebp1, Hnrnpu, Ssr4, mt-Nd3, Anxa1, Ssr1 
Regulation of fibroblast 
proliferation 
4.45 Cdk4, Trp53, Esr1, Anxa2, Sod2, Bax, Mif, 
pdgfa, Emd, Fth1, Fn1, ndufs4 
Regulation of smooth 
muscle cell migration 
4.17 Postn, Mif, Il6st, Igfbp5, Adamts1, Arpc2, 
Tmsb4x 
Regulation of leucocyte 
migration 
4.12 Rhoa, Trp53, Thy1, App, Calr, C1qbp, Selk, 
Rarres2, Rac1, Mmp14, Ednra, Ccl2 
Regulation of cell shape 3.51 Rhoa, Fermt2, myl12a, Wdr1, Ccl1, Rhoc, 
Cdc42, Anxa1, Il6, Fn1, Cfl1, Rhoj, Aldoa, 
Msn, Ccl2 
Cell matrix adhesion 3.05 Cd63, Rhoa, thy1, Fermt2, Actn1, Ctnnb1, 
Fn1, Itgb1, Nid1, Col3a1 
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Perivascular Pericytes 
Gene Ontology Term Fold Enrichment Associated Genes 
Negative regulation of 
plasminogen activation 
7.63 Thbs1, Serpine1, MMP14, Serpine2, Ctla2a, 
Myh9 
Wound healing involved 
in inflammatory response 
6.54 Timp1, Hif1a, Hmox1, Sdc1, Mif, Thbs1, 
Cebpb, Itgav, Ccl11, Cxcl1 
Regulation of collagen 
biosynthetic process 
6.07 Errfi1, Got1, Rap1a, Il6, Serpine1, Prdx5, 
Vim, Itgb1, Ccl2 
Regulation of focal 
adhesion assembly 
5.98 Thy1, Lims1, Rac1, Iqgap1, Cfl1, Gpm6b, 
Mmp14 
Positive regulation of 
endothelial cell apoptotic 
process 
5.89 Sop2, Xbp1, Thbs1, Serpine1, Ecscr, Hmox1, 
Col18a1, Zfp36 
Vasoconstriction 5.15 Rhoa, Manf, Acta2, Ednra, Ednrb 
Pdgfr signalling pathway 4.99 Plat, Pdgfa, Zfand5, Arid5b, Iqgap1 
Regulation of cell 
migration involved in 
sprouting angiogenesis 
4.75 Rhoa, Thbs1, Hmox1, Anxa1, Rhoj 
Regulation of coagulation 4.61 Procr, Anxa2, Cd9, Anxa5, Pdgfa, Serpine2 
Positive regulation of 
smooth muscle cell 
migration 
4.38 Postn, Mif, Pdgfa, Ifgbp5, Serpine1, Arpc2, 
Tmsb4x, Iqgap1, F3 
Cellular response to 
hypoxia 
4.14 Eif4ebp1, P4hb, Higd1a, Gnb1, Fam162a, 
Hif1a, Bnip3l, Bnip3 
Regulation of fibroblast 
proliferation 
3.78 Anxa2, Mmp9, Sod2, Bax, Mif, Pdgfa, 
Serpine1, Fth1, Fn1, Wnt5a 
Positive regulation of 
leucocyte chemotaxis 
3.53 Calr, Thbs1, Hspb1, Rac1, Serpine1, Ednra, 
Fn1, Wnt5a, Ccl2 
Response to TGBβ 3.39 Smad7, Pdcd5, Col4a2, Fermt2, Dbn1, 
Serpine1, Rock2, Ccl2, Actr3 
Mesenchymal cell 
differentiation 
2.88 Loxl2, Ddx5, Hif1a, Ednra, Fn1, Rtn1, Wnt5a, 
Clf1, Ednrb, Hes1 
 
 
5.4.5.8. Investigation of the phenotype of the repair-specific cell cluster identified 
by single cell sequencing 
One of the most striking results from the cluster analysis was the identification of a 
group of cells with a distinct gene signature that appeared to be specific to the repairing 
uterine tissue. Initial analysis revealed that the cluster expressed a mix of genes 
consistent with transitory cells with intermediate phenotypes. 
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The top 16 most differentially expressed genes which discriminated Cluster 5 from all 
other cell clusters were mapped onto the t-SNE plot to assess their distribution amongst 
the other clusters (putative cell types) (Figure 5-29). The expression of Sprr2d, Sprr2h, 
Edn1, Grem1, Pmaip1, Tnf and Cyp26b1 was exclusive to Cluster 5 while Slpi, Ptgs2 
and Fabp4 were also expressed by putative pericytes in the repairing dataset. Genes 
including Tgfbi, Tnc and Icam1 were expressed by all cells in the repairing dataset 
while Cd55 was expressed by stromal fibroblasts in both control and repairing tissues. 
Interestingly Des and Neat1 were expressed by all mesenchymal cell populations only 
more highly expressed by Cluster 5 (Figure 5-29)  
Gene ontology of these selected genes returned processes such as morphogenesis of 
an epithelium, regulation of smooth muscle cell contraction and angiogenesis 
supporting the hypothesis that Cluster 5 may be composed of mesenchymal cells 
undergoing a transdifferentiation event  such as FMT and/or MET. 
Figure 5-29. The expression of differentially expressed genes that distinguish cluster 5 
from all other cell clusters in the aggregate file containing both naïve and repairing single 
cell datasets of endometrial mesenchyme. The expression of Spli, Sprr2d, Sprr2h, Ptgs2, 
Edn1, Fabp4, Grem1, Pmaip1, Tnf, and Cyp26b1 was exclusive to the repair-specific cluster 
(cluster 5; blue dotted line). Tgfβ1, Tnc, Icam1, Cd55 were also expressed by other cell types 
in the repairing mesenchyme while Des and Neat1 were expressed throughout all cell clusters 
in both naïve and repairing tissues. 
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5.4.5.9. Gene ontology analysis of differentially expressed genes that distinguish  
the repair-specific cell cluster from other cell clusters identified by single cell 
sequencing 
The list of differentially expressed genes used to discriminate the repair-specific 
Cluster 5 from all other cell clusters was analysed using the online Gene Ontology 
Consortium (http://www.geneontology.org/) in an attempt to identify processes 
specific to mesenchymal cells in endometrial tissue during repair. Results are 
displayed as tables outlining the gene ontology terms and associated genes 
significantly upregulated in repairing tissues. Genes highlighted in bold were mapped 
onto the t-SNE plot to analyse distribution amongst other cell types/clusters (Figures 
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Gene Ontology Term Fold Enrichment Associated Genes 
Collagen metabolic 
process 
10.16 Mmp9, Mmp10, Mmp13, Mmp3, Plod2 
Smooth muscle cell 
differentiation 
7.31 Mmp9, Ctnn1b, Hmox1, Itgb3, Klf4, C3ar1, 
Edn1, Sod2, Ptgs2, Tnf, Pbpj 
Regulation of fibroblast 
proliferation 




5.90 Lgals3, Mmp9, Fn1, Col5a3, Plod2, Mmp13, 
Tnf, Tgfbi, Ero1l, P4ha1, Grem1, 
Regulation of stem cell 
proliferation 
5.52 Ctnnb1, Fgfr1, Pim1, Cxcl1, Hmga2 




4.80 Ctnn1b, Fn1, Sema3a, Fgfr1, Gja1, Edn1, 
Cited2, Pbpj, plaur 
Stem cell differentiation 4.44 Sema3a, Msi2, Grem1, Edn1, Cited2, Pbpj, 
Fzd1, Fn21 
Figure 5-30. GO terms associated with mesenchymal cell function enriched by genes 
expressed by Cluster 5. Expression of Mmp9. Mmp10, Sema3a, Col5a3, Lgals3, Fgfr1r, 
Ctnnb1 and Fn1 mapped to the aggregate t-SNE plot. 
Figure 5-30 outlines GO terms associated with mesenchymal cell function such as 
collagen metabolic process, fibroblast proliferation, matrix adhesion and 
mesenchymal cell differentiation. As before many genes were expressed by other cell 
types (stromal fibroblasts, vascular smooth muscle cells and pericytes) but exclusively 
in repairing tissue including Mmp9 and Mmp10. In contrast Col5a3, Lgals3, Fgfr1r, 
Ctnnb1 and Fn1 were also expressed by various cell types in the control tissue at 
similar or lower levels. Similar levels of expression of Mmp9, and Col5a3 was seen in 
Cluster 5 and Cluster 7 (pericytes in repairing endometrium) suggesting a level of 
similarity between these cell types either in phenotype or function. Notably Sema3a 
was almost exclusively expressed by Cluster 5 and involved in mesenchymal and stem 
cell differentiation processes (Figure 5-30). 
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Gene Ontology Term Fold Enrichment Associated Genes 
Regulation of angiogenesis 7.84 Ptgs2, Adm, Klf4, Cxcr4, Hmga2, Runx1, 
Itgb3, Plk, Lgals3, Grem1, Mmp9, 
Endothelial cell 
chemotaxis 
7.61 Ptgs2, Hmox1, Pdgfb, Klf4, Map2k3, Hspb1, 
Spred1, Itgb3, Plk2, fgfr1 
Positive regulation of 
vasoconstriction 
6.36 Edn1, Icam1, Ptgs2, Dusp5, Adm, Pfgfb, 
Tbxas1, Sema3a, Smad7, Mapk2k1 
 
Figure 5-31. GO terms associated with blood vessel function enriched by genes expressed 
by Cluster 5. Expression of Pdgfb, Edn1, Dusp5, Icam1, Ptgs2, Klf4, Adm and Hmox1 mapped 
to the aggregate t-SNE plot. 
 
Figure 5-31 outlines GO terms associated with blood vessel function such as 
angiogenesis and vasoconstriction. Interestingly Pdgfb, Edn1, Dusp5 and Icam1 are 
exclusively expressed by Cluster 5 and associated with regulation of vasoconstriction 
suggesting this is a primary function of these cells during endometrial repair. Ptgs2 
and Hmox1 are expressed by other cells in the repairing tissue perhaps also involved 
in endothelial cell chemotaxis, while Klf4 and Adm can be detected predominantly in 
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Gene Ontology Term Fold Enrichment Associated Genes 
Epithelial tube 
morphogenesis 
11.27 Grem1, Sprr2d, Ptgs2, Ctnnb1, Klf4, Smad7, 
Mmp12, Tnc, Fgfr1, Basp1, Fzd1, 
Epithelial cell migration 6.19 Ptgs2, Plk2, Fgfr1, Mapk2a3, Mmp9, Hsbp1, 
Hmox1, Pdgfb, Itgb3, 
Epithelial cell 
differentiation 
5.65 Grem1, Fem1b, Fndc3a, Sprr2d, Krt18, 
Ptgs2, Sprr2h, Cebpb, Rbpj, Basp1, Icam1, 
Epithelial cell proliferation 4.03 Ctnnb1, Hmox1, Pdgfb, Itgb3, Fgfr1, Twist2, 
F3, Mmp12, Hmga2, 
Epithelial cell 
development 
3.80 Fem1b, Fndc3a, EpCAM, Ctnnb1, Pfgfb, 
Prdm1, Fgfr1, Gja1, Icam1, Cxcr4, 
Figure 5-32. GO terms associated with epithelial cell function enriched by genes 
expressed by Cluster 5. Expression of Sprrd2, Grem1, Ptgs2, Plk2, Fem1b, Basp1, Fnd3ca, 
Ctnnb1, Krt8, Krt18, Epcam and Krt19 mapped to the aggregate t-SNE plot. 
 
Figure 5-32 outlines GO terms associated with epithelial cell function such as 
epithelial cell migration, differentiation, proliferation and development. Notably 
Sprrd2 and Grem1 are exclusively expressed by Cluster 5 and associated with 
epithelial tube morphogenesis and epithelial cell differentiation in line with these cells 
undergoing MET. Other genes are expressed but several other cell types/clusters in 
both control and repairing endometrial tissues. Interestingly, expression of Krt8, Krt18 
and EpCAM was seen in regions Cluster 5 and expressed highly by Cluster 8 
(epithelial cells in control endometrium) suggesting that a subset of Cluster 5 may 
infact have an epithelial cell phenotype, further indicating MET (Figure 5-32).  
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Gene Ontology Term Fold Enrichment Associated Genes 
Regulation of leucocyte 
adhesion to endothelium 
9.41 Tnf, Cebpb, Il23a, Klf4, Icam1, Smad7, 
Lgals3, Sdc4, Arg2, Runx1,  
Regulation of cytokine 
secretion 
9.25 Il1rap, Csf1r, Tnf, Arg2, Ccl3, Srgn, FN1,  
Il1r2, Ccr5, MMP12 
Neutrophil chemotaxis 8.76 Fcer1g, Cxcl2, Cxcl1, Lgals3, Ppbp, Ccl7, 
Il1rn, Ccl3, Pde4b, Spp1 
Negative regulation of 
immune response 
8.51 Tnf, Bcl1Smad7, Lgals3, Mmp12, Arg2, Ccr1, 
Hmox1, Grem1, Sdc4 
Regulation of macrophage 
differentiation 
7.03 Tnf, Prkch, Itgav, Itgb3, Nfkbia, Smad7, Ccr5, 
Grem1, Ifrd1, Pdgfb 
T cell receptor signalling 6.60 Bcl10, Lgals3, Pvr, Prkch, Elf1 
Leucocyte activation 6.32 Fcer1g, Cebpb, Bcl10, Fpr2, Icam1, Itgav, 
Cyp26b1, Rbpj, Cxcr4, Ctnnb1 
Myeloid leucocyte 
activation 
5.85 Fcer1g, Bcl10, Fpr2, Rbpj, Ndrg1, Clu, Tlr7 
Regulation of myeloid 
leucocyte differentiation 
4.34 Cebpb, Csf1r, Tnf, Il23a, Ccr1, Fam213a, 
Ctnnb1, Ccl3, Runx1, Itgb3,  
Cytokine production 4.23 Fcer1g, Il1rap, Fabp4, , Itgav, Ptgs2, Pbpj, 
Fgfr1 
 
Figure 5-33. GO terms associated with an inflammatory response enriched by genes 
expressed by Cluster 5. Expression of Fcer1g, Il23a, Tnf, Il1rap, Cxcl1, Cxcl2, Bcl10 and 
Cebpb mapped to the aggregate t-SNE plot. 
Figure 5-33 outlines GO terms associated with an inflammatory response including 
regulation of leucocyte adhesion to endothelium, neutrophil chemotaxis and regulation 
of macrophage differentiation. Notably Fcer1g, Il23a, Tnf and Il1rap were exclusively 
expressed by Cluster 5 genes attributed to leucocyte activation, adhesion and 
differentiation and cytokine production, functions perhaps attributed to cells of Cluster 
5. Similar levels of expression of Cxcl1, Cxcl2, Bcl10 and Cebpb was seen in Cluster 
5 and Cluster 7 (pericytes in repairing endometrium) further suggesting a level of 
similarity between these cell types either in phenotype or function. (Figure 5-33). 
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Gene ontology analysis of differentially expressed genes associated with the 
repair-specific Cluster 5 has identified key roles in wound healing, regeneration, 
mesenchymal cell function, blood vessel function, epithelial cell function and the 
inflammatory response. It has also identified key genes that can be exclusively 
attributed to cells of Cluster 5 including Cyp26b1, Pdgfb, Edn1, Dusp5, Icam1 Sprrd2, 
Grem1 Fcer1g, Il23a, Tnf and Il1rap. It is hypothesised that Cluster 5 represents 
mesenchymal cells undergoing a transdifferentiation event (FMT and/or MET) 
however the precise origin of these cells remains unknown. Further bioinformatic 
trajectory analysis and in vivo lineage tracing studies are required to compliment and 
extend this data.  
 
5.5 Discussion 
The human endometrium is a highly dynamic tissue that has a unique and remarkable 
capacity for scarless tissue repair during the ‘wounding’ stimulus of menstruation. The 
restoration of endometrial tissue homeostasis requires rapid reepithelialisation, stromal 
and vascular remodelling with a number of studies suggesting that a population of 
stem/progenitor cells that reside in the basal layer of the endometrium may play a key 
role in endometrial repair processes (Schwab and Gargett 2007, Cervelló and Simón 
2009, Cervelló et al. 2011, Masuda et al. 2012). In the current study the Edinburgh 
menses mouse model that recapitulates key features of human menstrual repair 
including focal hypoxia, tissue breakdown, reepithelialisation and inflammation 
(Cousins et al. 2014, Cousins et al. 2016b, Cousins et al. 2016c, Cousins et al. 2016d, 
Gibson et al. 2015) was used. In conjunction with the Pdgfrβ-BAC-eGFP transgenic 
mouse line, the dynamics of mesenchymal cell populations, in particular putative 
pericytes were investigated during endometrial repair. The results in this chapter 
expanded on those in Chapter 4 which had generated a gene expression profile of 
endometrial pericytes in endometrium from adult female mice (naïve). 
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5.5.1 Dynamic changes in mesenchymal cell populations during 
endometrial repair 
IHC identified Pdgfrβ, CD146 and NG2 in endometrial tissues over the time course of 
repair (0, 12, 24, 48hrs after progesterone withdrawal). Detailed analysis using 
co-staining of endothelial cells (CD31) and pericytes (NG2) revealed that in normal 
(naïve) endometrium CD31+ blood vessels were surrounded by NG2+ pericytes 
however during active repair (24hrs) pericyte coverage appeared reduced and there 
were some NG2+ cells in close proximity to the denuded stromal surface. Assessment 
of the results confirmed a significant decrease in the percentage of pericytes associated 
with blood vessels with a corresponding increase in the percentage of pericytes located 
in the stroma tissue irrespective of blood vessels. Pericytes detaching from blood 
vessels and migrating into the surrounding tissue is well documented in studies of 
development, wound healing and tumorigenesis (Stratman et al. 2009, Abramsson, 
Lindblom and Betsholtz 2003, Ansell and Izeta 2015) and during development 
(Gerhardt and Betsholtz 2003) where is it shown they guide the angiogenic sprout 
during angiogenesis. Evidence also suggests that during skin wound healing when 
pericytes dissociate from vasculature this can induce a differentiation event from a 
smooth muscle phenotype to a mesenchymal phenotype (Zebardast, Lickorish and 
Davies 2010). However, studies have also demonstrated that pericytes migrate away 
from blood vessels and differentiate into myofibroblasts in response to injury and are 
therefore effector cells in fibrosis (Humphreys 2012). Current results suggest that 
pericytes may be mobilised from their normal perivascular location to contribute to 
endometrial repair processes following menstruation although the functional 
significance remains unknown and further studies are needed to confirm this. Indeed 
pericytes residing in the vascular niche have been described as well positioned to 
respond to signals accompanying endometrial breakdown, modulate the inflammatory 
response and migrate through tissue to the site of damage (Spitzer et al. 2012). 
Analysis of GFP+ cell populations in Pdgfrβ-BAC-eGFP uterine tissues at 12, 24 and 
48hrs following progesterone withdrawal suggested that the stromal fibroblast 
population was relatively unchanged throughout endometrial breakdown and repair. 
In contrast, at 24hrs there were significantly more GFP+CD146+ pericytes in the 
tissue. Pericytes have been shown to proliferate in response to Pdgfrβ signalling and 
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TGFβ signalling, during development, angiogenesis and fibrosis (Humphreys 2012). 
These two pathways may well be in effect during endometrial repair. Unexpectedly, a 
phenotypically distinct transient population of cells characterised as GFPdimCD146mid 
was identified in 24hrs samples. The origin of this cell population remains unknown 
but we postulate two possible origins: they derive from stromal fibroblasts 
(GFPdimCD146-cells) that have increased expression of CD146; or they derive from 
pericytes (GFPbrightCD146+) that have decreased expression of Pdgfrβ and CD146.  It 
is also notable that at 24hrs data analysis of monocyte cell populations (Chapter 3) 
identified a rapid increase in monocytes at the same time point and these appeared to 
have a unique phenotype compared with tissue resident macrophages. 
MSCs have heterogeneity in expression of CD146 however it has been demonstrated 
that this does not affect CFU-F number, the osteogenic, chondrogenic and adipogenic 
differentiation ability or the ability for haematopoietic support (Espagnolle et al. 
2014). Interestingly MSCs with high CD146 expression have a lower proliferation  rate 
but a better potential for contraction of collagen matrix and it was therefore suggested 
that CD146 expression by MSCs is characteristic of commitment towards the vSMC 
lineage (Espagnolle et al. 2014). Another study indicates however that CD146 
expression defines MSCs with high multipotency (Feng et al. 2011) which suggests 
CD146 expression may be decreased by MSCs as they undergo transdifferentiation 
events. Fibroblasts and myofibroblasts do not express CD146 (Akamatsu et al. 2013) 
but pericytes are reported to have the ability to differentiate into fibroblasts and 
myofibroblasts (Humphreys 2012, Kramann and Humphreys 2014, Greenhalgh et al. 
2013, Hosaka et al. 2016). With this in mind it seems sensible to suggest that the 
transient, intermediate, mesenchymal cell population discovered in repairing 
endometrial tissues has arisen from the pericyte population (CD146+) and may be 
undergoing a trandifferentiation event to either become part of the CD146- fibroblast 
population or indeed the Pdgfrβ-CD146- cell population. Further lineage tracing 
studies are required to investigate the true origin of the intermediate cell population. 
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5.5.2 Investigation of the potential of mesenchymal cells to undergo 
a mesenchymal to epithelial transition (MET) during 
endometrial repair  
EpCAM was expressed exclusively by epithelial cells and not found to co-express with 
GFP in naïve Pdgfrβ-BAC-eGFP uterine tissue but GFP+EpCAM+ cells were 
identified by flow cytometry in tissue digests during the endometrial shedding/repair 
time window. This result was supported by IHC with a population of GFP+EpCAM+ 
cells detected both in regions of decidual detachment and also lining the luminal 
surface. Both results appear in agreement with our previous studies reporting evidence 
for MET  in the Edinburgh menses mouse model (Cousins et al. 2014). The suggestion 
that MET occurs during endometrial repair was first put forward by Garry et al, who 
used detailed SEM of menstrual phase human endometrium to provide evidence that 
stromal cells residing close to the luminal surface could contribute to the new epithelial 
cell layer (Garry et al. 2009, Garry et al. 2010). Restoration of the epithelial cell layer 
is essential for uterine function. When the epithelial-specific gene Cdh1 (E-cadherin) 
is knocked out in mice this is associated with abnormal epithelial development and 
reduced expression of epithelial markers including cytokeratin 8 and occludin 
(Reardon et al. 2012). Interestingly these genes were found to be upregulated during 
endometrial repair in mice with a corresponding decrease in stromal associated genes 
(Cousins et al. 2014). It must be kept in mind however that in this study whole uterine 
tissues were examined which cannot rule out the contribution of epithelial cells as well 
as remaining stromal cells to the transcriptomic signature. Furthermore, genetic fate 
mapping has been used to examine endometrial remodelling following parturition 
which showed that stromal derived cells (anti-Mullerian hormone (AMH) receptor 
type II expressing cells) incorporated into the luminal and glandular epithelium 
through MET (Huang et al. 2012). Using the same tools Patterson et al investigated 
endometrial repair in a mouse model and showed a population of cells exhibiting both 
stromal and epithelial cell markers in the myometrial epithelial border (Patterson et al. 
2013). 
It has been reported that the protein ‘smoothened’ a GPCR (encoded by Smo) is a 
master regulator of hepatic epithelial regeneration based on its ability to promote MET 
in hepatic stellate cells through Hedgehog, TGFβ and Wnt signalling pathways 
Chapter 5: Investigation of the role of mesenchymal progenitor cells in endometrial 
tissue breakdown and repair   334 
 
(Michelotti et al. 2013). In the endometrium it is believed that a balance in EMT and 
MET is important to repair processes: partial EMT may occur in epithelial cells to 
allow them to obtain a migratory phenotype; while MET may occur in stromal cells to 
allow them both to contribute to reepithelialisation (Cousins et al. 2014, Maybin and 
Critchley 2015) although the particular cell types which have this potential remain 
unknown.  
Cells that express both Pdfrβ and CD146 have been identified in human endometrium 
and classified as pericytes with MSC properties. Although their role in human 
menstrual physiology has not yet been investigated, they have been shown to give rise 
to both endometrial stromal and epithelial cell compartments in vitro and by 
xenografting studies in vivo (Schwab and Gargett 2007). In general, MSCs (pericytes) 
have been found to differentiate into various epithelial cell types after systemic 
administration in vivo such as airway epithelial cells, retinal pigment epithelial cells, 
skin epithelial cells, sebaceous duct cells, tubular epithelial cells in the kidney 
(Phinney and Prockop 2007) however little evidence exists to support pericytes giving 
rise to epithelial cells in the endometrium.  
It has been reported that CD146 is an important regulator of EMT with overexpression 
of CD146 in non-invasive epithelial breast cancer cells repressing the epithelial cell 
phenotype, inducing a mesenchymal cell phenotype and increasing migratory and 
invasive behaviour. (Zeng et al. 2012). Purified endometrial CD146+ cells cultured in 
a collagen-matrigel scaffold gave rise to epithelial-like cells which expressed genes 
including Spp1, Mmp2, ZO-1, Laminin alpha 2 and collagen type IV (Fayazi, Salehnia 
and Ziaei 2017). Applying this knowledge to the current results supports the theory 
that pericytes (PdgfrβbrightCD146+) can undergo MET and may downregulate CD146 
as they do so, giving rise to the newly identified intermediate cells 
(PdgfrβdimCD146mid) which we postulate are novel transient population of 
transdifferentiating pericytes. 
Some previous evidence of MET transition has been identified in endometrial tissues 
using lineage tracing methods (Huang et al. 2012, Patterson et al. 2013) however as 
these studies were carried out using constitutive-Cre systems they do not discount 
MET that may have occurred during development. Pilot experiments using the 
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NG2-CreERTM BAC tamoxifen-inducible mouse line, detailed in Chapter 4, have 
provided a novel way of tracking the fate of pericytes by lineage tracing but the use of 
the anti-oestrogen tamoxifen to induce the transgene requires some further refinement 
of methods before these mice can be used in the Edinburgh menses mouse model. 
5.5.3 Profiling of mesenchymal cells during endometrial repair by 
next generation sequencing and single cell sequencing revealed 
heterogeneity within the stromal compartment 
GFP+ cells purified from Pdgfrβ-BAC-eGFP endometrial tissue recovered during 
active breakdown/repair 24hrs after progesterone withdrawal were analysed by both 
RNAseq and single cell sequencing with their resulting transcriptional profiles 
compared to those previously generated using a similar population of GFP+ cell 
recovered from normal, cycling adult mouse endometrium (see Chapter 4). Profiling 
mesenchymal cells during endometrial repair by NGS revealed a wide range of 
transcriptomic changes with 616 significantly upregulated genes and 1013 
significantly downregulated genes. Gene ontology terms enriched by the significantly 
upregulated genes were largely associated with smooth muscle cell function, blood 
vessel function and regulation of the inflammatory response. Gene ontology terms 
enriched by the significantly downregulated genes included collagen fibril 
organisation, cell adhesion and regulation of cell localisation. Various studies have 
highlighted similar genes and pathways during endometrial breakdown and repair 
including ECM proteolysis, cell migration, haemostasis, vasoconstriction, 
inflammation, chemotaxis and wound healing (Spitzer et al. 2012, Talbi et al. 2006, 
Critchley et al. 2006a). 
Interestingly, in the current study some of the upregulated genes were associated with 
smooth muscle contraction, regulation of myoblast differentiation and smooth muscle 
cell proliferation (e.g. Tnc, Smad5, Tnf, Rgs2, Kcnma1, Ptgs2, Prickle1, Ifg2, Stc1, 
Ptch1, Ednra, Prdm1), which would be consistent with stromal cells undergoing FMT. 
Tenascin-C (Tnc) was highly upregulated in the repairing endometrial tissue. This 
gene encodes a glycoprotein that specifically attracts fibroblasts and promotes their 
differentiation into myofibroblasts in response to injury in a rat model of cardiac injury 
(Tamaoki et al. 2005). In knockout mice the appearance of myofibroblasts was delayed 
even though cardiac repair was achieved (Tamaoki et al. 2005). These results highlight 
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potential parallels between regulatory molecules involved in cardiac and endometrial 
repair.  Interestingly lineage tracing experiments in mice have  shown that 
injury-induced ADAM12 (a disintegrin and metalloprotease 12) positive cells are a 
pro-inflammatory subset of collagen-overproducing cells that differentiate into 
myofibroblasts and either ablating these cells or knocking down ADAM12 has been 
shown to be sufficient to decrease fibrosis and scarring in muscle and skin (Dulauroy 
et al. 2012). In the current data set ADAM12 was significantly downregulated in the 
repairing endometrial mesenchyme which appears to further support the hypothesis 
that endometrial repair involves a unique FMT response so that there is less ECM 
deposition and a fibrotic response does not occur. Further lineage tracing and gene 
profiling experiments will establish whether this response is specific to pericytes. 
Changes in genes associated with the morphogenesis of an epithelial sheet such as 
Mmp12, Notch2, Lama1, Spp1, Cdh1, Cd44, Hoxd11, Mmp9, Sani1, Tnc, Ptch1, Lef1, 
Ednra, Prickle1 and Lmo1 appear consistent with the evidence for EMT from this and 
other studies. For example, using tissues from the same mouse model system Cousins 
et al used a focussed gene array that contained a small selection of EMT/MET 
regulators: their results highlighted significant increases in several genes involved in 
the process including Krt7, Cdh1 Dcsc2, Spp1, Dsp, Mmp3, Mmp9, Snai1, Slug and 
Wt1 (Cousins et al, 2014). Bioinformatic analysis of the new dataset identified changes 
in genes associated with a number of signalling pathways including Wnt signalling, 
Hedgehog signalling, TGFβ signalling, BMP signalling, all of which have previously 
been implicated in regulation of wound healing and in both FMT and EMT.  
Single cell sequencing was used to complement NGS and further investigate 
transcriptomic changes within discrete mesenchymal cell populations. Single cell 
sequencing revealed novel heterogeneity of the endometrial mesenchyme that had not 
previously been described. Strikingly in normal endometrium cluster analysis 
identified 5 individual clusters of cells whereas cell sorting based on GFP intensity 
suggested there are only two (GFPdim stromal fibroblasts and GFPbright pericytes). 
When differential gene expression analysis was carried out to generate lists of genes 
specific to each cluster Clusters 1 and 4 were revealed as stromal fibroblasts with a 
high degree of similarity between their gene expression signatures.  However as the 
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cells in cluster 4 appeared to be associated with collagen biosynthesis and ECM 
assembly it is possible they represent a population of stromal myofibroblast-like cells 
that are involved in maintaining tissue architecture. In contrast Clusters 2 and 3 
appeared to be subpopulations of the cells previously identified as GFPbright pericytes. 
However as Cluster 3 had higher expression of genes associated with vascular smooth 
muscle cells (Myh11, Acta2, Tagln) while Custer 2 had higher expression of genes 
associated with pericytes (Kcnj8, Abcc9, Rgs5) it is hypothesised that they share a 
common phenotype but may differ in function.  
A comparison of the datasets generated from single cells recovered from naïve uterine 
tissues with those from endometrium undergoing active tissue repair (24hrs) revealed 
global gene expression changes in all mesenchymal cell populations in response to 
wounding which have not previously been described. Cluster analysis identified 9 
distinct clusters of cells which were identified using gene signatures detected in the 
analysis of normal uterine tissue. Gross gene changes could be detected in each cell 
compartment: stromal fibroblasts, vascular smooth muscle cells and perictyes, 
associated with repair processes. Strikingly, there was a population of cells specific 
only to the repairing tissue that could not be identified based on the previously 
identified characteristic gene signatures. Notably, genes upregulated in this cell cluster 
were enriched for biological processes associated with reproductive function, wound 
healing, mesenchymal cell function, blood vessel function, epithelial cell function and 
the inflammatory response. Signalling pathways identified included Pdgfr signalling, 
Tnf signalling, response to glucocorticoid and response to growth factors. 
It has been described that signalling by Cxcl12 through Cxcr4 and the expression of 
multiple MMPs is essential to the migration of MSCs during tissue repair (Spitzer et 
al. 2012, Son et al. 2006, Rafii et al. 2015). Interestingly the repair-specific cluster 
exclusively expressed Cxcr4 although Cxcl12 was not detected in the data set. This 
suggests that this cluster may represent migrating MSC-like cells responding to 
paracrine signalling via Cxcl12 generated by cells out with the mesenchymal 
compartment (immune cells). Notably the repair-specific cluster also expressed higher 
levels of Mmp3, Mmp9, Mmp10 and Mmp12 consistent with an important role for this 
cell cluster and the secretion of MMP proteins in tissue breakdown during 
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menstruation which has been highlighted in previous reports based on human (Gaide 
Chevronnay et al. 2012, Marbaix et al. 1996b, Marbaix et al. 1996a) and mouse tissues 
(Cousins et al. 2014, Kaitu'u et al. 2005).  
The repair-specific cluster also exclusively expressed Sprrd2, Grem1, Ptgs2, Plk2, 
Fem1b, Basp, Fnd3ca, Bmp7 and Ctnnb1 all of which are regulatory genes implicated 
in the morphogenesis of an epithelium. The expression of Krt8, Krt18, Krt19, Cdh1 
and Epcam was detected in a contaminating epithelial cell cluster in the naïve tissue 
but notably some of these genes were also present in the repair-specific cluster (Kalluri 
and Weinberg 2009). The transcription factor Klf4 has been demonstrated to drive the 
expression of epithelial genes including Cdh1 (Li et al. 2010) and Pax2, Bmp7 and 
Wt1 are all well-known drivers of the conversion of mesenchymal cells to epithelial 
cells through MET (Kalluri and Weinberg 2009). Klf4, Bmp7 and Wt1 were 
significantly upregulated in the repair-specific cluster with all the data above 
consistent with cells in this cluster undergoing MET.  
Cells in the repairing cluster also expressed Pdgfrβ and Mcam (CD146) (although to a 
lesser extent than the pericyte cluster) and were also genes expressed by pericytes and 
the stromal fibroblast cluster. Collectively this suggests that a ‘repair-unique’ cluster 
includes the cells identified by flow cytometry and defined as PdgfrβdimCD146mid. The 
origin of this cell population remains to be fully validated but is clearly important in 
defining a cell phenotype with an apparently important role in scarless endometrial 
tissue repair. 
In other studies single cell sequencing technologies have been used to analyse human 
endometrial biopsies highlighting transcripts including FOS, APOD and DCN 
implicated in decidualisation and SERPINF1 and LUM involved in the immune 
response (Krjutškov et al. 2016). Similarly uterine epithelial cells from neonatal to 
sexually mature mice have been analysed by single cell sequencing which has revealed 
a subpopulation of stem/progenitor cells and redefined a hierarchal map during 
epithelial development (Wu et al. 2017). To the best of my knowledge this is the first 
single cell dataset that specifically interrogates mesenchymal cells during endometrial 
repair using a defined and validated mouse model. This study has identified complex 
heterogeneity within the endometrial mesenchyme that has not previously been 
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reported allowing the landscape of the endometrial mesenchyme to be redefined which 
may change perspectives on the results of many studies. Identifying definitive 
molecular signatures for each subpopulation is an important future goal as this will 
drive in greater understanding of how the endometrial mesenchyme responds during 
scarless tissue repair.  
5.5.4 Future prospects 
The novel results presented in this chapter have revealed a dynamic role for 
endometrial pericytes in repair processes with a potential to undergo MET to 
contribute to reepithelialisation. To complement and extend these studies lineage 
tracing experiments are required to more thoroughly interrogate dynamics of 
mesenchymal and epithelial cell populations. In further experiments inducible Cre 
lines will be employed under control of cell specific markers to specifically trace the 
contribution of pericytes (NG2) and stromal fibroblasts (Pdgfrα) individually to 
endometrial repair. Initial results using NG2 immunohistochemistry have already 
suggested these cells become mobilised during the repair process. With such genetic 
tools further ablation studies could be carried out whereby the lines would be crossed 
with a floxed DTR line and upon administration of diphtheria toxin the cells would be 
ablated. This would determine how essential specific cell populations are to 
endometrial repair. Furthermore, conditional gene knockout studies could be carried 
out by crossing the cre lines with floxed mouse lines around various genes of interest 
allowing for the identification of therapeutic targets. 
Single cell sequencing analysis identified previously undetected heterogeneity within 
the endometrial mesenchyme. With the current single cell dataset it would be 
interesting to run bioinformatic comparisons to data sets generated in uninjured and 
injured kidney/liver/heart such as those already generated by the Henderson lab group 
(unpublished data). This would highlight any significant transcriptomic differences 
between a scarless wound healing response seen in the endometrium and a scarring 
response seen during liver/kidney/cardiac fibrosis. Such cross disciplinary studies may 
identify therapeutic approaches to target fibrosis in the kidney/liver/heart. 
Additionally, if pericytes are identified as a key player in scarless healing they could 
be manipulated in other tissues to alleviate fibrosis. The use of adoptive transfer studies 
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using endometrial pericytes as a cell-based therapy may also provide an experimental 
approach to alleviate fibrotic disease in other tissues. 
5.5.5 Concluding remarks 
These studies which have focussed on the role of perivascular pericytes in scarless 
endometrial tissue repair, have provided new and compelling evidence that 
endometrial pericytes have the ability to undergo MET and thereby contribute to both 
stromal remodelling and reepithelialisation. To complement and extend the current 
data, lineage tracing studies are planned building on identification of NG2 as a specific 
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Chapter 6 Final Discussion 
The endometrium is a dynamic steroid-dependent tissue that exhibits a unique ‘wound 
healing’ response that is both inflammatory and completely regenerative with 
complete restoration of a complex tissue architecture following menstruation without 
development of any scar tissue. The aim of this thesis was to use the endometrium as 
a paradigm for scarless tissue repair in which to interrogate the phenotype and function 
of both myeloid immune cells and mesenchymal progenitors and investigate their role 
during post-menstrual endometrial repair. As it is difficult to obtain human samples of 
menstrual endometrium, a previously established mouse model of endometrial 
breakdown and repair (Cousins et al. 2014), referred to in this thesis as the ‘Edinburgh 
menses mouse model’. The Edinburgh model has previously been characterised and 
shown to successfully recapitulate key processes of menstruation in women including 
focal hypoxia, tissue breakdown, immune cell influx and re-epithelialisation. In this 
model the mouse endometrium exhibits complete restoration of tissue integrity within 
48hours, recapitulating the rapid healing process observed in the human endometrium. 
In conjunction with different transgenic mouse lines the contribution of both myeloid 
immune cells (MacGreen, MacApple, CD68-eGFP) and mesenchymal progenitors 
(Pdgfrβ-BAC-eGFP, NG2-CreERTM BAC) has been thoroughly investigated. The 
studies presented in this thesis have revealed novel mechanisms contributing to 
scar-free endometrial repair processes, which are discussed below. 
6.1 A heterogeneous monocyte/macrophage population can 
be identified in endometrial tissue during repair 
Menstruation is associated with the sequential recruitment of neutrophils and 
macrophages that are believed to play key roles in the controlled break down of the 
tissue and its subsequent shedding (Evans and Salamonsen 2012). The studies 
outlined in this thesis have focussed on the contribution of macrophages to the 
regulation of endometrial inflammation and tissue breakdown. Evidence shows that 
macrophage numbers peak in the human endometrium during menstruation where 
they represent up to 15% of the leucocyte population (Salamonsen and Woolley 
1999). As macrophages are able to acquire a pro- or anti-inflammatory phenotype 
in response to signals from the microenvironment (Mantovani et al. 2013) it is likely 
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that discrete signals from the endometrial microenvironment affect macrophage 
phenotype and function. In Chapter 3, the aim was to determine the phenotype and 
spatial localisation of mononuclear phagocytes in endometrial tissue during 
homeostasis and endometrial repair.  
The MacGreen transgenic mouse was used to focus investigations on the 
monocyte/macrophage lineage as GFP is expressed specifically in cells under control 
of the CSF1R, a protein essential to the proliferation, differentiation and survival of 
monocytes and macrophages (Sasmono and Williams 2012). Results obtained 
demonstrated that numbers of GFP+ immune cells rapidly increased in the endometrial 
tissue in response to the ‘wounding’ stimulus of tissue breakdown. These cells were 
most abundant in the residual endometrium and shed tissue 24hrs following P4 
withdrawal and by 48hrs were much reduced seemingly in line with the resolution of 
inflammation and completion of repair. Further characterisation of immune cells using 
the mature macrophage marker F4/80 identified a heterogeneous population of 
immune cells of the monocyte/macrophage lineage present in repairing endometrial 
tissues with novel evidence for three subpopulations based on their expression of GFP 
and/or F4/80. The three populations showed discrete spatial localisation within the 
tissue: GFP+F4/80- inflammatory monocytes located most prominently in the shed 
tissue undergoing breakdown and in regions of residual endometrium undergoing 
repair; GFP+F4/80+ monocyte-derived macrophages localised to residual 
endometrium undergoing repair and not associated with shed tissue undergoing 
breakdown nor regions of endometrium where repair was complete; and GFP-F4/80+ 
presumptive tissue-resident macrophages which appeared relatively stable and 
unchanged during endometrial repair, and were dispersed throughout the tissue 
irrespective of areas of tissue breakdown and repair. It is reasonable to postulate that 
these distinct locations of monocyte/macrophage subpopulations in the endometrium 
may have significant impacts on their phenotype and function as has been shown in 
other studies (Schulz et al. 2012) but this will require further study to unravel. Taken 
together, my novel results support a dynamic spatio-temporal role for monocytes and 
macrophages in regulating endometrial repair which are summarised in Figure 6-1.  
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Figure 6-1. Schematic representation of the fate of mononuclear phagocytes during scar-
free endometrial tissue repair (left) in relation to three distinct phenotypes identified by 
IHC (right). (A) Endometrial repair is associated with a dynamic influx of monocytes from 
the circulation in response to the ‘wounding’ stimulus of menses which differentiate in 
response to spatially distinct signals within the tissue. (B) GFP+F4/80- monocytes ((1) green) 
cluster in the shed tissue undergoing active tissue breakdown, peaking at 24hrs after P4 
withdrawal. (C) A mixed population of GFP+F4/80- monocytes and GFP+F4/80+ monocyte-
derived macrophages ((2) green/red) cluster in areas of active repair and remodelling in close 
proximity to denuded stromal surfaces (yellow dotted line). (D) It is currently undetermined 
whether GFP+F4/80+ cells arise from an independent population of monocytes that influx 
independently of the GFP+F4/80- monocytes. (E) Tissue resident macrophages are located 
throughout the endometrial tissue and remain homeostatic during repair ((3) red). Upon 
completion of repair GFP+F480- monocytes may undergo differentiation to become part of 
the tissue resident macrophage population or (F) undergo apoptosis and be cleared from the 
tissue following resolution of inflammation. 
 
One of the major questions arising from this data was the identification of a 
macrophage population that was seemingly persisting independently of CSF1 
signalling (GFP-F4/80+ cells) which appeared at odds with reports that macrophages 
require CSF1 signalling to survive (Sasmono and Williams 2012, Jones and Ricardo 
2013). To address whether this result was in part a reflection of the site of insertion of 
the transgene in the MacGreen line two further transgenic mouse lines were utilised: 
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the MacApple line where mCherry (RFP) is expressed under control of the CSF1R 
promoter (Hawley et al. 2018) although the locus of insertion varies to that of the 
MacGreen line; and the CD68-eGFP line where eGFP is expressed under control of 
the CD68 promoter, a protein expressed by myeloid cells, specifically monocytes and 
macrophages (Iqbal et al. 2014). Using these different transgenic lines similar results 
were obtained when analysing the expression of the intrinsic reporter and F4/80. As in 
MacGreen tissues three subpopulations of labelled cells were always identified: 
Reporter+F4/80- cells, Reporter+F4/80+ cells and Reporter-F4/80+ cells and these all 
showed similar tissue distribution patterns in the endometrium during repair. When 
triple IHC was used to concurrently examine expression of GFP, CSF1R and F4/80 in 
MacGreen tissues the presence of an F4/80+ cell population that did not express either 
GFP or CSF1R was confirmed and this was backed up by gene expression analysis 
confirming isolated GFP-F4/80+ cells had very low expression levels of CSF1R 
mRNA when compared to GFP+F4/80- and GFP+F4/80+ cells.  
The experiments described above confirmed that three subpopulations of 
monocyte/macrophages exist in endometrium the numbers of which change 
dynamically during shedding/repair and further investigations have begun to explore 
the functional significance of this result. The expression of key candidate genes 
associated with currently ‘known’ monocyte/macrophage phenotypes was assessed 
by qRTPCR. This revealed that the different subpopulations expressed genes 
associated with alternatively activated, anti-inflammatory and pro-repair monocyte 
and macrophage phenotypes.  Notably the GFP+F4/80+ cell population exhibited 
markers usually assigned to both monocytes and macrophages suggesting further 
heterogeneity in this population. As these cells are specifically located to regions of 
repairing tissue and only present in abundance during the repair phase (24hrs in this 
study) we believe further studies on this population should be undertaken as they 
may help to decipher the role(s) played by macrophages in scar-free endometrial 
repair. 
Although the current studies were focussed on the myeloid lineage, the 
inflammatory response in the endometrium is believed to involve a complex 
interplay not only between the various immune cells but also cross-talk with other 
Chapter 6: Final discussion 345 
cells in the tissue microenvironment which will inevitably influence phenotype and 
function. To broaden current knowledge an interrogation of the other immune cell 
populations and their relationship to monocyte/macrophages is required. As 
described in detail in Chapter 5, single cell sequencing can be used to 
simultaneously examine a heterogeneous cell population and gene expression 
changes that may be relevant to different experimental conditions. To apply this 
technology to immune cells in the endometrial repair, a single cell sequencing 
dataset for total CD45+ cells in both naïve mouse endometrium and endometrium 
from mice at the 24hrs time point of the mouse model of endometrial breakdown 
and repair, has very recently been generated. Analysis is currently underway to 
interrogate the new dataset so as to better understand the different immune cell 
phenotypes present in the tissue, their relative proportions and how they interact to 
control the inflammatory response associated with endometrial repair.  
As the studies in this thesis were designed to explore the roles of both immune cells 
and mesenchymal cells in the endometrial repair processes, new hypotheses can be 
generated by comparing different sets of the data: one such example is summarised 
in Figure 6-2. Interestingly by examining endometrial pericytes (Figure 6-2 (A) 
white arrows) and immune cells (Figure 6-2 (B) yellow arrows) separately (Chapters 
3 and 4), both cell types were found to be clustering in close proximity to the 
denuded stromal surface (Figure 6-2 (A-B) yellow dotted line) in tissue regions 
undergoing active tissue repair. Without performing a double stain for these two cell 
types a definitive conclusion cannot be drawn, however it seems possible  that these 
different cell populations may interact at the interface of endometrial repair. 
Whether pericytes govern immune cell function or the other way around or both, 
and how these regulatory mechanisms influence endometrial repair is an important 
future line of study that can increase our knowledge of the mechanisms 
underpinning scar-free tissue repair. 
Data mining of the bulk RNA sequencing dataset generated from tissues recovered 
from Pdgfrβ+ mice during repair has revealed changes in expression of mRNAs for 
cytokines and chemokines (summarised in Figure 6-2 (C)) indicating a substantial 
role for these cells in regulating immune cell trafficking and function. By analysing 
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the single cell dataset of mesenchymal cells generated in the studies described in 
Chapter 5 further detail can be obtained. Many molecules that regulate the 
inflammatory response were identified and a few have been discussed as examples 
below. Specifically, it appears that the upregulation of Cxcl1 and Cxcl2 in the total 
tissue sample can be specifically attributed to the pericyte population during repair 
(Figure 6-2 (D-E) red dotted line) and to the new repair-specific mesenchymal cell 
cluster currently of unknown identity (Figure 6-2 (D-E) green dotted line). CXCL1 
has mitogenic properties and is involved in several wound healing processes 
including angiogenesis, and inflammation, specifically neutrophil recruitment 
(Vries et al. 2015). CXCL1 has also been shown to be important for the migration 
of progenitor cells in the spinal cord (Tsai et al. 2002) and signals through the 
CXCR2 receptor. CXCL2 is a related chemokine to CXCL1 also signalling through 
CXCR2 and is chemotactic for both polymorphonuclear leucocytes and 
haematopoietic stem cells (Pelus and Fukuda 2006). CXCL2 has also been shown 
to be implicated in the migration of smooth muscle cells in the airways (Al-Alwan 
et al. 2013). Similarly, the expression of Il123a and Tnf was most abundant in the 
new ‘repair-specific’ cell cluster (Figure 6-2 (F-G) green dotted line) and appeared 
not to be expressed by other cell types. IL23a is a cytokine which has been shown 
to promote the upregulation of MMP9, increase angiogenesis and regulate T cell 
functions specifically Th17 responses (Kikly et al. 2006) and TNF is a well 
described pro-inflammatory cytokine which has various roles in regulating immune 
cells. This suggests that both cells identified by their profile as pericytes as well as 
the newly identified population of ‘repair specific’ cells can play critical roles in 
regulating the inflammatory response, signalling to immune cell subtypes and 
stimulating stem cell responses. Interactions between mesenchymal cells and 
immune cells require further investigation. 
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Figure 6-2. Expression of factors that regulate the inflammatory response by 
mesenchymal cells during active endometrial repair (24h after P4 withdrawal). (A) IHC 
for NG2+ pericytes (green) and CD31+ endothelial cells (red) showing pericytes clustering 
near to the denuded stromal surface (white dotted line). (B) IHC for GFP (green) and F480 
(red) expressing immune cells showing clusters near to the denuded stromal surface (white 
dotted line). Myometrium = M, Stroma =S, lumen = L. (C) The expression of various cytokines 
and chemokines by mesenchymal cells during endometrial repair as determined by RNA 
sequencing. (D-G) expression of Cxcl1, Cxcl2, Il23a and Tnf by mesenchymal cells during 
endometrial repair as determined by single cell sequencing. 
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6.2 Identification of a pericyte specific marker in mouse 
endometrial tissues  
As the endometrium exhibits an unparalleled regenerative capacity many studies 
including this one, have hypothesised that a population of mesenchymal 
stem/progenitor cells exist in the tissue that are in part responsible for the rapid and 
scar-free tissue repair (Gargett et al. 2016). This concept was first introduced in 
1978 by Prainishnikov however evidence for the existence of endometrial stem cells 
only came about in 2004 when Chan et al identified populations of clonogenic cells 
in both the epithelial and stromal cell compartment (Chan et al. 2004). Since then, 
various studies have identified stem/progenitor cells in the endometrium (both human 
and rodent) which have been shown to have functions in maintaining tissue 
homeostasis (Gargett and Masuda 2010). However, the majority of current knowledge 
on the characterisation of endometrial stem/progenitor cells has been gathered using 
in vitro studies on a heterogeneous populations of stromal cells which does not exclude 
contamination from other cell types or effects of different culture conditions (Masuda 
et al. 2012). Therefore there was a need for a more robust characterisation of these 
cells which has been addressed by the studies in this thesis which have used transgenic 
mice combined with extensive image, flow and genomic analyses. 
Studies in the human endometrium have used PDGFRβ and CD146 co-expression to 
identify a population of endometrial MSCs (Schwab and Gargett 2007). Notably these 
markers were also found to be expressed by stromal LRC in mouse tissue hypothesised 
to represent the MSC population in mice (Chan and Gargett 2006a). Stromal LRCs are 
located near CD31+ endothelial cells and express various stem cell markers including 
c-kit/CD117 and Oct4 (Cervelló et al. 2007).  A further study has confirmed that 
Pdgfrβ and CD146 are co-expressed in a population of perivascular cells in the mouse 
endometrium, as well as mouse embryonic stem cells and therefore it is believed that 
these cells may possess stem cell activity (Parasar et al. 2017). Investigations carried 
out in this thesis utilised the Pdgfrβ-BAC-eGFP transgenic reporter mouse line in 
which GFP is expressed under the control of the Pdgfrβ promoter (Henderson et al. 
2013). This mouse has been already been used in a number of studies to identify 
mesenchymal cells in various tissues including liver, kidney and brain (Henderson et 
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al. 2013, Zhang et al. 2018, Vanlandewijck et al. 2018, Martin et al. 2016) but has not 
previously been used to study mesenchymal cells in the endometrium. Robust 
reporting by GFP provided a reliable and reproducible way to target endometrial 
mesenchymal cells and an additional novel finding was that the two subpopulations of 
mesenchymal cells, stromal fibroblasts and pericytes could be easily separated based 
on the intensity of GFP expression. Having an intrinsic reporter to identify and isolate 
cells by flow cytometry and FACS methods has bypassed the difficulties encountered 
when relying purely on antibody detection including cross reactivity, unspecific 
staining and cleaved epitopes.  
IHC, flow cytometry and sequencing methods were employed to show that the two 
subpopulations of Pdgfrβ expressing cells could be further distinguished by discrete 
localisation and gene expression profiles. Of particular interest was the identification 
of GFPbright cells which expressed CD146, αSMA and NG2 and were located in close 
proximity to CD31 expressing endothelial cells therefore occupying a perivascular 
niche. In line with phenotypes described by other studies (Schwab and Gargett 2007, 
Spitzer et al. 2012, Crisan et al. 2009, Murray et al. 2014), these new results confirmed 
that the mouse endometrium houses a population of perivascular cells that express both 
Pdgfrβ and CD146. Further characterisation using a panel of markers commonly used 
to identify perivascular pericytes in various tissues (Crisan et al. 2008, Crisan et al. 
2009) identified these cells as endometrial pericytes. As GFP expression in the Pdgfrβ-
BAC-eGFP transgenic mouse line is a readout of Pdgfrβ gene promoter activity 
(Henderson et al. 2013) this indicates that GFPbright pericytes in the endometrium may 
specifically upregulate expression of Pdgfrβ which may be of functional importance, 
although this is still to be investigated.  
The IHC and gene expression studies have highlighted that Pdgfrβ is also expressed 
by stromal fibroblasts while CD146 is also expressed by endothelial cells, therefore 
neither is an exclusive marker of pericytes. Similarly upon validation of top hits from 
the RNA sequencing study the majority of genes were also expressed by other 
mesenchymal populations as summarised in Figure 6-3. Notably this detailed anlaysis 
demonstrated that expression of NG2 was exclusive to GFPbright pericytes and the 
mRNA was not detected in GFPdim stromal fibroblasts nor in CD31+ endothelial cells. 
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These results showed that NG2 fulfilled the criteria to be a pericyte-specific 
identification marker in mouse endometrium and may be useful in targeting these cells 
in downstream applications (Figure 6-3). 
 
Figure 6-3. qPCR gene expression analysis of putative pericyte genes in mesenchymal 
cell populations isolated from naïve Pdgfrβ-BAC-eGFP uterus. All genes were expressed 
by GFPbright pericytes, while VCAM1, MCAM (CD146) and Kitl were also expressed by 
CD31+ endothelial cells. Minimal expression of RGS4, VCAM1 and Runx1 was detected in 
GFPdim stromal fibroblasts. NG2 (encoded by Cspg4) was exclusively expressed by GFPbright 
pericytes as highlighted by the red dotted line (n=5). 
 
As NG2 was determined to be a pericyte specific marker for endometrial tissues the 
NG2-CreERTM BAC transgenic mouse line, where TdTomato is expressed under 
control of the NG2 promoter when induced with tamoxifen, was purchased from 
JAX. Preliminary results using these transgenic mice have shown promise as 
TdTomato positive cells were shown to co-express NG2, CD146 and Pdgfrβ and were 
located in close association with CD31+ endothelial cells, consistent with results 
obtained using the Pdgfrβ-BAC-eGFP mouse line and those reported in the literature 
(Schwab and Gargett 2007, Spitzer et al. 2012, Crisan et al. 2009, Murray et al. 2014).  
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Several interesting comparisons can be drawn when identifying endometrial pericytes 
using different transgenic lines, as summarised in Figure 6-4. Immunohistochemistry 
demonstrates that both GFPbright cells in Pdgfrβ-BAC-eGFP and TdTomato+ cells in 
NG2-CreERTM BAC uterine tissues have a perivascular location and similar 
morphology with rounded cell bodies and long membranous processes that wrap 
around blood vessels (Figure 6-4 (A-B)). Quantification by flow cytometry revealed 
that GFPbright cells in the adult Pdgfrβ-BAC-eGFP uterus represent 8.33±0.36% live 
cells while TdTomato+ cells in uterine tissues recovered from NG2-CreERTM BAC 
adult female mice represented only 4.12±0.23% of live cells (Figure 6-4 (C-D)). The 
discrepancy in these values may be due to the fact that Pdgfrβ and CD146 
co-expression identifies a larger population of cells than NG2 does. Interestingly this 
hypothesis can be explored by analysing the single cell sequencing dataset discussed 
in Chapter 5, where 4 clusters of mesenchymal cells were identified in the GFP+ cell 
population (all mesenchymal cells). Clusters 1 and 4 had low expression of Pdgfrβ 
representing the GFPdim stromal fibroblasts while clusters 2 and 3 had high expression 
of Pdgfrβ representing the GFPbright pericytes (Figure 6-4 (E)). Notably when analysing 
NG2 (Cspg4) expression in this dataset, cluster 2 was highly positive while cluster 3 
was less so (Figure 6-4 (F)), indicating that Pdgfrβ/CD146 identify a heterogeneous 
population of cells (clusters 2 and 3) of which NG2 expressing cells represent a subset 
(Cluster 2). 
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Figure 6-4. Comparison of data generated from Pdgfrβ-BAC-eGFP and NG2-CreERTM 
BAC transgenic mice. (A) GFP expression in Pdgfrβ-BAC-eGFP uterine tissue indicating 
Pdgfrβ expressing cells, white arrows. (B) TdTomato expression in NG2-CreERTM BAC 
uterine tissue indicating NG2 expressing cells, yellow arrows. Flow cytometry analysis of (C) 
GFP+ cell populations in Pdgfrβ-BAC-eGFP uterine tissue displaying both GFP+CD146+ and 
GFP+CD146- subpopulations representing 8.33±0.36% and 40.05±2.25% of live cells 
respectively and  (D) NG2+ cell population in  NG2-CreERTM BAC uterine tissue representing 
4.12±0.23% of live cells. (E-F) Single cell sequencing analysis of GFP+ cells from naive 
Pdgfrβ-BAC-eGFP uterine tissue identified 4 unique clusters of mesenchymal cells 
distinguished by dotted lines, all of which express Pdgfrβ and some of which express NG2. 
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Further bioinformatic analysis of the single cell sequencing dataset revealed that the 
two clusters identified within the GFPbright cell population isolated from the 
Pdgfrβ-BAC-eGFP uterus have discrete genetic signatures (illustrated in Figure 6-5). 
This analysis identified clusters 2 and 3 as pericytes and vSMCs respectively. In 
various studies it has been concluded that adult MSCs in human tissues share common 
markers and characteristics with vSMCs, pericytes and endothelial cells (Rastegar et 
al. 2010, Bianco et al. 2001, Perkins and Fleischman 1990, Kinner, Zaleskas and 
Spector 2002) however in light of the current findings it may be that markers used in 
these studies do not definitively identify MSCs. Notably the new single cell 
sequencing dataset generated in the current study has shown that the commonplace 
markers used to identify pericytes (Pdgfrβ and CD146) also identify vSMCs in mouse 
endometrial tissue. Uncovering such heterogeneity will allow for future studies to be 
designed appropriately in order to target each population separately and avoid results 
that are due to a mixed cell response. In this study, the expression of NG2 was 
homogenous throughout the pericyte population (Figure 6-4 (F)) further confirming 
NG2 as a pericyte specific marker in mouse endometrium and verifying the use of the 
NG2-CreERTM BAC transgenic mouse line to specifically target endometrial pericytes 
in future investigations. 
 
 
Figure 6-5. Heatmap of differentially expressed genes between clusters 2 and 3 from the 
single cell sequencing study on GFP+ mesenchymal cells isolated from naive Pdgfrβ-
BAC-eGFP uterine tissue. Cluster 2 expressed genes associated with a pericyte phenotype 
including Kcnj8, Abcc9, Ednrb, RGS5 and NG2. Cluster 3 expressed genes associated with a 
vascular smooth muscle cell phenotype including Cnn1, Acta2, Tagln, Myh11 and Pln. 
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6.3 Endometrial pericytes undergo an MET during 
endometrial repair to contribute to rapid re-
epithelialisation  
The Pdgfrβ-BAC-eGFP transgenic mouse line has been invaluable in investigating 
mesenchymal dynamics during endometrial repair which was the aim of Chapter 5. 
Flow cytometry demonstrated that there was an increase in pericytes in endometrial 
tissue during repair (24hrs) which would be in agreement with other studies where 
pericytes have been shown to proliferate in response to Pdgfrβ and TGFβ signalling 
during development, angiogenesis and fibrosis in various tissues (Humphreys et al., 
Humphreys 2012). What was more exciting was the identification of a new population 
of cells present only in endometrial tissue during repair, of an intermediate phenotype 
between that of pericytes and stromal fibroblasts characterised as GFPdimCD146mid. 
This transient cell population could either originate from stromal fibroblasts 
(GFPdimCD146-cells) that have increased expression of CD146, or from pericytes 
(GFPbrightCD146+) that have decreased expression of Pdgfrβ and CD146, or indeed 
from both. One study has shown that CD146 expression is varied amongst MSCs and 
that MSCs with high expression of CD146 show lower proliferative potential and 
greater contractile properties and therefore may be of the vSMC phenotype 
(Espagnolle et al. 2014), while another study has demonstrated that CD146 expression 
correlates with increased multipotency (Feng et al. 2011). Although the origin of the 
intermediate cell population is at present unknown I would speculate that they have 
arisen from CD146+ pericytes which have multipotent potential and that they represent 
cells undergoing trans-differentiation to either become part of the CD146- stromal 
fibroblast population or indeed the Pdgfrβ-CD146- cell population. This cannot be 
definitively determined without employing robust lineage tracing methods. 
Previous work in the Saunders’ laboratory demonstrated that during endometrial repair 
cells of the stromal compartment are able to undergo an MET to differentiate into new 
epithelial cells and aid in re-epithelialisation of the denuded stromal surface (Cousins 
et al. 2014). This phenomenon has also been reported in endometrial tissues following 
artificial menstruation or parturition in mice using elegant lineage tracing strategies 
where cells of mesenchymal origin become established in the new epithelial cell layer 
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(Patterson et al. 2013, Huang et al. 2012). However, without a targeted approach, these 
studies failed to identify which cell populations in the stromal compartment have the 
ability to respond and undergo MET. With this in mind the current study aimed to look 
in more detail at stromal fibroblasts and pericytes specifically using the 
Pdgfrβ-BAC-eGFP mouse line and various techniques to interrogate MET during 
endometrial repair (summaried in Figure 6-6). Interestingly it was found that during 
repair cells expressing both stromal and epithelial cell markers could be identified by 
flow cytometry, most predominantly seen in the pericyte and novel intermediate cell 
population at 24hrs following P4 withdrawal (Figure 6-6 (A-C)). IHC confirmed the 
existence of these cells during endometrial repair and localised them to regions of 
denuded stroma and in regions of newly synthesised epithelium (Figure 6-6 (D-E) 
yellow arrows). Taken together these results suggest that endometrial pericytes have 
the ability to undergo MET during endometrial repair in order to enhance rapid 
re-epithelialisation, and that the intermediate cell population identified only in 
repairing tissues may represent the MET transitioning cells. 
This hypothesis can also be addressed by investigating epithelial cell marker 
expression in the single cell sequencing dataset of total mesenchymal cells in repairing 
endometrial tissues (Figure 6-6 (F-I)). Notably epithelial cell markers Cdh1, Epcam, 
Krt8 and Krt18 were expressed by the population of epithelial cells identified in the 
naive dataset as contamination (Figure 6-6 (F-I) cluster 9, blue dotted line), but what 
was interesting to see was that Epcam, Krt8 and Krt18 were expressed in the 
repair-specific cluster at 24hrs which otherwise expressed mesenchymal identification 
markers (Figure 6-6 (G-I) cluster 5, red dotted line). These data therefore appear 
consistent with idenfication of the ‘repair specific’ cluster as MET transitioning cells. 
Of note these cells did not express Cdh1 (Figure 6-6 (F) cluster 5, red dotted line), an 
epithelial cell adhesion molecule, indicating that at 24hrs, transitioning cells do not yet 
have the capacity to establish the cell adhesion contacts required to form an intact  
epithelial cell layer, but are instead of a migratory phenotype. 
Although the human MSC population has not been investigated in menstrual tissue 
samples, MSCs isolated based on expression of Pdgfrβ and CD146 have been shown 
to give rise to both stromal and epithelial cells in vitro and in vivo in xenografting 
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techniques (Schwab and Gargett 2007). The studies outlined in this thesis are the first 
to demonstrate that endometrial pericytes have the ability to undergo an MET during 
endometrial repair to reinstate the epithelial cell layer, which may be re-named as a 
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Figure 6-6. Summarised data supporting a role for MET during endometrial repair 
identified using the Pdgfrβ-BAC-eGFP transgenic mouse line. Expression of the epithelial 
cell marker EpCAM by (A) stromal fibroblasts, (B) pericytes and (C) repair-specific 
intermediate cells in naive endometrial tissues and during various phases of endometrial repair. 
IHC detection of cells expressing GFP (white arrows) and EpCAM (red arrows) in (D) naive 
endometrial tissues and (E) endometrial tissue during repair at 24hrs of the mouse model. 
GFP+EpCAM cells are denoted by yellow arrows. Lumen= L, stroma= S and epithelium= E. 
(F-I) Expression of Cdh1, Epcam, Krt8 and Krt18 in the single cell sequencing dataset 
examining total mesenchymal cells from naive endometrial tissues and from endometrial 
tissue during repair at 24hrs of the mouse model, separated by grey dotted lines. Cluster 9 
(blue dotted line) represents epithelial cell contamination in the naive subset while cluster 5 
(red dotted line) represents the repair-specific cell population.  
 
In general MSCs (identified by Pdgfrβ and CD146, indicative of a pericyte phenotype) 
have been shown to differentiate into various epithelial cell types after systemic 
administration in vivo (Phinney and Prockop 2007) however this has not previously 
been investigated in endometrial tissues. Furthermore, CD146 has been identified as 
an important regulator of EMT as overexpression of CD146 in non-invasive epithelial 
breast cancer cells represses the epithelial cell phenotype and induces migratory and 
invasive behaviour indicative of a mesenchymal cell phenotype. Conversely, 
downregulation of CD146 in mesenchymal breast cancer cells reversed the migratory 
phenotype and reinstated an epithelial one (Zeng et al. 2012). Additionally, CD146+ 
cells purified from human endometrium and cultured in a collagen-matrigel scaffold 
gave rise to epithelial-like cells which expressed genes including Spp1, Mmp2, ZO-1, 
Laminin alpha 2 and collagen type IV (Fayazi et al. 2017). Pericytes have been found 
to influence the progression of EMT in cancer (Cooke et al. 2012) and it has also been 
postulated that mesenchymal products generated by EMT in cancer progression often 
express multiple pericyte markers (αSMA, NG2) and associate with blood vessels thus 
phenotypically and functionally resembling pericytes. Therefore some cancer-
associated EMT may represent an epithelial-to-pericyte transition (Shenoy and Lu 
2017, Lu and Shenoy 2017) and as EMT is a reversible process, a pericyte-to-epithelial 
transition (PET) may also be contributing to the malignant phenotype.  
Applying this knowledge to the current results supports the theory that pericytes 
(PdgfrβbrightCD146+) can undergo MET and may downregulate CD146 as they do so. 
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This supports previous evidence for MET by the stromal compartment during 
endometrial repair (Cousins et al. 2014) however this is the first study to demonstrate 
the ability of pericytes to undergo PET during endometrial repair. As the phenotype of 
the intermediate cells (PdgfrβdimCD146mid) is currently unknown it can be postulated 
that they are transdifferentiating pericytes. It cannot be ruled out however that stromal 
fibroblasts may also undergo an MET and contribute to the intermediate cell 
population. Figure 6-7 outlines the proposed contribution of mesenchymal stromal 
fibroblasts and pericytes to re-epithelialisation during endometrial repair. 





Figure 6-7. Schematic representation of the contribution of mesenchymal cell populations to endometrial repair processes. (1) Prior to tissue 
breakdown stromal cells of the endometrium have undergone decidualisation during the secretory phase of the menstrual cycle. (2) P4 withdrawal initiates 
menstruation and decidualised stromal tissue undergoes tissue breakdown and shedding leaving behind a denuded stromal surface. (3) Mesenchymal 
cells in the basal endometrium are stimulated to respond: stromal fibroblasts undergo MET and pericytes undergo PET to contribute to rapid re-
epithelialisation. Pericytes may also undergo a pericyte-to-mesenchymal transition to replenish lost fibroblasts and regain tissue integrity. (4) Upon 
completion of repair, endometrial tissue is fully restored and cell populations return to homeostasis in preparation for the subsequent menstrual cycle 
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6.4 Future prospects of the studies outlined in this thesis 
6.4.1 Lineage tracing mesenchymal cells in endometrial repair 
Although evidence for MET during endometrial repair has been gathered the tools 
used in this thesis are inadequate to definitively conclude that this mechanisms takes 
place. When analysing Pdgfrβ-BAC-eGFP uterine tissue 48hrs after P4 withdrawal, 
cells that express both stromal and epithelial cell markers were not detected by either 
flow cytometry or IHC. This is because the Pdgfrβ-BAC-eGFP transgenic line is a 
knock-in reporter system and therefore if the Pdgfrβ gene promoter is ‘switched off’ 
as it would be in a fully transformed epithelial cell, GFP expression is lost. This means 
there is no historic evidence of the origin of new epithelial cells if they have in fact 
arisen from the mesenchymal cell compartment. A definitive conclusion therefore 
cannot be drawn without employing an inducible-Cre system to specifically target each 
mesenchymal subpopulation individually and solidify current results. The principles 
of inducible Cre technology is outlined in Figure 6-8 (A-C).  
As discussed above in chapter 4, NG2 was identified as a pericyte specific marker and 
the NG2-CreERTM BAC transgenic mouse line has already been acquired and initial 
investigations have highlighted it as a promising tool with which to lineage trace 
pericytes in particular. Further analysis of the single cell sequencing has confirmed 
that NG2 is most highly expressed in the pericyte population, making it an ideal 
candidate for lineage tracing (Figure 6-8 (D)). To further decipher the origin of the 
intermediate cells a lineage tracing strategy for the stromal fibroblasts is also required. 
Analysis of the single cell sequencing dataset has identified that Pdgfrα is expressed 
exclusively by the stromal fibroblasts (Figure 6-8 (E)).  Through a collaboration with 
Professor Neil Henderson an inducible Pdgfrα-CreERT line has also been acquired 
and will be used in future lineage tracing experimentation to determine the specific 
contribution of stromal fibroblasts to endometrial repair. 
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Figure 6-8. Schematic representation of the principles behind the inducible-cre system 
for lineage tracing. (A) The Cre construct is composed of CreERTM that contains the mouse 
oestrogen receptor ligand binding domain with a mutation that only allows the ligand 
tamoxifen to bind, under control of the promoter region of a gene of interest. When this 
promoter is active and the GOI is transcribed this gives gene-specific expression of CreERTM. 
CreERTM is only activated when tamoxifen (TMX) is administered and binds, translocating 
the CreERTM:TMX complex to the nucleus. (B) The reporter construct is located in the broadly 
expressed ROSA26 locus and contains a loxP-flanked STOP codon upstream of a reporter 
gene (fluorescent protein) under control of the ubiquitously expressed CAG promoter. 
Following TMX administration, activated Cre recombines the loxP-flanked STOP codon 
leading to its excision and (C) downstream expression of the reporter protein and signal 
generation. This technique allows for the spatio-temporal control of reporter proteins that then 
‘tattoo’ the cells of interest indefinitely. The single cell sequencing dataset of mesenchymal 
cells from naïve endometrial tissue can be analysed to show exclusive expression of (D) NG2 
by pericytes and (E) Pdgfrα by stromal fibroblasts highlighting these genes as promising 
reporter systems for each cell type for use in downstream lineage tracing experiments. 
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Lineage tracing has been used to demonstrate MET in the endometrium following 
artificially induced menstruation and natural parturition in mice (Huang et al. 2012, 
Patterson et al. 2013) however these studies made use of the constitutive-Cre system 
(Amhr2-Cre: R26R) and therefore this strategy does not rule out the effects of Cre 
expression that may have occurred during development. Similarly constitutive-Cre 
expression may have toxic side effects associated with prolonged Cre activity which 
should be taken into account when examining these tissues. The advantages of 
employing an inducible-Cre system is it allows for strict spatial and temporal control 
over Cre activity which results in irreversible labelling of a cell population of interest 
and it is very fast acting upon Tamoxifen administration. Disadvantages must also be 
noted: the transgene may be influenced by the integration site and there is potential 
toxicity of both the Cre and Tamoxifen which should be accounted for as well as 
potential leakiness of the Cre (Feil, Valtcheva and Feil 2009). What is more, 
Tamoxifen is an antagonist for the oestrogen receptor which will therefore impact on 
oestrogen-dependent endometrial tissue growth (Goodsell 2002) and the ability to 
upregulate PR expression in response to E2. Bearing this in mind, before using the 
inducible-Cre lines outlined above (NG2-CreERTM BAC, Pdgfrα-CreERT), various 
optimisation experiments will need to be undertaken to confirm specificity of each line 
and ensure side effects are controlled for. Once control experiments are completed it 
is hoped these two transgenic lines will allow for discrimination between two potential 
origins of MET transformed epithelial cells identified in endometrial repair.  
Such genetic tools would also allow for genetic ablation studies whereby the Cre lines 
are crossed with a floxed DTR line and upon administration of diptheria toxin the cells 
would be ablated. This approach would allow for new insights into how essential 
specific cell populations are to endometrial repair. Furthermore, conditional gene 
knockout studies could be carried out by crossing the Cre lines with floxed mouse lines 
targeting genes of interest to facilitate the identification of new therapeutic targets. 
With these tools in place various unanswered questions could be addressed: do 
pericytes represent a true progenitor cell population in the endometrium? Do all 
pericytes/stromal cells have the ability to undergo PET/MET during endometrial repair 
or is a specific subset responsible? What signals are important in regulating this 
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response? Can the endometrial healing response be further enhanced? Such studies 
would further advance our understanding of the scarless healing response.  
6.4.2 Analysis of a fibrotic response in endometrial tissues 
Another interesting aspect to this work is the relationship between cell phenotype and 
development of fibrosis. In other tissues pericytes and fibroblasts are reported to 
undergo a FMT during wound healing which is essential for the synthesis of ECM 
proteins and contraction of the wound:  in the case of aberrant repair the persistence of 
myofibroblasts results in ECM accumulation and formation of persistent scar tissue 
(Leavitt et al. 2016, Hinz et al. 2012). Both bulk mRNA sequencing and single cell 
sequencing studies outlined in this thesis highlighted drastic changes in the expression 
of collagens during endometrial repair. To complement and extend the main studies in 
this thesis a preliminary investigation of the expression of collagens in endometrial 
tissues was conducted using PSR staining, and the myofibroblast phenotype was 
investigated by IHC looking at the well described MF marker (αSMA). Interestingly 
there was a striking change in the pattern of collagen deposition whereby in normal 
endometrium the myometrium was composed of dense collagen I fibres and the stroma 
composed of loose collage III fibres, while in the repairing endometrium the 
myometrium was still composed of dense collagen I fibres however, the regions of 
stroma undergoing repair and underlying new epithelium were collagen negative 
(Figure 6-9).  
In addition, a population GFP+αSMA+ cells were located in endometrial tissue at 
24hrs, predominantly located in regions of stroma adjacent to the denuded surface and 
undergoing active repair, indicative of a myofibroblast phenotype (Figure 6-10). As 
endometrial repair shares common features with wound healing it is not unexpected to 
identify an FMT occurring here. Interestingly however, myofibroblast-like cells 
(GFP+αSMA+) were located in collagen negative regions of tissue. These results 
together suggest that an FMT is taking place during endometrial repair however the 
resulting myofibroblast-like cells do not display the functional characteristics of true 
myofibroblasts in that they have decreased ECM synthesis properties. The phenotype 
of adult skin myofibroblasts has been shown to be altered by application of 
UCMSC-conditioned media whereby they displayed characteristics of foetal 
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fibroblasts: a decreased expression of αSMA, decreased TGFβ1:3 ratio and increased 
expression of MMPs. Wounds treated with the same media were shown to heal faster 
and have decreased collagen accumulation (Li et al. 2017). Myofibroblasts in the 
endometrium therefore may exhibit similar properties to foetal myofibroblasts, A host 
of cytokines, growth factors, hypoxia and ECM components have been implicated in 
the regulation of FMT (Leavitt et al. 2016) it is therefore proposed that strict control 
of these factors in the human endometrium may alter myofibroblast phenotype 
therefore underpin its ability to restrict deposition of collagen which may be integral 
the endometrium’s ability to heal month on month without scarring. This area of 
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Figure 6-9. PSR staining to visualise collagen content of both naïve and repairing (24hrs) 
uterine tissues. Brightfield images of (A) naïve uterus and (B) repairing 24hrs uterus showing 
collagen positive regions in red/pink and collagen negative regions in yellow/white. Polarised 
light images of (A’) naïve uterus and (B’) repairing 24hrs uterus showing collagen I bundles 
in yellow/orange and collagen III bundles in green. (C-C’) Brightfield and polarised light 
images of regions of endometrium undergoing active tissue repair (arrows). Myometrium (M), 
Stroma (S), Luminal Epithelium (LE), Glandular Epithelium (GE) and shed cells (blue dashed 
line) (representative images, n=5, scale bar = 500μm).  
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Figure 6-10. The expression of GFP and αSMA in Pdgfrβ-BAC-eGFP uterine tissues at 
24hrs and the association with collagen deposition. (A-B) IHC staining for GFP (green) and 
αSMA (red) showing GFP+aSMA+ cells (white arrows) in the functional stromal region close 
to the degrading decidua (dashed line). (A’-B’) PSR stain showing collagen positive regions 
(red/pink) in the myometrium and endometrial stroma adjacent to this and collagen negative 
regions (yellow/white) of the endometrial stroma in close proximity to the denuded stromal 
surface and shed tissue. Myometrium (M), stroma (S), luminal epithelium (LE) (representative 
images, n=5, scale bar = 500μm) 
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6.4.3 How can these results inform our understanding of the 
mechanisms of postpartum endometrial repair?  
In the initial planning stages of this project it was hoped to investigate the repair 
processes that occur in the postpartum uterus and compare these to mechanisms of 
post-menstrual repair, however due to time constraints this work was not started. It is 
believed that the menstrual cycle is an evolutionary mechanism that has arisen in order 
to precondition the uterine tissues to the physiological stresses associated with 
placentation and pregnancy (Brosens et al. 2009, Emera, Romero and Wagner 2012b). 
The degree of physiological tissue injury experienced by the uterus following 
parturition is much greater than that during menstruation as the placenta and 
membranes are completely shed exposing much larger area of denuded stroma. Despite 
this major difference it has been proposed that repair mechanisms are broadly similar 
(Brosens et al. 2009). In women the postpartum period begins immediately after 
delivery of the infant and placenta and continues for 6-8 weeks as physiological 
changes return to baseline (Plunk et al. 2013). This period is known as uterine 
involution which requires ECM remodelling, cellular proliferation and apoptosis to 
allow the uterus to return to its pre-pregnant state (Takamoto, Leppert and Yu 1998).  
Due to the difficulties in sampling tissues from these time phases, the molecular 
mechanisms underlying postpartum repair and uterine involution in women remain 
relatively unknown (Salamonsen 2003b) although a number of studies have been 
carried out in animal models that highlight a role for myometrial contraction, hypoxia, 
ECM remodelling, inflammation and progenitor cells (Sharman 1952, Thomson et al. 
1999, Yoshii et al. 2014, Hsu et al. 2014, Huang et al. 2012, Cao et al. 2015). Studying 
postpartum repair in rodents has the potential to inform human biology as the mouse 
and rat also have a haemochorial type of placentation and go through similar dramatic 
changes in cellular organisation during pregnancy and following parturition (Yoshii et 
al. 2014, Cao et al. 2015). Defects in postpartum repair may underlie issues such as 
postpartum haemorrhage, subfertility, miscarriage and recurrent pregnancy loss. The 
new understanding and genomic datasets developed in the current thesis could easily 
be translated to studies investigating postpartum endometrial repair in mice and offer 
the potential to inform our understanding of postpartum endometrial repair in women.  
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6.4.4 Cross disciplinary research studies 
The human endometrium represents the only adult tissue to undergo regular and 
repeated cycles of degeneration and regeneration under normal physiological 
conditions (Gargett and Masuda 2010). Similarities exist between menstrual 
endometrial tissue repair and scar-free wound healing observed in both foetal skin and 
the oral mucosa including extensive cellular proliferation, matrix deposition and 
re-epithelialisation, however in these tissues it is believed that a diminished 
inflammatory response and altered fibroblast phenotype are responsible for the scar-
free healing response, two mechanisms which have not been definitively observed in 
the endometrium (Szpaderska et al. 2003, Martin and Leibovich 2005, Leavitt et al. 
2016). Parallels can also be drawn with the wound healing response of the epidermis 
including the migration of fibroblasts, inflammation, re-epithelialisation and tissue 
remodelling, the biggest difference being that the endometrium does not synthesise 
scar tissue during repair (Shaw and Martin 2009, Leavitt et al. 2016, Critchley et al. 
2006a). The endometrium therefore may represent a tissue that employs a mix of 
mechanisms characteristic of scarless and scarring tissue repair and could therefore be 
used as model system to inform both processes.  
The research outlined in this thesis has scope for developing into further 
cross-disciplinary studies, in particular comparing mechanisms of endometrial repair 
with mechanisms that contribute to the progression of fibrosis in response to repeated 
injury in other tissues such as the skin, liver and kidney. If we can understand the 
relationship between cell types in the endometrium and how they work together to 
ensure scarless healing this knowledge could be applied to other tissue systems: 
comparing intrinsic properties of different cell types and the signals from the 
microenvironment which influences cell phenotype and function. These studies would 
highlight targets that might allow for in situ manipulation of cellular responses during 
fibrosis and scarring or maybe identify a cell population that could be used in adoptive 
transfer experiments to alleviate fibrosis (endometrial pericytes?). In particular the 
single cell dataset generated using mesenchymal cells from naive and repairing 
endometrial tissues, can be directly compared with similar datasets generated by 
Professor Neil Henderson’s laboratory using comparable techniques to investigate 
mesenchymal cell changes in the liver, kidney and heart. Bioinformatic data analysis 
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may reveal differences in mesenchymal cell phenotype or function specific to each 
wound healing/non-healing response and therefore identify targets for future use. Of 
particular interest is to identify a factor which when manipulated may alleviate fibrosis 
in the liver/kidney or induce a fibrotic response in the endometrium. Cross disciplinary 
studies comparing the endometrium to other tissues will also help to reliably place the 
endometrium in the wound healing continuum and validate its use as a model in which 
to uncover mechanisms of scarless tissue repair. 
6.5 Translational aspects for patient benefit 
Restoration of uterine tissue homeostasis following menstruation must be rapid and 
complete to ensure continued functional success of the uterus. It is believed that 
aberrant endometrial repair may predispose to several gynaecological conditions 
including heavy menstrual bleeding, Asherman’s syndrome and endometriosis 
(Dimitrov et al. 2008). Despite the prevalence and health burden that these conditions 
pose, and extensive research their aetiology and pathogenesis remain poorly 
understood (Gargett and Chan 2006). For each condition a link to dysregulated 
macrophage function has been suggested. Careful characterisation of macrophage 
phenotype and function in physiological endometrial repair and proliferative disorders 
therefore may inform the development of therapies to treat such conditions. Similarly, 
because MSCs/stem/progenitor cells are believed to play a key role in physiological 
endometrial repair it has been suggested that abnormalities in the location and/or 
function of endometrial stem/progenitor cells may contribute to both the development 
and persistence of various gynaecological conditions (Deane et al. 2013, Dimitrov et 
al. 2008). Understanding the role of stem/progenitor cells in endometrial physiology 
and the pathogenesis of these diseases is considered as a key opportunity in the 
discovery of new treatment options.  
As previously discussed, cross disciplinary studies may highlight important 
similarities and differences between wound healing responses of the endometrium and 
other tissues. Further investigation of the contribution of stem/progenitor cells and/or 
macrophages to the scar-free repair process exhibited by endometrial tissue may 
identify these cells as targets in conditions where chronic inflammation and excessive 
fibrosis are a problem. Such knowledge would inform the development of cell-based 
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therapies or treatments chronic inflammation, fibrosis and excessive scarring that 
effects many adult tissues including the liver, kidney, skin and heart. These conditions 
present a huge burden on public health and are believed to be due to aberrant wound 
healing and although recent advances have been made with regards to stem cell 
biology, a lack of a standardised model hinders translation of this knowledge (Leavitt 
et al. 2016). Defining which cells and signals truly promotes scarless endometrial 
wound healing in vivo will improve translatability of findings and aid in discovery of 
treatment options for various fibrotic conditions. 
Stem cell based therapies have been found to accelerate wound closure and encourage 
tissue regeneration of the skin and other tissues (Lee, Ayoub and Agrawal 2016), 
through both differentiation and production of pro-repair and anti-inflammatory 
factors (Wu et al. 2007, Leavitt et al. 2016). For example, amniotic fluid-derived MSCs 
have been shown to rescue renal function and resolve fibrosis when injected into the 
renal artery in a preclinical porcine model of renal transplantation (Baulier et al. 2014). 
In addition, transplantation of BM-MSCs on collagen scaffolds have shown promise 
in enhancing regeneration of injured uterine tissue in rats (Ding et al. 2014). A more 
recent study in which umbilical cord MSC-conditioned media was applied to dermal 
fibroblasts induced a phenotype that was reminiscent of foetal fibroblasts believed to 
be consistent with scar-free wound healing. When mouse full-thickness skin wounds 
were treated with this media they showed enhanced wound healing and decreased 
collagen formation (Li et al. 2017). MSCs are multipotent and can differentiate into 
various mesodermal cell lineages and have potential use in both autologous and 
allogenic transplantation as they are immunologically silent (Tamama and Kerpedjieva 
2012) making them ideal candidates in the development of various cell-based therapies 
to tackle scarring in disease.  
If the endometrial pericytes identified and characterised in this thesis are found to have 
regenerative MSC-like properties then they could be used in future cell-based 
therapies. Notably endometrial pericytes can be obtained from routine endometrial 
biopsies or menstrual effluent in an outpatient setting and without the need for 
anaesthetic (Masuda et al. 2010, Maybin and Critchley 2015) offering the potential 
that they could replace the need for painful bone marrow biopsies currently used to 
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obtain haematopoietic stem cells (Maybin and Critchley 2015). To support this idea it 
is worth noting, the application of human umbilical cord pericytes embedded in a fibrin 
gel to full thickness cutaneous wounds showed improved re-epithelialisation, greater 
tensile strength, more organised collagen fibres and enhanced angiogenesis (Zebardast 
et al. 2010). Similarly pericytes from adipose tissue have been shown to increase 
vascularisarion, promote collagen deposition and enhance remodelling in an excisional 
wound model (Paquet-Fifield et al. 2009). Finally pericytes have been shown to 
enhance epidermal regeneration in an organotypic skin culture model (Zamora et al. 
2013). Endometrial MSCs/pericytes are highly proliferative (Gargett et al. 2009) so 
would be ideal candidates for in vitro expansion and use in cell-based therapies, the 
endometrium therefore provides a readily accessible source of cells that could have 
widespread clinical applications in the future. 
6.6 Concluding remarks 
Using transgenic mouse lines and the robust Edinburgh mouse model of endometrial 
breakdown and repair the contribution of both myeloid immune cells and 
mesenchymal progenitor cells to endometrial repair has been investigated. New data 
identified dynamic changes in the number and localisation of mononuclear phagocytes 
in regions of endometrial tissue undergoing active repair, with a previously unknown 
role for alternative monocytes. Furthermore complex heterogeneity in the 
monocyte/macrophage population has been revealed associated with discrete regions 
of the repairing tissue, which may have functional implications for endometrial repair 
processes. Additional characterisation of these monocyte/macrophage subpopulations 
may give insight into the role of unique heterogeneity in scar-free tissue repair. 
This is also the first study to characterise a perivascular pericyte population in the 
mouse endometrium and define NG2 as a pericyte specific marker in this tissue. It is 
suggested that endometrial pericytes represent a mesenchymal progenitor cell 
population that have important roles in re-epithelialisation during endometrial repair, 
undergoing a pericyte-to-epithelial transition (PET) in concert with other mechanisms 
to rapidly reinstate the epithelial cell layer. Progenitor cells are the immediate progeny 
of tissue stem cells and the true stem cell population that gives rise to pericytes in the 
endometrium remains to be determined. Single cell sequencing had identified novel 
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heterogeneity within the endometrial pericyte population revealing that methods 
commonly used to target mesenchymal stem cells (MSCs) may in fact be identifying 
both MSCs/pericytes and vSMCs. More definitive markers are therefore required to 
discriminate between cell populations. Having determined robust methods of 
identification and isolation, future studies will focus on functional characteristics of 
these cells, lineage tracing and targeted inhibition/stimulation studies to more 
thoroughly understand their role in endometrial breakdown and repair.  
The endometrium provides a robust physiological model in which to study various 
mechanisms associated with tissue repair including inflammation, angiogenesis and 
differentiation. Studies like those presented in this thesis are important to inform future 
work and fill gaps in the knowledge so that one day we can uncover mechanisms 
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Appendix 5.1. Top 100 most significantly upregulated genes in repairing samples 
when compared to naive samples. RNAseq. FDR <0.05. 




LogFC P-value FDR <0.05 
Mmp10 0.192611314 495.95818 11.2432086 9.71E-06 0.001359377 
Erv3 0.045257809 84.0704655 10.71748135 6.49E-06 0.001024937 
Mmp12 0.112752673 154.8354046 10.3423004 1.04E-06 0.000252339 
Mmp13 0.255816556 231.8863547 9.800783712 0.000174931 0.009061145 
Sprr2h 0 7.674410321 9.660603129 9.79E-05 0.006430275 
Cd177 0 7.251583962 9.575453439 0.001254616 0.028421027 
Jakmip1 0.008520914 11.10935265 9.187891507 1.44E-06 0.000338097 
Tnfrsf9 0.01261252 11.4483069 9.164302927 1.98E-05 0.002174383 
Slpi 0 5.283499957 9.129152766 0.000430007 0.016091638 
Cxcl5 0.145989044 83.00211007 8.998444358 7.58E-08 4.63E-05 
Parvb 0.024675058 13.62585254 8.521122087 0.000207972 0.01010534 
Onecut3 0.018492264 9.958627792 8.437463465 0.000301689 0.012868605 
Gpr55 0 2.800546567 8.204691479 0.000863689 0.023524625 
Tnf 0.009246132 5.640869553 8.197978843 1.24E-05 0.001582367 
Tnc 5.473751472 1555.833241 8.151385875 1.28E-07 6.48E-05 
Abca13 0 2.284936928 7.896652941 0.000641762 0.0201544 
Gareml 0 2.03374187 7.727634526 0.002173574 0.037626717 
Olfr505-ps1 0 1.715232757 7.487670018 0.001870948 0.035214312 
Tph1 0 1.675092592 7.471207085 0.000296895 0.012702769 
Lama1 0.579926874 96.79574453 7.402468391 1.94E-06 0.000397164 
Ctnnd2 0.091362769 15.24264456 7.317967332 2.68E-06 0.000502385 
Nccrp1 0 1.426811239 7.247691261 0.001112081 0.026711533 
Ptprn 0.189028612 30.53674021 7.217093422 2.05E-07 8.44E-05 
Il23a 0.027056728 5.151658687 7.094824017 0.000404091 0.015555815 
Pmaip1 0.099100306 13.3496406 6.883746254 6.71E-05 0.005085459 
Cntn3 0.645734597 77.5487802 6.879002008 2.72E-08 2.26E-05 
Slc5a7 0.08492125 10.4059451 6.878734677 5.08E-05 0.00424783 
Gdap1 0.051731786 7.410215138 6.859942119 0.00100242 0.025163336 
Fam167a 0.010990292 2.264316352 6.845431489 0.000652647 0.020324261 
Hs3st3b1 0.017767046 3.169080274 6.813610433 9.49E-05 0.006324106 
Myom2 0.028507163 4.265241857 6.800887906 0.00189685 0.035451495 
Dusp9 0 0.981838393 6.707551213 0.002448828 0.040062893 
Fam83b 0.011511855 1.965549243 6.641733679 0.002111108 0.037100182 
Wnt2 0.032269843 3.930703856 6.60074578 0.000345267 0.013952278 
Ereg 0.170861444 16.23735086 6.575360719 0.000143461 0.008012998 
Cyp11a1 0 0.856621351 6.511805974 0.0019001 0.035462706 
H19 0.266592985 24.75493067 6.488998264 1.84E-06 0.000394339 
Chodl 6.307622148 556.4212 6.452630926 0.000157756 0.008450687 
Tgfbi 1.289687263 112.7243018 6.42190615 1.90E-09 2.23E-06 
Acap1 0.049597048 4.725477929 6.328794257 0.001239234 0.028253536 
Pcdha2 0.055447945 5.140268045 6.287716435 0.001529205 0.031560155 
Cldn2 0.023023711 2.344733067 6.261255821 0.001743987 0.033884487 
Kcna1 0.047852459 4.107454455 6.251085281 0.000665798 0.020430076 
Lck 0.034133682 3.468850806 6.244429792 0.003377213 0.047348629 
Ifitm7 0.037759161 3.503917574 6.166029699 0.002233477 0.037933326 
Pigyl 0.109336808 8.167876868 6.145896137 0.001458012 0.030878956 
Cbx8 0.017041829 1.831500939 6.046137994 0.002352953 0.039126851 
Grip1os1 0.017729362 1.819502617 6.016589866 0.001281406 0.028761884 
Lcp2 0.075305478 5.337675619 6.012669288 0.001171804 0.027484175 
Stk32c 0.037071627 3.027779459 5.975553825 0.001880296 0.035303233 
Ptgs2 9.702823909 598.7562275 5.952372343 7.29E-08 4.63E-05 
Appendices 397 
Cited1 0 0.573839986 5.933452633 0.003080496 0.045137899 
Rims3 0.145216769 9.129001601 5.900509684 0.003101315 0.045281236 
Wipf3 0.403969416 24.44235098 5.872696452 2.49E-05 0.002562769 
Col8a1 4.05559421 235.9685682 5.868560643 3.59E-11 2.09E-07 
Hmga2 1.291790599 75.27728177 5.861928965 6.29E-05 0.00484825 
Kcnf1 0.021005192 1.722071559 5.848035423 0.001939503 0.035719588 
Zfp689 0.164362571 10.08563616 5.843818515 0.001524977 0.031527509 
Btnl10 0.040019019 2.677160601 5.765446073 0.003737749 0.049686401 
Tac2 0.208796274 11.64610947 5.726976092 0.000816265 0.02294268 
Agtr1b 0.078791256 4.617888521 5.721685685 0.002375288 0.039322051 
Dctpp1 0.211290089 11.30445497 5.692210995 0.002095899 0.037008149 
Fen1 0 0.480500739 5.681039796 0.00239913 0.039597304 
Cd83 0.102476219 5.820461529 5.656359795 0.001678218 0.033393391 
Fam189a1 0.105186078 6.096885183 5.653464523 0.002527575 0.04087073 
Plek2 0.023949841 1.761410869 5.628287709 0.002046526 0.036661622 
Rasal1 0.037759161 2.294284313 5.588792342 0.003338353 0.047105056 
Parvg 0 0.418257602 5.487938679 0.003757897 0.049781747 
Cdh4 0.010014899 0.859356514 5.482826807 0.002262638 0.038282592 
Stxbp5l 0.033745954 1.815376721 5.47304435 0.001475294 0.03106005 
Snord16a 0.009246132 0.787738492 5.379176963 0.003687891 0.049347705 
Speer4e 0.043329789 2.268355109 5.366670377 0.001801281 0.034426895 
Spp1 0.976727048 39.91647584 5.324052535 1.91E-06 0.000397164 
Gatm 2.506420699 96.46750681 5.258381893 3.99E-07 0.000138925 
Ttc9 0.009246132 0.720873278 5.249347278 0.002747969 0.042638522 
Tes 5.04646613 188.3008376 5.212457819 3.17E-10 1.01E-06 
Arc 0.020757987 1.074238591 5.187794139 0.002445198 0.04003293 
Stra6 5.178319584 181.6579177 5.123092735 1.20E-05 0.001557026 
Tead4 0.16926942 5.982473511 5.072744527 0.000693768 0.020874912 
Clu 0.348424863 11.28564111 4.961939136 0.001272274 0.028671605 
Lef1 2.760784681 84.80746962 4.926968918 2.21E-10 8.19E-07 
Kcnma1 8.190361893 225.4057473 4.777558072 3.75E-11 2.09E-07 
Kcnmb2 0.975602016 25.86511302 4.715229976 0.001584778 0.0322112 
Fst 1.750804875 45.01400457 4.665004163 2.97E-06 0.000547235 
Gipc2 0.383264024 9.785216578 4.646179499 0.00288926 0.043556041 
Tmem108 0.238592911 6.238433431 4.643349184 0.001485626 0.03106005 
Slc2a1 3.1787423 78.07519056 4.618926085 5.42E-07 0.00017096 
Sfrp2 15.22049027 366.4942383 4.576420328 2.36E-05 0.002489778 
Hs3st3a1 0.368896416 8.664094723 4.538270824 0.001817746 0.034622698 
A3galt2 0.448943992 10.14310494 4.463464345 0.002348032 0.039103429 
Cemip 3.59742022 77.79093471 4.427304874 0.00029278 0.012609377 
Kif26b 1.448743902 31.08524067 4.418503053 5.32E-05 0.004384043 
Serpine2 15.16047351 325.4502619 4.417608455 8.57E-10 1.32E-06 
Speer4c 0.122593117 2.81395094 4.39782471 0.002282596 0.038474097 
Ddit4 0.281725655 6.138860813 4.393635137 0.002737998 0.042558719 
Flt1 2.806311108 58.9919908 4.390577855 3.43E-05 0.003153821 
Igsf11 0.714456362 15.2592845 4.389197547 0.001644359 0.032837039 
Sprr1a 0.789691581 15.56273462 4.284011234 0.002512543 0.040746016 
Cdh5 5.018368436 98.23442448 4.28009585 6.74E-10 1.15E-06 




Appendix 5-2. Top 100 most significantly downregulated genes in repairing samples 
when compared to naive samples: RNAseq. FDR <0.05 




LogFC P-value FDR <0.05 
Vcam1 18.87612 0 -10.9576 7.70E-08 4.63E-05 
Ces2g 14.98131 0 -10.6217 1.00E-05 0.001384095 
Clca1 13.28959 0 -10.4559 4.51E-06 0.000767291 
Asb4 13.12932 0 -10.4326 6.08E-07 0.000174188 
Zcchc16 11.60277 0 -10.2586 2.75E-05 0.002711056 
Tmod1 25.90097 0.015361301 -9.92398 2.48E-09 2.76E-06 
Sphkap 24.39947 0.014478712 -9.84058 2.95E-08 2.26E-05 
Crabp1 8.041571 0 -9.73353 0.000312 0.01311522 
Aldh1a1 123.7077 0.128831026 -9.72553 5.78E-12 6.43E-08 
Ltf 7.409469 0 -9.6104 5.98E-05 0.004668477 
Il31ra 7.352368 0 -9.59967 2.02E-06 0.000409847 
Ube2t 7.344575 0 -9.59774 7.67E-06 0.001154335 
Lgr6 96.94894 0.116242478 -9.53581 3.91E-07 0.000138064 
Adamtsl3 6.880863 0 -9.50374 0.000138 0.007983703 
Pcdh12 6.161984 0 -9.34644 8.06E-06 0.001196664 
Arsi 5.815426 0 -9.27028 2.38E-05 0.002495151 
Fhl5 5.00413 0 -9.04249 9.94E-05 0.006472006 
Gfra1 32.28628 0.049495506 -9.042 2.12E-07 8.59E-05 
Prss23os 4.505037 0 -8.89254 3.64E-05 0.003290656 
Olfr78 13.14954 0.019749985 -8.89158 1.51E-06 0.000342751 
Gbp11 4.385322 0 -8.85822 0.000645 0.020191026 
Chst13 4.168863 0 -8.78885 0.000221 0.010423267 
Slc38a4 4.042288 0 -8.73851 2.84E-05 0.002776442 
Esco2 4.023685 0 -8.72881 0.000206 0.01006253 
Pitpnm3 3.69344 0 -8.61623 0.000168 0.008881228 
Mug1 128.0082 0.320167773 -8.61413 1.09E-07 5.64E-05 
Cfap100 10.53778 0.019655492 -8.57479 2.74E-07 0.000101675 
Slc6a13 10.01382 0.015361301 -8.56925 3.06E-05 0.002924838 
Fermt1 3.509144 0 -8.54144 0.000265 0.011905013 
Cadm2 22.59851 0.049589999 -8.53049 9.25E-08 5.02E-05 
Gdpd2 9.910633 0.021545657 -8.47081 9.63E-06 0.001357456 
Ppp2r2c 3.298611 0 -8.46676 0.00258 0.041301723 
Nrk 730.4203 2.119082988 -8.43557 6.78E-06 0.0010563 
Gpr87 3.249793 0 -8.43084 0.000333 0.013632465 
Slc28a3 3.245888 0 -8.42659 0.000115 0.007064455 
Ebf2 3.229965 0 -8.41555 0.001226 0.02821222 
Gm14329 3.138684 0 -8.37012 0.000623 0.019954732 
Dtwd1 3.069308 0 -8.3446 5.17E-05 0.004280818 
Cd300a 3.072398 0 -8.34309 0.000456 0.016495096 
Htra1 58.21763 0.171009257 -8.31438 2.11E-12 4.70E-08 
Tmem229a 399.825 1.267626953 -8.28853 1.49E-06 0.000342751 
Ugt1a5 2.928183 0 -8.27548 7.78E-05 0.005695067 
Ramp3 18.0807 0.045201315 -8.25341 1.19E-06 0.000285572 
Cdnf 2.90462 0 -8.25284 0.00033 0.01360408 
Adh7 2.71271 0 -8.16817 0.000132 0.007707299 
Plppr4 18.0637 0.054672286 -8.16394 0.000745 0.021798813 
Spock3 7.874384 0.019655492 -8.15624 0.000662 0.020430076 
Slitrk6 2.680745 0 -8.14744 0.000791 0.022581451 
Slc44a3 2.682988 0 -8.14616 0.000279 0.012196067 
Ugt1a7c 2.675706 0 -8.14429 0.000511 0.017511175 
Grip2 2.618624 0 -8.11012 0.000513 0.017535384 
Ccdc81 2.594924 0 -8.1069 9.48E-05 0.006324106 
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Pdzrn4 2.595921 0 -8.10241 0.000394 0.015369726 
Rgs1 2.549462 0 -8.08908 0.001617 0.032503906 
Col6a5 17.30204 0.056562451 -8.08122 2.00E-08 1.78E-05 
Ptpn5 16.65389 0.050378095 -8.07881 2.63E-06 0.000499967 
Ano5 23.29262 0.086182629 -8.07461 4.65E-06 0.000778881 
Crtac1 21.02661 0.071041163 -8.04413 2.24E-07 8.92E-05 
Ehf 2.481379 0 -8.04057 0.000686 0.02071257 
Klhl4 2.46747 0 -8.02932 0.00019 0.009466803 
Tmprss11g 2.453125 0 -8.01698 0.000489 0.017037895 
Pcolce2 2.404193 0 -8.00192 0.000169 0.008890506 
Naip1 2.372204 0 -7.97096 0.000192 0.00955267 
Mmp27 2.2391 0 -7.88793 0.000399 0.015449665 
Six1 2.205024 0 -7.85986 0.00033 0.01360408 
Lrrc23 2.18217 0 -7.85334 0.0023 0.038482515 
Grin2b 78.18713 0.329686532 -7.81461 1.36E-05 0.001686751 
Adh1 198.0982 0.920533228 -7.76303 8.75E-08 4.99E-05 
Krt84 2.027137 0 -7.75985 0.002532 0.040917416 
P2ry13 2.023485 0 -7.74914 0.003151 0.045582272 
Trem2 2.001787 0 -7.73264 0.002135 0.037254293 
Hs3st5 13.24499 0.05388419 -7.72942 8.43E-06 0.001234746 
Hoxc6 1.997399 0 -7.72412 0.000188 0.00944629 
Uqcc3 1.986676 0 -7.7197 0.000193 0.00955351 
Cd163 1.986359 0 -7.71787 0.000722 0.0214293 
Fam26e 9.987311 0.043091314 -7.71573 2.23E-06 0.000439667 
Frmd7 1.975673 0 -7.7052 0.000889 0.023784175 
Pm20d1 16.84421 0.073728669 -7.70133 4.51E-07 0.000147589 
Prrx2 1.944704 0 -7.6983 0.000273 0.012103498 
Ptprb 1.958816 0 -7.69357 0.000908 0.024061664 
Scin 1.9531 0 -7.69183 0.000153 0.008360403 
Plxna4os2 1.953175 0 -7.68435 0.003552 0.048414103 
Uroc1 1.900605 0 -7.6588 0.001649 0.032877045 
Zakit 1.904787 0 -7.65459 0.000451 0.016446942 
Dhrs9 1.900491 0 -7.65114 0.000396 0.015404211 
Map10 1.869318 0 -7.62923 0.000137 0.007983703 
Npy1r 5.118415 0.014478712 -7.62154 1.31E-05 0.001646277 
Xirp1 1.809889 0 -7.58148 0.002358 0.039181877 
Tspan15 1.808048 0 -7.57739 0.000464 0.016687778 
BC050972 1.798502 0 -7.57396 0.000168 0.008890506 
Nrip3 5.296504 0.019749985 -7.57361 4.70E-05 0.003977595 
BC037032 1.788751 0 -7.55997 0.001331 0.029438967 
Smim6 1.743011 0 -7.54165 0.000536 0.018019646 
Oxct2a 1.720906 0 -7.51314 0.000973 0.024635942 
Slc5a9 1.713305 0 -7.50415 0.001234 0.028253536 
Kcnv2 1.70686 0 -7.497 0.000289 0.012526957 
Sema3b 5.107127 0.021545657 -7.49533 1.10E-05 0.001475267 
F2rl2 1.65763 0 -7.4681 0.001041 0.025796999 
Efcab1 1.663464 0 -7.46543 0.000479 0.016839053 




Appendix 5-3: Top 100 differentially expressed genes that identify each cell cluster 
in the naïve endometrial mesenchyme, singe cell sequencing. 
Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 
Saa3 Kcnj8 Rergl Clec3b Fcgbp 
Wnt16 Abcc9 Pln Mmp3 Prap1 
Cxcl14 Higd1b Sncg Ly6c1 Lcn2 
Dio2 Vtn Cnn1 Col14a1 Tmem213 
Smoc2 Akr1cl Tagln Inmt Tspan1 
Ccl8 Sept4 Acta2 Igfbp3 Epcam 
Aspg Ednrb Map3k7cl Cxcl16 Pigr 
Hsd11b2 Id4 Sorbs2 Slc43a3 Arg1 
Ngfr Art3 Cdc42ep3 Cd55 S100g 
Mfap4 Rgs5 Lmod1 Penk Plet1 
Aldh1a2 Ndufa4l2 Hspb1 Adh1 Aqp5 
Wt1 Fhl2 Myh11 Lum Sftpd 
Gxylt2 Ifitm1 Pcp4l1 Efemp1 Krt8 
Cdh11 Myo1b Nrip2 Fbln1 BC048679 
Wnt5a Adap2os Crim1 Mgp Serpina1e 
Rbp4 Slc11a1 Mustn1 Col15a1 Clca1 
Ramp2 Nrp1 Rcan2 Plpp3 Pdzk1ip1 
Steap3 Adap2 Mob2 Col3a1 Ltf 
Ccl11 Gucy1b3 Rasd1 Figf Wfdc2 
Twist2 Rem1 Crip1 Hpgd Aoc1 
Fbln2 Esam Bcam Gsn 4833423E24Rik 
Mfap5 Klhl23 Rbpms2 Postn Fxyd3 
Dkk3 Slc7a2 Klf2 Lama4 Cdh1 
Tmem119 Btbd3 Ptp4a3 Col1a1 Alox15 
Srgn Pten Net1 Ms4a4d Sprr2f 
Sema3c Thy1 Ptgis Fbln1 Slc39a4 
Rorb Gjc1 Tpm1 Akap12 Smim22 
Rev3l Olfr558 Tpm2 Ctsh Urah 
Dpep1 Notch3 Kcnab1 Loxl1 Padi2 
Igfbp4 Timp3 Csrp2 Scara5 Cxcl17 
Pla1a Tinagl1 Kitl Cd248 Krt19 
Chchd10 Gucy1a3 Crtc3 Lamc1 Krt18 
Mmp11 Vstm4 Myl9 Apoe Cldn7 
Htra1 Mfge8 Pdgfa Dpt Ckmt1 
Islr Pdgfrb Tbx3os1 Col1a2 Rmst 
F3 Aspn Tm4sf1 Meg3 Krt7 
Sfrp2 1810011O10Rik Hspb2 Fxyd5 Rnf128 
Ctla2a Maged2 Rrad S100a16 Mecom 
Col6a4 Ebf1 Mir143hg CD34 Fxyd4 
Spon2 Ier5 Rgs4 S100a6 Tspan8 
Acot1 Cspg4 Mcam S100a10 Car2 
Cped1 Sept7 Crip2 Rcn3 Elf3 
Gja1 Tmem176a Ppp1r12b Adamts2 Trpv6 
Maf Gm13889 Pdlim3 Sparc Sult1d1 
Ahnak2 Pkig AI838599 Col5a1 Plekhs1 
Mdk Ndrg2 Cd200 Pcolce Cbr2 
Sfrp4 Mgst3 Zak Serpinh1 Fut9 
Lsp1 Hes1 Cryab C1qtnf3 Prom1 
Nbl1 Zeb2 Ltbp1 Ly6a Pglyrp1 
Dcn Rasl11a Ckb Mgst1 Bcat1 
Rnase4 P2ry14 Pi15 Htra3 Muc1 
Pdgfra Rasl12 Epas1 Abi3bp Dgat2 
Scpep1 Nudt4 Rasl12 Col5a2 Cfb 
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Pamr1 Fxyd6 Dstn Gpx7 Atp1b1 
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Olfml3 Serping1 Csrp1 Vkorc1 Lbp 
Itih5 Junb Atp1b2 Man1a Anpep 
Igfbp6 Vasp Anxa11 Igfbp6 Cndp2 
Gpx3 Limd1 Rasl11a Thbd Cldn10 
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Appendix 5-4. Top 100 differentially expressed genes in the 8 clusters identified in 
the combined dataset of control and repairing endometrial mesenchyme, single cell 
sequencing. 
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